data_2kew_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kew _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 123' ' ' ARG . 4.7 mm . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.84 132.69 55.65 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.496 177.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.704 ' HD2' HG23 ' A' ' 131' ' ' THR . 16.3 mmtm -126.86 129.15 47.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.83 136.27 54.81 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.05 0.929 . . . . 0.0 110.698 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.786 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.94 148.66 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.092 178.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.786 ' N ' HG12 ' A' ' 16' ' ' ILE . 77.3 m -94.89 119.25 33.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 172.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 16' ' ' ILE . 22.7 mt -91.06 108.57 19.95 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -74.95 87.88 2.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 C-N-CA 116.647 -2.021 . . . . 0.0 106.709 176.087 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.76 167.26 14.6 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.165 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 98.1 Cg_endo -82.14 158.56 17.8 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.364 1.376 . . . . 0.0 110.198 167.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 1.036 HD12 ' HB2' ' A' ' 91' ' ' ASP . 10.8 tt -54.63 -32.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.684 0.754 . . . . 0.0 110.986 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 5.7 pt20 -68.42 -31.41 70.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.223 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 142' ' ' VAL . 82.5 mttt -81.92 -37.04 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.965 -1.085 . . . . 0.0 110.418 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.605 HG21 HG13 ' A' ' 142' ' ' VAL . 6.2 t -62.5 -34.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.612 167.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.554 ' HA ' ' HG3' ' A' ' 71' ' ' PRO . 1.2 t-105 -55.21 -43.39 74.4 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.765 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.711 ' C ' HG21 ' A' ' 31' ' ' THR . 27.4 tp10 -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.929 173.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.63 HG23 HD12 ' A' ' 138' ' ' LEU . 4.7 m -100.9 -9.34 21.67 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -171.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.903 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.0 m -131.75 -63.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.64 2.018 . . . . 0.0 114.316 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.667 ' HA ' HD11 ' A' ' 74' ' ' LEU . 32.0 p -97.38 63.31 1.79 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 109.646 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.711 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.5 t -157.56 -174.61 4.95 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.238 -164.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.9 p -62.45 175.31 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.644 1.177 . . . . 0.0 110.918 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 14.4 mt-10 -47.42 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.341 1.457 . . . . 0.0 113.594 -165.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.06 -40.79 93.99 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.975 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.903 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.5 -39.73 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 122.221 1.01 . . . . 0.0 110.727 172.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.423 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.5 pt? -73.67 100.74 3.45 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 116.932 -1.907 . . . . 0.0 108.116 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 49.2 mttm -132.33 153.0 51.17 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 111.53 -2.577 . . . . 0.0 107.434 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.774 ' HG3' HG12 ' A' ' 68' ' ' VAL . 22.7 mt-10 -123.27 130.55 52.89 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.867 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.93 40.17 71.64 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.809 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.867 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.01 172.42 6.84 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 48.2 mt-10 . . . . . 0 C--N 1.302 -1.489 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.402 161.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 34.5 m . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.87 128.75 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.867 ' HB ' HE22 ' A' ' 50' ' ' GLN . 70.6 t -82.55 130.09 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.592 HD13 ' OE2' ' A' ' 77' ' ' GLU . 5.1 mp -70.15 -50.14 43.49 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.719 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.42 15.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.765 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.774 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -138.65 135.27 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.879 0.847 . . . . 0.0 110.747 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.81 140.33 32.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.139 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.87 128.07 93.3 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -166.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.665 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -4.63 68.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 125.963 4.442 . . . . 0.0 115.012 -156.831 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' GLN . 4.6 p -139.29 -50.06 0.51 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.924 171.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.68 133.15 25.0 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.148 0.499 . . . . 0.0 109.715 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.667 HD11 ' HA ' ' A' ' 30' ' ' SER . 9.6 tt -131.84 125.77 32.63 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' HG12 ' A' ' 65' ' ' VAL . 62.4 m -137.64 123.66 20.26 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.131 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.526 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.0 p90 -152.34 158.19 42.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' HD13 ' A' ' 66' ' ' LEU . 27.2 mt-10 . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.434 -1.27 0 CA-C-O 121.441 0.638 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 90.8 m -120.5 136.92 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.55 -170.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.614 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 19.2 m-30 -112.27 131.07 55.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.453 ' CG ' HD12 ' A' ' 101' ' ' ILE . 8.3 mm100 -116.37 125.62 52.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.287 0.565 . . . . 0.0 109.601 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD23 ' HD1' ' A' ' 98' ' ' PHE . 1.5 tm? -121.53 142.77 49.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -172.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.424 ' N ' HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -110.1 119.57 39.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.036 ' HB2' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.472 -2.042 0 CA-C-O 121.896 0.855 . . . . 0.0 110.028 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.266 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.456 HG23 HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -111.92 128.44 56.15 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.502 -0.749 . . . . 0.0 109.949 -163.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.0 115.48 5.25 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 118.418 -1.849 . . . . 0.0 110.087 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.786 ' HD1' HD23 ' A' ' 89' ' ' LEU . 27.5 t80 -104.26 127.15 51.86 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.898 0.856 . . . . 0.0 111.882 -170.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.3 m -123.18 117.08 24.53 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.315 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.816 HD23 ' HE1' ' A' ' 130' ' ' TRP . 4.6 tt -107.27 138.37 43.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.238 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.621 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.6 mp -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.198 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.43 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.1 m170 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 166.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.647 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 14.1 p . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.098 0.475 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.477 ' HB2' ' CG1' ' A' ' 12' ' ' ILE . 8.9 ptt180 -66.38 -29.89 70.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.16 -28.38 70.29 Favored Glycine 0 C--O 1.24 0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.679 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.647 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.9 mtpp -61.37 -43.27 99.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.073 0.94 . . . . 0.0 108.722 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 1.009 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 10.8 mmt -76.08 -23.51 55.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.043 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.615 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 14.9 t70 -76.62 -15.5 59.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.722 -171.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.54 -58.02 0.19 Allowed Glycine 0 C--O 1.244 0.723 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.717 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.86 -16.24 76.31 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.919 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 1.009 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 6.6 t-105 -82.19 -24.12 35.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.505 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.704 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -78.83 -34.2 45.41 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.751 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -53.99 -54.98 28.24 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 118.249 -1.929 . . . . 0.0 110.057 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.56 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 53.1 mt -70.55 -54.55 17.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 100' ' ' LEU . 21.8 t -83.37 -44.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 121.36 -0.838 . . . . 0.0 112.331 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.75 ' HA ' HG21 ' A' ' 16' ' ' ILE . 40.4 t-20 -72.93 -39.94 65.84 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.736 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.741 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 2.2 tt0 -95.49 -45.82 6.93 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.687 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.046 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.7 tpp180 -83.07 -31.79 27.14 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.677 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 21.0 tp -64.54 -40.31 95.36 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 118.626 -1.229 . . . . 0.0 107.713 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.565 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.6 tmm_? -66.33 -30.23 70.59 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.046 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -68.65 -46.12 70.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HB1' HG23 ' A' ' 28' ' ' THR . . . -71.76 -28.72 63.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.792 -0.568 . . . . 0.0 110.183 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 138' ' ' LEU . 33.1 m -85.88 -21.61 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 9.6 mm-40 -148.17 -56.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.627 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 21.7 pt-20 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 124.021 0.928 . . . . 0.0 112.024 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG23 ' CB ' ' A' ' 126' ' ' MET . 1.5 tp . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.513 HG23 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -127.37 134.68 49.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.848 ' HB3' ' CZ2' ' A' ' 130' ' ' TRP . 20.8 tptt -138.73 152.03 47.63 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.665 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -124.42 141.87 51.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.079 0.943 . . . . 0.0 112.083 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.829 HD12 HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -142.02 148.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.593 171.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.695 ' N ' HG13 ' A' ' 16' ' ' ILE . 33.5 m -98.57 117.68 33.55 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 162.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.829 HD21 HD12 ' A' ' 16' ' ' ILE . 28.1 mt -93.59 109.4 21.02 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -75.35 88.26 2.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 117.158 -1.817 . . . . 0.0 106.84 177.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.753 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.45 166.16 17.1 Favored Pre-proline 0 C--O 1.217 -0.625 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.241 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 92.3 Cg_endo -78.88 157.15 27.34 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.232 1.288 . . . . 0.0 109.783 167.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.753 HD13 ' HA ' ' A' ' 91' ' ' ASP . 4.5 tp -53.24 -36.82 26.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.756 0.788 . . . . 0.0 110.673 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.61 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.3 pt20 -61.57 -32.41 72.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.2 -1.364 . . . . 0.0 114.073 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 27' ' ' GLU . 54.3 mtpt -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.721 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 HG12 ' A' ' 142' ' ' VAL . 2.7 t -66.97 -34.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.296 169.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.703 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.82 -41.91 71.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.586 172.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.686 ' C ' HG21 ' A' ' 31' ' ' THR . 6.0 tp10 -66.89 -29.97 70.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.931 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.598 ' O ' HG21 ' A' ' 28' ' ' THR . 5.2 m -101.67 -9.55 20.81 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 -170.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.882 ' HA ' HG13 ' A' ' 35' ' ' ILE . 28.3 m -130.13 -64.3 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.47 1.941 . . . . 0.0 113.916 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.659 ' HA ' HD12 ' A' ' 74' ' ' LEU . 30.8 p -97.58 65.29 1.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.852 -1.155 . . . . 0.0 109.132 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.686 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -156.77 -176.37 5.94 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.649 -166.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 35' ' ' ILE . 16.9 m -63.19 173.64 1.42 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.687 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.425 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 12.1 mt-10 -47.88 -5.31 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.905 1.682 . . . . 0.0 114.612 -164.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.52 -37.59 83.16 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.804 -1.188 . . . . 0.0 110.613 170.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.882 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.45 -37.57 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.771 0.796 . . . . 0.0 110.62 170.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.571 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.6 pt? -73.05 102.15 3.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.976 -1.89 . . . . 0.0 108.911 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -131.13 150.6 52.07 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.062 -2.335 . . . . 0.0 106.91 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.5 131.74 54.0 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.55 39.54 45.52 Favored Glycine 0 N--CA 1.463 0.476 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.831 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' A' ' 47' ' ' LYS . 2.2 pm0 -107.63 173.95 6.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 124.427 1.091 . . . . 0.0 109.579 -171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 78.7 mt-10 . . . . . 0 C--N 1.307 -1.255 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.234 158.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.847 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 31.2 t . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.17 126.84 23.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.568 HG11 ' HB ' ' A' ' 68' ' ' VAL . 40.4 t -79.9 127.26 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.178 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.5 mm? -71.06 -46.14 62.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.132 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.41 140.51 15.3 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.281 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -139.06 127.57 28.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.007 172.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -141.95 139.81 32.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.564 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.07 127.92 91.54 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 1.013 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.21 60.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 1 C-N-CA 126.869 5.046 . . . . 0.0 116.066 -162.403 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -136.86 -44.48 0.58 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.245 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG3' HE22 ' A' ' 88' ' ' GLN . 30.8 tt0 -144.19 134.4 24.33 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.558 0.694 . . . . 0.0 110.584 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -137.38 126.41 24.35 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.564 ' O ' HG12 ' A' ' 65' ' ' VAL . 73.5 m -139.43 126.25 20.8 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.191 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.847 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 21.4 p90 -152.32 155.09 36.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.594 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 47.7 mt-10 . . . . . 0 CA--C 1.5 -0.96 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.382 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 75' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.876 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 93.0 m -121.38 131.67 54.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 22.1 m-30 -111.22 124.44 52.22 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.404 HE22 ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -114.86 126.91 55.35 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 122.424 1.107 . . . . 0.0 109.668 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.013 HD21 ' HB3' ' A' ' 71' ' ' PRO . 22.6 tp -128.61 144.38 51.14 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.673 -165.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.722 ' H ' HD11 ' A' ' 89' ' ' LEU . 4.0 tp10 -110.71 130.41 55.58 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.535 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.753 ' HA ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.497 -1.087 0 O-C-N 124.203 0.939 . . . . 0.0 110.132 -170.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.584 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.83 131.59 54.92 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.454 0.645 . . . . 0.0 109.979 -158.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.76 113.35 4.62 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.861 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.844 ' HD1' HD13 ' A' ' 89' ' ' LEU . 6.5 t80 -104.89 129.94 53.14 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.848 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.8 m -122.47 116.09 23.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 1.0 ' HB3' ' HZ2' ' A' ' 130' ' ' TRP . 7.2 tt -110.62 139.23 46.08 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.285 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.8 mp -115.99 124.91 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.365 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.626 ' CD2' HD22 ' A' ' 100' ' ' LEU . 4.7 m170 . . . . . 0 C--N 1.299 -1.616 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 7.8 p . . . . . 0 N--CA 1.443 -0.817 0 CA-C-O 120.874 0.369 . . . . 0.0 111.574 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.474 ' HB2' HD12 ' A' ' 12' ' ' ILE . 28.0 ptt180 -68.1 -28.29 67.21 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -65.43 -32.0 82.1 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 39.1 mmtm -62.48 -38.04 88.28 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.729 0.776 . . . . 0.0 109.237 172.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 102' ' ' HIS . 19.9 mtt -82.01 -7.73 59.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.541 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.497 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 31.0 t70 -92.57 -15.3 27.11 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.042 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -133.47 -53.96 0.08 OUTLIER Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.734 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.35 -18.76 73.69 Favored Glycine 0 CA--C 1.499 -0.957 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 1.0 ' HZ2' ' HB3' ' A' ' 100' ' ' LEU . 21.1 t90 -55.6 -63.86 1.03 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.678 -1.261 . . . . 0.0 110.913 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.9 p -63.8 -28.31 69.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.009 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -55.95 -59.28 10.89 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 118.494 -1.812 . . . . 0.0 110.289 168.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 1.7 mp -72.41 -54.46 16.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.806 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.8 t -81.16 -44.2 20.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 O-C-N 121.561 -0.712 . . . . 0.0 112.017 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.551 ' HA ' HD13 ' A' ' 16' ' ' ILE . 44.1 t30 -79.12 -38.11 36.94 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 117.92 -1.512 . . . . 0.0 108.735 -171.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.931 ' HG2' ' HE2' ' A' ' 140' ' ' LYS . 15.4 tt0 -94.82 -45.53 7.27 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 118.385 -1.326 . . . . 0.0 110.785 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.047 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.4 tpp180 -83.43 -33.0 25.8 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.806 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 34.5 tp -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.059 -1.456 . . . . 0.0 107.098 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.519 ' HA ' HG23 ' A' ' 142' ' ' VAL . 4.4 tmm_? -65.8 -30.76 71.44 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.09 -47.51 68.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.187 0.517 . . . . 0.0 112.366 176.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -70.1 -27.44 64.6 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.782 -0.574 . . . . 0.0 109.771 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 138' ' ' LEU . 28.9 m -94.12 -12.78 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -153.24 -56.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.58 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 18.3 pt-20 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 124.496 1.118 . . . . 0.0 113.338 -169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' CB ' ' A' ' 126' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -113.38 134.05 54.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.844 174.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.785 ' HD3' HG22 ' A' ' 131' ' ' THR . 7.8 mmpt? -122.01 130.9 53.68 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.25 54.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.129 0.966 . . . . 0.0 111.437 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.847 HD12 ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -153.49 149.06 13.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.687 178.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.838 ' N ' HG12 ' A' ' 16' ' ' ILE . 28.1 m -95.06 121.1 36.33 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.652 HD22 ' CD1' ' A' ' 16' ' ' ILE . 96.1 mt -91.65 108.34 19.84 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.613 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 1.3 mt-10 -77.58 87.15 3.89 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 116.62 -2.032 . . . . 0.0 106.768 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.774 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -158.47 169.03 11.25 Favored Pre-proline 0 C--O 1.214 -0.811 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.639 -176.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 95.7 Cg_endo -83.62 152.61 13.38 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.749 0.966 . . . . 0.0 109.9 163.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.76 HG23 ' OD2' ' A' ' 91' ' ' ASP . 7.3 tt -55.02 -32.1 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.829 0.823 . . . . 0.0 111.289 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.655 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 4.6 pt20 -66.56 -30.48 70.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.953 -1.476 . . . . 0.0 113.407 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 58.1 tptt -81.69 -35.99 29.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 122.066 0.936 . . . . 0.0 110.011 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 89' ' ' LEU . 2.7 t -66.04 -33.64 64.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.641 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.598 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.195 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.769 ' C ' HG23 ' A' ' 31' ' ' THR . 23.4 tt0 -66.64 -28.28 68.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.106 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 28' ' ' THR . 5.4 m -100.21 -9.35 22.54 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.888 ' HA ' HG13 ' A' ' 35' ' ' ILE . 32.9 m -131.08 -63.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.334 1.879 . . . . 0.0 113.415 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.637 ' HA ' HD11 ' A' ' 74' ' ' LEU . 27.7 p -96.74 65.54 2.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.56 -1.338 . . . . 0.0 108.663 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.769 HG23 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.97 -174.7 4.96 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.729 -165.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.499 ' O ' HG21 ' A' ' 35' ' ' ILE . 1.3 p -60.68 171.78 1.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.022 0.929 . . . . 0.0 110.315 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 4.1 mt-10 -47.76 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.571 1.549 . . . . 0.0 113.698 -162.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.02 -36.41 81.14 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.256 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.888 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.79 -44.22 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 121.718 0.77 . . . . 0.0 111.639 173.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.773 -178.65 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -71.72 103.55 3.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.754 1.74 . . . . 0.0 109.369 -172.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HB3' ' CB ' ' A' ' 50' ' ' GLN . 6.5 mmtp -131.62 154.71 48.62 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 111.625 -2.534 . . . . 0.0 107.514 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' CD ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -120.42 134.15 55.32 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.375 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.98 38.95 61.57 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.441 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -109.94 151.52 26.99 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.361 -168.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 160.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 120.494 0.188 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.6 pttt -143.27 141.62 31.1 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.615 HG13 ' HB ' ' A' ' 68' ' ' VAL . 95.9 t -83.54 132.16 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.316 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.799 HD21 ' OE1' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -82.84 -39.79 21.2 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.378 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . . . -157.85 140.76 14.95 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.17 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -140.21 132.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.16 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -141.68 138.65 32.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.942 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.77 123.02 82.24 Favored Pre-proline 0 CA--C 1.503 -0.847 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -168.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.988 ' HB3' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 0.02 62.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.602 1 C-N-CA 126.322 4.681 . . . . 0.0 115.732 -159.845 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 p -133.21 -41.99 0.88 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.727 167.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -144.78 133.27 21.98 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -129.48 128.65 43.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 169.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.866 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 49.1 m -138.06 121.93 17.69 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.247 168.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' HD1' HD23 ' A' ' 74' ' ' LEU . 2.3 p90 -154.35 151.1 28.66 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.712 0.768 . . . . 0.0 111.378 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.799 ' OE1' HD21 ' A' ' 66' ' ' LEU . 25.6 mp0 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.904 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.866 ' O ' ' HA ' ' A' ' 75' ' ' SER . 53.3 t . . . . . 0 N--CA 1.424 -1.761 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.733 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 14.4 m -121.52 135.78 55.0 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 122.102 2.228 . . . . 0.0 115.441 -158.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.694 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.5 m-30 -110.07 131.93 54.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.26 128.09 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.864 0.84 . . . . 0.0 110.631 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.988 HD11 ' HB3' ' A' ' 71' ' ' PRO . 2.5 tt -121.28 143.29 49.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.636 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.479 ' N ' HD23 ' A' ' 89' ' ' LEU . 5.2 tp10 -110.53 130.83 55.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.788 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 22' ' ' ILE . 8.5 t70 . . . . . 0 CA--C 1.487 -1.448 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.968 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.774 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.619 HG23 HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -106.71 131.34 53.94 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.274 -0.891 . . . . 0.0 111.041 -154.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.69 113.58 4.75 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.125 -1.512 . . . . 0.0 109.887 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.539 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 17.7 t80 -105.35 128.96 53.76 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.434 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 m -122.07 114.7 21.28 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD21 ' NE1' ' A' ' 130' ' ' TRP . 6.0 tt -105.55 136.21 45.55 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 118.589 -1.245 . . . . 0.0 110.777 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.675 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.5 mp -110.29 121.32 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.799 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.512 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.618 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.645 0.26 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.546 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 48.0 ttt180 -63.66 -33.12 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.414 0.626 . . . . 0.0 109.415 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.14 -30.81 67.05 Favored Glycine 0 C--O 1.24 0.487 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.266 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 50.6 mttm -62.84 -34.88 78.26 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.409 0.623 . . . . 0.0 109.42 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.91 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 13.9 mtt -75.17 -27.38 59.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.939 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.512 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 7.2 t70 -75.97 -14.79 60.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.788 -169.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.52 -57.37 0.2 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.897 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -70.95 -19.63 77.17 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.77 -171.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.91 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -74.43 -33.39 62.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.264 0.532 . . . . 0.0 111.351 -171.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.785 HG22 ' HD3' ' A' ' 14' ' ' LYS . 1.4 p -74.65 -33.99 62.63 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.274 171.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.76 -52.1 26.46 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.752 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 mm -85.54 -48.01 16.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.302 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.715 HG21 HD13 ' A' ' 100' ' ' LEU . 25.6 t -78.81 -42.52 24.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 O-C-N 120.689 -1.257 . . . . 0.0 111.488 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.612 ' HA ' HG22 ' A' ' 16' ' ' ILE . 43.0 t-20 -76.56 -39.55 52.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.933 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.859 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 4.0 tt0 -93.61 -46.97 7.03 Favored 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.947 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.9 tpp180 -81.6 -33.23 31.64 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.2 tp -65.01 -40.61 95.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 120.579 1.536 . . . . 0.0 107.401 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.847 ' HB2' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.87 -36.77 82.23 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 169.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.859 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 15.6 mtmt -69.09 -43.8 73.8 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 28' ' ' THR . . . -71.04 -28.33 64.3 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.894 -0.504 . . . . 0.0 110.491 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.6 HG13 HG21 ' A' ' 25' ' ' VAL . 30.0 m -93.44 -17.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -149.1 -58.61 0.21 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.497 -174.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.615 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 11.3 pt-20 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.537 1.135 . . . . 0.0 112.972 -161.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 123' ' ' ARG . 86.8 mt . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.66 132.29 53.42 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HZ2' ' HA ' ' A' ' 127' ' ' ASP . 26.9 tptt -128.88 133.64 47.99 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -122.51 136.96 55.01 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.241 1.019 . . . . 0.0 112.203 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.751 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.57 148.47 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.665 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.751 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.9 m -96.95 120.58 37.57 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.405 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' HB3' HG22 ' A' ' 142' ' ' VAL . 22.4 mt -91.03 108.31 19.78 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.791 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -74.51 89.09 2.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 116.64 -2.024 . . . . 0.0 106.852 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.56 169.46 10.32 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.34 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 93.1 Cg_endo -82.83 158.83 16.04 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.088 1.858 . . . . 0.0 110.388 164.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.908 HD12 ' HB2' ' A' ' 91' ' ' ASP . 3.5 tp -56.08 -36.34 44.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.573 0.701 . . . . 0.0 110.456 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.515 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.2 pt20 -61.5 -32.85 72.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.064 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.873 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.6 tmtp? -82.12 -36.48 27.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.83 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 142' ' ' VAL . 3.1 t -67.28 -33.53 63.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.701 171.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.651 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.75 -42.49 71.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.541 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.688 ' C ' HG23 ' A' ' 31' ' ' THR . 10.3 tp10 -67.23 -29.42 69.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.889 173.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 4.0 m -101.34 -8.85 21.7 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.9 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.3 m -131.23 -64.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 121.796 2.089 . . . . 0.0 113.784 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.651 ' HA ' HD12 ' A' ' 74' ' ' LEU . 33.8 p -97.11 65.41 2.03 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.981 -1.074 . . . . 0.0 109.156 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.688 HG23 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -155.62 -177.75 6.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.047 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.0 m -63.67 171.23 2.77 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.166 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -49.2 -3.34 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.265 1.826 . . . . 0.0 114.836 -161.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.21 -35.28 69.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.608 169.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.9 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -68.34 -36.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.766 0.793 . . . . 0.0 111.302 170.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.747 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 31' ' ' THR . 15.2 mt-30 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 68' ' ' VAL . 2.5 pt? -73.09 102.91 3.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 117.826 -1.55 . . . . 0.0 109.003 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 70.2 mttt -133.09 152.54 51.95 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.514 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.706 ' HG3' HG13 ' A' ' 68' ' ' VAL . 25.5 mt-10 -124.66 131.77 53.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 119.107 0.867 . . . . 0.0 112.897 174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.62 34.54 60.57 Favored Glycine 0 C--N 1.328 0.128 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.224 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.891 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.93 173.27 6.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.442 1.097 . . . . 0.0 108.59 -173.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.708 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 7.7 mp0 . . . . . 0 C--N 1.306 -1.301 0 C-N-CA 118.566 -1.253 . . . . 0.0 109.111 157.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 8.8 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HZ1' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -141.31 132.41 26.29 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -173.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.891 ' HB ' HE22 ' A' ' 50' ' ' GLN . 55.9 t -82.89 125.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.703 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.628 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -61.45 -54.67 40.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.765 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.19 145.3 16.49 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.527 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.706 HG13 ' HG3' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -134.89 129.35 51.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.106 0.955 . . . . 0.0 110.453 173.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -134.55 139.36 45.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.789 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.48 122.87 78.7 Favored Pre-proline 0 CA--C 1.506 -0.749 0 O-C-N 123.711 0.632 . . . . 0.0 109.428 -165.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 1.06 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.6 60.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.196 1 C-N-CA 126.78 4.987 . . . . 0.0 115.684 -158.525 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -132.71 -45.41 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.53 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.59 132.85 23.17 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.369 0.604 . . . . 0.0 109.932 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.7 tt -129.78 125.63 36.25 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.718 ' HG ' HG21 ' A' ' 86' ' ' THR . 49.6 m -138.38 124.9 20.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.009 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.573 ' CB ' HG23 ' A' ' 65' ' ' VAL . 12.2 p90 -152.31 157.53 41.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 43.0 mt-10 . . . . . 0 C--N 1.313 -0.994 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.431 -1.403 0 CA-C-O 121.525 0.678 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.73 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 90.4 m -121.1 133.17 55.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.794 -168.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.639 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.6 m-30 -112.9 132.8 55.16 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.551 -0.718 . . . . 0.0 109.835 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -122.29 125.9 46.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.761 0.791 . . . . 0.0 110.43 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.06 HD21 ' HB3' ' A' ' 71' ' ' PRO . 63.1 tp -124.78 144.64 50.15 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.672 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -110.53 123.4 49.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.66 0.384 . . . . 0.0 110.453 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.908 ' HB2' HD12 ' A' ' 22' ' ' ILE . 8.5 t70 . . . . . 0 CA--C 1.505 -0.77 0 CA-C-O 121.234 0.54 . . . . 0.0 110.882 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.495 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -106.44 126.05 51.76 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 119.777 1.171 . . . . 0.0 109.005 -164.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.68 117.43 5.65 Favored Glycine 0 CA--C 1.491 -1.455 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.503 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.67 ' HE2' HD12 ' A' ' 100' ' ' LEU . 13.8 t80 -103.66 126.74 50.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.803 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.4 m -122.34 115.36 22.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.039 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.67 HD12 ' HE2' ' A' ' 98' ' ' PHE . 6.2 tt -107.51 137.31 45.77 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.104 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.73 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -120.05 125.96 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.727 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' HD21 ' A' ' 100' ' ' LEU . 1.9 m170 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.612 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 8.6 p . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 12' ' ' ILE . 15.0 ttp85 -63.16 -31.14 72.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -73.94 -34.37 55.95 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.013 175.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.612 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 30.7 mmmt -60.6 -42.32 96.55 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.011 0.91 . . . . 0.0 109.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.661 ' HA ' ' HE1' ' A' ' 126' ' ' MET . 3.7 mmt -81.63 -24.61 36.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.911 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 14' ' ' LYS . 19.4 t70 -76.7 -14.98 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.763 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -129.12 -51.97 0.11 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.894 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.92 -32.02 82.54 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.774 -0.713 . . . . 0.0 113.148 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.711 ' HA ' ' CE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -62.65 -55.72 24.35 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 118.138 0.969 . . . . 0.0 110.513 -175.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.692 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.3 p -62.47 -28.95 70.17 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.513 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.2 -63.56 5.06 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 118.828 -1.653 . . . . 0.0 111.173 169.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.541 HG13 ' HE3' ' A' ' 130' ' ' TRP . 1.1 pt -77.16 -49.56 22.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.775 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.0 p -79.45 -43.4 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 112.436 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.739 HD21 ' HB ' ' A' ' 16' ' ' ILE . 10.7 t-20 -74.84 -40.83 60.8 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.993 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.748 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 3.6 tp10 -95.82 -46.16 6.68 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.857 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.054 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 13.8 tpp180 -82.75 -32.02 28.06 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.775 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 49.0 tp -64.38 -40.49 95.92 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.637 ' HB2' HD13 ' A' ' 16' ' ' ILE . 3.7 tmm_? -65.59 -29.95 70.62 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.175 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.054 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -71.37 -46.59 60.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 177.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 28' ' ' THR . . . -67.56 -28.84 68.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.194 0.521 . . . . 0.0 109.668 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.873 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 24.1 m -94.05 -15.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.64 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -149.7 -58.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.278 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.727 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 9.9 tt0 . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 124.563 1.145 . . . . 0.0 112.925 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.652 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.93 134.33 55.28 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.875 ' HD3' HG23 ' A' ' 131' ' ' THR . 8.9 mmpt? -123.49 131.5 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.2 133.74 54.72 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.396 1.093 . . . . 0.0 111.566 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.741 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.8 148.19 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.814 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.741 ' N ' HG12 ' A' ' 16' ' ' ILE . 15.6 m -97.25 120.01 36.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.571 HD21 ' CD1' ' A' ' 16' ' ' ILE . 23.3 mt -90.02 107.65 19.25 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.892 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -76.83 87.28 3.42 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 116.641 -2.024 . . . . 0.0 107.044 177.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.769 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.65 165.39 18.52 Favored Pre-proline 0 C--O 1.213 -0.839 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.937 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 80.4 Cg_endo -75.7 157.71 39.75 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 120.752 0.968 . . . . 0.0 110.193 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 91' ' ' ASP . 2.5 tt -52.67 -35.75 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.842 0.83 . . . . 0.0 111.108 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.547 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 2.1 pt20 -68.63 -29.66 68.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.355 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -75.6 -40.58 56.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.042 0.925 . . . . 0.0 109.421 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.658 HG22 HG11 ' A' ' 142' ' ' VAL . 8.5 t -66.45 -35.43 74.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.133 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.536 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 1.9 t90 -55.72 -43.75 76.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.96 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.713 ' C ' HG22 ' A' ' 31' ' ' THR . 37.7 tt0 -67.98 -28.75 67.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.889 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.589 ' O ' HG21 ' A' ' 28' ' ' THR . 7.0 m -101.55 -9.02 21.37 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.903 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -131.07 -65.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 121.174 1.807 . . . . 0.0 113.811 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.656 ' HA ' HD13 ' A' ' 74' ' ' LEU . 21.9 p -97.49 68.34 2.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.505 -1.372 . . . . 0.0 109.057 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.713 HG22 ' C ' ' A' ' 27' ' ' GLU . 2.2 t -156.32 -177.44 6.59 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.154 -169.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.748 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 17.4 m -62.25 170.52 2.26 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.293 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.75 -8.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 126.092 1.757 . . . . 0.0 114.435 -156.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.78 -33.91 75.18 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.08 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.903 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.81 -44.53 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 121.679 0.752 . . . . 0.0 112.398 173.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 121.54 0.686 . . . . 0.0 110.03 178.674 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.748 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 20.2 mt-30 . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 31' ' ' THR . 2.5 pt? -72.29 101.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 123.388 1.566 . . . . 0.0 109.834 -172.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HB3' ' CG ' ' A' ' 50' ' ' GLN . 4.4 mptp? -132.08 153.79 50.1 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 112.233 -2.258 . . . . 0.0 107.193 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.726 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.3 mt-10 -122.48 134.96 54.56 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 119.265 0.938 . . . . 0.0 112.345 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.06 35.99 42.49 Favored Glycine 0 N--CA 1.462 0.405 0 O-C-N 124.057 0.848 . . . . 0.0 112.121 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.89 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.1 173.32 6.37 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.188 -1.006 . . . . 0.0 108.502 -171.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 17.5 mp0 . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.431 156.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 31.9 m . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -148.28 129.28 14.44 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.89 ' HB ' HE22 ' A' ' 50' ' ' GLN . 59.2 t -83.21 131.32 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.052 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.59 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -66.78 -54.54 21.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.626 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.04 146.14 17.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.294 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.726 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -138.17 136.16 44.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.934 176.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 20.9 mt-30 -141.28 137.4 32.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.329 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 134.24 94.0 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.754 ' C ' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -4.55 64.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.306 1 C-N-CA 125.872 4.381 . . . . 0.0 115.665 -157.782 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.481 ' N ' ' HB2' ' A' ' 89' ' ' LEU . 6.5 p -137.83 -49.56 0.58 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.561 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -147.97 144.19 27.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 110.271 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 8.7 tt -142.84 125.34 15.73 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.639 ' O ' HG13 ' A' ' 65' ' ' VAL . 74.2 m -136.92 124.12 21.78 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.544 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.542 ' CB ' HG21 ' A' ' 65' ' ' VAL . 9.2 p90 -152.7 156.41 39.11 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.59 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 51.8 mt-10 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 121.493 0.663 . . . . 0.0 109.645 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 102' ' ' HIS . 16.3 m . . . . . 0 N--CA 1.427 -1.611 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 85.6 m -120.85 138.28 54.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.325 -169.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.667 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 18.9 m-30 -111.61 130.87 55.61 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -116.49 125.57 52.13 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.929 1.347 . . . . 0.0 109.778 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.754 ' HB2' ' C ' ' A' ' 71' ' ' PRO . 1.8 mt -122.21 139.43 53.78 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.813 -158.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' HG22 ' A' ' 96' ' ' THR . 3.6 tp10 -115.5 132.2 56.7 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 122.189 -0.32 . . . . 0.0 111.083 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.828 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.066 0 O-C-N 124.317 1.011 . . . . 0.0 109.819 -173.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.35 136.35 49.66 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.645 0.736 . . . . 0.0 110.962 -157.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.65 115.26 5.17 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 118.9 -1.619 . . . . 0.0 110.06 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.708 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 12.7 t80 -108.21 125.95 52.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.643 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -123.78 116.19 22.6 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.595 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.9 HD23 ' HE1' ' A' ' 130' ' ' TRP . 4.2 tt -108.1 140.49 41.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.742 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -119.67 124.27 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.881 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 168.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.666 HG22 ' HE2' ' A' ' 126' ' ' MET . 13.0 p . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.587 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.5 ptt180 -68.52 -28.41 66.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -69.97 -29.29 70.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 122' ' ' VAL . 13.1 mmmm -61.87 -38.9 89.99 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.264 1.03 . . . . 0.0 108.634 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.926 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 20.7 mtt -75.9 -28.08 57.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.386 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.591 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 20.0 t70 -78.01 -15.54 58.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.876 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.05 -54.44 0.21 Allowed Glycine 0 C--O 1.244 0.772 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.789 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.82 -17.14 80.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.302 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.926 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 43.7 t-105 -89.0 -14.19 37.08 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.706 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.875 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.2 p -82.47 -32.81 28.7 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.562 164.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.69 -53.9 36.33 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 118.24 -1.934 . . . . 0.0 109.417 168.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.9 mt -69.45 -55.76 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.982 -0.609 . . . . 0.0 112.588 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.724 HG23 HD13 ' A' ' 100' ' ' LEU . 38.6 t -84.12 -44.94 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.362 -0.836 . . . . 0.0 112.291 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.685 ' HA ' HG23 ' A' ' 16' ' ' ILE . 36.6 t-20 -72.55 -40.01 67.03 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.559 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.785 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.5 tt0 -97.26 -45.56 6.45 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.66 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.758 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 17.2 tpp180 -82.5 -31.7 29.15 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.696 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.8 tp -64.06 -40.12 95.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 120.08 1.309 . . . . 0.0 108.274 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 2.9 tmt_? -62.75 -32.18 73.27 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.785 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 50.8 mtmt -74.72 -43.37 55.4 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 28' ' ' THR . . . -67.13 -28.79 68.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.778 -0.576 . . . . 0.0 110.229 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.658 HG11 HG22 ' A' ' 25' ' ' VAL . 32.9 m -87.32 -21.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 63.2 mm-40 -143.7 -63.57 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.131 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.712 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 35.5 tt0 . . . . . 0 N--CA 1.476 0.869 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.066 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.733 HG12 ' HG2' ' A' ' 123' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.438 -1.04 0 CA-C-O 121.172 0.511 . . . . 0.0 109.788 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -122.8 133.68 54.44 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.601 173.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -126.08 128.15 46.92 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 p -125.62 137.61 53.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.68 1.229 . . . . 0.0 112.711 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.9 149.54 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 112.687 -2.051 . . . . 0.0 108.123 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.806 ' N ' HG12 ' A' ' 16' ' ' ILE . 59.2 m -93.51 119.15 32.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.593 HD22 ' CD1' ' A' ' 16' ' ' ILE . 16.4 mt -89.73 107.68 19.24 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 2.2 pt-20 -73.95 87.94 1.84 Allowed 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 117.145 -1.822 . . . . 0.0 106.128 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -152.3 168.89 10.43 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.284 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -80.01 150.73 20.8 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.166 1.244 . . . . 0.0 109.455 164.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.753 HD12 ' HB3' ' A' ' 91' ' ' ASP . 14.1 tt -55.41 -32.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.737 0.78 . . . . 0.0 110.947 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.614 ' HG3' ' HB2' ' A' ' 21' ' ' PRO . 1.1 pp0? -68.88 -29.41 67.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.897 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 4.6 tppp? -79.47 -38.15 35.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.764 HG23 HG11 ' A' ' 142' ' ' VAL . 9.4 t -64.82 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.58 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.625 ' CZ2' ' HB3' ' A' ' 70' ' ' ALA . 1.2 t-105 -54.7 -41.52 70.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.465 173.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.776 ' C ' HG22 ' A' ' 31' ' ' THR . 33.3 mm-40 -68.58 -28.29 66.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.29 170.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.603 HG23 HD13 ' A' ' 138' ' ' LEU . 3.6 m -99.95 -10.2 21.92 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.904 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.0 m -131.66 -64.19 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 121.324 1.875 . . . . 0.0 113.696 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.676 ' HA ' HD12 ' A' ' 74' ' ' LEU . 24.0 p -98.1 66.85 1.85 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.776 HG22 ' C ' ' A' ' 27' ' ' GLU . 2.5 t -157.22 -177.36 6.55 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.6 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' ILE . 30.7 m -62.08 172.33 1.44 Allowed 'General case' 0 C--N 1.311 -1.079 0 O-C-N 124.025 0.828 . . . . 0.0 109.62 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 7.0 mt-10 -48.0 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.983 1.713 . . . . 0.0 114.769 -163.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.34 -34.81 68.87 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.823 169.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.904 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.24 -36.26 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 121.978 0.894 . . . . 0.0 111.124 170.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.908 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.41 101.92 3.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 117.29 -1.764 . . . . 0.0 109.774 -171.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 69.6 mttt -133.36 152.88 51.95 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-N 112.048 -2.342 . . . . 0.0 107.725 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.729 ' HG3' HG13 ' A' ' 68' ' ' VAL . 24.7 mt-10 -123.48 129.35 51.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 118.937 0.789 . . . . 0.0 112.167 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.22 64.0 Favored Glycine 0 N--CA 1.461 0.349 0 CA-C-O 122.081 0.823 . . . . 0.0 111.856 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.837 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.58 172.7 6.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.38 -1.41 . . . . 0.0 107.989 -177.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 31.8 mt-10 . . . . . 0 C--N 1.301 -1.522 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.89 159.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 59.9 m . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.787 ' HZ3' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -143.46 131.02 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.837 ' HB ' HE22 ' A' ' 50' ' ' GLN . 53.0 t -80.92 127.56 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.524 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.545 HD23 ' HG3' ' A' ' 77' ' ' GLU . 4.2 mm? -66.89 -50.73 61.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 174.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.41 142.79 15.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.667 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.729 HG13 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -136.21 132.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.553 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -137.84 138.13 38.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.743 -173.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.15 124.42 86.8 Favored Pre-proline 0 CA--C 1.507 -0.694 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.527 -167.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.607 ' C ' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.61 64.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.574 1 C-N-CA 126.085 4.523 . . . . 0.0 115.267 -158.279 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 13.4 p -133.13 -46.78 0.84 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.862 166.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -146.73 141.98 27.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.428 0.632 . . . . 0.0 110.983 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.5 tt -138.92 124.9 19.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.579 ' O ' HG11 ' A' ' 65' ' ' VAL . 69.4 m -137.44 125.36 22.68 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.41 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.546 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 11.4 p90 -151.77 157.27 41.75 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.545 ' HG3' HD23 ' A' ' 66' ' ' LEU . 32.7 mt-10 . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.957 0.884 . . . . 0.0 108.932 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.203 0.525 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 63.8 m -126.18 132.56 51.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.077 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.625 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 19.9 m-85 -111.8 131.28 55.44 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.178 0.989 . . . . 0.0 110.851 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 96' ' ' THR . 1.8 tm? -119.91 140.34 51.03 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.704 -171.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' N ' HD11 ' A' ' 89' ' ' LEU . 6.1 tp10 -119.17 139.49 51.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.798 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.753 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.5 p-10 . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt . . . . . 0 N--CA 1.431 -1.415 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.743 HG23 HD13 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.29 125.56 52.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.987 169.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.72 115.79 5.31 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.713 ' HD1' HD21 ' A' ' 89' ' ' LEU . 14.1 t80 -102.6 127.74 49.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.569 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.1 m -123.32 114.84 20.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 1.005 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.9 tt -106.98 136.31 47.05 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.329 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.6 mp -119.05 124.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.018 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.436 ' CD2' HD23 ' A' ' 100' ' ' LEU . 2.0 m170 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.716 HG21 ' HD2' ' A' ' 125' ' ' LYS . 8.3 p . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.702 0.763 . . . . 0.0 109.043 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.733 ' HG2' HG12 ' A' ' 12' ' ' ILE . 1.7 tmt_? -62.6 -33.85 75.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.481 172.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -72.52 -29.82 65.28 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.203 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.716 ' HD2' HG21 ' A' ' 122' ' ' VAL . 57.7 mttm -60.69 -42.83 97.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.285 1.04 . . . . 0.0 109.083 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.728 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 5.9 mmt -78.99 -20.91 47.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.595 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.8 t70 -76.47 -15.42 59.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.311 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.0 -52.35 0.13 Allowed Glycine 0 C--O 1.249 1.06 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.555 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.6 -21.65 72.87 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.79 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 1.005 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -73.5 -30.72 63.31 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.79 -171.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.2 p -74.17 -39.17 63.39 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.158 171.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -52.5 -53.06 33.89 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 118.218 -1.944 . . . . 0.0 110.492 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.663 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 82.4 mt -73.18 -55.2 13.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.733 HG22 HD11 ' A' ' 100' ' ' LEU . 17.5 t -84.39 -43.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 121.637 -0.664 . . . . 0.0 112.141 -177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.853 ' HA ' HG23 ' A' ' 16' ' ' ILE . 6.3 t30 -70.35 -40.02 74.32 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.321 -0.952 . . . . 0.0 108.574 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.845 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 3.5 tt0 -96.24 -45.45 6.83 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.917 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.699 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 tpp180 -82.01 -33.43 30.08 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.655 ' O ' HG21 ' A' ' 142' ' ' VAL . 18.5 tp -64.47 -40.15 95.15 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.465 -1.294 . . . . 0.0 107.945 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.5 tmm_? -65.36 -29.74 70.5 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.845 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 54.3 mtmt -72.59 -45.18 60.39 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 28' ' ' THR . . . -69.24 -29.87 67.89 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.764 HG11 HG23 ' A' ' 25' ' ' VAL . 23.3 m -86.63 -18.39 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 10.5 mm-40 -152.25 -51.58 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.632 ' N ' ' HA ' ' A' ' 140' ' ' LYS . 12.3 pt-20 . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.91 0.862 . . . . 0.0 110.873 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 126' ' ' MET . 2.1 mm . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -120.04 131.36 55.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.922 ' HD2' HG22 ' A' ' 131' ' ' THR . 30.4 mmtm -127.52 128.97 46.56 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.591 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.44 135.58 54.71 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.398 1.094 . . . . 0.0 111.382 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.13 148.07 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 112.764 -2.017 . . . . 0.0 108.717 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.728 ' N ' HG12 ' A' ' 16' ' ' ILE . 2.0 m -96.17 119.35 34.51 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.091 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 16' ' ' ILE . 25.1 mt -91.79 108.53 19.98 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.892 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -75.09 89.24 2.45 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.379 -2.128 . . . . 0.0 106.177 175.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.39 168.25 12.54 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.439 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.2 Cg_endo -82.74 157.97 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.334 1.356 . . . . 0.0 110.289 165.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 1.04 HD12 ' HB2' ' A' ' 91' ' ' ASP . 13.5 tt -57.46 -32.49 41.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 121.967 0.889 . . . . 0.0 110.638 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -68.28 -30.96 70.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -177.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 59.6 tptt -82.34 -39.06 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.232 -0.917 . . . . 0.0 109.92 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.651 HG21 HG12 ' A' ' 142' ' ' VAL . 2.9 t -61.74 -34.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.245 166.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.609 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -55.1 -42.26 72.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.372 0.669 . . . . 0.0 109.755 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.712 ' C ' HG23 ' A' ' 31' ' ' THR . 34.1 tt0 -66.32 -28.37 68.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.463 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 28' ' ' THR . 4.7 m -100.84 -10.01 21.12 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.81 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.6 m -131.01 -64.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 121.56 1.982 . . . . 0.0 113.981 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.654 ' HA ' HD11 ' A' ' 74' ' ' LEU . 35.1 p -97.31 65.61 1.99 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.869 -1.144 . . . . 0.0 108.847 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.712 HG23 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -156.15 -177.54 6.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.641 -167.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' GLY . 23.8 m -62.99 169.92 3.03 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.665 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 3.2 mt-10 -48.51 -2.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.024 1.73 . . . . 0.0 114.612 -163.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -56.93 -31.88 61.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.987 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.81 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.45 -36.16 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.547 0.689 . . . . 0.0 111.692 170.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.311 -1.083 0 O-C-N 122.008 -0.432 . . . . 0.0 111.339 167.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.01 102.19 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 116.771 -1.972 . . . . 0.0 108.763 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.499 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 50.3 mttm -130.09 150.8 51.19 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 112.036 -2.347 . . . . 0.0 106.683 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CG ' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.79 129.65 50.86 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.536 -0.866 . . . . 0.0 113.06 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.73 37.43 68.8 Favored Glycine 0 N--CA 1.463 0.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.13 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.582 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -109.35 173.52 6.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.948 0.899 . . . . 0.0 109.734 -171.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 . . . . . 0 C--N 1.303 -1.425 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.51 156.507 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.741 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 41.6 t . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.582 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 21.6 pttp -135.93 133.88 38.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG11 ' HB ' ' A' ' 68' ' ' VAL . 71.0 t -84.16 127.38 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.908 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.783 HD11 ' OE1' ' A' ' 77' ' ' GLU . 0.9 OUTLIER -77.64 -39.28 45.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.286 179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.81 138.72 13.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.196 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.685 ' HB ' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -139.52 126.68 24.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.208 1.004 . . . . 0.0 110.91 174.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -137.01 139.05 41.14 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.621 -173.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.0 127.65 92.05 Favored Pre-proline 0 CA--C 1.504 -0.791 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -167.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.68 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -5.07 65.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 1 C-N-CA 126.263 4.642 . . . . 0.0 115.392 -157.861 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.8 p -135.53 -48.48 0.7 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.156 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.51 131.94 20.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 109.893 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.734 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.2 tt -131.84 124.67 30.06 Favored 'General case' 0 C--O 1.202 -1.4 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.489 ' O ' HG12 ' A' ' 65' ' ' VAL . 67.6 m -137.92 123.49 19.71 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.269 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 11.5 p90 -154.01 153.9 32.77 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.754 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.783 ' OE1' HD11 ' A' ' 66' ' ' LEU . 3.5 mp0 . . . . . 0 N--CA 1.436 -1.136 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.61 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 121.544 0.688 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.786 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 95.7 m -120.15 136.9 54.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.832 -168.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.67 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 18.6 m-85 -115.08 131.61 56.87 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -122.06 128.85 51.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.82 0.819 . . . . 0.0 110.708 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.68 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 0.9 OUTLIER -121.71 145.07 48.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.976 -171.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 1.6 tt0 -109.68 120.53 42.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 1.04 ' HB2' HD12 ' A' ' 22' ' ' ILE . 2.9 t70 . . . . . 0 CA--C 1.497 -1.078 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -110.86 128.57 55.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.553 0.692 . . . . 0.0 110.274 -161.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.34 116.65 5.43 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 119.112 -1.518 . . . . 0.0 110.264 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.704 ' HE2' HD13 ' A' ' 100' ' ' LEU . 22.2 t80 -103.78 126.66 51.06 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.943 -170.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 m -123.04 115.39 21.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.443 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.788 ' CD2' ' HE1' ' A' ' 130' ' ' TRP . 4.8 tt -107.89 140.77 40.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.691 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.786 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.7 mp -120.41 125.82 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.975 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.47 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.3 m170 . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.59 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.2 p . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -65.1 -30.24 71.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.05 -30.73 67.35 Favored Glycine 0 C--O 1.238 0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.963 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.59 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.3 mtpp -59.78 -42.51 93.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.24 1.019 . . . . 0.0 108.796 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 1.018 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 9.8 mmt -78.22 -25.54 47.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.685 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.463 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 22.9 t0 -78.02 -13.75 59.76 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.873 -168.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.84 -53.78 0.16 Allowed Glycine 0 C--O 1.251 1.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.628 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.636 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -68.83 -27.3 73.99 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.457 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 10.7 t-105 -73.07 -30.45 63.7 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.182 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -70.32 -39.52 74.74 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.925 172.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.73 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -50.2 -50.41 34.3 Favored Glycine 0 C--N 1.308 -0.98 0 C-N-CA 118.236 -1.935 . . . . 0.0 110.933 168.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 129' ' ' GLY . 27.1 mm -73.48 -55.41 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 122.317 -0.519 . . . . 0.0 112.186 -175.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 1.4 p -83.72 -44.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 O-C-N 121.717 -0.614 . . . . 0.0 112.503 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.766 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.6 t30 -70.89 -40.84 71.98 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.73 ' HB3' ' O ' ' A' ' 132' ' ' GLY . 36.5 tt0 -96.38 -46.41 6.4 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.273 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.053 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.1 tpp180 -84.61 -31.44 24.26 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 29.7 tp -63.23 -40.0 96.2 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 118.261 -1.375 . . . . 0.0 107.779 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.1 tmm_? -66.11 -30.86 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 170.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.053 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 3.0 mtpt -67.73 -45.04 76.17 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.02 -29.92 65.99 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.431 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.651 HG12 HG21 ' A' ' 25' ' ' VAL . 27.8 m -89.67 -16.89 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.565 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 139' ' ' ARG . 9.9 mt-10 -148.23 -61.17 0.25 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 12.6 tt0 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.932 0.893 . . . . 0.0 111.801 -169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -119.51 133.31 55.74 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.572 0.701 . . . . 0.0 110.436 178.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.885 ' HD3' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.62 127.7 31.69 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.4 ' C ' ' HZ1' ' A' ' 14' ' ' LYS . 2.9 m -124.55 150.41 45.9 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.363 1.078 . . . . 0.0 112.103 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.76 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.11 148.12 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 113.142 -1.844 . . . . 0.0 108.541 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.76 ' N ' HG12 ' A' ' 16' ' ' ILE . 29.6 m -95.01 119.6 33.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.008 172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.558 HD21 ' CD1' ' A' ' 16' ' ' ILE . 17.6 mt -90.55 108.51 19.84 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.854 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.1 pt-20 -73.54 88.71 1.66 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 116.848 -1.941 . . . . 0.0 106.87 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.741 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.94 165.99 17.32 Favored Pre-proline 0 C--O 1.215 -0.763 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.506 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.0 Cg_endo -78.23 155.34 29.12 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.256 1.304 . . . . 0.0 110.359 168.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 91' ' ' ASP . 8.6 tt -52.73 -37.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.681 0.753 . . . . 0.0 111.029 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 11.0 pt20 -60.2 -32.15 70.82 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.33 -1.304 . . . . 0.0 114.061 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -79.92 -38.05 33.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.845 0.831 . . . . 0.0 110.097 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.672 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.8 -33.12 59.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.225 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.626 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -54.69 -43.15 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.8 172.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.713 ' C ' HG23 ' A' ' 31' ' ' THR . 24.6 tt0 -68.45 -28.59 67.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.52 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.574 HG23 HD13 ' A' ' 138' ' ' LEU . 4.5 m -101.45 -9.38 21.13 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 117.63 2.456 . . . . 0.0 117.63 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.938 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.6 m -132.09 -64.61 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.318 1.872 . . . . 0.0 113.89 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 74' ' ' LEU . 17.1 p -97.19 66.85 2.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.679 -1.263 . . . . 0.0 108.702 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.713 HG23 ' C ' ' A' ' 27' ' ' GLU . 4.7 t -157.62 -174.64 4.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.811 -167.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.499 ' O ' HG21 ' A' ' 35' ' ' ILE . 2.4 p -60.35 169.41 1.68 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 10.7 mt-10 -49.9 -8.01 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.805 1.642 . . . . 0.0 114.004 -161.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.39 -36.73 85.3 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.16 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.938 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.34 -41.38 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 117.642 0.721 . . . . 0.0 112.168 173.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 -177.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 31' ' ' THR . 39.2 mt-30 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 31' ' ' THR . 2.4 pt? -73.31 103.32 3.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 116.882 -1.927 . . . . 0.0 108.505 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -130.71 150.24 51.98 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.407 -2.179 . . . . 0.0 106.972 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.703 ' OE2' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -123.45 131.72 53.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.05 40.8 59.18 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.106 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.823 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -109.46 174.4 5.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.494 1.118 . . . . 0.0 109.426 -172.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 49.0 mt-10 . . . . . 0 C--N 1.308 -1.209 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.468 155.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.427 -1.607 0 CA-C-O 120.519 0.2 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -138.95 140.14 38.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.823 ' HB ' HE22 ' A' ' 50' ' ' GLN . 54.1 t -79.95 131.99 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.068 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -77.88 -44.93 25.64 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.486 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.703 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.34 135.8 11.3 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.544 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.627 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -130.44 127.41 62.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.904 174.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.35 138.3 44.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.61 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.97 93.43 Favored Pre-proline 0 CA--C 1.502 -0.865 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.984 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.54 62.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 1 C-N-CA 126.274 4.649 . . . . 0.0 115.583 -159.35 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -133.65 -52.67 0.87 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.394 169.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -143.18 132.92 23.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.502 0.667 . . . . 0.0 110.29 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.67 HD13 ' HA ' ' A' ' 30' ' ' SER . 8.8 tt -129.21 125.88 37.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.535 ' O ' HG11 ' A' ' 65' ' ' VAL . 63.2 m -137.98 126.37 23.28 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 12.2 p90 -151.19 155.64 39.28 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.31 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.517 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 43.0 mt-10 . . . . . 0 C--N 1.313 -1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 121.235 0.541 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 80.1 m -126.53 136.2 52.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.829 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.3 m-85 -111.09 130.51 55.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.402 ' HG3' HD11 ' A' ' 101' ' ' ILE . 5.0 mm100 -115.66 127.73 55.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.742 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.984 HD12 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mt -123.74 144.64 49.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.188 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.12 120.19 41.49 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.692 ' HB3' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.276 0 O-C-N 123.822 0.701 . . . . 0.0 110.254 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.854 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.22 129.65 56.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.444 -0.785 . . . . 0.0 110.585 -160.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.38 115.1 5.04 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 118.443 -1.837 . . . . 0.0 110.442 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' HE2' HD23 ' A' ' 100' ' ' LEU . 11.9 t80 -105.65 130.98 53.57 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.588 -171.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -122.03 122.43 39.29 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.588 170.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.663 ' HG ' ' NE1' ' A' ' 130' ' ' TRP . 0.1 OUTLIER -104.85 136.63 43.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.5 mt -127.2 122.78 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.056 176.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.477 ' NE2' ' HZ2' ' A' ' 130' ' ' TRP . 1.3 m170 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.614 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -28.46 67.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.67 76.2 Favored Glycine 0 C--O 1.24 0.511 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.338 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.6 mtpp -60.21 -42.26 94.76 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.061 0.934 . . . . 0.0 109.415 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.921 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 11.3 mmt -76.89 -23.94 52.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.501 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.87 -14.43 58.66 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.314 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.96 -50.56 0.24 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.189 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -28.12 69.34 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.74 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.921 ' HB2' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -69.85 -26.62 64.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.885 HG22 ' HD3' ' A' ' 14' ' ' LYS . 2.0 p -81.73 -39.42 24.24 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.186 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.54 -52.95 48.74 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.083 -2.008 . . . . 0.0 109.897 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 66.2 mt -75.69 -55.59 10.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 114.741 -0.729 . . . . 0.0 112.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 22.0 t -82.54 -43.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 121.424 -0.797 . . . . 0.0 111.011 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.76 ' HB3' ' O ' ' A' ' 131' ' ' THR . 15.3 t-20 -72.75 -40.31 66.13 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.071 -172.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.873 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.3 tt0 -97.54 -45.65 6.33 Favored 'General case' 0 N--CA 1.42 -1.947 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.664 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.618 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.8 tpp180 -81.98 -33.03 30.39 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.611 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 19.2 tp -63.2 -40.56 97.84 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.367 -1.333 . . . . 0.0 107.626 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.817 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.0 tmm_? -65.18 -30.9 71.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.428 171.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.873 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 53.0 mtmt -73.76 -45.98 48.5 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.452 ' HB2' HG23 ' A' ' 28' ' ' THR . . . -68.18 -29.55 68.44 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.704 -0.622 . . . . 0.0 109.934 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.623 HG11 HG22 ' A' ' 25' ' ' VAL . 25.4 m -84.79 -21.85 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.406 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 13.4 mm-40 -147.29 -60.83 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.573 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 29.9 tt0 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.767 0.794 . . . . 0.0 111.461 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.475 HG23 ' HB2' ' A' ' 126' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.099 0.476 . . . . 0.0 110.603 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.1 p -117.49 134.1 55.22 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 121.197 0.522 . . . . 0.0 109.785 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.911 ' HD2' HG21 ' A' ' 131' ' ' THR . 0.0 OUTLIER -125.49 129.81 50.51 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -121.51 137.68 54.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.014 0.911 . . . . 0.0 110.857 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.774 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.1 148.52 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.177 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.774 ' N ' HG12 ' A' ' 16' ' ' ILE . 18.9 m -95.98 118.47 32.65 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.592 ' HB3' HG23 ' A' ' 142' ' ' VAL . 25.2 mt -91.12 110.32 21.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.86 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.4 pt-20 -75.06 88.42 2.41 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 116.871 -1.932 . . . . 0.0 106.993 175.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.697 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.28 167.15 14.94 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.721 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -81.94 156.31 17.82 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.348 1.365 . . . . 0.0 110.005 166.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.946 HD12 ' HB2' ' A' ' 91' ' ' ASP . 14.0 tt -54.43 -33.59 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.632 0.729 . . . . 0.0 110.747 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.643 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.7 pt20 -64.12 -31.05 72.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.865 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 1.077 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 4.4 tmtm? -81.76 -37.8 26.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.163 0.982 . . . . 0.0 109.071 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.538 HG21 HG13 ' A' ' 142' ' ' VAL . 3.2 t -64.4 -33.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.661 169.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.62 ' CZ2' ' HB2' ' A' ' 70' ' ' ALA . 1.2 t-105 -55.1 -42.66 73.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.927 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.701 ' C ' HG22 ' A' ' 31' ' ' THR . 34.8 tt0 -68.18 -28.33 67.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.167 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 m -101.1 -10.13 20.74 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -171.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.886 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -130.91 -65.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.348 1.885 . . . . 0.0 113.98 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.721 ' HA ' HD12 ' A' ' 74' ' ' LEU . 1.3 p -98.41 66.0 1.69 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.669 -1.269 . . . . 0.0 109.43 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 27' ' ' GLU . 4.6 t -156.06 -174.97 5.19 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.583 -166.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.1 m -60.99 169.04 2.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.161 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.08 -7.88 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 125.934 1.693 . . . . 0.0 114.387 -157.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.53 -36.04 83.03 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.288 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.886 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -62.13 -39.91 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.764 0.792 . . . . 0.0 112.147 174.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.542 -178.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD22 ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 104.77 4.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.655 1.693 . . . . 0.0 110.007 -171.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 69.4 mttt -134.06 153.29 51.9 Favored 'General case' 0 C--O 1.202 -1.408 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.295 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.741 ' HG3' HG11 ' A' ' 68' ' ' VAL . 23.6 mt-10 -123.13 131.28 53.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 119.251 0.932 . . . . 0.0 112.771 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.15 34.63 62.78 Favored Glycine 0 CA--C 1.509 -0.301 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.827 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.584 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -106.76 173.23 6.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.073 -1.064 . . . . 0.0 108.943 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.509 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.996 157.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 25.1 pttm -140.11 131.09 26.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 75' ' ' SER . 51.2 t -82.75 128.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.9 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -68.43 -48.46 64.53 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.849 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.34 145.84 16.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.639 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -141.91 132.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.451 173.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -141.25 138.85 33.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.473 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.62 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.91 127.74 93.34 Favored Pre-proline 0 N--CA 1.444 -0.774 0 O-C-N 123.751 0.657 . . . . 0.0 109.531 -167.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HD3' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -3.26 62.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 1 C-N-CA 126.181 4.587 . . . . 0.0 115.744 -156.446 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.6 p -130.23 -52.55 1.11 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.592 166.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.06 135.34 29.09 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.29 0.567 . . . . 0.0 109.959 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.7 tt -136.17 125.73 25.25 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.599 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.4 m -137.49 125.16 22.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CB ' HG21 ' A' ' 65' ' ' VAL . 11.7 p90 -150.74 158.0 43.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.579 ' HG3' HD22 ' A' ' 66' ' ' LEU . 23.4 mt-10 . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.34 0.59 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 92.8 m -121.38 136.5 54.95 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.318 -171.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.654 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 22.1 m-30 -112.07 131.65 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.496 ' CG ' HD13 ' A' ' 101' ' ' ILE . 7.2 mm-40 -115.87 121.9 43.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD21 ' HD1' ' A' ' 98' ' ' PHE . 3.4 tm? -125.28 142.82 51.28 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.714 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.576 ' H ' HD22 ' A' ' 89' ' ' LEU . 2.8 tp10 -110.84 134.12 52.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.946 ' HB2' HD12 ' A' ' 22' ' ' ILE . 1.2 t70 . . . . . 0 CA--C 1.476 -1.903 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.847 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.86 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.54 136.61 48.64 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.099 -1.001 . . . . 0.0 111.16 -156.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 114.36 4.96 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 119.208 -1.472 . . . . 0.0 109.986 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.923 ' HD1' HD21 ' A' ' 89' ' ' LEU . 15.3 t80 -105.22 127.16 52.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.191 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -123.98 116.67 23.24 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.939 HD22 ' HE1' ' A' ' 130' ' ' TRP . 5.0 tt -106.37 136.37 46.24 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.144 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.753 HD11 HG21 ' A' ' 86' ' ' THR . 1.6 mp -114.23 123.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.871 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.476 ' CD2' HD23 ' A' ' 100' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.663 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.9 p . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.491 0.662 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -33.33 74.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.336 170.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -70.39 -30.66 68.95 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.663 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.5 mtpp -60.5 -42.01 95.5 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 122.076 0.941 . . . . 0.0 109.355 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.685 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 8.7 mmt -80.91 -20.83 41.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.106 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.586 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.7 t70 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.693 -170.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.22 -50.52 0.11 Allowed Glycine 0 C--O 1.246 0.876 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.221 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.619 ' O ' HG13 ' A' ' 133' ' ' ILE . . . -65.92 -22.37 70.31 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.988 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.939 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -70.94 -33.74 70.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.593 -173.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.911 HG21 ' HD2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -71.06 -39.32 72.31 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.104 172.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.48 -55.4 13.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 118.938 -1.601 . . . . 0.0 111.17 174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 129' ' ' GLY . 1.3 mt -81.85 -48.71 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.362 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.747 HG22 HD12 ' A' ' 100' ' ' LEU . 35.5 t -80.03 -44.08 22.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 121.177 -0.952 . . . . 0.0 111.368 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.742 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.0 t30 -72.45 -40.37 67.07 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.761 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.798 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 5.3 tt0 -95.82 -46.0 6.75 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 118.216 -1.393 . . . . 0.0 111.609 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.982 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.0 tpp180 -83.11 -33.82 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.707 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 27.9 tp -63.01 -39.86 96.03 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.592 ' HB2' HD13 ' A' ' 16' ' ' ILE . 3.1 tmm_? -66.17 -30.33 70.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.679 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.982 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -68.95 -48.08 64.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.796 -0.565 . . . . 0.0 112.33 175.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -66.29 -28.42 68.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.129 0.49 . . . . 0.0 110.188 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 1.077 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 28.7 m -95.64 -15.11 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.995 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -149.48 -54.2 0.17 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.649 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 68.7 tt0 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.747 HG22 ' CH2' ' A' ' 130' ' ' TRP . 5.4 mm . . . . . 0 N--CA 1.441 -0.894 0 CA-C-O 120.412 0.149 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -131.68 145.82 51.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 1.106 ' HB2' ' HE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -137.95 150.87 47.42 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -127.04 138.02 53.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.853 0.835 . . . . 0.0 111.861 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.716 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -150.79 147.74 15.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.194 173.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.716 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.2 m -96.24 119.83 35.45 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.327 172.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 HD21 ' CD1' ' A' ' 16' ' ' ILE . 20.5 mt -90.35 107.76 19.35 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.929 ' HG3' ' HE ' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -74.03 88.03 1.88 Allowed 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 116.8 -1.96 . . . . 0.0 107.11 176.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.32 168.64 11.73 Favored Pre-proline 0 C--O 1.22 -0.491 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.194 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 83.8 Cg_endo -80.49 151.54 19.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.07 1.18 . . . . 0.0 110.253 166.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 71' ' ' PRO . 6.7 tt -54.76 -36.15 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.593 0.711 . . . . 0.0 111.078 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.709 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 1.1 pt20 -60.95 -32.1 71.64 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.638 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.481 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.8 mmtm -82.29 -35.54 27.92 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.343 -0.848 . . . . 0.0 110.83 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.705 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.39 -32.52 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 170.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.597 ' CE3' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.64 -42.85 71.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.746 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.703 ' C ' HG22 ' A' ' 31' ' ' THR . 9.6 tp10 -65.96 -28.44 68.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.844 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.668 HG21 HD13 ' A' ' 138' ' ' LEU . 5.0 m -100.06 -7.03 25.46 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.927 ' HA ' HG13 ' A' ' 35' ' ' ILE . 22.6 m -134.99 -61.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.951 -1.718 . . . . 0.0 113.596 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.637 ' HA ' HD22 ' A' ' 74' ' ' LEU . 32.3 p -96.46 63.69 2.14 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 120.33 -1.482 . . . . 0.0 109.617 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.703 HG22 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.91 -174.4 4.83 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.236 -165.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 35' ' ' ILE . 3.5 p -61.09 173.24 0.85 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.307 1.043 . . . . 0.0 110.496 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 5.2 mt-10 -47.55 -6.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.559 . . . . 0.0 114.216 -166.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.24 -40.08 91.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.585 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.927 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.01 -36.6 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.449 0.642 . . . . 0.0 111.139 171.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.726 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.14 102.14 3.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 123.691 1.71 . . . . 0.0 109.099 -172.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.626 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 55.4 mttt -134.32 154.26 51.42 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 111.593 -2.549 . . . . 0.0 107.364 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.716 ' HG3' HG11 ' A' ' 68' ' ' VAL . 20.5 mt-10 -122.45 125.67 46.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 119.281 0.946 . . . . 0.0 111.967 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.77 81.93 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.795 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.45 159.54 15.84 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 25.2 mp0 . . . . . 0 N--CA 1.435 -1.208 0 C-N-CA 118.482 -1.287 . . . . 0.0 108.777 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.7 OUTLIER -148.98 134.0 18.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.566 0.621 . . . . 0.0 109.718 -175.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG22 ' CB ' ' A' ' 76' ' ' PHE . 71.4 t -74.52 127.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.228 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -68.11 -49.45 61.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.246 177.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.21 146.19 15.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.841 HG22 HD12 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -136.48 122.11 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.43 1.11 . . . . 0.0 110.473 173.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 11.7 mm100 -131.48 137.5 48.59 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.266 -172.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.81 123.99 83.46 Favored Pre-proline 0 CA--C 1.501 -0.919 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -166.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.872 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.56 65.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.34 1 C-N-CA 126.487 4.791 . . . . 0.0 115.248 -160.146 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -135.42 -46.85 0.69 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.713 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 28.4 tt0 -146.35 130.68 17.6 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.841 HD12 HG22 ' A' ' 68' ' ' VAL . 1.9 tp -130.74 127.66 39.23 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.569 ' O ' HG12 ' A' ' 65' ' ' VAL . 38.6 t -137.55 127.53 25.79 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.951 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.645 ' CB ' HG22 ' A' ' 65' ' ' VAL . 13.8 p90 -148.98 144.2 26.62 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.969 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HG3' HD22 ' A' ' 66' ' ' LEU . 47.9 mt-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-O 122.135 0.969 . . . . 0.0 112.651 -168.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 85' ' ' VAL . 33.3 m . . . . . 0 N--CA 1.403 -2.796 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.835 HG22 HD12 ' A' ' 101' ' ' ILE . 29.3 m -117.53 129.2 55.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.96 -175.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 44.9 m-85 -118.66 128.32 54.41 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.806 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -117.0 125.59 51.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.818 0.818 . . . . 0.0 109.801 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.872 HD12 ' HB3' ' A' ' 71' ' ' PRO . 3.4 mt -124.04 144.18 49.99 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.05 -169.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 121.09 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.522 ' OD2' HD11 ' A' ' 22' ' ' ILE . 9.9 t0 . . . . . 0 CA--C 1.493 -1.236 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.2 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.847 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.103 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -108.57 127.97 54.42 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 -162.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.1 115.68 5.17 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 118.466 -1.826 . . . . 0.0 110.665 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 19.8 t80 -106.39 130.7 54.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.18 0.991 . . . . 0.0 113.223 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.3 m -124.28 122.11 36.84 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.769 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.722 HD22 ' CH2' ' A' ' 130' ' ' TRP . 5.9 tt -104.67 136.55 43.99 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.496 -0.881 . . . . 0.0 111.114 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.835 HD12 HG22 ' A' ' 86' ' ' THR . 2.4 mp -118.11 127.25 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.346 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.692 ' CG ' ' HZ2' ' A' ' 130' ' ' TRP . 13.4 m170 . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 160.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.709 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 9.8 p . . . . . 0 N--CA 1.443 -0.775 0 CA-C-O 121.088 0.471 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -62.31 -35.41 78.97 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.19 -31.61 69.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.461 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.709 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 36.7 mtpt -62.9 -43.89 97.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 121.614 0.721 . . . . 0.0 110.599 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 6.9 mmt -81.97 -27.83 33.0 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.84 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.93 -16.06 58.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.882 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.61 -36.13 0.11 Allowed Glycine 0 C--O 1.243 0.695 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.397 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.648 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -69.03 -22.82 76.08 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.987 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 1.106 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 4.0 m0 -68.04 -33.22 74.18 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 117.922 0.861 . . . . 0.0 112.635 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.6 p -74.94 -33.15 61.92 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.81 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.804 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.67 -68.28 1.78 Allowed Glycine 0 C--N 1.312 -0.782 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.13 168.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 129' ' ' GLY . 15.9 pt -71.0 -50.26 43.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 121.513 -0.992 . . . . 0.0 112.184 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.763 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 5.7 t -81.1 -42.99 20.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 O-C-N 121.64 -0.662 . . . . 0.0 112.047 -176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.801 ' HB3' ' O ' ' A' ' 131' ' ' THR . 20.0 t-20 -75.56 -42.99 50.85 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 117.482 -1.687 . . . . 0.0 108.152 -174.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.911 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 11.3 tp10 -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.579 -169.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.054 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.0 tpp180 -83.71 -31.97 25.77 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.763 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.4 tp -66.53 -39.64 88.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 117.854 -1.538 . . . . 0.0 107.288 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.929 ' HE ' ' HG3' ' A' ' 19' ' ' GLU . 2.6 tmt_? -63.55 -32.79 74.36 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.302 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 1.054 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.58 -45.16 72.75 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -73.56 -28.75 62.02 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 110.141 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.692 HG12 HG21 ' A' ' 25' ' ' VAL . 25.5 m -86.73 -19.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 19.6 mm-40 -143.7 -64.8 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.288 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 71.5 tt0 . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.028 -165.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.31 97.71 2.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -90.44 -37.51 13.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.676 0.75 . . . . 0.0 109.331 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -112.3 163.54 14.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.776 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -93.04 121.45 34.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.958 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 9.6 tt0 -104.45 -47.02 4.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.188 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -152.55 -69.83 0.16 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.547 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . . . 60.22 -168.59 0.16 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -164.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.749 ' HB3' HG11 ' A' ' 122' ' ' VAL . 3.8 pp -74.91 121.88 86.25 Favored Pre-proline 0 C--N 1.307 -1.253 0 C-N-CA 117.619 -1.633 . . . . 0.0 107.394 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.721 ' HD2' ' HD3' ' A' ' 123' ' ' ARG . 64.5 Cg_exo -52.27 151.7 16.82 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.076 1.851 . . . . 0.0 109.638 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -53.27 112.89 0.97 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.696 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 123' ' ' ARG . 4.7 mm -103.22 124.96 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.208 -173.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.84 132.69 55.65 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.496 177.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.704 ' HD2' HG23 ' A' ' 131' ' ' THR . 16.3 mmtm -126.86 129.15 47.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.83 136.27 54.81 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.05 0.929 . . . . 0.0 110.698 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.786 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.94 148.66 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.092 178.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.786 ' N ' HG12 ' A' ' 16' ' ' ILE . 77.3 m -94.89 119.25 33.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 172.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 16' ' ' ILE . 22.7 mt -91.06 108.57 19.95 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -74.95 87.88 2.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 C-N-CA 116.647 -2.021 . . . . 0.0 106.709 176.087 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.76 167.26 14.6 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.165 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 98.1 Cg_endo -82.14 158.56 17.8 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.364 1.376 . . . . 0.0 110.198 167.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 1.036 HD12 ' HB2' ' A' ' 91' ' ' ASP . 10.8 tt -54.63 -32.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.684 0.754 . . . . 0.0 110.986 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 5.7 pt20 -68.42 -31.41 70.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.223 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 142' ' ' VAL . 82.5 mttt -81.92 -37.04 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.965 -1.085 . . . . 0.0 110.418 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.605 HG21 HG13 ' A' ' 142' ' ' VAL . 6.2 t -62.5 -34.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.612 167.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.554 ' HA ' ' HG3' ' A' ' 71' ' ' PRO . 1.2 t-105 -55.21 -43.39 74.4 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.765 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.711 ' C ' HG21 ' A' ' 31' ' ' THR . 27.4 tp10 -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.929 173.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.63 HG23 HD12 ' A' ' 138' ' ' LEU . 4.7 m -100.9 -9.34 21.67 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -171.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.903 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.0 m -131.75 -63.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.64 2.018 . . . . 0.0 114.316 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.667 ' HA ' HD11 ' A' ' 74' ' ' LEU . 32.0 p -97.38 63.31 1.79 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 109.646 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.711 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.5 t -157.56 -174.61 4.95 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.238 -164.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 1.9 p -62.45 175.31 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.644 1.177 . . . . 0.0 110.918 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.043 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 14.4 mt-10 -47.42 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.341 1.457 . . . . 0.0 113.594 -165.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.06 -40.79 93.99 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.975 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.903 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.5 -39.73 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 122.221 1.01 . . . . 0.0 110.727 172.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 33' ' ' GLU . . . -55.91 -32.65 63.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.423 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -50.96 -49.84 59.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.769 ' HB2' HG22 ' A' ' 133' ' ' ILE . 11.4 p-90 -80.31 -37.01 33.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.362 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.89 -72.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.772 0.32 . . . . 0.0 111.549 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 27.9 ttt 178.35 139.7 0.26 Allowed Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -40.63 101.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.772 2.981 . . . . 0.0 114.034 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -158.13 163.37 37.66 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.236 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 1.043 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 10.9 p-10 -114.64 51.84 0.87 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 32' ' ' SER . 16.3 t80 -40.96 138.77 0.99 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.303 169.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -135.17 139.24 44.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.5 pt? -73.67 100.74 3.45 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 116.932 -1.907 . . . . 0.0 108.116 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 49.2 mttm -132.33 153.0 51.17 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 111.53 -2.577 . . . . 0.0 107.434 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.774 ' HG3' HG12 ' A' ' 68' ' ' VAL . 22.7 mt-10 -123.27 130.55 52.89 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.867 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.93 40.17 71.64 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.809 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.867 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.01 172.42 6.84 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.2 mt-10 -124.8 128.16 48.3 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.402 161.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CD1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -132.74 138.78 47.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 62' ' ' PRO . 81.3 t60 -139.6 157.26 46.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.827 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.62 ' HA ' ' OD1' ' A' ' 43' ' ' ASP . 6.5 mp -68.77 15.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' HIS . 39.6 mt-30 -139.97 157.73 45.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.848 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 19.7 m -58.33 -55.22 47.89 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.848 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 12.5 Cg_exo -71.23 111.33 3.06 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.975 1.784 . . . . 0.0 110.497 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -70.11 -30.36 67.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.052 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.3 -115.84 4.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -81.51 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.552 2.168 . . . . 0.0 111.3 173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -73.4 115.49 41.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 55.1 Cg_endo -88.63 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.284 1.989 . . . . 0.0 112.374 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 34.5 m -129.86 154.1 47.62 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.87 128.75 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.867 ' HB ' HE22 ' A' ' 50' ' ' GLN . 70.6 t -82.55 130.09 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.592 HD13 ' OE2' ' A' ' 77' ' ' GLU . 5.1 mp -70.15 -50.14 43.49 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.719 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.42 15.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.765 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.774 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -138.65 135.27 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.879 0.847 . . . . 0.0 110.747 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.81 140.33 32.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.139 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.87 128.07 93.3 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -166.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.665 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -4.63 68.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 125.963 4.442 . . . . 0.0 115.012 -156.831 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' GLN . 4.6 p -139.29 -50.06 0.51 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.924 171.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.68 133.15 25.0 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.148 0.499 . . . . 0.0 109.715 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.667 HD11 ' HA ' ' A' ' 30' ' ' SER . 9.6 tt -131.84 125.77 32.63 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' HG12 ' A' ' 65' ' ' VAL . 62.4 m -137.64 123.66 20.26 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.131 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.526 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.0 p90 -152.34 158.19 42.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 27.2 mt-10 -114.79 131.31 56.85 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.505 ' HB3' ' NE1' ' A' ' 83' ' ' TRP . 56.9 t-105 -94.01 117.23 29.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.0 -1.454 . . . . 0.0 113.122 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t70 41.62 -106.15 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 113.599 -1.637 . . . . 0.0 114.913 167.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 2.6 t -89.09 -29.95 19.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.47 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.991 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.3 mp0 -91.41 154.29 19.27 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.522 ' N ' HG21 ' A' ' 112' ' ' ILE . . . -90.89 32.51 5.07 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.635 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.777 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.78 117.6 21.58 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.132 -177.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' CG1' HD21 ' A' ' 66' ' ' LEU . 43.1 t -80.75 80.51 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.058 166.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.776 HG13 ' HB2' ' A' ' 83' ' ' TRP . 17.3 m -83.07 124.03 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.857 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 90.8 m -120.5 136.92 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.55 -170.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.614 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 19.2 m-30 -112.27 131.07 55.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.453 ' CG ' HD12 ' A' ' 101' ' ' ILE . 8.3 mm100 -116.37 125.62 52.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.287 0.565 . . . . 0.0 109.601 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.786 HD23 ' HD1' ' A' ' 98' ' ' PHE . 1.5 tm? -121.53 142.77 49.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -172.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.424 ' N ' HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -110.1 119.57 39.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.036 ' HB2' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -81.6 111.65 18.09 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 121.896 0.855 . . . . 0.0 110.028 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 1.031 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 52.4 mt -125.24 123.45 39.56 Favored 'General case' 0 N--CA 1.399 -3.004 0 CA-C-N 113.264 -1.789 . . . . 0.0 106.643 162.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.89 -26.87 8.86 Favored Glycine 0 N--CA 1.479 1.554 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 159.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 1.031 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 4.6 tp10 -52.65 -154.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 111.499 -2.35 . . . . 0.0 109.254 150.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.79 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.04 175.76 6.2 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -177.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.456 HG23 HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -111.92 128.44 56.15 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.502 -0.749 . . . . 0.0 109.949 -163.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.0 115.48 5.25 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 118.418 -1.849 . . . . 0.0 110.087 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.786 ' HD1' HD23 ' A' ' 89' ' ' LEU . 27.5 t80 -104.26 127.15 51.86 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.898 0.856 . . . . 0.0 111.882 -170.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.3 m -123.18 117.08 24.53 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.315 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.816 HD23 ' HE1' ' A' ' 130' ' ' TRP . 4.6 tt -107.27 138.37 43.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.238 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.621 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.6 mp -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.198 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.43 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.1 m170 -117.54 114.36 23.33 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 166.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.7 t -143.99 165.38 27.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.79 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 83' ' ' TRP . . . -170.89 150.81 14.54 Favored Glycine 0 C--N 1.312 -0.781 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -121.09 142.21 50.06 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 106' ' ' LYS . 11.8 ttpp 90.66 34.55 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.833 1.333 . . . . 0.0 112.756 171.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.893 ' HG2' ' HA ' ' A' ' 112' ' ' ILE . 10.3 mp0 -121.6 163.12 32.71 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 122.217 -0.302 . . . . 0.0 110.488 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 6' ' ' GLU . 88.1 Cg_endo -92.67 -153.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.433 2.755 . . . . 0.0 112.92 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.01 -16.51 62.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.96 0.886 . . . . 0.0 110.291 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' O ' ' HB3' ' A' ' 119' ' ' SER . 41.2 tt0 -74.75 162.29 28.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.577 166.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.724 HG21 ' H ' ' A' ' 113' ' ' GLY . 14.8 m -74.79 -179.87 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-O 123.638 1.685 . . . . 0.0 112.117 -168.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.991 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -52.17 -30.95 13.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 110.213 -3.176 . . . . 0.0 112.602 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.724 ' H ' HG21 ' A' ' 111' ' ' VAL . . . 145.87 74.99 0.02 OUTLIER Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.494 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 97.2 mttt 77.43 16.13 1.63 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.467 0.707 . . . . 0.0 110.77 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.86 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -64.61 -28.62 69.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.884 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.418 ' C ' HD21 ' A' ' 116' ' ' ASN . 0.2 OUTLIER -179.47 -70.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 111' ' ' VAL . 38.3 tt0 -172.63 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.324 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.661 ' HB2' HG13 ' A' ' 121' ' ' VAL . 48.5 mmtm -91.46 138.06 31.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.225 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB2' ' C ' ' A' ' 8' ' ' ALA . 98.4 p -58.92 -35.19 72.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.966 0.888 . . . . 0.0 109.393 174.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 6.0 p -67.44 -40.5 85.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.764 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 118' ' ' LYS . 16.7 m -70.5 -35.93 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.159 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 9' ' ' LEU . 14.1 p -66.86 -38.14 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.098 0.475 . . . . 0.0 110.678 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.721 ' HD3' ' HD2' ' A' ' 10' ' ' PRO . 8.9 ptt180 -66.38 -29.89 70.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.16 -28.38 70.29 Favored Glycine 0 C--O 1.24 0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.679 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.647 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.9 mtpp -61.37 -43.27 99.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.073 0.94 . . . . 0.0 108.722 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 1.009 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 10.8 mmt -76.08 -23.51 55.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.043 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.615 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 14.9 t70 -76.62 -15.5 59.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.722 -171.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.54 -58.02 0.19 Allowed Glycine 0 C--O 1.244 0.723 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.717 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.86 -16.24 76.31 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.919 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 1.009 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 6.6 t-105 -82.19 -24.12 35.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.505 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.704 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -78.83 -34.2 45.41 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.751 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -53.99 -54.98 28.24 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 118.249 -1.929 . . . . 0.0 110.057 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 38' ' ' TRP . 53.1 mt -70.55 -54.55 17.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.756 HG23 ' CZ3' ' A' ' 38' ' ' TRP . 21.8 t -83.37 -44.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 121.36 -0.838 . . . . 0.0 112.331 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.75 ' HA ' HG21 ' A' ' 16' ' ' ILE . 40.4 t-20 -72.93 -39.94 65.84 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.736 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.741 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 2.2 tt0 -95.49 -45.82 6.93 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.687 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.046 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.7 tpp180 -83.07 -31.79 27.14 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.677 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 21.0 tp -64.54 -40.31 95.36 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 118.626 -1.229 . . . . 0.0 107.713 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.6 tmm_? -66.33 -30.23 70.59 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.046 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -68.65 -46.12 70.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HB1' HG23 ' A' ' 28' ' ' THR . . . -71.76 -28.72 63.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.792 -0.568 . . . . 0.0 110.183 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 138' ' ' LEU . 33.1 m -85.88 -21.61 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 9.6 mm-40 -148.17 -56.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.627 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 21.7 pt-20 42.61 -152.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.021 0.928 . . . . 0.0 112.024 -169.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.7 tt -153.7 -51.15 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.31 147.84 50.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.769 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -116.61 -45.64 2.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.551 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -119.77 100.16 7.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -67.46 -7.26 24.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -135.03 -73.44 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.753 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -142.06 151.74 42.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.954 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 C--O 1.245 0.834 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.25 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.565 0.221 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.87 -67.51 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.903 0.382 . . . . 0.0 111.778 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.26 -38.55 56.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -112.63 152.76 28.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.6 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.477 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 12.8 m120 -74.97 122.78 24.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 5.5 tp10 -85.05 -109.09 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.608 -163.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.863 ' HB3' ' HA ' ' A' ' 110' ' ' GLN . 0.1 OUTLIER -104.46 -45.86 4.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.67 0.271 . . . . 0.0 110.595 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.835 ' HA ' ' HA ' ' A' ' 112' ' ' ILE . . . 72.19 155.85 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.919 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.88 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 0.0 OUTLIER -73.44 142.96 82.0 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.758 -174.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.41 ' O ' HD22 ' A' ' 9' ' ' LEU . 31.7 Cg_exo -59.76 142.0 97.89 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.504 2.136 . . . . 0.0 109.924 171.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.64 122.2 8.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 112.325 -163.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG23 ' CB ' ' A' ' 126' ' ' MET . 1.5 tp -106.57 129.74 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.513 HG23 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -127.37 134.68 49.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.848 ' HB3' ' CZ2' ' A' ' 130' ' ' TRP . 20.8 tptt -138.73 152.03 47.63 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.665 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -124.42 141.87 51.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.079 0.943 . . . . 0.0 112.083 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.829 HD12 HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -142.02 148.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.593 171.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.695 ' N ' HG13 ' A' ' 16' ' ' ILE . 33.5 m -98.57 117.68 33.55 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 162.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.829 HD21 HD12 ' A' ' 16' ' ' ILE . 28.1 mt -93.59 109.4 21.02 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -75.35 88.26 2.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 117.158 -1.817 . . . . 0.0 106.84 177.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.753 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.45 166.16 17.1 Favored Pre-proline 0 C--O 1.217 -0.625 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.241 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 92.3 Cg_endo -78.88 157.15 27.34 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.232 1.288 . . . . 0.0 109.783 167.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.753 HD13 ' HA ' ' A' ' 91' ' ' ASP . 4.5 tp -53.24 -36.82 26.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.756 0.788 . . . . 0.0 110.673 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.61 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.3 pt20 -61.57 -32.41 72.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.2 -1.364 . . . . 0.0 114.073 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 27' ' ' GLU . 54.3 mtpt -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.721 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG22 HG12 ' A' ' 142' ' ' VAL . 2.7 t -66.97 -34.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.296 169.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.703 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.82 -41.91 71.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.586 172.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.686 ' C ' HG21 ' A' ' 31' ' ' THR . 6.0 tp10 -66.89 -29.97 70.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.931 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.598 ' O ' HG21 ' A' ' 28' ' ' THR . 5.2 m -101.67 -9.55 20.81 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 -170.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.882 ' HA ' HG13 ' A' ' 35' ' ' ILE . 28.3 m -130.13 -64.3 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.47 1.941 . . . . 0.0 113.916 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.659 ' HA ' HD12 ' A' ' 74' ' ' LEU . 30.8 p -97.58 65.29 1.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.852 -1.155 . . . . 0.0 109.132 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.686 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -156.77 -176.37 5.94 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.649 -166.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 35' ' ' ILE . 16.9 m -63.19 173.64 1.42 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.687 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CA ' ' A' ' 43' ' ' ASP . 12.1 mt-10 -47.88 -5.31 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.905 1.682 . . . . 0.0 114.612 -164.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.52 -37.59 83.16 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.804 -1.188 . . . . 0.0 110.613 170.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.882 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.45 -37.57 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.771 0.796 . . . . 0.0 110.62 170.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HB3' ' C ' ' A' ' 42' ' ' ASN . . . -53.97 -30.77 48.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.571 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -46.27 -49.6 17.15 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 1.008 ' HB2' HG23 ' A' ' 133' ' ' ILE . 7.1 p-90 -92.61 129.57 38.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.256 -0.277 . . . . 0.0 110.335 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 38' ' ' TRP . 69.6 t80 81.56 95.63 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.098 0.874 . . . . 0.0 112.412 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.1 mmt 67.27 161.95 0.14 Allowed Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.276 169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.05 116.88 3.75 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 C-N-CA 122.776 2.317 . . . . 0.0 110.437 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.514 ' C ' ' HB3' ' A' ' 36' ' ' ALA . 12.6 t-20 -154.67 165.54 36.22 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.738 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' CA ' ' HG2' ' A' ' 33' ' ' GLU . 3.5 p-10 -155.65 39.52 0.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.47 0.652 . . . . 0.0 110.15 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.55 ' HD2' HD13 ' A' ' 35' ' ' ILE . 21.4 t80 -46.83 142.55 3.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.375 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -138.77 141.26 38.83 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.6 pt? -73.05 102.15 3.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.976 -1.89 . . . . 0.0 108.911 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -131.13 150.6 52.07 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.062 -2.335 . . . . 0.0 106.91 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.591 ' HG3' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.5 131.74 54.0 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.55 39.54 45.52 Favored Glycine 0 N--CA 1.463 0.476 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.831 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' A' ' 47' ' ' LYS . 2.2 pm0 -107.63 173.95 6.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 124.427 1.091 . . . . 0.0 109.579 -171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 1.014 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 78.7 mt-10 -123.53 127.04 47.77 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.234 158.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.67 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -134.24 127.14 31.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 62' ' ' PRO . 1.4 p80 -149.56 136.67 19.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.041 163.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.0 tp -105.69 -28.27 10.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' HG3' ' OG ' ' A' ' 56' ' ' SER . 8.5 pt20 -101.16 -162.4 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.93 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.442 ' OG ' ' HG3' ' A' ' 55' ' ' GLN . 16.0 m 70.92 136.12 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.251 0 O-C-N 123.945 0.778 . . . . 0.0 112.811 168.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.66 -142.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.138 2.559 . . . . 0.0 110.81 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.1 t80 77.15 -47.13 0.5 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.222 0.609 . . . . 0.0 111.243 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 60' ' ' PRO . . . 105.0 -116.66 5.35 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.361 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 59' ' ' GLY . 19.7 Cg_exo -67.27 151.12 81.34 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.143 2.562 . . . . 0.0 112.365 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.5 m 61.58 66.05 1.64 Allowed Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.499 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 1.014 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 48.6 Cg_endo -74.69 -80.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.943 1.762 . . . . 0.0 111.372 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.847 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 31.2 t -126.12 151.6 47.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.666 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.17 126.84 23.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.568 HG11 ' HB ' ' A' ' 68' ' ' VAL . 40.4 t -79.9 127.26 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.178 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.5 mm? -71.06 -46.14 62.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.132 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.41 140.51 15.3 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.281 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG13 ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -139.06 127.57 28.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.007 172.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -141.95 139.81 32.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.564 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.07 127.92 91.54 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 1.013 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.21 60.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 1 C-N-CA 126.869 5.046 . . . . 0.0 116.066 -162.403 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -136.86 -44.48 0.58 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.245 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG3' HE22 ' A' ' 88' ' ' GLN . 30.8 tt0 -144.19 134.4 24.33 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.558 0.694 . . . . 0.0 110.584 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -137.38 126.41 24.35 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.564 ' O ' HG12 ' A' ' 65' ' ' VAL . 73.5 m -139.43 126.25 20.8 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.191 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.847 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 21.4 p90 -152.32 155.09 36.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.813 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 47.7 mt-10 -117.96 128.71 55.06 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.382 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -102.24 118.8 37.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.39 -1.277 . . . . 0.0 113.847 -161.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER 55.73 -146.05 0.59 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.846 169.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.4 t -61.98 -28.92 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.683 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.977 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 1.9 mp0 -83.4 141.82 31.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.532 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.595 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -95.98 44.05 2.09 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.286 -170.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.813 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -92.02 119.58 31.87 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.258 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.562 ' CA ' ' HG2' ' A' ' 77' ' ' GLU . 4.3 p -84.68 95.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.093 166.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' HB ' ' CD2' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -85.1 129.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.876 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 93.0 m -121.38 131.67 54.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 22.1 m-30 -111.22 124.44 52.22 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.404 HE22 ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -114.86 126.91 55.35 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 122.424 1.107 . . . . 0.0 109.668 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.013 HD21 ' HB3' ' A' ' 71' ' ' PRO . 22.6 tp -128.61 144.38 51.14 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.673 -165.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.722 ' H ' HD11 ' A' ' 89' ' ' LEU . 4.0 tp10 -110.71 130.41 55.58 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.535 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.753 ' HA ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -96.29 106.45 18.66 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 124.203 0.939 . . . . 0.0 110.132 -170.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 1.029 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 15.6 mt -126.48 134.73 50.86 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.79 -24.12 67.93 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 160.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 1.029 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 6.7 tp10 -54.85 -158.86 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.251 -2.474 . . . . 0.0 109.024 152.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.771 ' H ' ' HG3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -96.72 169.18 10.05 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.83 131.59 54.92 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.454 0.645 . . . . 0.0 109.979 -158.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.76 113.35 4.62 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.861 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.844 ' HD1' HD13 ' A' ' 89' ' ' LEU . 6.5 t80 -104.89 129.94 53.14 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.848 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.8 m -122.47 116.09 23.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 1.0 ' HB3' ' HZ2' ' A' ' 130' ' ' TRP . 7.2 tt -110.62 139.23 46.08 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.285 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.8 mp -115.99 124.91 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.365 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.626 ' CD2' HD22 ' A' ' 100' ' ' LEU . 4.7 m170 -118.02 112.83 20.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -142.71 165.76 26.5 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -167.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 8' ' ' ALA . . . -160.26 131.99 2.82 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.838 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.423 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 4.5 m0 -129.94 131.24 45.91 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.793 0.797 . . . . 0.0 111.913 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 23.3 tttm -174.22 -104.73 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 165.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.921 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.6 pt-20 -124.65 -175.42 0.39 Allowed Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.679 -169.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.921 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 67.5 Cg_endo -73.26 -173.25 1.22 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.606 2.204 . . . . 0.0 115.221 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.4 m120 59.22 96.53 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.864 0.866 . . . . 0.0 110.584 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.863 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -105.63 114.74 29.09 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -156.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.684 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 3.6 p -146.65 176.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 141.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.977 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -61.78 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 118.951 0.796 . . . . 0.0 111.871 178.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -168.32 -88.86 0.07 OUTLIER Glycine 0 C--O 1.222 -0.64 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.491 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 73.9 tttt -125.92 45.63 2.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 163.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.485 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -68.05 -39.97 82.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.209 -1.814 . . . . 0.0 111.618 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.4 -65.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.04 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.684 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 7.8 tp10 -167.31 -81.19 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB2' HG13 ' A' ' 121' ' ' VAL . 34.5 mmtp -94.96 154.67 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.764 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.88 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 89.8 p -65.78 -35.05 79.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.798 0.808 . . . . 0.0 109.196 168.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 4.3 m -66.04 -41.2 91.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 118' ' ' LYS . 13.9 m -71.82 -36.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.987 -176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.831 HG12 HD13 ' A' ' 112' ' ' ILE . 7.8 p -69.68 -36.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.574 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 120' ' ' SER . 28.0 ptt180 -68.1 -28.29 67.21 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -65.43 -32.0 82.1 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 39.1 mmtm -62.48 -38.04 88.28 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.729 0.776 . . . . 0.0 109.237 172.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.601 ' HE3' ' HG ' ' A' ' 9' ' ' LEU . 19.9 mtt -82.01 -7.73 59.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.541 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.497 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 31.0 t70 -92.57 -15.3 27.11 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.042 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -133.47 -53.96 0.08 OUTLIER Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.734 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.35 -18.76 73.69 Favored Glycine 0 CA--C 1.499 -0.957 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 1.0 ' HZ2' ' HB3' ' A' ' 100' ' ' LEU . 21.1 t90 -55.6 -63.86 1.03 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.678 -1.261 . . . . 0.0 110.913 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.9 p -63.8 -28.31 69.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.009 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -55.95 -59.28 10.89 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 118.494 -1.812 . . . . 0.0 110.289 168.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 1.008 HG23 ' HB2' ' A' ' 38' ' ' TRP . 1.7 mp -72.41 -54.46 16.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.806 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.8 t -81.16 -44.2 20.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 O-C-N 121.561 -0.712 . . . . 0.0 112.017 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.551 ' HA ' HD13 ' A' ' 16' ' ' ILE . 44.1 t30 -79.12 -38.11 36.94 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 117.92 -1.512 . . . . 0.0 108.735 -171.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.931 ' HG2' ' HE2' ' A' ' 140' ' ' LYS . 15.4 tt0 -94.82 -45.53 7.27 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 118.385 -1.326 . . . . 0.0 110.785 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.047 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.4 tpp180 -83.43 -33.0 25.8 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.806 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 34.5 tp -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.059 -1.456 . . . . 0.0 107.098 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.519 ' HA ' HG23 ' A' ' 142' ' ' VAL . 4.4 tmm_? -65.8 -30.76 71.44 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.09 -47.51 68.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.187 0.517 . . . . 0.0 112.366 176.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' A' ' 28' ' ' THR . . . -70.1 -27.44 64.6 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.782 -0.574 . . . . 0.0 109.771 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 138' ' ' LEU . 28.9 m -94.12 -12.78 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -153.24 -56.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.58 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 18.3 pt-20 35.18 77.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.496 1.118 . . . . 0.0 113.338 -169.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.621 ' O ' HD12 ' A' ' 145' ' ' LEU . 2.1 pp -68.27 125.69 27.21 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 169.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.19 162.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.389 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.2 t60 174.68 -24.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -85.87 -48.42 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.226 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -86.01 105.24 16.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.543 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -125.89 18.39 7.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.978 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.7 m80 56.62 -149.93 0.45 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.382 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.165 -0.921 . . . . 0.0 109.339 172.057 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.613 0.244 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.9 -45.39 4.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.065 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.87 -38.83 92.29 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.51 0.671 . . . . 0.0 109.692 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -112.47 145.69 39.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -75.84 130.54 38.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.657 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -42.02 -62.74 0.86 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.53 1.144 . . . . 0.0 112.45 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -140.02 -60.43 0.53 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -143.72 -52.32 0.34 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.006 168.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.837 HD22 ' HE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -86.14 105.06 6.48 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.43 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 39.5 Cg_exo -58.59 152.77 53.17 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.308 2.005 . . . . 0.0 111.778 -175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.79 121.71 17.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.81 0.814 . . . . 0.0 110.996 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' CB ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -107.73 136.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -113.38 134.05 54.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.844 174.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.785 ' HD3' HG22 ' A' ' 131' ' ' THR . 7.8 mmpt? -122.01 130.9 53.68 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.25 54.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.129 0.966 . . . . 0.0 111.437 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.847 HD12 ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -153.49 149.06 13.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.687 178.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.838 ' N ' HG12 ' A' ' 16' ' ' ILE . 28.1 m -95.06 121.1 36.33 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.652 HD22 ' CD1' ' A' ' 16' ' ' ILE . 96.1 mt -91.65 108.34 19.84 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.613 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 1.3 mt-10 -77.58 87.15 3.89 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 116.62 -2.032 . . . . 0.0 106.768 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.774 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -158.47 169.03 11.25 Favored Pre-proline 0 C--O 1.214 -0.811 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.639 -176.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 95.7 Cg_endo -83.62 152.61 13.38 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.749 0.966 . . . . 0.0 109.9 163.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.76 HG23 ' OD2' ' A' ' 91' ' ' ASP . 7.3 tt -55.02 -32.1 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.829 0.823 . . . . 0.0 111.289 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.655 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 4.6 pt20 -66.56 -30.48 70.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.953 -1.476 . . . . 0.0 113.407 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 58.1 tptt -81.69 -35.99 29.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 122.066 0.936 . . . . 0.0 110.011 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 89' ' ' LEU . 2.7 t -66.04 -33.64 64.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.641 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.598 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.195 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.769 ' C ' HG23 ' A' ' 31' ' ' THR . 23.4 tt0 -66.64 -28.28 68.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.106 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 28' ' ' THR . 5.4 m -100.21 -9.35 22.54 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.888 ' HA ' HG13 ' A' ' 35' ' ' ILE . 32.9 m -131.08 -63.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.334 1.879 . . . . 0.0 113.415 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.637 ' HA ' HD11 ' A' ' 74' ' ' LEU . 27.7 p -96.74 65.54 2.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.56 -1.338 . . . . 0.0 108.663 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.769 HG23 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.97 -174.7 4.96 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.729 -165.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 1.3 p -60.68 171.78 1.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.022 0.929 . . . . 0.0 110.315 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.021 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 4.1 mt-10 -47.76 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.571 1.549 . . . . 0.0 113.698 -162.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.02 -36.41 81.14 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.256 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.888 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.79 -44.22 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 121.718 0.77 . . . . 0.0 111.639 173.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.4 -32.74 65.12 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.773 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.9 -14.43 53.43 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.721 ' CZ3' HG23 ' A' ' 134' ' ' VAL . 8.0 p-90 -98.68 22.42 10.0 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.154 0.888 . . . . 0.0 110.872 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 35' ' ' ILE . 6.7 p90 -174.22 67.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.554 167.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.445 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 0.9 OUTLIER 77.78 120.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.379 173.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 40' ' ' MET . 3.1 Cg_endo -51.03 120.43 6.7 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.111 3.208 . . . . 0.0 114.526 -177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -156.41 142.06 17.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.563 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 1.021 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.2 p-10 -84.25 55.98 3.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.735 0.779 . . . . 0.0 111.02 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' SER . 19.4 t80 -63.55 139.39 58.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.41 164.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.405 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 1.5 mp0 -139.89 147.55 40.78 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 168.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -71.72 103.55 3.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.754 1.74 . . . . 0.0 109.369 -172.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HB3' ' CB ' ' A' ' 50' ' ' GLN . 6.5 mmtp -131.62 154.71 48.62 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 111.625 -2.534 . . . . 0.0 107.514 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' CD ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -120.42 134.15 55.32 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.375 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.98 38.95 61.57 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.441 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -109.94 151.52 26.99 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.361 -168.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -113.98 128.86 56.57 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 160.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.757 ' HZ ' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -95.55 114.86 26.66 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.083 -167.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -135.77 139.04 43.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.6 tp 52.52 64.08 1.99 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.643 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.405 ' HG2' ' CD ' ' A' ' 45' ' ' GLN . 6.7 tp-100 -111.02 -67.42 1.0 Allowed 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.193 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.739 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 20.3 m -121.24 -54.21 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.476 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 11.0 Cg_endo -91.11 -75.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.358 2.038 . . . . 0.0 112.511 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.733 ' HD1' ' HB2' ' A' ' 57' ' ' PRO . 1.0 OUTLIER -159.24 -61.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.68 81.08 0.08 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.857 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HD3' ' CD2' ' A' ' 58' ' ' PHE . 94.0 Cg_endo -89.53 62.32 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.907 2.405 . . . . 0.0 112.031 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t 57.57 65.65 3.37 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.547 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.555 ' O ' ' HA ' ' A' ' 79' ' ' ASP . 79.7 Cg_endo -91.42 -89.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.704 2.269 . . . . 0.0 113.299 -175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -100.85 165.88 11.13 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.432 -170.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.6 pttt -143.27 141.62 31.1 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.757 HG21 ' HZ ' ' A' ' 52' ' ' PHE . 95.9 t -83.54 132.16 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.316 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.799 HD21 ' OE1' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -82.84 -39.79 21.2 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.378 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . . . -157.85 140.76 14.95 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.17 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -140.21 132.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.16 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -141.68 138.65 32.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.942 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.77 123.02 82.24 Favored Pre-proline 0 CA--C 1.503 -0.847 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -168.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.988 ' HB3' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 0.02 62.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.602 1 C-N-CA 126.322 4.681 . . . . 0.0 115.732 -159.845 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 p -133.21 -41.99 0.88 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.727 167.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -144.78 133.27 21.98 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -129.48 128.65 43.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 169.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.866 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 49.1 m -138.06 121.93 17.69 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.247 168.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.632 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 p90 -154.35 151.1 28.66 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.712 0.768 . . . . 0.0 111.378 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.799 ' OE1' HD21 ' A' ' 66' ' ' LEU . 25.6 mp0 -126.11 134.51 51.32 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.904 -173.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.863 ' HA ' ' HB3' ' A' ' 63' ' ' CYS . 8.7 t-105 -79.66 125.05 29.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.43 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER 53.74 -146.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.164 175.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.476 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.0 t -78.31 -38.36 42.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.646 1.212 . . . . 0.0 108.841 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.616 ' OE2' ' HA2' ' A' ' 113' ' ' GLY . 1.7 pt-20 -142.5 142.33 32.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.567 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.703 ' HA2' ' CB ' ' A' ' 105' ' ' TRP . . . 126.52 30.43 0.84 Allowed Glycine 0 C--N 1.29 -1.996 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -160.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.837 ' HE3' HD22 ' A' ' 9' ' ' LEU . 31.1 m0 -65.03 144.45 57.27 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 113.471 -1.365 . . . . 0.0 108.016 -174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -126.88 -32.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.606 172.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.866 ' O ' ' HA ' ' A' ' 75' ' ' SER . 53.3 t 73.81 -108.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.133 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.733 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 14.4 m -121.52 135.78 55.0 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 122.102 2.228 . . . . 0.0 115.441 -158.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.694 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.5 m-30 -110.07 131.93 54.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.26 128.09 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.864 0.84 . . . . 0.0 110.631 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.988 HD11 ' HB3' ' A' ' 71' ' ' PRO . 2.5 tt -121.28 143.29 49.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.636 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.479 ' N ' HD23 ' A' ' 89' ' ' LEU . 5.2 tp10 -110.53 130.83 55.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.788 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 22' ' ' ILE . 8.5 t70 -94.74 109.12 21.11 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.968 -176.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 12.9 mt -122.92 131.37 53.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 167.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.28 -27.15 38.8 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 160.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.3 tp10 -55.11 -158.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 111.442 -2.379 . . . . 0.0 109.84 153.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.774 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -100.88 -179.15 3.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -177.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.619 HG23 HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -106.71 131.34 53.94 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.274 -0.891 . . . . 0.0 111.041 -154.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.69 113.58 4.75 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.125 -1.512 . . . . 0.0 109.887 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.539 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 17.7 t80 -105.35 128.96 53.76 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.434 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 m -122.07 114.7 21.28 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD21 ' NE1' ' A' ' 130' ' ' TRP . 6.0 tt -105.55 136.21 45.55 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 118.589 -1.245 . . . . 0.0 110.777 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.675 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.5 mp -110.29 121.32 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.799 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.31 109.24 15.57 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.618 170.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.857 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.8 t -99.23 122.88 43.0 Favored 'General case' 0 N--CA 1.4 -2.969 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 146.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.742 ' HA2' ' O ' ' A' ' 83' ' ' TRP . . . -174.36 173.21 45.92 Favored Glycine 0 C--N 1.277 -2.748 0 C-N-CA 115.355 -3.307 . . . . 0.0 118.475 -158.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 1.009 ' HB2' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -112.12 155.57 23.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.171 -2.015 . . . . 0.0 110.214 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 53.6 tptt -123.78 -65.08 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 31.7 tt0 172.1 -65.02 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 O-C-N 123.952 0.782 . . . . 0.0 112.277 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 7.1 Cg_exo -73.19 139.08 28.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 115.339 -163.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 70.47 -163.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.141 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 1.03 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -57.92 120.18 8.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.402 0.62 . . . . 0.0 109.474 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.864 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.7 p -158.58 -168.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.318 -171.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 1.009 HG13 ' HB2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -44.42 -34.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 123.99 0.806 . . . . 0.0 109.911 169.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.864 ' H ' HG11 ' A' ' 111' ' ' VAL . . . -54.92 89.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 164.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.516 ' HD2' ' C ' ' A' ' 113' ' ' GLY . 1.1 mptp? 62.34 60.48 1.41 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.953 ' CB ' ' HA ' ' A' ' 112' ' ' ILE . . . -54.26 -10.48 0.38 Allowed 'General case' 0 C--N 1.352 0.687 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -172.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -63.18 -19.28 64.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.038 0.381 . . . . 0.0 110.869 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 1.03 ' HB3' ' HB2' ' A' ' 110' ' ' GLN . 14.4 mm-40 -79.64 -150.11 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.864 ' HB2' ' HG3' ' A' ' 110' ' ' GLN . 9.8 mmtm -81.25 90.46 6.1 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 124.336 2.017 . . . . 0.0 113.389 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.853 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -68.61 -29.33 67.82 Favored 'General case' 0 C--N 1.269 -2.891 0 CA-C-N 110.918 -2.855 . . . . 0.0 108.978 154.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -61.74 -34.53 76.0 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.008 -1.058 . . . . 0.0 111.184 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.713 HG13 ' HB3' ' A' ' 118' ' ' LYS . 27.7 m -72.9 -36.83 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.631 -176.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 119' ' ' SER . 10.0 p -60.88 -36.22 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.546 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 48.0 ttt180 -63.66 -33.12 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.414 0.626 . . . . 0.0 109.415 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.14 -30.81 67.05 Favored Glycine 0 C--O 1.24 0.487 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.266 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 50.6 mttm -62.84 -34.88 78.26 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.409 0.623 . . . . 0.0 109.42 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.91 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 13.9 mtt -75.17 -27.38 59.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.939 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 7.2 t70 -75.97 -14.79 60.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.788 -169.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.52 -57.37 0.2 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.897 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -70.95 -19.63 77.17 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.77 -171.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.91 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -74.43 -33.39 62.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.264 0.532 . . . . 0.0 111.351 -171.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.785 HG22 ' HD3' ' A' ' 14' ' ' LYS . 1.4 p -74.65 -33.99 62.63 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.274 171.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.76 -52.1 26.46 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.752 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 mm -85.54 -48.01 16.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.302 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.721 HG23 ' CZ3' ' A' ' 38' ' ' TRP . 25.6 t -78.81 -42.52 24.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 O-C-N 120.689 -1.257 . . . . 0.0 111.488 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.612 ' HA ' HG22 ' A' ' 16' ' ' ILE . 43.0 t-20 -76.56 -39.55 52.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.933 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.859 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 4.0 tt0 -93.61 -46.97 7.03 Favored 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.947 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.9 tpp180 -81.6 -33.23 31.64 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.2 tp -65.01 -40.61 95.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 120.579 1.536 . . . . 0.0 107.401 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.847 ' HB2' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.87 -36.77 82.23 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 169.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.859 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 15.6 mtmt -69.09 -43.8 73.8 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 28' ' ' THR . . . -71.04 -28.33 64.3 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.894 -0.504 . . . . 0.0 110.491 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.6 HG13 HG21 ' A' ' 25' ' ' VAL . 30.0 m -93.44 -17.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -149.1 -58.61 0.21 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.497 -174.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.818 ' HG3' ' H ' ' A' ' 145' ' ' LEU . 11.3 pt-20 34.37 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.537 1.135 . . . . 0.0 112.972 -161.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.818 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 2.6 mm? 53.5 35.0 19.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.205 0.526 . . . . 0.0 110.457 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.49 119.88 9.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.716 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -86.14 94.68 9.34 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.713 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -50.8 -58.28 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.376 -166.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 57.18 -151.65 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.654 0.596 . . . . 0.0 109.653 -172.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 69.75 91.9 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 111.085 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -118.83 136.7 53.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.061 -177.323 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.2 28.64 7.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.125 0.488 . . . . 0.0 110.256 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -65.68 -48.5 71.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -137.07 174.03 11.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.094 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.18 119.23 24.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 7' ' ' ASN . 3.7 tt0 -88.86 -62.0 1.58 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.068 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.46 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 2.5 p30 -107.14 -26.56 11.05 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.518 -169.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . . . -69.27 152.88 44.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 160.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -66.49 128.43 93.85 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.62 156.72 59.49 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.008 1.805 . . . . 0.0 109.928 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -55.29 120.47 7.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.703 0.763 . . . . 0.0 110.47 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 123' ' ' ARG . 86.8 mt -104.39 126.07 59.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.094 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.66 132.29 53.42 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HZ2' ' HA ' ' A' ' 127' ' ' ASP . 26.9 tptt -128.88 133.64 47.99 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -122.51 136.96 55.01 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.241 1.019 . . . . 0.0 112.203 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.751 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.57 148.47 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.665 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.751 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.9 m -96.95 120.58 37.57 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.405 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' HB3' HG22 ' A' ' 142' ' ' VAL . 22.4 mt -91.03 108.31 19.78 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.791 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -74.51 89.09 2.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 116.64 -2.024 . . . . 0.0 106.852 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.56 169.46 10.32 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.34 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 93.1 Cg_endo -82.83 158.83 16.04 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.088 1.858 . . . . 0.0 110.388 164.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.908 HD12 ' HB2' ' A' ' 91' ' ' ASP . 3.5 tp -56.08 -36.34 44.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.573 0.701 . . . . 0.0 110.456 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.515 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.2 pt20 -61.5 -32.85 72.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.064 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.873 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.6 tmtp? -82.12 -36.48 27.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.83 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 142' ' ' VAL . 3.1 t -67.28 -33.53 63.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.701 171.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.651 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.75 -42.49 71.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.541 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.688 ' C ' HG23 ' A' ' 31' ' ' THR . 10.3 tp10 -67.23 -29.42 69.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.889 173.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 4.0 m -101.34 -8.85 21.7 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.9 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.3 m -131.23 -64.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 121.796 2.089 . . . . 0.0 113.784 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.651 ' HA ' HD12 ' A' ' 74' ' ' LEU . 33.8 p -97.11 65.41 2.03 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.981 -1.074 . . . . 0.0 109.156 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.688 HG23 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -155.62 -177.75 6.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.047 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.0 m -63.67 171.23 2.77 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.166 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -49.2 -3.34 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.265 1.826 . . . . 0.0 114.836 -161.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.21 -35.28 69.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.608 169.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.9 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -68.34 -36.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.766 0.793 . . . . 0.0 111.302 170.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 33' ' ' GLU . . . -53.36 -29.34 33.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.747 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -54.73 -41.39 70.31 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.588 ' CE2' HD11 ' A' ' 138' ' ' LEU . 9.5 p-90 -91.02 33.67 0.94 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.512 -0.742 . . . . 0.0 109.83 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HD1' ' O ' ' A' ' 40' ' ' MET . 2.7 t80 -141.67 144.89 34.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.672 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 22.2 mmt -73.21 158.87 86.25 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 30.7 Cg_exo -12.2 98.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 125.348 4.032 . . . . 0.0 115.17 -163.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 20.5 t-20 -156.32 153.86 29.71 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.1 -170.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -152.93 42.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.59 0.709 . . . . 0.0 110.385 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.564 ' CE2' HD13 ' A' ' 74' ' ' LEU . 39.9 t80 -49.32 143.01 6.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.919 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 31' ' ' THR . 15.2 mt-30 -138.8 143.5 38.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 68' ' ' VAL . 2.5 pt? -73.09 102.91 3.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 117.826 -1.55 . . . . 0.0 109.003 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 70.2 mttt -133.09 152.54 51.95 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.514 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.706 ' HG3' HG13 ' A' ' 68' ' ' VAL . 25.5 mt-10 -124.66 131.77 53.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 119.107 0.867 . . . . 0.0 112.897 174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.62 34.54 60.57 Favored Glycine 0 C--N 1.328 0.128 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.224 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.891 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.93 173.27 6.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.442 1.097 . . . . 0.0 108.59 -173.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.94 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 7.7 mp0 -118.06 129.11 55.36 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.566 -1.253 . . . . 0.0 109.111 157.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.648 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.68 131.99 41.9 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.624 ' HE1' ' HA ' ' A' ' 57' ' ' PRO . 4.9 p80 -148.2 139.17 23.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.066 165.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -109.58 -19.51 13.18 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.68 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -102.6 146.77 27.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.267 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.577 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 70.8 m 53.48 90.33 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 97.1 Cg_endo -84.3 66.34 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.683 2.256 . . . . 0.0 112.749 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 56' ' ' SER . 5.0 p90 -134.27 26.62 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.343 0.592 . . . . 0.0 110.542 173.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.44 132.66 7.02 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.24 -63.94 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.587 2.191 . . . . 0.0 111.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.892 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.7 m -128.59 114.58 19.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.94 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 70.2 Cg_endo -75.37 -111.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 123.038 2.492 . . . . 0.0 113.874 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 8.8 m -101.93 157.48 16.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.928 -172.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HB3' ' HZ1' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -141.31 132.41 26.29 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -173.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.891 ' HB ' HE22 ' A' ' 50' ' ' GLN . 55.9 t -82.89 125.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.703 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.628 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -61.45 -54.67 40.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.765 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.19 145.3 16.49 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.527 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.706 HG13 ' HG3' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -134.89 129.35 51.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.106 0.955 . . . . 0.0 110.453 173.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -134.55 139.36 45.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.789 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.48 122.87 78.7 Favored Pre-proline 0 CA--C 1.506 -0.749 0 O-C-N 123.711 0.632 . . . . 0.0 109.428 -165.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 1.06 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.6 60.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.196 1 C-N-CA 126.78 4.987 . . . . 0.0 115.684 -158.525 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -132.71 -45.41 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.53 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.59 132.85 23.17 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.369 0.604 . . . . 0.0 109.932 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.7 tt -129.78 125.63 36.25 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.718 ' HG ' HG21 ' A' ' 86' ' ' THR . 49.6 m -138.38 124.9 20.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.009 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.602 ' HE2' ' HE3' ' A' ' 78' ' ' TRP . 12.2 p90 -152.31 157.53 41.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 43.0 mt-10 -118.49 132.46 56.23 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.602 ' HE3' ' HE2' ' A' ' 76' ' ' PHE . 69.0 t-105 -104.7 130.77 52.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.935 -167.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 80' ' ' THR . 1.1 t70 57.06 -153.54 0.37 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.367 168.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.404 ' H ' ' CG ' ' A' ' 79' ' ' ASP . 5.5 t -54.15 -33.45 57.98 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.48 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.891 ' HG3' ' HA ' ' A' ' 112' ' ' ILE . 13.5 mm-40 -90.61 172.4 8.71 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.422 -167.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.885 ' HA2' ' HE2' ' A' ' 106' ' ' LYS . . . -105.66 22.3 32.49 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.534 -163.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.83 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -72.72 112.61 8.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.089 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.55 88.07 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.868 161.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 83' ' ' TRP . 14.3 m -86.67 119.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.545 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.73 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 90.4 m -121.1 133.17 55.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.794 -168.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.639 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.6 m-30 -112.9 132.8 55.16 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.551 -0.718 . . . . 0.0 109.835 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -122.29 125.9 46.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.761 0.791 . . . . 0.0 110.43 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.06 HD21 ' HB3' ' A' ' 71' ' ' PRO . 63.1 tp -124.78 144.64 50.15 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.672 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -110.53 123.4 49.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.66 0.384 . . . . 0.0 110.453 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.908 ' HB2' HD12 ' A' ' 22' ' ' ILE . 8.5 t70 -94.61 111.27 23.04 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.234 0.54 . . . . 0.0 110.882 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.658 ' CB ' ' HB3' ' A' ' 94' ' ' GLU . 19.4 mt -120.36 152.86 37.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.372 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.4 -23.36 68.36 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 163.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.968 ' HG2' ' HD3' ' A' ' 95' ' ' LYS . 17.8 tt0 -58.9 -160.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 111.086 -2.557 . . . . 0.0 108.698 155.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.968 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -100.44 -175.97 3.07 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -173.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.495 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -106.44 126.05 51.76 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 119.777 1.171 . . . . 0.0 109.005 -164.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.68 117.43 5.65 Favored Glycine 0 CA--C 1.491 -1.455 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.503 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.67 ' HE2' HD12 ' A' ' 100' ' ' LEU . 13.8 t80 -103.66 126.74 50.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.803 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.4 m -122.34 115.36 22.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.039 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.67 HD12 ' HE2' ' A' ' 98' ' ' PHE . 6.2 tt -107.51 137.31 45.77 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.104 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.73 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -120.05 125.96 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.727 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' HD21 ' A' ' 100' ' ' LEU . 1.9 m170 -119.25 113.66 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -131.46 160.93 33.72 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.676 ' HA3' HD12 ' A' ' 9' ' ' LEU . . . -140.7 128.78 3.89 Favored Glycine 0 C--N 1.314 -0.691 0 O-C-N 124.046 0.841 . . . . 0.0 111.952 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -132.77 125.36 29.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.885 ' HE2' ' HA2' ' A' ' 82' ' ' GLY . 3.7 tppt? -177.34 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.75 0.31 . . . . 0.0 110.773 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 41.2 mm-40 -118.19 130.19 24.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.171 -174.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 3.1 Cg_exo -81.18 62.19 8.4 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.165 2.576 . . . . 0.0 111.999 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.412 ' HB2' ' H ' ' A' ' 110' ' ' GLN . 3.9 m120 -120.71 -85.88 0.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' H ' ' HB2' ' A' ' 109' ' ' ASN . 4.3 pm0 -140.77 152.72 45.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.836 HG22 HG21 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -107.92 -177.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.46 -1.296 . . . . 0.0 112.816 -171.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.929 HD12 HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.65 -45.72 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 111.78 -2.464 . . . . 0.0 114.774 -160.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 1.013 ' HA2' ' HB ' ' A' ' 122' ' ' VAL . . . 59.93 -127.41 44.15 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -164.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.586 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 12.9 ptmm? -82.68 128.79 34.69 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 146.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.781 ' HB2' ' CZ2' ' A' ' 83' ' ' TRP . . . -48.37 -11.39 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 -142.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 114' ' ' LYS . 18.6 p30 -101.61 29.84 4.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 120.036 1.289 . . . . 0.0 111.627 169.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.747 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 46.8 mm-40 -116.76 -157.29 0.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.781 0.432 . . . . 0.0 111.793 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.794 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.9 mttt -99.31 161.94 13.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.759 ' HA ' HG11 ' A' ' 111' ' ' VAL . 2.7 p -71.79 -45.24 62.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.257 -1.338 . . . . 0.0 114.374 173.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 m -65.99 -31.47 72.38 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.407 1.099 . . . . 0.0 108.044 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.794 ' HB ' ' HB2' ' A' ' 118' ' ' LYS . 12.7 t -71.7 -45.59 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.421 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 1.013 ' HB ' ' HA2' ' A' ' 113' ' ' GLY . 8.6 p -60.27 -40.48 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 12' ' ' ILE . 15.0 ttp85 -63.16 -31.14 72.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -73.94 -34.37 55.95 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.013 175.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 30.7 mmmt -60.6 -42.32 96.55 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.011 0.91 . . . . 0.0 109.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.661 ' HA ' ' HE1' ' A' ' 126' ' ' MET . 3.7 mmt -81.63 -24.61 36.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.911 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 14' ' ' LYS . 19.4 t70 -76.7 -14.98 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.763 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -129.12 -51.97 0.11 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.894 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.92 -32.02 82.54 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.774 -0.713 . . . . 0.0 113.148 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.711 ' CE3' ' HA ' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -62.65 -55.72 24.35 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 118.138 0.969 . . . . 0.0 110.513 -175.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.692 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.3 p -62.47 -28.95 70.17 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.513 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.2 -63.56 5.06 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 118.828 -1.653 . . . . 0.0 111.173 169.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.541 HG13 ' HE3' ' A' ' 130' ' ' TRP . 1.1 pt -77.16 -49.56 22.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.775 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.0 p -79.45 -43.4 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 112.436 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.739 HD21 ' HB ' ' A' ' 16' ' ' ILE . 10.7 t-20 -74.84 -40.83 60.8 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.993 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.748 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 3.6 tp10 -95.82 -46.16 6.68 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.857 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.054 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 13.8 tpp180 -82.75 -32.02 28.06 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.775 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 49.0 tp -64.38 -40.49 95.92 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.637 ' HB2' HD13 ' A' ' 16' ' ' ILE . 3.7 tmm_? -65.59 -29.95 70.62 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.175 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.054 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -71.37 -46.59 60.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 177.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 28' ' ' THR . . . -67.56 -28.84 68.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.194 0.521 . . . . 0.0 109.668 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.873 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 24.1 m -94.05 -15.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.64 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -149.7 -58.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.278 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.727 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 9.9 tt0 52.13 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.563 1.145 . . . . 0.0 112.925 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 53.5 tp 173.64 -75.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -167.55 88.64 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.944 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -131.59 99.29 4.75 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -65.22 -25.22 67.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.017 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 51.17 26.65 3.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.937 1.295 . . . . 0.0 112.234 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -166.64 64.64 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.69 -31.85 52.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.49 175.577 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 107.93 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.305 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -62.43 -44.36 96.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.785 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -173.21 127.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.52 129.01 55.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.0 111.08 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.564 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 5.5 tp10 -105.64 -67.19 0.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.918 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' A' ' 110' ' ' GLN . 12.3 t-20 -162.34 -40.92 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 108' ' ' PRO . . . 84.37 151.51 0.08 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 163.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.89 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 1.4 pp -82.51 157.63 67.2 Favored Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.193 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD2' ' HD3' ' A' ' 123' ' ' ARG . 8.5 Cg_exo -71.23 146.72 51.95 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.027 1.818 . . . . 0.0 108.737 162.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.48 124.82 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.533 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.652 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -106.45 127.84 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.93 134.33 55.28 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.875 ' HD3' HG23 ' A' ' 131' ' ' THR . 8.9 mmpt? -123.49 131.5 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.2 133.74 54.72 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.396 1.093 . . . . 0.0 111.566 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.741 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.8 148.19 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.814 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.741 ' N ' HG12 ' A' ' 16' ' ' ILE . 15.6 m -97.25 120.01 36.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.571 HD21 ' CD1' ' A' ' 16' ' ' ILE . 23.3 mt -90.02 107.65 19.25 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.892 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -76.83 87.28 3.42 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 116.641 -2.024 . . . . 0.0 107.044 177.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.769 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.65 165.39 18.52 Favored Pre-proline 0 C--O 1.213 -0.839 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.937 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 80.4 Cg_endo -75.7 157.71 39.75 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 120.752 0.968 . . . . 0.0 110.193 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 91' ' ' ASP . 2.5 tt -52.67 -35.75 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.842 0.83 . . . . 0.0 111.108 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.547 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 2.1 pt20 -68.63 -29.66 68.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.355 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -75.6 -40.58 56.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.042 0.925 . . . . 0.0 109.421 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.658 HG22 HG11 ' A' ' 142' ' ' VAL . 8.5 t -66.45 -35.43 74.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.133 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.536 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 1.9 t90 -55.72 -43.75 76.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.96 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.713 ' C ' HG22 ' A' ' 31' ' ' THR . 37.7 tt0 -67.98 -28.75 67.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.889 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.589 ' O ' HG21 ' A' ' 28' ' ' THR . 7.0 m -101.55 -9.02 21.37 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.903 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -131.07 -65.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 121.174 1.807 . . . . 0.0 113.811 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.656 ' HA ' HD13 ' A' ' 74' ' ' LEU . 21.9 p -97.49 68.34 2.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.505 -1.372 . . . . 0.0 109.057 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.713 HG22 ' C ' ' A' ' 27' ' ' GLU . 2.2 t -156.32 -177.44 6.59 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.154 -169.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.748 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 17.4 m -62.25 170.52 2.26 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.293 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -49.75 -8.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 126.092 1.757 . . . . 0.0 114.435 -156.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.78 -33.91 75.18 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.08 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.903 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.81 -44.53 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 121.679 0.752 . . . . 0.0 112.398 173.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . . . -56.7 -31.67 64.71 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.54 0.686 . . . . 0.0 110.03 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 52.1 tttp -78.78 50.03 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.424 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.77 ' CZ3' HG22 ' A' ' 134' ' ' VAL . 13.8 m0 -94.72 64.63 2.98 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.725 -1.235 . . . . 0.0 108.169 168.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 38' ' ' TRP . 92.5 t80 77.35 -17.1 0.59 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.146 0.578 . . . . 0.0 110.464 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.48 ' CG ' ' HD2' ' A' ' 41' ' ' PRO . 24.7 ttt -96.41 151.63 38.18 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.47 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 40' ' ' MET . 87.3 Cg_exo -47.37 149.9 3.91 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 113.041 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.649 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 9.6 p30 -99.69 155.24 17.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -177.17 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.509 0.505 . . . . 0.0 111.792 -172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.687 ' HD2' HD13 ' A' ' 35' ' ' ILE . 30.0 t80 -65.56 140.86 58.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.748 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 20.2 mt-30 -139.62 144.85 37.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 31' ' ' THR . 2.5 pt? -72.29 101.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 123.388 1.566 . . . . 0.0 109.834 -172.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HB3' ' CG ' ' A' ' 50' ' ' GLN . 4.4 mptp? -132.08 153.79 50.1 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 112.233 -2.258 . . . . 0.0 107.193 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.726 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.3 mt-10 -122.48 134.96 54.56 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 119.265 0.938 . . . . 0.0 112.345 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.06 35.99 42.49 Favored Glycine 0 N--CA 1.462 0.405 0 O-C-N 124.057 0.848 . . . . 0.0 112.121 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.89 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.1 173.32 6.37 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.188 -1.006 . . . . 0.0 108.502 -171.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.852 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 17.5 mp0 -118.76 130.94 56.08 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.431 156.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -128.51 128.22 43.92 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.896 0.379 . . . . 0.0 111.433 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.869 ' HB3' ' HG3' ' A' ' 62' ' ' PRO . 34.9 p-80 -140.56 140.64 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.622 -171.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.4 mt -89.05 -42.68 11.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 167.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -137.39 153.81 50.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.388 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 19.8 m -91.24 113.99 60.19 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 8.3 Cg_exo -72.03 72.2 2.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.341 2.694 . . . . 0.0 112.264 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 59.1 21.36 9.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.934 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' HA2' ' HD3' ' A' ' 60' ' ' PRO . . . -170.26 140.02 5.81 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.359 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 2.9 Cg_exo -77.21 43.13 1.24 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.59 2.86 . . . . 0.0 112.528 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.4 m -148.77 94.78 4.04 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.869 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 86.5 Cg_endo -83.21 -113.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.7 2.267 . . . . 0.0 112.85 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.686 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 31.9 m -102.0 161.36 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.472 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -148.28 129.28 14.44 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.89 ' HB ' HE22 ' A' ' 50' ' ' GLN . 59.2 t -83.21 131.32 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.052 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.59 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -66.78 -54.54 21.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.626 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.04 146.14 17.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.294 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.726 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -138.17 136.16 44.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.934 176.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 20.9 mt-30 -141.28 137.4 32.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.329 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 134.24 94.0 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.754 ' C ' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -4.55 64.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.306 1 C-N-CA 125.872 4.381 . . . . 0.0 115.665 -157.782 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.481 ' N ' ' HB2' ' A' ' 89' ' ' LEU . 6.5 p -137.83 -49.56 0.58 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.561 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -147.97 144.19 27.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 110.271 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 87' ' ' PHE . 8.7 tt -142.84 125.34 15.73 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.639 ' O ' HG13 ' A' ' 65' ' ' VAL . 74.2 m -136.92 124.12 21.78 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.544 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.542 ' CB ' HG21 ' A' ' 65' ' ' VAL . 9.2 p90 -152.7 156.41 39.11 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.791 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 51.8 mt-10 -118.67 132.89 56.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.493 0.663 . . . . 0.0 109.645 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -107.14 130.43 54.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.925 -160.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' THR . 3.5 t70 51.51 -114.55 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.069 1.348 . . . . 0.0 114.408 170.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.461 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.9 t -103.5 -15.51 15.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.352 -169.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.93 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 14.2 mp0 -94.89 151.28 19.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.85 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.49 38.51 3.21 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.411 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -86.43 116.87 24.85 Favored 'General case' 0 CA--C 1.486 -1.51 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.722 -177.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.495 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 4.2 p -86.47 84.94 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.131 -1.849 . . . . 0.0 106.539 165.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 83' ' ' TRP . 16.3 m -84.42 123.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.335 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 85.6 m -120.85 138.28 54.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.325 -169.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.667 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 18.9 m-30 -111.61 130.87 55.61 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -116.49 125.57 52.13 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.929 1.347 . . . . 0.0 109.778 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.754 ' HB2' ' C ' ' A' ' 71' ' ' PRO . 1.8 mt -122.21 139.43 53.78 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.813 -158.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' HG22 ' A' ' 96' ' ' THR . 3.6 tp10 -115.5 132.2 56.7 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 122.189 -0.32 . . . . 0.0 111.083 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.828 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.16 107.32 19.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.317 1.011 . . . . 0.0 109.819 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.943 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 17.9 mt -126.58 134.26 50.87 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 167.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.66 -25.44 63.44 Favored Glycine 0 N--CA 1.47 0.953 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 161.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.943 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 15.9 tt0 -55.17 -158.8 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 111.155 -2.523 . . . . 0.0 109.23 154.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -98.54 175.1 6.13 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.35 136.35 49.66 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.645 0.736 . . . . 0.0 110.962 -157.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.65 115.26 5.17 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 118.9 -1.619 . . . . 0.0 110.06 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.708 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 12.7 t80 -108.21 125.95 52.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.643 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -123.78 116.19 22.6 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.595 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.9 HD23 ' HE1' ' A' ' 130' ' ' TRP . 4.2 tt -108.1 140.49 41.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.742 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -119.67 124.27 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.881 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -118.78 110.31 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 168.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.871 ' HA ' HD13 ' A' ' 9' ' ' LEU . 33.9 t -144.23 163.91 32.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.782 -167.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.495 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -154.2 132.7 3.62 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.618 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 71.5 t-105 -79.42 122.52 26.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.744 0.772 . . . . 0.0 111.772 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.849 ' HG3' ' H ' ' A' ' 107' ' ' GLU . 2.9 tptm 159.42 -156.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.068 1.347 . . . . 0.0 107.748 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.849 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 40.6 mt-10 -121.33 116.25 30.98 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 117.991 0.359 . . . . 0.0 110.413 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 35.8 Cg_endo -64.28 137.32 55.57 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 124.067 3.178 . . . . 0.0 116.964 -164.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 179.61 -64.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.95 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.784 ' O ' ' HB3' ' A' ' 119' ' ' SER . 6.2 tp60 -96.4 162.11 13.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.226 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.647 HG13 ' C ' ' A' ' 117' ' ' GLU . 14.6 m -74.18 -179.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 CA-C-O 123.304 1.526 . . . . 0.0 112.101 -164.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.93 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -52.86 -45.76 51.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 111.377 -2.647 . . . . 0.0 112.036 -177.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 6' ' ' GLU . . . -161.45 -74.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.827 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 4.7 tmtt? -140.55 43.75 1.86 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 169.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.859 ' HB1' ' HG2' ' A' ' 81' ' ' GLU . . . -71.56 -26.18 62.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.501 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -178.93 -79.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.296 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.647 ' C ' HG13 ' A' ' 111' ' ' VAL . 1.7 tm-20 -164.48 -74.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.695 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.858 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 24.9 mttm -92.68 141.49 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 111.644 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.89 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 78.6 p -66.38 -41.48 89.33 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.447 0.642 . . . . 0.0 111.478 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.6 m -66.7 -30.3 70.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.703 0.764 . . . . 0.0 109.617 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.858 ' HB ' ' HB2' ' A' ' 118' ' ' LYS . 13.8 t -71.57 -44.26 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.468 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.716 HG11 HD11 ' A' ' 112' ' ' ILE . 13.0 p -65.42 -39.31 84.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.454 0.471 . . . . 0.0 111.238 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.587 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.5 ptt180 -68.52 -28.41 66.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -69.97 -29.29 70.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.1 mmmm -61.87 -38.9 89.99 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.264 1.03 . . . . 0.0 108.634 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.926 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 20.7 mtt -75.9 -28.08 57.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.386 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.591 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 20.0 t70 -78.01 -15.54 58.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.876 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.05 -54.44 0.21 Allowed Glycine 0 C--O 1.244 0.772 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.789 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.82 -17.14 80.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.302 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.926 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 43.7 t-105 -89.0 -14.19 37.08 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.706 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.875 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.2 p -82.47 -32.81 28.7 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.562 164.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.69 -53.9 36.33 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 118.24 -1.934 . . . . 0.0 109.417 168.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.9 mt -69.45 -55.76 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.982 -0.609 . . . . 0.0 112.588 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.77 HG22 ' CZ3' ' A' ' 38' ' ' TRP . 38.6 t -84.12 -44.94 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.362 -0.836 . . . . 0.0 112.291 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.685 ' HA ' HG23 ' A' ' 16' ' ' ILE . 36.6 t-20 -72.55 -40.01 67.03 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.559 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.785 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.5 tt0 -97.26 -45.56 6.45 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.66 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.758 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 17.2 tpp180 -82.5 -31.7 29.15 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.696 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.8 tp -64.06 -40.12 95.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 120.08 1.309 . . . . 0.0 108.274 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 2.9 tmt_? -62.75 -32.18 73.27 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.785 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 50.8 mtmt -74.72 -43.37 55.4 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 28' ' ' THR . . . -67.13 -28.79 68.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.778 -0.576 . . . . 0.0 110.229 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.658 HG11 HG22 ' A' ' 25' ' ' VAL . 32.9 m -87.32 -21.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 63.2 mm-40 -143.7 -63.57 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.131 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.712 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 35.5 tt0 59.72 137.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.066 -171.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.57 51.21 1.23 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.678 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 32.87 56.41 0.43 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.131 1.373 . . . . 0.0 113.792 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 69.76 -67.56 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.942 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.9 t60 73.04 129.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -166.17 127.12 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.601 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -131.93 135.26 46.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.03 106.95 7.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.4 t60 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.064 175.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.8 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 113' ' ' GLY . . . -140.44 82.92 1.88 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -99.86 -32.56 10.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.211 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -112.64 158.5 19.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.996 0.427 . . . . 0.0 111.17 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 80' ' ' THR . 27.8 p-10 -98.93 144.91 27.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.608 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.668 ' HG3' ' N ' ' A' ' 7' ' ' ASN . 7.0 pt-20 -144.4 -48.06 0.26 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.371 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.668 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 9.0 p30 -116.93 -120.75 0.3 Allowed 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 112' ' ' ILE . . . 164.42 166.99 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.679 -170.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.868 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -81.46 155.67 71.38 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.383 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.28 142.22 29.6 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.094 1.863 . . . . 0.0 109.805 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.92 119.39 5.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.359 0.6 . . . . 0.0 110.964 -170.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.733 HG12 ' HG2' ' A' ' 123' ' ' ARG . 0.8 OUTLIER -105.16 127.56 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.788 -177.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -122.8 133.68 54.44 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.601 173.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -126.08 128.15 46.92 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 p -125.62 137.61 53.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.68 1.229 . . . . 0.0 112.711 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.9 149.54 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 112.687 -2.051 . . . . 0.0 108.123 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.806 ' N ' HG12 ' A' ' 16' ' ' ILE . 59.2 m -93.51 119.15 32.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.593 HD22 ' CD1' ' A' ' 16' ' ' ILE . 16.4 mt -89.73 107.68 19.24 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 2.2 pt-20 -73.95 87.94 1.84 Allowed 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 117.145 -1.822 . . . . 0.0 106.128 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . . . -152.3 168.89 10.43 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.284 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -80.01 150.73 20.8 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.166 1.244 . . . . 0.0 109.455 164.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.753 HD12 ' HB3' ' A' ' 91' ' ' ASP . 14.1 tt -55.41 -32.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.737 0.78 . . . . 0.0 110.947 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.614 ' HG3' ' HB2' ' A' ' 21' ' ' PRO . 1.1 pp0? -68.88 -29.41 67.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.897 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 4.6 tppp? -79.47 -38.15 35.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.764 HG23 HG11 ' A' ' 142' ' ' VAL . 9.4 t -64.82 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.58 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.625 ' CZ2' ' HB3' ' A' ' 70' ' ' ALA . 1.2 t-105 -54.7 -41.52 70.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.465 173.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.776 ' C ' HG22 ' A' ' 31' ' ' THR . 33.3 mm-40 -68.58 -28.29 66.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.29 170.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.603 HG23 HD13 ' A' ' 138' ' ' LEU . 3.6 m -99.95 -10.2 21.92 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.904 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.0 m -131.66 -64.19 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 121.324 1.875 . . . . 0.0 113.696 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.676 ' HA ' HD12 ' A' ' 74' ' ' LEU . 24.0 p -98.1 66.85 1.85 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.776 HG22 ' C ' ' A' ' 27' ' ' GLU . 2.5 t -157.22 -177.36 6.55 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.6 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 35' ' ' ILE . 30.7 m -62.08 172.33 1.44 Allowed 'General case' 0 C--N 1.311 -1.079 0 O-C-N 124.025 0.828 . . . . 0.0 109.62 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.64 ' HG2' ' HB2' ' A' ' 43' ' ' ASP . 7.0 mt-10 -48.0 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.983 1.713 . . . . 0.0 114.769 -163.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.34 -34.81 68.87 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.823 169.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.904 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.24 -36.26 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 121.978 0.894 . . . . 0.0 111.124 170.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 33' ' ' GLU . . . -54.02 -29.97 45.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.908 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -46.53 -46.14 19.06 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.71 ' CZ3' HG21 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -79.31 70.66 5.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.748 0.704 . . . . 0.0 111.674 -175.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 69.06 169.1 0.29 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.603 167.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 76.3 mtp 64.08 112.98 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.242 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.45 106.74 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.253 2.635 . . . . 0.0 112.816 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 78' ' ' TRP . 31.2 t-20 -156.43 164.95 37.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.34 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.64 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 8.4 p-10 -154.5 38.58 0.43 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.004 0.907 . . . . 0.0 108.798 173.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 74' ' ' LEU . 29.2 t80 -42.41 144.29 0.53 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.282 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -140.13 141.36 36.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.41 101.92 3.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 117.29 -1.764 . . . . 0.0 109.774 -171.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 69.6 mttt -133.36 152.88 51.95 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-N 112.048 -2.342 . . . . 0.0 107.725 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.729 ' HG3' HG13 ' A' ' 68' ' ' VAL . 24.7 mt-10 -123.48 129.35 51.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 118.937 0.789 . . . . 0.0 112.167 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.22 64.0 Favored Glycine 0 N--CA 1.461 0.349 0 CA-C-O 122.081 0.823 . . . . 0.0 111.856 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.837 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.58 172.7 6.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.38 -1.41 . . . . 0.0 107.989 -177.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.721 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 31.8 mt-10 -124.62 128.55 49.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.89 159.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -130.62 125.73 34.85 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -146.94 139.32 24.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.381 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 54' ' ' LEU . 2.0 tm? -90.12 -11.33 41.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -70.86 -179.91 2.42 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.366 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -53.31 127.49 48.28 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.712 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.96 165.42 32.39 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.436 2.757 . . . . 0.0 111.666 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 59.02 26.36 14.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.657 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.81 -154.2 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.31 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.71 146.28 72.38 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.939 2.426 . . . . 0.0 112.014 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -63.97 122.96 80.29 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.718 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.721 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 72.7 Cg_endo -78.55 -86.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.534 2.156 . . . . 0.0 113.576 -171.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.664 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 59.9 m -130.37 159.59 36.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.292 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.787 ' HB2' ' HZ3' ' A' ' 64' ' ' LYS . 4.4 ttmp? -143.46 131.02 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.837 ' HB ' HE22 ' A' ' 50' ' ' GLN . 53.0 t -80.92 127.56 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.524 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.545 HD23 ' HG3' ' A' ' 77' ' ' GLU . 4.2 mm? -66.89 -50.73 61.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 174.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.41 142.79 15.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.667 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.729 HG13 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -136.21 132.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.553 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -137.84 138.13 38.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.743 -173.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.15 124.42 86.8 Favored Pre-proline 0 CA--C 1.507 -0.694 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.527 -167.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.607 ' C ' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.61 64.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.574 1 C-N-CA 126.085 4.523 . . . . 0.0 115.267 -158.279 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 13.4 p -133.13 -46.78 0.84 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.862 166.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -146.73 141.98 27.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.428 0.632 . . . . 0.0 110.983 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.5 tt -138.92 124.9 19.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.579 ' O ' HG11 ' A' ' 65' ' ' VAL . 69.4 m -137.44 125.36 22.68 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.41 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.546 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 11.4 p90 -151.77 157.27 41.75 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 32.7 mt-10 -116.29 131.96 56.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.957 0.884 . . . . 0.0 108.932 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.718 ' HB3' ' CE3' ' A' ' 83' ' ' TRP . 3.6 t90 -104.52 104.21 14.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.159 -1.837 . . . . 0.0 114.35 -155.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.649 ' HB2' ' HD1' ' A' ' 78' ' ' TRP . 2.0 t70 59.14 -123.14 1.23 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 161.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.838 HG23 ' HE2' ' A' ' 114' ' ' LYS . 4.6 t -81.15 -20.71 40.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.268 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.025 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.3 mp0 -97.19 172.05 8.06 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.671 ' H ' HG21 ' A' ' 112' ' ' ILE . . . -126.88 48.65 0.96 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.142 -1.504 . . . . 0.0 113.655 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.792 ' HB2' HG12 ' A' ' 85' ' ' VAL 0.259 0.0 OUTLIER -81.32 137.84 35.74 Favored 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 117.507 -1.677 . . . . 0.0 107.476 172.594 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.432 ' H ' ' CA ' ' A' ' 104' ' ' GLY . 17.6 t -85.97 71.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 125.126 1.516 . . . . 0.0 106.969 163.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.792 HG12 ' HB2' ' A' ' 83' ' ' TRP . 31.6 m -65.98 130.47 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.203 0.525 . . . . 0.0 110.264 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 63.8 m -126.18 132.56 51.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.077 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.625 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 19.9 m-85 -111.8 131.28 55.44 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.178 0.989 . . . . 0.0 110.851 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 96' ' ' THR . 1.8 tm? -119.91 140.34 51.03 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.704 -171.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.587 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 6.1 tp10 -119.17 139.49 51.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.798 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.753 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.5 p-10 -110.74 110.55 21.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.587 ' HG ' ' HG3' ' A' ' 90' ' ' GLU . 56.1 mt -125.04 104.98 8.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.015 -0.428 . . . . 0.0 110.33 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.16 0.51 Allowed Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.69 117.47 23.55 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 118.416 -1.314 . . . . 0.0 111.437 151.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 92' ' ' LEU . 9.2 ptmt -179.99 162.8 1.03 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 162.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.743 HG23 HD13 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.29 125.56 52.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.987 169.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.72 115.79 5.31 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.713 ' HD1' HD21 ' A' ' 89' ' ' LEU . 14.1 t80 -102.6 127.74 49.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.569 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.1 m -123.32 114.84 20.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 1.005 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.9 tt -106.98 136.31 47.05 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.329 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.6 mp -119.05 124.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.018 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.436 ' CD2' HD23 ' A' ' 100' ' ' LEU . 2.0 m170 -116.69 106.66 13.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -146.44 165.14 30.29 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.731 -1.577 . . . . 0.0 107.853 -171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' CA ' ' H ' ' A' ' 84' ' ' VAL . . . -165.08 173.46 40.92 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -78.52 133.5 37.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 118.019 0.909 . . . . 0.0 111.016 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 7' ' ' ASN . 26.2 tptp 75.45 121.21 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.058 0.849 . . . . 0.0 110.872 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -134.43 83.24 44.0 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -175.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 33.4 Cg_endo -97.13 -105.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.756 2.971 . . . . 0.0 113.55 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -135.14 -42.5 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.597 ' O ' ' HB3' ' A' ' 119' ' ' SER . 8.0 tt0 -67.89 157.51 34.76 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.263 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 112' ' ' ILE . 3.1 m -80.05 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.615 1.674 . . . . 0.0 112.542 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 1.025 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -53.98 -45.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 110.129 -3.214 . . . . 0.0 110.941 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -169.38 -85.99 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.902 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 30.9 ttpt -115.73 22.89 12.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.781 0.801 . . . . 0.0 108.852 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.741 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -63.47 -22.37 66.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER 170.52 -78.1 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.43 ' C ' HG11 ' A' ' 111' ' ' VAL . 38.4 tt0 -170.73 -55.76 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.138 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.626 ' HB2' HG23 ' A' ' 121' ' ' VAL . 64.6 mmtt -94.77 127.52 40.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.217 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.868 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 94.8 p -59.59 -32.22 70.19 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 8.9 p -63.45 -41.99 98.64 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.609 -0.682 . . . . 0.0 111.945 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.626 HG23 ' HB2' ' A' ' 118' ' ' LYS . 20.7 m -72.08 -35.17 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 122.033 -0.417 . . . . 0.0 110.801 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.837 HG13 HD12 ' A' ' 112' ' ' ILE . 8.3 p -65.78 -33.75 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.702 0.763 . . . . 0.0 109.043 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.733 ' HG2' HG12 ' A' ' 12' ' ' ILE . 1.7 tmt_? -62.6 -33.85 75.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.481 172.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -72.52 -29.82 65.28 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.203 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.716 ' HD2' HG21 ' A' ' 122' ' ' VAL . 57.7 mttm -60.69 -42.83 97.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.285 1.04 . . . . 0.0 109.083 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.728 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 5.9 mmt -78.99 -20.91 47.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.595 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.8 t70 -76.47 -15.42 59.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.311 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.0 -52.35 0.13 Allowed Glycine 0 C--O 1.249 1.06 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.555 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.6 -21.65 72.87 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.79 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 1.005 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -73.5 -30.72 63.31 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.79 -171.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.2 p -74.17 -39.17 63.39 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.158 171.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -52.5 -53.06 33.89 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 118.218 -1.944 . . . . 0.0 110.492 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.663 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 82.4 mt -73.18 -55.2 13.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.733 HG22 HD11 ' A' ' 100' ' ' LEU . 17.5 t -84.39 -43.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 121.637 -0.664 . . . . 0.0 112.141 -177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.853 ' HA ' HG23 ' A' ' 16' ' ' ILE . 6.3 t30 -70.35 -40.02 74.32 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.321 -0.952 . . . . 0.0 108.574 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.845 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 3.5 tt0 -96.24 -45.45 6.83 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.917 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.699 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 tpp180 -82.01 -33.43 30.08 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.655 ' O ' HG21 ' A' ' 142' ' ' VAL . 18.5 tp -64.47 -40.15 95.15 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.465 -1.294 . . . . 0.0 107.945 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.5 tmm_? -65.36 -29.74 70.5 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.845 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 54.3 mtmt -72.59 -45.18 60.39 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 28' ' ' THR . . . -69.24 -29.87 67.89 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.764 HG11 HG23 ' A' ' 25' ' ' VAL . 23.3 m -86.63 -18.39 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 10.5 mm-40 -152.25 -51.58 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.632 ' N ' ' HA ' ' A' ' 140' ' ' LYS . 12.3 pt-20 40.95 47.04 2.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.91 0.862 . . . . 0.0 110.873 -169.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.83 65.34 9.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.748 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.62 141.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.184 0.992 . . . . 0.0 113.486 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -110.33 5.66 21.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -69.01 135.07 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.353 -174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 152' ' ' HIS . 12.4 m-70 -147.01 154.69 41.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 75.63 -40.92 0.43 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -171.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -87.59 1.53 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 163.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 149' ' ' HIS . 5.4 t-80 . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.213 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtm . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.99 78.94 1.26 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.73 0.3 . . . . 0.0 111.796 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -69.97 -40.26 75.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -153.34 153.29 32.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.978 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -110.38 145.39 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 7' ' ' ASN . 21.9 tt0 -66.07 -55.37 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.214 0.531 . . . . 0.0 110.08 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . 1.3 m-20 -175.36 -80.74 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.698 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.683 ' HA ' ' CB ' ' A' ' 119' ' ' SER . . . -111.14 -153.01 0.51 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 123' ' ' ARG . 2.1 tt -75.85 113.42 27.06 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.9 Cg_exo -71.76 -147.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.652 2.234 . . . . 0.0 110.124 176.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.689 ' HA ' ' HG ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -74.84 115.09 14.04 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.206 169.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.513 ' CG1' HD21 ' A' ' 9' ' ' LEU . 2.1 mm -106.24 121.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 162.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -120.04 131.36 55.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.922 ' HD2' HG22 ' A' ' 131' ' ' THR . 30.4 mmtm -127.52 128.97 46.56 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.591 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.44 135.58 54.71 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.398 1.094 . . . . 0.0 111.382 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.13 148.07 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 112.764 -2.017 . . . . 0.0 108.717 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.728 ' N ' HG12 ' A' ' 16' ' ' ILE . 2.0 m -96.17 119.35 34.51 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.091 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 16' ' ' ILE . 25.1 mt -91.79 108.53 19.98 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.892 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -75.09 89.24 2.45 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.379 -2.128 . . . . 0.0 106.177 175.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.39 168.25 12.54 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.439 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.2 Cg_endo -82.74 157.97 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.334 1.356 . . . . 0.0 110.289 165.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 1.04 HD12 ' HB2' ' A' ' 91' ' ' ASP . 13.5 tt -57.46 -32.49 41.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 121.967 0.889 . . . . 0.0 110.638 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -68.28 -30.96 70.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -177.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 59.6 tptt -82.34 -39.06 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.232 -0.917 . . . . 0.0 109.92 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.651 HG21 HG12 ' A' ' 142' ' ' VAL . 2.9 t -61.74 -34.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.245 166.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.609 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -55.1 -42.26 72.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.372 0.669 . . . . 0.0 109.755 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.712 ' C ' HG23 ' A' ' 31' ' ' THR . 34.1 tt0 -66.32 -28.37 68.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.463 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 28' ' ' THR . 4.7 m -100.84 -10.01 21.12 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.81 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.6 m -131.01 -64.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 121.56 1.982 . . . . 0.0 113.981 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.654 ' HA ' HD11 ' A' ' 74' ' ' LEU . 35.1 p -97.31 65.61 1.99 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.869 -1.144 . . . . 0.0 108.847 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.712 HG23 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -156.15 -177.54 6.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.641 -167.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 23.8 m -62.99 169.92 3.03 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.968 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 3.2 mt-10 -48.51 -2.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.024 1.73 . . . . 0.0 114.612 -163.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -56.93 -31.88 61.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.987 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.81 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.45 -36.16 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.547 0.689 . . . . 0.0 111.692 170.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -53.03 -33.76 53.3 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.008 -0.432 . . . . 0.0 111.339 167.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 45.6 mmtm -79.87 33.42 0.27 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.833 ' CZ3' HG21 ' A' ' 134' ' ' VAL . 1.5 m0 -87.35 -54.53 4.24 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 163.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.787 ' HB3' HD13 ' A' ' 133' ' ' ILE . 43.5 t80 171.04 62.33 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.875 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 17.8 tpt -153.67 124.7 3.55 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 22.0 Cg_exo -67.72 106.35 1.27 Allowed 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 122.379 2.053 . . . . 0.0 113.031 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.601 HD22 ' HA ' ' A' ' 36' ' ' ALA . 7.1 p30 -157.95 148.14 20.39 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.185 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.968 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 6.4 p30 -109.12 42.22 1.48 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.664 0.745 . . . . 0.0 109.01 172.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' A' ' 32' ' ' SER . 25.9 t80 -60.66 141.67 56.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.7 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -138.8 144.12 39.2 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.01 102.19 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 116.771 -1.972 . . . . 0.0 108.763 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 50.3 mttm -130.09 150.8 51.19 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 112.036 -2.347 . . . . 0.0 106.683 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CG ' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.79 129.65 50.86 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.536 -0.866 . . . . 0.0 113.06 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.73 37.43 68.8 Favored Glycine 0 N--CA 1.463 0.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.13 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.582 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -109.35 173.52 6.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.948 0.899 . . . . 0.0 109.734 -171.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.916 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 54.2 mp0 -118.78 130.62 55.89 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.51 156.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.732 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -130.54 129.96 43.5 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.597 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 13.0 p80 -146.46 136.75 23.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.897 171.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tt -88.17 -27.89 21.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.597 ' HG2' ' HB2' ' A' ' 53' ' ' HIS . 11.7 pt20 -59.56 136.38 57.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.844 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 57' ' ' PRO . 39.5 m -67.94 -37.41 11.54 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.304 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 56' ' ' SER . 81.5 Cg_exo -44.76 136.17 9.62 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.226 1.951 . . . . 0.0 112.803 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -76.59 78.9 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.836 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.84 112.5 3.72 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.2 -49.94 15.29 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.033 2.489 . . . . 0.0 112.545 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -138.81 94.87 9.99 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.916 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 61.8 Cg_endo -72.92 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.229 1.953 . . . . 0.0 111.599 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.741 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 41.6 t -121.79 149.51 43.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.455 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.582 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 21.6 pttp -135.93 133.88 38.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.685 HG11 ' HB ' ' A' ' 68' ' ' VAL . 71.0 t -84.16 127.38 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.908 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.783 HD11 ' OE1' ' A' ' 77' ' ' GLU . 0.9 OUTLIER -77.64 -39.28 45.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.286 179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.81 138.72 13.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.196 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.685 ' HB ' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -139.52 126.68 24.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.208 1.004 . . . . 0.0 110.91 174.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -137.01 139.05 41.14 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.621 -173.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.0 127.65 92.05 Favored Pre-proline 0 CA--C 1.504 -0.791 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -167.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.68 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -5.07 65.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 1 C-N-CA 126.263 4.642 . . . . 0.0 115.392 -157.861 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.8 p -135.53 -48.48 0.7 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.156 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.51 131.94 20.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 109.893 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.734 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.2 tt -131.84 124.67 30.06 Favored 'General case' 0 C--O 1.202 -1.4 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.489 ' O ' HG12 ' A' ' 65' ' ' VAL . 67.6 m -137.92 123.49 19.71 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.269 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 11.5 p90 -154.01 153.9 32.77 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.754 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.868 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 3.5 mp0 -118.67 126.72 52.55 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.61 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.588 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -82.35 130.63 35.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.796 -166.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' H ' ' HB2' ' A' ' 63' ' ' CYS . 11.9 t0 33.07 -108.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.943 1.402 . . . . 0.0 114.602 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.472 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 3.9 t -91.78 -31.86 15.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.123 -168.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.075 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.5 mp0 -81.75 154.34 26.04 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.608 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -94.69 33.05 5.57 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.311 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.868 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.77 114.61 21.73 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.562 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 1.031 HG13 ' HA2' ' A' ' 104' ' ' GLY . 6.8 p -85.14 75.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 O-C-N 125.028 1.455 . . . . 0.0 108.05 167.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.753 HG11 ' HB2' ' A' ' 83' ' ' TRP . 14.7 m -69.97 120.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.818 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.786 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 95.7 m -120.15 136.9 54.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.832 -168.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.67 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 18.6 m-85 -115.08 131.61 56.87 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -122.06 128.85 51.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.82 0.819 . . . . 0.0 110.708 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.68 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 0.9 OUTLIER -121.71 145.07 48.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.976 -171.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 1.6 tt0 -109.68 120.53 42.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 1.04 ' HB2' HD12 ' A' ' 22' ' ' ILE . 2.9 t70 -94.86 110.78 22.62 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 23.1 mt -120.18 144.89 47.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.851 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.78 -24.74 64.81 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 163.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.732 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 16.6 tt0 -57.31 -158.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 110.968 -2.616 . . . . 0.0 109.119 154.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -99.14 -178.48 3.94 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 -174.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -110.86 128.57 55.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.553 0.692 . . . . 0.0 110.274 -161.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.34 116.65 5.43 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 119.112 -1.518 . . . . 0.0 110.264 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.704 ' HE2' HD13 ' A' ' 100' ' ' LEU . 22.2 t80 -103.78 126.66 51.06 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.943 -170.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 m -123.04 115.39 21.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.443 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.788 ' CD2' ' HE1' ' A' ' 130' ' ' TRP . 4.8 tt -107.89 140.77 40.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.691 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.786 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.7 mp -120.41 125.82 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.975 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.47 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.3 m170 -118.29 110.04 17.04 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.689 ' HG ' ' HA ' ' A' ' 11' ' ' ASP . 66.3 m -146.34 164.29 32.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.575 -174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 1.031 ' HA2' HG13 ' A' ' 84' ' ' VAL . . . -170.23 176.76 43.81 Favored Glycine 0 C--N 1.312 -0.795 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -75.01 147.71 40.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.52 0.66 . . . . 0.0 110.672 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -120.67 167.49 12.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.524 -167.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -167.6 -60.45 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.983 172.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 89.9 Cg_endo -100.88 168.37 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.803 2.336 . . . . 0.0 112.796 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.27 49.85 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.179 0.99 . . . . 0.0 110.059 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.542 ' O ' ' HB3' ' A' ' 119' ' ' SER . 8.7 tt0 -139.64 162.32 35.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.369 -166.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.724 HG21 ' H ' ' A' ' 112' ' ' ILE . 1.3 p -77.22 174.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.077 0.941 . . . . 0.0 109.931 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 1.075 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -53.48 -31.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.78 -167.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 111' ' ' VAL . . . 156.0 60.18 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 67.05 31.0 7.16 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 0.0 110.683 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.747 ' HB1' ' HG2' ' A' ' 81' ' ' GLU . . . -68.57 -24.86 64.66 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -171.84 -67.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.555 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -169.41 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.773 ' HB2' HG13 ' A' ' 121' ' ' VAL . 50.5 mttm -93.01 147.18 23.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.324 0.583 . . . . 0.0 111.971 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.683 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p -58.38 -37.28 74.95 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.89 166.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 9.5 t -69.77 -36.06 75.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.574 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 118' ' ' LYS . 11.9 m -71.29 -37.12 64.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.602 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.847 HG12 HD11 ' A' ' 112' ' ' ILE . 12.2 p -67.14 -41.84 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.714 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . 17.0 ptt180 -65.1 -30.24 71.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.05 -30.73 67.35 Favored Glycine 0 C--O 1.238 0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.963 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 25.3 mtpp -59.78 -42.51 93.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.24 1.019 . . . . 0.0 108.796 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 1.018 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 9.8 mmt -78.22 -25.54 47.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.685 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.463 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 22.9 t0 -78.02 -13.75 59.76 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.873 -168.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.84 -53.78 0.16 Allowed Glycine 0 C--O 1.251 1.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.628 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.636 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -68.83 -27.3 73.99 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.457 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 10.7 t-105 -73.07 -30.45 63.7 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.182 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -70.32 -39.52 74.74 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.925 172.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.73 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -50.2 -50.41 34.3 Favored Glycine 0 C--N 1.308 -0.98 0 C-N-CA 118.236 -1.935 . . . . 0.0 110.933 168.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.787 HD13 ' HB3' ' A' ' 39' ' ' PHE . 27.1 mm -73.48 -55.41 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 122.317 -0.519 . . . . 0.0 112.186 -175.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.833 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 1.4 p -83.72 -44.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 O-C-N 121.717 -0.614 . . . . 0.0 112.503 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.766 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.6 t30 -70.89 -40.84 71.98 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.73 ' HB3' ' O ' ' A' ' 132' ' ' GLY . 36.5 tt0 -96.38 -46.41 6.4 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.273 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.053 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.1 tpp180 -84.61 -31.44 24.26 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 29.7 tp -63.23 -40.0 96.2 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 118.261 -1.375 . . . . 0.0 107.779 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.1 tmm_? -66.11 -30.86 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 170.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.053 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 3.0 mtpt -67.73 -45.04 76.17 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.02 -29.92 65.99 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.431 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.651 HG12 HG21 ' A' ' 25' ' ' VAL . 27.8 m -89.67 -16.89 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.565 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 139' ' ' ARG . 9.9 mt-10 -148.23 -61.17 0.25 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 12.6 tt0 60.63 131.37 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.932 0.893 . . . . 0.0 111.801 -169.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.94 89.95 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.496 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.7 100.48 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -139.42 62.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.576 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -54.37 -49.71 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.405 0.622 . . . . 0.0 109.801 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -151.8 128.21 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.001 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.405 ' HB3' ' H ' ' A' ' 151' ' ' HIS . 40.0 t60 -116.46 -84.9 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.405 ' H ' ' HB3' ' A' ' 150' ' ' HIS . 0.0 OUTLIER 168.58 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.835 0.709 . . . . 0.0 109.091 176.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.458 176.653 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 21.0 ptp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . . . -85.67 -166.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.014 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.64 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 14.5 mm100 -66.19 -47.93 72.3 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.242 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.69 128.04 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.589 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -111.49 120.44 42.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 0.0 109.652 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.4 -70.5 0.79 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.147 0.499 . . . . 0.0 111.064 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.813 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -149.39 -54.77 0.17 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.582 ' CB ' ' HA ' ' A' ' 112' ' ' ILE . . . 68.44 163.5 0.22 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 160.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.791 ' HG ' ' HB3' ' A' ' 123' ' ' ARG . 0.8 OUTLIER -72.05 129.68 87.56 Favored Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.585 170.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.686 ' HD2' HD23 ' A' ' 9' ' ' LEU . 24.5 Cg_exo -63.98 -152.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.265 1.977 . . . . 0.0 111.006 167.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' HB2' ' A' ' 103' ' ' SER . 10.3 p-10 -72.45 114.14 10.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.343 0.592 . . . . 0.0 110.642 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 168.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -119.51 133.31 55.74 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.572 0.701 . . . . 0.0 110.436 178.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.885 ' HD3' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.62 127.7 31.69 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.4 ' C ' ' HZ1' ' A' ' 14' ' ' LYS . 2.9 m -124.55 150.41 45.9 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.363 1.078 . . . . 0.0 112.103 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.76 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.11 148.12 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 113.142 -1.844 . . . . 0.0 108.541 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.76 ' N ' HG12 ' A' ' 16' ' ' ILE . 29.6 m -95.01 119.6 33.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.008 172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.558 HD21 ' CD1' ' A' ' 16' ' ' ILE . 17.6 mt -90.55 108.51 19.84 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.854 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.1 pt-20 -73.54 88.71 1.66 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 116.848 -1.941 . . . . 0.0 106.87 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.741 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.94 165.99 17.32 Favored Pre-proline 0 C--O 1.215 -0.763 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.506 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.0 Cg_endo -78.23 155.34 29.12 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.256 1.304 . . . . 0.0 110.359 168.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 91' ' ' ASP . 8.6 tt -52.73 -37.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.681 0.753 . . . . 0.0 111.029 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 11.0 pt20 -60.2 -32.15 70.82 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.33 -1.304 . . . . 0.0 114.061 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -79.92 -38.05 33.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.845 0.831 . . . . 0.0 110.097 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.672 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.8 -33.12 59.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.225 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.626 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -54.69 -43.15 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.8 172.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.713 ' C ' HG23 ' A' ' 31' ' ' THR . 24.6 tt0 -68.45 -28.59 67.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.52 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.574 HG23 HD13 ' A' ' 138' ' ' LEU . 4.5 m -101.45 -9.38 21.13 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 117.63 2.456 . . . . 0.0 117.63 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.938 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.6 m -132.09 -64.61 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.318 1.872 . . . . 0.0 113.89 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 74' ' ' LEU . 17.1 p -97.19 66.85 2.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.679 -1.263 . . . . 0.0 108.702 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.713 HG23 ' C ' ' A' ' 27' ' ' GLU . 4.7 t -157.62 -174.64 4.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.811 -167.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.499 ' O ' HG21 ' A' ' 35' ' ' ILE . 2.4 p -60.35 169.41 1.68 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.928 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 10.7 mt-10 -49.9 -8.01 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.805 1.642 . . . . 0.0 114.004 -161.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.39 -36.73 85.3 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.16 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.938 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.34 -41.38 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 117.642 0.721 . . . . 0.0 112.168 173.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -56.11 -31.89 63.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -56.3 -39.55 72.9 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.83 ' HB2' HG23 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -60.45 -33.66 72.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.116 1.325 . . . . 0.0 111.594 -172.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.569 ' HB2' ' HZ3' ' A' ' 130' ' ' TRP . 54.7 t80 -114.64 -50.85 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 112.144 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.614 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.6 mmm -108.59 -174.12 0.29 Allowed Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.871 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 31.7 Cg_exo -63.63 -158.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.741 1.628 . . . . 0.0 110.166 163.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.928 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 5.2 p-10 -99.37 142.15 31.23 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 53' ' ' HIS . 28.7 t70 -174.69 -55.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.239 0.337 . . . . 0.0 111.144 -171.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CE2' HD11 ' A' ' 74' ' ' LEU . 29.5 t80 -68.11 140.21 56.21 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.797 0.808 . . . . 0.0 112.703 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 31' ' ' THR . 39.2 mt-30 -140.46 147.8 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 171.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 31' ' ' THR . 2.4 pt? -73.31 103.32 3.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 116.882 -1.927 . . . . 0.0 108.505 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -130.71 150.24 51.98 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.407 -2.179 . . . . 0.0 106.972 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.703 ' OE2' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -123.45 131.72 53.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.05 40.8 59.18 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.106 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.823 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -109.46 174.4 5.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.494 1.118 . . . . 0.0 109.426 -172.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.712 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 49.0 mt-10 -123.27 128.92 50.64 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.468 155.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.547 ' O ' ' HD1' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -133.44 133.8 42.78 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.703 ' HB2' ' HG3' ' A' ' 62' ' ' PRO . 2.1 t-80 -148.22 136.96 21.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.493 170.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt 26.58 -90.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.133 1.521 . . . . 0.0 113.482 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.35 60.61 1.29 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.976 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.4 m -150.79 96.24 3.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.822 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.76 -39.95 7.88 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.604 2.203 . . . . 0.0 111.625 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -126.36 147.65 49.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.231 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 60' ' ' PRO . . . 126.42 -103.21 0.67 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 59' ' ' GLY . 5.9 Cg_exo -77.73 97.93 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.743 2.295 . . . . 0.0 111.343 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 p -62.25 110.61 3.47 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.811 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 38.2 Cg_endo -97.4 -102.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.468 2.112 . . . . 0.0 114.418 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.823 ' HB3' ' HA ' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -118.83 160.05 22.61 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.845 -169.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HD3' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -138.95 140.14 38.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.823 ' HB ' HE22 ' A' ' 50' ' ' GLN . 54.1 t -79.95 131.99 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.068 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -77.88 -44.93 25.64 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.486 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.703 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.34 135.8 11.3 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.544 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.627 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -130.44 127.41 62.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.904 174.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.35 138.3 44.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.61 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.97 93.43 Favored Pre-proline 0 CA--C 1.502 -0.865 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.984 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.54 62.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 1 C-N-CA 126.274 4.649 . . . . 0.0 115.583 -159.35 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -133.65 -52.67 0.87 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.394 169.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -143.18 132.92 23.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.502 0.667 . . . . 0.0 110.29 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.67 HD13 ' HA ' ' A' ' 30' ' ' SER . 8.8 tt -129.21 125.88 37.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.535 ' O ' HG11 ' A' ' 65' ' ' VAL . 63.2 m -137.98 126.37 23.28 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HE2' ' HD1' ' A' ' 78' ' ' TRP . 12.2 p90 -151.19 155.64 39.28 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.31 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.809 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 43.0 mt-10 -118.07 131.01 56.48 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.823 ' HA ' ' HB3' ' A' ' 63' ' ' CYS . 5.8 t90 -107.8 124.45 50.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -161.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.601 ' H ' ' HB3' ' A' ' 63' ' ' CYS . 1.0 OUTLIER 43.98 -131.95 0.73 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.216 -1.356 . . . . 0.0 114.131 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.64 ' HA ' ' HB2' ' A' ' 3' ' ' GLN . 7.5 t -76.84 -29.91 56.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.076 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.971 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 6.0 mp0 -81.46 148.14 29.39 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -86.66 37.6 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.142 -173.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.889 ' HB3' HG11 ' A' ' 85' ' ' VAL . 5.0 m-90 -71.99 118.63 15.09 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.51 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.614 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 p -95.91 90.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 156.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG11 ' HB3' ' A' ' 83' ' ' TRP . 11.0 m -89.91 127.13 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.26 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 80.1 m -126.53 136.2 52.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.829 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.3 m-85 -111.09 130.51 55.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' HG3' HD11 ' A' ' 101' ' ' ILE . 5.0 mm100 -115.66 127.73 55.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.742 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.984 HD12 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mt -123.74 144.64 49.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.188 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.12 120.19 41.49 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.692 ' HB3' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.57 108.41 16.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 O-C-N 123.822 0.701 . . . . 0.0 110.254 -174.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.989 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 39.4 mt -127.49 136.01 51.17 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.23 -25.27 66.33 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 159.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.989 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.0 tp10 -54.53 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.328 -2.436 . . . . 0.0 108.675 152.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.854 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.92 175.73 6.04 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.22 129.65 56.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.444 -0.785 . . . . 0.0 110.585 -160.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.38 115.1 5.04 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 118.443 -1.837 . . . . 0.0 110.442 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' HE2' HD23 ' A' ' 100' ' ' LEU . 11.9 t80 -105.65 130.98 53.57 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.588 -171.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -122.03 122.43 39.29 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.588 170.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.663 ' HG ' ' NE1' ' A' ' 130' ' ' TRP . 0.1 OUTLIER -104.85 136.63 43.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 3.5 mt -127.2 122.78 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.056 176.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.477 ' NE2' ' HZ2' ' A' ' 130' ' ' TRP . 1.3 m170 -119.53 112.2 19.05 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 40.3 t -137.91 162.75 33.22 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.614 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -147.24 143.27 11.11 Favored Glycine 0 C--N 1.299 -1.52 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.768 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 7.7 t-105 -79.73 120.77 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.52 1.16 . . . . 0.0 110.381 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.813 ' HB3' ' O ' ' A' ' 7' ' ' ASN . 20.8 tptt 147.67 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 O-C-N 125.062 1.476 . . . . 0.0 109.385 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -111.22 140.58 23.05 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 122.532 0.333 . . . . 0.0 111.066 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.603 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 71.3 Cg_endo -73.27 137.84 26.6 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.18 2.586 . . . . 0.0 115.194 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.479 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 28.3 t-20 171.13 -62.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.676 1.19 . . . . 0.0 108.635 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 119' ' ' SER . 9.2 tt0 -97.7 160.86 14.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.697 173.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.736 HG21 ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -80.27 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 118.751 0.705 . . . . 0.0 112.189 -164.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.971 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -52.65 -41.01 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.48 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.695 ' H ' HG11 ' A' ' 111' ' ' VAL . . . -178.5 -66.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.638 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 41.7 tttm -131.96 14.31 4.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.956 0.884 . . . . 0.0 108.64 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.559 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -59.84 -42.6 93.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.057 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 2.0 t-20 174.65 40.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.016 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.702 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 34.2 tt0 69.89 -71.75 0.12 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HB2' HG12 ' A' ' 121' ' ' VAL . 73.3 mmtt -94.93 136.49 35.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.608 ' O ' HG12 ' A' ' 122' ' ' VAL . 69.0 p -64.18 -35.1 79.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.617 0.722 . . . . 0.0 110.021 171.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 20.2 m -67.4 -37.56 83.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.384 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 118' ' ' LYS . 15.9 m -71.67 -37.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.189 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 112' ' ' ILE . 14.7 p -67.1 -37.14 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.791 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.33 -28.46 67.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.67 76.2 Favored Glycine 0 C--O 1.24 0.511 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.338 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.6 mtpp -60.21 -42.26 94.76 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.061 0.934 . . . . 0.0 109.415 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.921 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 11.3 mmt -76.89 -23.94 52.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.501 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.87 -14.43 58.66 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.314 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.96 -50.56 0.24 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.189 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -28.12 69.34 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.74 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.921 ' HB2' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -69.85 -26.62 64.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.885 HG22 ' HD3' ' A' ' 14' ' ' LYS . 2.0 p -81.73 -39.42 24.24 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.186 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.54 -52.95 48.74 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.083 -2.008 . . . . 0.0 109.897 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.83 HG23 ' HB2' ' A' ' 38' ' ' TRP . 66.2 mt -75.69 -55.59 10.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 114.741 -0.729 . . . . 0.0 112.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.752 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 22.0 t -82.54 -43.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 121.424 -0.797 . . . . 0.0 111.011 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.76 ' HB3' ' O ' ' A' ' 131' ' ' THR . 15.3 t-20 -72.75 -40.31 66.13 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.071 -172.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.873 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.3 tt0 -97.54 -45.65 6.33 Favored 'General case' 0 N--CA 1.42 -1.947 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.664 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.618 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.8 tpp180 -81.98 -33.03 30.39 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.611 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 19.2 tp -63.2 -40.56 97.84 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.367 -1.333 . . . . 0.0 107.626 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.817 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.0 tmm_? -65.18 -30.9 71.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.428 171.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.873 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 53.0 mtmt -73.76 -45.98 48.5 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.452 ' HB2' HG23 ' A' ' 28' ' ' THR . . . -68.18 -29.55 68.44 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.704 -0.622 . . . . 0.0 109.934 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.623 HG11 HG22 ' A' ' 25' ' ' VAL . 25.4 m -84.79 -21.85 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.406 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 13.4 mm-40 -147.29 -60.83 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.573 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 29.9 tt0 45.43 41.89 7.06 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.767 0.794 . . . . 0.0 111.461 -170.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 147' ' ' HIS . 3.4 mm? -85.14 139.67 31.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.806 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.13 87.05 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.759 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 152' ' ' HIS . 94.9 m-70 -138.77 54.09 1.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.845 175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -167.35 12.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -81.28 -57.29 3.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' ' 152' ' ' HIS . 68.7 m-70 -133.31 56.47 1.85 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 85.8 t60 70.79 -1.3 2.67 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.104 0.954 . . . . 0.0 108.888 -164.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 147' ' ' HIS . 41.7 t-80 . . . . . 0 C--O 1.246 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.349 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 62.5 mtt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . 66.56 75.98 0.31 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 109.943 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -79.43 -47.81 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.155 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -124.66 128.28 48.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.165 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.704 ' HB2' ' HG2' ' A' ' 110' ' ' GLN . 25.6 p-10 -80.68 125.23 29.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.75 -157.81 0.24 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.656 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.6 t30 87.35 -16.98 0.35 Allowed 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 125.111 1.364 . . . . 0.0 111.627 166.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.613 ' C ' ' HB2' ' A' ' 119' ' ' SER . . . 60.58 -154.95 0.36 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.226 -169.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD13 HD13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.4 135.02 94.64 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.54 130.69 41.36 Favored 'Trans proline' 0 CA--C 1.514 -0.488 0 C-N-CA 121.911 1.741 . . . . 0.0 109.141 172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -52.35 121.41 6.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.917 0.865 . . . . 0.0 111.242 -162.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.475 HG23 ' HB2' ' A' ' 126' ' ' MET . 0.9 OUTLIER -106.62 127.01 62.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.603 -169.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.1 p -117.49 134.1 55.22 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 121.197 0.522 . . . . 0.0 109.785 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.911 ' HD2' HG21 ' A' ' 131' ' ' THR . 0.0 OUTLIER -125.49 129.81 50.51 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -121.51 137.68 54.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.014 0.911 . . . . 0.0 110.857 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.774 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.1 148.52 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.177 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.774 ' N ' HG12 ' A' ' 16' ' ' ILE . 18.9 m -95.98 118.47 32.65 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.592 ' HB3' HG23 ' A' ' 142' ' ' VAL . 25.2 mt -91.12 110.32 21.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.86 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.4 pt-20 -75.06 88.42 2.41 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 116.871 -1.932 . . . . 0.0 106.993 175.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.697 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.28 167.15 14.94 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.721 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -81.94 156.31 17.82 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.348 1.365 . . . . 0.0 110.005 166.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.946 HD12 ' HB2' ' A' ' 91' ' ' ASP . 14.0 tt -54.43 -33.59 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.632 0.729 . . . . 0.0 110.747 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.643 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.7 pt20 -64.12 -31.05 72.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.865 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 1.077 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 4.4 tmtm? -81.76 -37.8 26.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.163 0.982 . . . . 0.0 109.071 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.538 HG21 HG13 ' A' ' 142' ' ' VAL . 3.2 t -64.4 -33.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.661 169.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.62 ' CZ2' ' HB2' ' A' ' 70' ' ' ALA . 1.2 t-105 -55.1 -42.66 73.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.927 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.701 ' C ' HG22 ' A' ' 31' ' ' THR . 34.8 tt0 -68.18 -28.33 67.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.167 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 m -101.1 -10.13 20.74 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -171.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.886 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -130.91 -65.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.348 1.885 . . . . 0.0 113.98 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.721 ' HA ' HD12 ' A' ' 74' ' ' LEU . 1.3 p -98.41 66.0 1.69 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.669 -1.269 . . . . 0.0 109.43 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 27' ' ' GLU . 4.6 t -156.06 -174.97 5.19 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.583 -166.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.1 m -60.99 169.04 2.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.161 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.732 ' CB ' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -51.08 -7.88 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 125.934 1.693 . . . . 0.0 114.387 -157.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.53 -36.04 83.03 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.288 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.886 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -62.13 -39.91 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.764 0.792 . . . . 0.0 112.147 174.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -55.54 -31.82 62.43 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.542 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -62.23 -23.46 66.68 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.733 ' CZ3' HG21 ' A' ' 134' ' ' VAL . 8.5 p-90 -91.71 52.84 2.1 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.472 1.033 . . . . 0.0 110.982 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 126' ' ' MET . 19.5 t80 -179.17 -55.03 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.251 171.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.823 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 84.1 mtp -135.1 -174.2 0.4 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.749 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.823 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 9.8 Cg_endo -54.8 -175.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 111.436 166.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.732 ' HB2' ' CB ' ' A' ' 33' ' ' GLU . 9.1 p30 -98.06 143.14 28.92 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.683 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' N ' ' HB3' ' A' ' 33' ' ' GLU . 28.2 t70 -170.57 -56.02 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.417 -171.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.527 ' HD2' HD12 ' A' ' 35' ' ' ILE . 23.6 t80 -61.18 136.62 58.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.469 0.652 . . . . 0.0 112.694 -172.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -140.85 143.29 34.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.618 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 104.77 4.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.655 1.693 . . . . 0.0 110.007 -171.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.499 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 69.4 mttt -134.06 153.29 51.9 Favored 'General case' 0 C--O 1.202 -1.408 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.295 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.741 ' HG3' HG11 ' A' ' 68' ' ' VAL . 23.6 mt-10 -123.13 131.28 53.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 119.251 0.932 . . . . 0.0 112.771 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.15 34.63 62.78 Favored Glycine 0 CA--C 1.509 -0.301 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.827 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.584 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -106.76 173.23 6.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.073 -1.064 . . . . 0.0 108.943 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 1.016 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -118.7 130.15 55.67 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.996 157.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.499 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.1 136.05 48.05 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 120.936 0.398 . . . . 0.0 111.945 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' SER . 18.2 p80 -139.42 139.03 36.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.971 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -110.93 -54.69 2.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.076 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -98.82 25.42 6.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.224 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 15.1 m -125.71 89.12 53.05 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.268 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.54 -23.66 36.82 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.37 2.047 . . . . 0.0 110.898 173.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -128.87 97.94 4.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.92 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.4 79.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.391 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.56 135.3 26.0 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.685 2.257 . . . . 0.0 111.183 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.836 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 50.1 m 55.65 68.41 2.43 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.746 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 1.016 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 62.1 Cg_endo -75.05 -87.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.924 1.75 . . . . 0.0 111.911 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.703 ' HB3' ' H ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -119.68 149.47 41.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.439 -178.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 25.1 pttm -140.11 131.09 26.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 75' ' ' SER . 51.2 t -82.75 128.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.9 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -68.43 -48.46 64.53 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.849 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.34 145.84 16.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.639 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -141.91 132.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.451 173.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -141.25 138.85 33.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.473 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.62 ' HB2' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.91 127.74 93.34 Favored Pre-proline 0 N--CA 1.444 -0.774 0 O-C-N 123.751 0.657 . . . . 0.0 109.531 -167.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HD3' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -3.26 62.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 1 C-N-CA 126.181 4.587 . . . . 0.0 115.744 -156.446 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.6 p -130.23 -52.55 1.11 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.592 166.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.06 135.34 29.09 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.29 0.567 . . . . 0.0 109.959 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.761 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.7 tt -136.17 125.73 25.25 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.599 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.4 m -137.49 125.16 22.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CB ' HG21 ' A' ' 65' ' ' VAL . 11.7 p90 -150.74 158.0 43.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 23.4 mt-10 -116.45 130.65 56.88 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.0 113.89 25.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.036 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.703 ' H ' ' HB3' ' A' ' 63' ' ' CYS . 14.5 t70 41.51 -118.59 0.4 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.465 . . . . 0.0 114.86 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.447 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 5.1 t -78.24 -35.82 47.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.547 -167.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.777 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 21.0 mp0 -83.1 171.32 13.86 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.07 40.87 2.33 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.296 -1.431 . . . . 0.0 111.909 -173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.913 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -71.86 112.87 8.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.053 -176.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 17.1 t -89.51 73.19 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 83' ' ' TRP . 10.5 m -79.39 122.76 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.158 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 92.8 m -121.38 136.5 54.95 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.318 -171.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.654 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 22.1 m-30 -112.07 131.65 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.496 ' CG ' HD13 ' A' ' 101' ' ' ILE . 7.2 mm-40 -115.87 121.9 43.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD21 ' HD1' ' A' ' 98' ' ' PHE . 3.4 tm? -125.28 142.82 51.28 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.714 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.576 ' H ' HD22 ' A' ' 89' ' ' LEU . 2.8 tp10 -110.84 134.12 52.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.946 ' HB2' HD12 ' A' ' 22' ' ' ILE . 1.2 t70 -92.87 111.63 23.31 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.847 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 1.031 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 16.6 mt -123.55 124.55 43.08 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.75 -28.12 10.61 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 159.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 1.031 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 4.3 tp10 -53.49 -156.59 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 111.515 -2.343 . . . . 0.0 109.427 151.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.86 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.0 175.82 5.63 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.54 136.61 48.64 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.099 -1.001 . . . . 0.0 111.16 -156.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 114.36 4.96 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 119.208 -1.472 . . . . 0.0 109.986 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.923 ' HD1' HD21 ' A' ' 89' ' ' LEU . 15.3 t80 -105.22 127.16 52.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.191 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -123.98 116.67 23.24 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.939 HD22 ' HE1' ' A' ' 130' ' ' TRP . 5.0 tt -106.37 136.37 46.24 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.144 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.753 HD11 HG21 ' A' ' 86' ' ' THR . 1.6 mp -114.23 123.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.871 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.619 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -118.28 112.2 19.76 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -142.46 159.58 41.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.573 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -141.23 150.66 22.01 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.765 -169.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.5 160.05 26.69 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -90.34 136.69 32.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.448 0.642 . . . . 0.0 112.426 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.534 ' HG3' ' HD2' ' A' ' 108' ' ' PRO . 38.0 tt0 -132.42 143.55 49.28 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.534 ' HD2' ' HG3' ' A' ' 107' ' ' GLU . 73.1 Cg_exo -41.05 142.42 0.82 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.305 2.67 . . . . 0.0 113.222 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.592 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 84.6 m-20 73.19 -175.92 0.16 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -165.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.704 ' HG2' ' HB2' ' A' ' 5' ' ' ASN . 3.7 pt20 -135.39 109.07 8.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 116.398 -2.121 . . . . 0.0 113.932 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.885 HG13 ' H ' ' A' ' 113' ' ' GLY . 7.0 p -151.8 -176.41 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 153.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 2.0 mm -55.68 -36.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 119.451 1.023 . . . . 0.0 110.894 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.885 ' H ' HG13 ' A' ' 111' ' ' VAL . . . 179.1 -82.74 0.06 OUTLIER Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.665 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 2.2 mppt? -122.84 30.05 6.58 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 169.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -71.11 -41.28 70.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.887 -171.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 118' ' ' LYS . 2.2 t30 -172.02 12.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.582 ' C ' ' HB ' ' A' ' 111' ' ' VAL . 47.2 mt-10 67.75 -37.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.62 0.768 . . . . 0.0 112.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.769 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 4.3 mptp? -94.25 102.49 14.5 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.613 ' HB2' ' C ' ' A' ' 8' ' ' ALA . 88.2 p -61.23 -40.92 95.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.983 0.42 . . . . 0.0 112.007 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 p -69.01 -36.57 77.95 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.563 -0.71 . . . . 0.0 110.991 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.769 ' HB ' ' CB ' ' A' ' 118' ' ' LYS . 56.1 t -73.15 -37.1 51.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.57 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 112' ' ' ILE . 12.9 p -65.99 -35.67 75.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.491 0.662 . . . . 0.0 109.691 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.623 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.64 -33.33 74.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.336 170.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -70.39 -30.66 68.95 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.663 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.5 mtpp -60.5 -42.01 95.5 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 122.076 0.941 . . . . 0.0 109.355 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.685 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 8.7 mmt -80.91 -20.83 41.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.106 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.586 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.7 t70 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.693 -170.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.22 -50.52 0.11 Allowed Glycine 0 C--O 1.246 0.876 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.221 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.619 ' O ' HG13 ' A' ' 133' ' ' ILE . . . -65.92 -22.37 70.31 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.988 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.939 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -70.94 -33.74 70.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.593 -173.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.911 HG21 ' HD2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -71.06 -39.32 72.31 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.104 172.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.48 -55.4 13.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 118.938 -1.601 . . . . 0.0 111.17 174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 129' ' ' GLY . 1.3 mt -81.85 -48.71 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.362 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.747 HG22 HD12 ' A' ' 100' ' ' LEU . 35.5 t -80.03 -44.08 22.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 121.177 -0.952 . . . . 0.0 111.368 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.742 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.0 t30 -72.45 -40.37 67.07 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.761 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.798 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 5.3 tt0 -95.82 -46.0 6.75 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 118.216 -1.393 . . . . 0.0 111.609 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.982 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.0 tpp180 -83.11 -33.82 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.707 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 27.9 tp -63.01 -39.86 96.03 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.592 ' HB2' HD13 ' A' ' 16' ' ' ILE . 3.1 tmm_? -66.17 -30.33 70.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.679 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.982 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -68.95 -48.08 64.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.796 -0.565 . . . . 0.0 112.33 175.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -66.29 -28.42 68.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.129 0.49 . . . . 0.0 110.188 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 1.077 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 28.7 m -95.64 -15.11 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.995 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -149.48 -54.2 0.17 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.649 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 68.7 tt0 46.24 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.608 ' HB3' ' HD2' ' A' ' 149' ' ' HIS . 43.4 tp -165.1 107.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.914 169.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -4.05 11.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.405 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -53.33 -58.95 5.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.702 0.626 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -165.23 83.46 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.608 ' HD2' ' HB3' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -104.11 -78.41 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.23 71.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.244 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -66.71 130.97 44.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.661 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.5 p80 . . . . . 0 C--O 1.243 0.722 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.451 0.167 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.78 70.01 1.86 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.145 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.6 -44.51 6.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.891 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -153.44 140.32 19.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.408 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 5.3 m-20 -82.49 121.74 27.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -98.28 -53.27 3.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.477 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 119' ' ' SER . 33.8 t-20 -99.02 -65.44 0.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 5' ' ' ASN . . . -53.15 129.14 30.2 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.637 HD13 HD13 ' A' ' 12' ' ' ILE . 53.7 tp -66.73 129.59 94.07 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 122.322 0.249 . . . . 0.0 111.001 -171.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 9' ' ' LEU . 1.3 Cg_endo -81.22 -159.98 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.68 2.92 . . . . 0.0 112.709 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.43 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 7.6 p-10 -61.59 135.82 57.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.68 0.752 . . . . 0.0 110.019 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.747 HG22 ' CH2' ' A' ' 130' ' ' TRP . 5.4 mm -132.74 131.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.032 -167.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -131.68 145.82 51.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 1.106 ' HB2' ' HE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -137.95 150.87 47.42 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -127.04 138.02 53.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.853 0.835 . . . . 0.0 111.861 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.716 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -150.79 147.74 15.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.194 173.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.716 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.2 m -96.24 119.83 35.45 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.327 172.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 HD21 ' CD1' ' A' ' 16' ' ' ILE . 20.5 mt -90.35 107.76 19.35 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.929 ' HG3' ' HE ' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -74.03 88.03 1.88 Allowed 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 116.8 -1.96 . . . . 0.0 107.11 176.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.32 168.64 11.73 Favored Pre-proline 0 C--O 1.22 -0.491 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.194 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 83.8 Cg_endo -80.49 151.54 19.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.07 1.18 . . . . 0.0 110.253 166.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 71' ' ' PRO . 6.7 tt -54.76 -36.15 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.593 0.711 . . . . 0.0 111.078 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.709 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 1.1 pt20 -60.95 -32.1 71.64 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.638 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.481 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.8 mmtm -82.29 -35.54 27.92 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.343 -0.848 . . . . 0.0 110.83 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.705 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.39 -32.52 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 170.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.597 ' CE3' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.64 -42.85 71.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.746 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.703 ' C ' HG22 ' A' ' 31' ' ' THR . 9.6 tp10 -65.96 -28.44 68.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.844 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.668 HG21 HD13 ' A' ' 138' ' ' LEU . 5.0 m -100.06 -7.03 25.46 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.927 ' HA ' HG13 ' A' ' 35' ' ' ILE . 22.6 m -134.99 -61.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.951 -1.718 . . . . 0.0 113.596 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.637 ' HA ' HD22 ' A' ' 74' ' ' LEU . 32.3 p -96.46 63.69 2.14 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 120.33 -1.482 . . . . 0.0 109.617 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.703 HG22 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.91 -174.4 4.83 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.236 -165.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 3.5 p -61.09 173.24 0.85 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.307 1.043 . . . . 0.0 110.496 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.03 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 5.2 mt-10 -47.55 -6.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.559 . . . . 0.0 114.216 -166.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.24 -40.08 91.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.585 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.927 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.01 -36.6 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.449 0.642 . . . . 0.0 111.139 171.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . . . -52.78 -32.21 42.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.726 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.57 -166.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 170.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.723 ' CZ3' HG23 ' A' ' 134' ' ' VAL . 22.2 p-90 41.8 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.314 0.578 . . . . 0.0 111.657 -167.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.45 ' HZ ' HD13 ' A' ' 100' ' ' LEU . 32.8 m-85 -151.44 -95.53 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.591 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 66.5 mtm -156.94 170.63 8.63 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.644 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 73.5 Cg_exo -42.31 115.55 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.19 2.594 . . . . 0.0 113.869 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.861 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 24.9 t-20 -156.71 162.14 39.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 1.03 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 30.0 t0 -136.95 41.1 2.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.385 1.088 . . . . 0.0 108.829 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 32' ' ' SER . 24.7 t80 -50.75 142.43 11.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.358 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -139.43 138.01 36.11 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.14 102.14 3.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 123.691 1.71 . . . . 0.0 109.099 -172.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.626 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 55.4 mttt -134.32 154.26 51.42 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 111.593 -2.549 . . . . 0.0 107.364 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.716 ' HG3' HG11 ' A' ' 68' ' ' VAL . 20.5 mt-10 -122.45 125.67 46.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 119.281 0.946 . . . . 0.0 111.967 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.77 81.93 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.795 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.45 159.54 15.84 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 25.2 mp0 -114.2 126.39 55.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.482 -1.287 . . . . 0.0 108.777 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -133.42 139.03 46.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -133.45 148.01 51.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.281 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -50.75 -70.11 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.184 0.516 . . . . 0.0 110.865 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -149.27 -49.4 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.25 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 m -77.87 115.54 51.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.38 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -84.26 62.01 6.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.764 2.309 . . . . 0.0 111.64 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -51.68 -42.68 62.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.863 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.05 137.07 13.76 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.67 -46.22 35.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.719 2.279 . . . . 0.0 111.711 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.9 m -113.31 105.92 54.93 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 57.8 Cg_endo -73.61 -94.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.144 1.896 . . . . 0.0 113.629 -173.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 2.0 m -130.64 163.78 26.42 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.571 -172.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.7 OUTLIER -148.98 134.0 18.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.566 0.621 . . . . 0.0 109.718 -175.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG22 ' CB ' ' A' ' 76' ' ' PHE . 71.4 t -74.52 127.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.228 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' H ' ' HA ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -68.11 -49.45 61.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.246 177.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.21 146.19 15.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.841 HG22 HD12 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -136.48 122.11 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.43 1.11 . . . . 0.0 110.473 173.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 11.7 mm100 -131.48 137.5 48.59 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.266 -172.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.81 123.99 83.46 Favored Pre-proline 0 CA--C 1.501 -0.919 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -166.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.872 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.56 65.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.34 1 C-N-CA 126.487 4.791 . . . . 0.0 115.248 -160.146 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -135.42 -46.85 0.69 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.713 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 28.4 tt0 -146.35 130.68 17.6 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.841 HD12 HG22 ' A' ' 68' ' ' VAL . 1.9 tp -130.74 127.66 39.23 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.569 ' O ' HG12 ' A' ' 65' ' ' VAL . 38.6 t -137.55 127.53 25.79 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.951 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.645 ' CB ' HG22 ' A' ' 65' ' ' VAL . 13.8 p90 -148.98 144.2 26.62 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.969 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.025 ' HG2' HG22 ' A' ' 84' ' ' VAL . 47.9 mt-10 -126.43 151.15 48.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.135 0.969 . . . . 0.0 112.651 -168.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 2.7 t90 -118.72 139.19 51.94 Favored 'General case' 0 C--O 1.19 -2.075 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.902 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.49 ' HB2' ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER 32.68 -99.12 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 168.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.653 ' HA ' ' HB3' ' A' ' 105' ' ' TRP . 5.6 t -159.17 97.05 1.35 Allowed 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.041 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 43.9 mt-10 -145.16 -172.4 3.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 125.149 1.379 . . . . 0.0 110.568 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.649 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -94.65 -6.73 60.68 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.524 156.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.827 ' HE1' ' HD3' ' A' ' 106' ' ' LYS 0.277 0.4 OUTLIER -101.63 136.68 41.06 Favored 'General case' 0 C--N 1.379 1.848 0 CA-C-N 120.927 2.364 . . . . 0.0 114.362 173.816 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 1.048 HG11 ' H ' ' A' ' 103' ' ' SER . 6.7 p -95.29 -178.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 159.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 85' ' ' VAL . 33.3 m -121.81 99.22 6.75 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.052 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 160.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.835 HG22 HD12 ' A' ' 101' ' ' ILE . 29.3 m -117.53 129.2 55.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.96 -175.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 44.9 m-85 -118.66 128.32 54.41 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.806 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -117.0 125.59 51.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.818 0.818 . . . . 0.0 109.801 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.872 HD12 ' HB3' ' A' ' 71' ' ' PRO . 3.4 mt -124.04 144.18 49.99 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.05 -169.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 121.09 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' O ' HD22 ' A' ' 92' ' ' LEU . 9.9 t0 -80.88 110.3 16.27 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.2 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 45.6 mt -125.02 139.36 53.88 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 165.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.03 61.3 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.83 ' HG3' ' H ' ' A' ' 95' ' ' LYS . 5.0 tp10 -56.65 -157.91 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 111.319 -2.441 . . . . 0.0 109.423 153.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.847 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -99.57 -179.44 4.2 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -173.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -108.57 127.97 54.42 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 -162.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.1 115.68 5.17 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 118.466 -1.826 . . . . 0.0 110.665 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 19.8 t80 -106.39 130.7 54.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.18 0.991 . . . . 0.0 113.223 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.3 m -124.28 122.11 36.84 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.769 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.722 HD22 ' CH2' ' A' ' 130' ' ' TRP . 5.9 tt -104.67 136.55 43.99 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.496 -0.881 . . . . 0.0 111.114 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.835 HD12 HG22 ' A' ' 86' ' ' THR . 2.4 mp -118.11 127.25 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.346 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.692 ' CG ' ' HZ2' ' A' ' 130' ' ' TRP . 13.4 m170 -115.29 104.74 12.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 160.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 1.048 ' H ' HG11 ' A' ' 84' ' ' VAL . 3.3 t -148.05 120.41 8.43 Favored 'General case' 0 C--O 1.206 -1.228 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.998 ' HA3' ' N ' ' A' ' 84' ' ' VAL . . . 177.43 -166.49 36.99 Favored Glycine 0 C--N 1.28 -2.574 0 C-N-CA 116.606 -2.711 . . . . 0.0 118.894 -149.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.832 ' HA ' ' H ' ' A' ' 81' ' ' GLU . 64.7 m95 -127.92 156.99 41.75 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 112.324 -1.938 . . . . 0.0 111.188 164.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.833 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 37.4 tttm 179.45 147.26 0.22 Allowed 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 166.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.0 mt-10 50.39 -173.18 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 168.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.915 ' HA ' ' HB3' ' A' ' 114' ' ' LYS . 68.5 Cg_endo -116.66 132.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.079 0 C-N-CA 125.036 3.824 . . . . 0.0 117.178 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 14.7 t-20 160.02 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 125.641 1.576 . . . . 0.0 109.26 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -99.99 112.2 24.49 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 123.625 1.679 . . . . 0.0 110.937 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 1.029 HG23 ' H ' ' A' ' 112' ' ' ILE . 11.0 p -165.34 -156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.98 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 1.029 ' H ' HG23 ' A' ' 111' ' ' VAL 0.253 1.4 mt -42.13 -45.39 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.24 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 1.041 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -146.92 -69.94 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 167.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.915 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 56.5 mttp -151.66 38.24 0.6 Allowed 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.892 0.853 . . . . 0.0 109.98 173.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.692 ' H ' ' CG1' ' A' ' 111' ' ' VAL . . . -54.02 -41.34 67.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.533 1.533 . . . . 0.0 114.628 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 62.6 t30 137.62 -35.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.486 1.116 . . . . 0.0 108.098 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.658 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 5.1 mm-40 -87.97 -169.12 2.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.962 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HB2' HG11 ' A' ' 121' ' ' VAL . 73.2 mmtt -91.28 151.81 20.74 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.446 168.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.643 ' O ' HG11 ' A' ' 122' ' ' VAL . 5.0 p -57.38 -42.51 82.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.016 0.436 . . . . 0.0 111.347 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 t -67.99 -43.61 78.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 118' ' ' LYS . 5.6 m -72.5 -36.56 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.229 0.538 . . . . 0.0 109.61 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.709 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 9.8 p -66.52 -36.63 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.066 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.568 ' HA ' HD21 ' A' ' 9' ' ' LEU . 42.3 ttp180 -62.31 -35.41 78.97 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.19 -31.61 69.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.461 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.709 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 36.7 mtpt -62.9 -43.89 97.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 121.614 0.721 . . . . 0.0 110.599 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 6.9 mmt -81.97 -27.83 33.0 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.84 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.93 -16.06 58.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.882 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.61 -36.13 0.11 Allowed Glycine 0 C--O 1.243 0.695 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.397 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.648 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -69.03 -22.82 76.08 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.987 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 1.106 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 4.0 m0 -68.04 -33.22 74.18 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 117.922 0.861 . . . . 0.0 112.635 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.801 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.6 p -74.94 -33.15 61.92 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.81 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.804 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.67 -68.28 1.78 Allowed Glycine 0 C--N 1.312 -0.782 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.13 168.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 129' ' ' GLY . 15.9 pt -71.0 -50.26 43.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 121.513 -0.992 . . . . 0.0 112.184 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.763 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 5.7 t -81.1 -42.99 20.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 O-C-N 121.64 -0.662 . . . . 0.0 112.047 -176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.801 ' HB3' ' O ' ' A' ' 131' ' ' THR . 20.0 t-20 -75.56 -42.99 50.85 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 117.482 -1.687 . . . . 0.0 108.152 -174.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.911 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 11.3 tp10 -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.579 -169.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.054 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.0 tpp180 -83.71 -31.97 25.77 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.763 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.4 tp -66.53 -39.64 88.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 117.854 -1.538 . . . . 0.0 107.288 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.929 ' HE ' ' HG3' ' A' ' 19' ' ' GLU . 2.6 tmt_? -63.55 -32.79 74.36 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.302 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 1.054 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.58 -45.16 72.75 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -73.56 -28.75 62.02 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 110.141 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.692 HG12 HG21 ' A' ' 25' ' ' VAL . 25.5 m -86.73 -19.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 19.6 mm-40 -143.7 -64.8 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.288 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 71.5 tt0 43.88 -106.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.028 -165.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 22.0 tp 50.65 21.86 0.98 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -84.88 -62.2 1.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.845 -0.534 . . . . 0.0 110.02 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.54 120.7 24.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -121.12 -23.97 5.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 150' ' ' HIS . 19.2 t-80 -66.37 129.79 41.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.658 172.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 10.8 t-80 75.54 -55.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.765 0.666 . . . . 0.0 111.111 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -160.59 148.45 16.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.8 p80 . . . . . 0 C--O 1.244 0.77 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.563 174.238 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 123' ' ' ARG . 4.7 mm . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.84 132.69 55.65 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.496 177.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 131' ' ' THR . 16.3 mmtm -126.86 129.15 47.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.83 136.27 54.81 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.05 0.929 . . . . 0.0 110.698 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.782 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.94 148.66 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.092 178.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.782 ' N ' HG12 ' A' ' 16' ' ' ILE . 77.3 m -94.89 119.25 33.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 172.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.627 HD23 ' CD1' ' A' ' 16' ' ' ILE . 22.7 mt -91.06 108.57 19.95 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -74.95 87.88 2.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 C-N-CA 116.647 -2.021 . . . . 0.0 106.709 176.087 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.76 167.26 14.6 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.165 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 98.1 Cg_endo -82.14 158.56 17.8 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.364 1.376 . . . . 0.0 110.198 167.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.045 HD12 ' HB2' ' A' ' 91' ' ' ASP . 10.8 tt -54.63 -32.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.684 0.754 . . . . 0.0 110.986 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 5.7 pt20 -68.42 -31.41 70.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.223 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 142' ' ' VAL . 82.5 mttt -81.92 -37.04 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.965 -1.085 . . . . 0.0 110.418 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG22 HG11 ' A' ' 142' ' ' VAL . 6.2 t -62.5 -34.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.612 167.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 71' ' ' PRO . 1.2 t-105 -55.21 -43.39 74.4 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.765 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.745 ' C ' HG21 ' A' ' 31' ' ' THR . 27.4 tp10 -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.929 173.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.9 -9.34 21.67 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -171.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.877 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.0 m -131.75 -63.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.64 2.018 . . . . 0.0 114.316 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.606 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 32.0 p -97.38 63.31 1.79 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 109.646 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.745 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.5 t -157.56 -174.61 4.95 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.238 -164.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.9 p -62.45 175.31 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.644 1.177 . . . . 0.0 110.918 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 14.4 mt-10 -47.42 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.341 1.457 . . . . 0.0 113.594 -165.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.06 -40.79 93.99 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.975 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.877 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.5 -39.73 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 122.221 1.01 . . . . 0.0 110.727 172.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.423 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.5 pt? -73.67 100.74 3.45 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 116.932 -1.907 . . . . 0.0 108.116 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 49.2 mttm -132.33 153.0 51.17 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 111.53 -2.577 . . . . 0.0 107.434 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.793 ' HG3' HG12 ' A' ' 68' ' ' VAL . 22.7 mt-10 -123.27 130.55 52.89 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.867 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.93 40.17 71.64 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.809 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.786 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.3 pm0 -108.01 172.42 6.84 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 48.2 mt-10 . . . . . 0 C--N 1.302 -1.489 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.402 161.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 34.5 m . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 20.9 pttp -145.87 128.75 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.786 ' N ' HE22 ' A' ' 50' ' ' GLN . 70.6 t -82.55 130.09 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.6 HD11 ' OE2' ' A' ' 77' ' ' GLU . 5.1 mp -70.15 -50.14 43.49 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.719 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.42 15.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.765 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.793 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -138.65 135.27 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.879 0.847 . . . . 0.0 110.747 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.81 140.33 32.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.139 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.87 128.07 93.3 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -166.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.691 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -4.63 68.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 125.963 4.442 . . . . 0.0 115.012 -156.831 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' GLN . 4.6 p -139.29 -50.06 0.51 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.924 171.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.68 133.15 25.0 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.148 0.499 . . . . 0.0 109.715 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.6 tt -131.84 125.77 32.63 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.4 m -137.64 123.66 20.26 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.131 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.0 p90 -152.34 158.19 42.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.6 ' OE2' HD11 ' A' ' 66' ' ' LEU . 27.2 mt-10 . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.434 -1.27 0 CA-C-O 121.441 0.638 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.69 HG22 HD13 ' A' ' 101' ' ' ILE . 90.8 m -120.5 136.92 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.55 -170.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.64 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.2 m-30 -112.27 131.07 55.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.459 ' CG ' HD11 ' A' ' 101' ' ' ILE . 8.3 mm100 -116.37 125.62 52.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.287 0.565 . . . . 0.0 109.601 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 ' HD1' ' A' ' 98' ' ' PHE . 1.5 tm? -121.53 142.77 49.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -172.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.435 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -110.1 119.57 39.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.045 ' HB2' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.472 -2.042 0 CA-C-O 121.896 0.855 . . . . 0.0 110.028 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.682 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.266 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -111.92 128.44 56.15 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.502 -0.749 . . . . 0.0 109.949 -163.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.0 115.48 5.25 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 118.418 -1.849 . . . . 0.0 110.087 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.799 ' HD1' HD23 ' A' ' 89' ' ' LEU . 27.5 t80 -104.26 127.15 51.86 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.898 0.856 . . . . 0.0 111.882 -170.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.3 m -123.18 117.08 24.53 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.315 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.071 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.6 tt -107.27 138.37 43.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.238 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.198 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.1 m170 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 166.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.648 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 14.1 p . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.098 0.475 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HB2' ' CG1' ' A' ' 12' ' ' ILE . 8.9 ptt180 -66.38 -29.89 70.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.16 -28.38 70.29 Favored Glycine 0 C--O 1.24 0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.679 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.9 mtpp -61.37 -43.27 99.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.073 0.94 . . . . 0.0 108.722 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 1.044 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 10.8 mmt -76.08 -23.51 55.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.043 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.619 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 14.9 t70 -76.62 -15.5 59.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.722 -171.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.54 -58.02 0.19 Allowed Glycine 0 C--O 1.244 0.723 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.717 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.86 -16.24 76.31 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.919 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.071 ' HE1' HD22 ' A' ' 100' ' ' LEU . 6.6 t-105 -82.19 -24.12 35.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.505 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -78.83 -34.2 45.41 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.751 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -53.99 -54.98 28.24 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 118.249 -1.929 . . . . 0.0 110.057 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 53.1 mt -70.55 -54.55 17.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 100' ' ' LEU . 21.8 t -83.37 -44.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 121.36 -0.838 . . . . 0.0 112.331 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.728 ' HA ' HG21 ' A' ' 16' ' ' ILE . 40.4 t-20 -72.93 -39.94 65.84 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.736 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.742 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 2.2 tt0 -95.49 -45.82 6.93 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.687 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.7 tpp180 -83.07 -31.79 27.14 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.699 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 21.0 tp -64.54 -40.31 95.36 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 118.626 -1.229 . . . . 0.0 107.713 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.564 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.6 tmm_? -66.33 -30.23 70.59 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -68.65 -46.12 70.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.631 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.76 -28.72 63.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.792 -0.568 . . . . 0.0 110.183 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 25' ' ' VAL . 33.1 m -85.88 -21.61 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 9.6 mm-40 -148.17 -56.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.651 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 21.7 pt-20 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 124.021 0.928 . . . . 0.0 112.024 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.572 HG21 ' CB ' ' A' ' 126' ' ' MET . 1.5 tp . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -127.37 134.68 49.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.838 ' HB3' ' CZ2' ' A' ' 130' ' ' TRP . 20.8 tptt -138.73 152.03 47.63 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.665 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -124.42 141.87 51.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.079 0.943 . . . . 0.0 112.083 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.835 HD11 HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -142.02 148.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.593 171.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.69 ' N ' HG13 ' A' ' 16' ' ' ILE . 33.5 m -98.57 117.68 33.55 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 162.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.835 HD23 HD11 ' A' ' 16' ' ' ILE . 28.1 mt -93.59 109.4 21.02 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.673 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -75.35 88.26 2.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 117.158 -1.817 . . . . 0.0 106.84 177.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.45 166.16 17.1 Favored Pre-proline 0 C--O 1.217 -0.625 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.241 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 92.3 Cg_endo -78.88 157.15 27.34 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.232 1.288 . . . . 0.0 109.783 167.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.82 HD13 ' HA ' ' A' ' 91' ' ' ASP . 4.5 tp -53.24 -36.82 26.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.756 0.788 . . . . 0.0 110.673 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.3 pt20 -61.57 -32.41 72.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.2 -1.364 . . . . 0.0 114.073 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' GLU . 54.3 mtpt -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.721 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.548 HG22 HG11 ' A' ' 142' ' ' VAL . 2.7 t -66.97 -34.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.296 169.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.711 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.82 -41.91 71.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.586 172.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.723 ' C ' HG21 ' A' ' 31' ' ' THR . 6.0 tp10 -66.89 -29.97 70.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.931 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.699 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.2 m -101.67 -9.55 20.81 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 -170.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.865 ' HA ' HG13 ' A' ' 35' ' ' ILE . 28.3 m -130.13 -64.3 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.47 1.941 . . . . 0.0 113.916 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.647 ' HB3' HD12 ' A' ' 74' ' ' LEU . 30.8 p -97.58 65.29 1.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.852 -1.155 . . . . 0.0 109.132 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.723 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -156.77 -176.37 5.94 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.649 -166.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 35' ' ' ILE . 16.9 m -63.19 173.64 1.42 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.687 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.1 mt-10 -47.88 -5.31 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.905 1.682 . . . . 0.0 114.612 -164.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.52 -37.59 83.16 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.804 -1.188 . . . . 0.0 110.613 170.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.865 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.45 -37.57 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.771 0.796 . . . . 0.0 110.62 170.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.571 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.6 pt? -73.05 102.15 3.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.976 -1.89 . . . . 0.0 108.911 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -131.13 150.6 52.07 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.062 -2.335 . . . . 0.0 106.91 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.603 ' HG3' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.5 131.74 54.0 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.55 39.54 45.52 Favored Glycine 0 N--CA 1.463 0.476 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.831 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 47' ' ' LYS . 2.2 pm0 -107.63 173.95 6.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 124.427 1.091 . . . . 0.0 109.579 -171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 78.7 mt-10 . . . . . 0 C--N 1.307 -1.255 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.234 158.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.847 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 31.2 t . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.17 126.84 23.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 76' ' ' PHE . 40.4 t -79.9 127.26 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.178 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.614 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.5 mm? -71.06 -46.14 62.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.132 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.532 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.41 140.51 15.3 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.281 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -139.06 127.57 28.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.007 172.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -141.95 139.81 32.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.564 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.07 127.92 91.54 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -168.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.999 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.21 60.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 1 C-N-CA 126.869 5.046 . . . . 0.0 116.066 -162.403 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -136.86 -44.48 0.58 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.245 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 30.8 tt0 -144.19 134.4 24.33 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.558 0.694 . . . . 0.0 110.584 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -137.38 126.41 24.35 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 m -139.43 126.25 20.8 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.191 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.847 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 21.4 p90 -152.32 155.09 36.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.614 ' HG3' HD21 ' A' ' 66' ' ' LEU . 47.7 mt-10 . . . . . 0 CA--C 1.5 -0.96 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.382 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 75' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.898 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 93.0 m -121.38 131.67 54.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.678 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -111.22 124.44 52.22 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -114.86 126.91 55.35 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 122.424 1.107 . . . . 0.0 109.668 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 71' ' ' PRO . 22.6 tp -128.61 144.38 51.14 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.673 -165.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.722 ' H ' HD12 ' A' ' 89' ' ' LEU . 4.0 tp10 -110.71 130.41 55.58 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.535 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.82 ' HA ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.497 -1.087 0 O-C-N 124.203 0.939 . . . . 0.0 110.132 -170.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.584 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.83 131.59 54.92 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.454 0.645 . . . . 0.0 109.979 -158.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.76 113.35 4.62 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.861 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.85 ' HD1' HD13 ' A' ' 89' ' ' LEU . 6.5 t80 -104.89 129.94 53.14 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.848 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.8 m -122.47 116.09 23.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.022 ' HB3' ' HZ2' ' A' ' 130' ' ' TRP . 7.2 tt -110.62 139.23 46.08 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.285 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.8 mp -115.99 124.91 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.365 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.596 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.616 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 7.8 p . . . . . 0 N--CA 1.443 -0.817 0 CA-C-O 120.874 0.369 . . . . 0.0 111.574 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' HB2' HD13 ' A' ' 12' ' ' ILE . 28.0 ptt180 -68.1 -28.29 67.21 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -65.43 -32.0 82.1 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 39.1 mmtm -62.48 -38.04 88.28 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.729 0.776 . . . . 0.0 109.237 172.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 102' ' ' HIS . 19.9 mtt -82.01 -7.73 59.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.541 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.495 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 31.0 t70 -92.57 -15.3 27.11 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.042 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -133.47 -53.96 0.08 OUTLIER Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.734 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.35 -18.76 73.69 Favored Glycine 0 CA--C 1.499 -0.957 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.022 ' HZ2' ' HB3' ' A' ' 100' ' ' LEU . 21.1 t90 -55.6 -63.86 1.03 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.678 -1.261 . . . . 0.0 110.913 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.9 p -63.8 -28.31 69.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.009 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -55.95 -59.28 10.89 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 118.494 -1.812 . . . . 0.0 110.289 168.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.511 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 1.7 mp -72.41 -54.46 16.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.824 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.8 t -81.16 -44.2 20.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 O-C-N 121.561 -0.712 . . . . 0.0 112.017 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 131' ' ' THR . 44.1 t30 -79.12 -38.11 36.94 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 117.92 -1.512 . . . . 0.0 108.735 -171.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.942 ' HG2' ' HE2' ' A' ' 140' ' ' LYS . 15.4 tt0 -94.82 -45.53 7.27 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 118.385 -1.326 . . . . 0.0 110.785 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.4 tpp180 -83.43 -33.0 25.8 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.824 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 34.5 tp -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.059 -1.456 . . . . 0.0 107.098 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HA ' HG22 ' A' ' 142' ' ' VAL . 4.4 tmm_? -65.8 -30.76 71.44 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.09 -47.51 68.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.187 0.517 . . . . 0.0 112.366 176.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -70.1 -27.44 64.6 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.782 -0.574 . . . . 0.0 109.771 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 138' ' ' LEU . 28.9 m -94.12 -12.78 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -153.24 -56.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.599 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 18.3 pt-20 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 124.496 1.118 . . . . 0.0 113.338 -169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -113.38 134.05 54.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.844 174.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.808 ' HD3' HG23 ' A' ' 131' ' ' THR . 7.8 mmpt? -122.01 130.9 53.68 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.25 54.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.129 0.966 . . . . 0.0 111.437 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -153.49 149.06 13.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.687 178.228 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' HG12 ' A' ' 16' ' ' ILE . 28.1 m -95.06 121.1 36.33 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 16' ' ' ILE . 96.1 mt -91.65 108.34 19.84 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 1.3 mt-10 -77.58 87.15 3.89 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 116.62 -2.032 . . . . 0.0 106.768 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.807 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -158.47 169.03 11.25 Favored Pre-proline 0 C--O 1.214 -0.811 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.639 -176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 95.7 Cg_endo -83.62 152.61 13.38 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.749 0.966 . . . . 0.0 109.9 163.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.733 HG21 ' OD2' ' A' ' 91' ' ' ASP . 7.3 tt -55.02 -32.1 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.829 0.823 . . . . 0.0 111.289 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.677 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 4.6 pt20 -66.56 -30.48 70.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.953 -1.476 . . . . 0.0 113.407 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.593 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 58.1 tptt -81.69 -35.99 29.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 122.066 0.936 . . . . 0.0 110.011 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' A' ' 89' ' ' LEU . 2.7 t -66.04 -33.64 64.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.641 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.195 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.816 ' C ' HG21 ' A' ' 31' ' ' THR . 23.4 tt0 -66.64 -28.28 68.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.106 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.556 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.4 m -100.21 -9.35 22.54 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.884 ' HA ' HG13 ' A' ' 35' ' ' ILE . 32.9 m -131.08 -63.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.334 1.879 . . . . 0.0 113.415 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 27.7 p -96.74 65.54 2.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.56 -1.338 . . . . 0.0 108.663 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.816 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.97 -174.7 4.96 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.729 -165.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.3 p -60.68 171.78 1.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.022 0.929 . . . . 0.0 110.315 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 4.1 mt-10 -47.76 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.571 1.549 . . . . 0.0 113.698 -162.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.02 -36.41 81.14 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.256 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.884 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.79 -44.22 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 121.718 0.77 . . . . 0.0 111.639 173.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.773 -178.65 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.618 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -71.72 103.55 3.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.754 1.74 . . . . 0.0 109.369 -172.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.686 ' HB3' ' CB ' ' A' ' 50' ' ' GLN . 6.5 mmtp -131.62 154.71 48.62 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 111.625 -2.534 . . . . 0.0 107.514 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' CD ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -120.42 134.15 55.32 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.375 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.98 38.95 61.57 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.441 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -109.94 151.52 26.99 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.361 -168.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 160.97 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 120.494 0.188 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.6 pttt -143.27 141.62 31.1 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.647 HG11 ' HB ' ' A' ' 68' ' ' VAL . 95.9 t -83.54 132.16 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.316 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.819 HD23 ' OE1' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -82.84 -39.79 21.2 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.378 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . . . -157.85 140.76 14.95 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.17 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -140.21 132.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.16 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -141.68 138.65 32.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.942 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.77 123.02 82.24 Favored Pre-proline 0 CA--C 1.503 -0.847 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -168.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 0.02 62.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.602 1 C-N-CA 126.322 4.681 . . . . 0.0 115.732 -159.845 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 p -133.21 -41.99 0.88 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.727 167.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -144.78 133.27 21.98 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -129.48 128.65 43.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 169.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 49.1 m -138.06 121.93 17.69 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.247 168.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.629 ' HD1' HD21 ' A' ' 74' ' ' LEU . 2.3 p90 -154.35 151.1 28.66 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.712 0.768 . . . . 0.0 111.378 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.819 ' OE1' HD23 ' A' ' 66' ' ' LEU . 25.6 mp0 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.904 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.878 ' O ' ' HA ' ' A' ' 75' ' ' SER . 53.3 t . . . . . 0 N--CA 1.424 -1.761 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 14.4 m -121.52 135.78 55.0 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 122.102 2.228 . . . . 0.0 115.441 -158.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.5 m-30 -110.07 131.93 54.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -121.26 128.09 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.864 0.84 . . . . 0.0 110.631 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 71' ' ' PRO . 2.5 tt -121.28 143.29 49.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.636 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 89' ' ' LEU . 5.2 tp10 -110.53 130.83 55.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.788 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.733 ' OD2' HG21 ' A' ' 22' ' ' ILE . 8.5 t70 . . . . . 0 CA--C 1.487 -1.448 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.968 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.807 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -106.71 131.34 53.94 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.274 -0.891 . . . . 0.0 111.041 -154.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.69 113.58 4.75 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.125 -1.512 . . . . 0.0 109.887 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.7 t80 -105.35 128.96 53.76 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.434 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 m -122.07 114.7 21.28 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 134' ' ' VAL . 6.0 tt -105.55 136.21 45.55 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 118.589 -1.245 . . . . 0.0 110.777 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.742 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.5 mp -110.29 121.32 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.807 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.512 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.618 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.604 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.645 0.26 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.554 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 48.0 ttt180 -63.66 -33.12 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.414 0.626 . . . . 0.0 109.415 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.14 -30.81 67.05 Favored Glycine 0 C--O 1.24 0.487 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.266 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 50.6 mttm -62.84 -34.88 78.26 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.409 0.623 . . . . 0.0 109.42 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.904 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 13.9 mtt -75.17 -27.38 59.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.939 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 7.2 t70 -75.97 -14.79 60.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.788 -169.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.52 -57.37 0.2 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.897 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -70.95 -19.63 77.17 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.77 -171.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.904 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -74.43 -33.39 62.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.264 0.532 . . . . 0.0 111.351 -171.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.808 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.4 p -74.65 -33.99 62.63 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.274 171.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.76 -52.1 26.46 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.752 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 mm -85.54 -48.01 16.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.302 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 100' ' ' LEU . 25.6 t -78.81 -42.52 24.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 O-C-N 120.689 -1.257 . . . . 0.0 111.488 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.607 ' HB3' ' O ' ' A' ' 131' ' ' THR . 43.0 t-20 -76.56 -39.55 52.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.933 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.851 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 4.0 tt0 -93.61 -46.97 7.03 Favored 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.947 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.804 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.9 tpp180 -81.6 -33.23 31.64 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.673 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.2 tp -65.01 -40.61 95.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 120.579 1.536 . . . . 0.0 107.401 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.924 ' HB2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.87 -36.77 82.23 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 169.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 15.6 mtmt -69.09 -43.8 73.8 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.04 -28.33 64.3 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.894 -0.504 . . . . 0.0 110.491 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 138' ' ' LEU . 30.0 m -93.44 -17.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -149.1 -58.61 0.21 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.497 -174.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.647 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 11.3 pt-20 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.537 1.135 . . . . 0.0 112.972 -161.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 123' ' ' ARG . 86.8 mt . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.66 132.29 53.42 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 130' ' ' TRP . 26.9 tptt -128.88 133.64 47.99 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -122.51 136.96 55.01 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.241 1.019 . . . . 0.0 112.203 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.745 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.57 148.47 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.665 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.745 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.9 m -96.95 120.58 37.57 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.405 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG21 ' A' ' 142' ' ' VAL . 22.4 mt -91.03 108.31 19.78 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.813 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -74.51 89.09 2.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 116.64 -2.024 . . . . 0.0 106.852 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.56 169.46 10.32 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.34 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 93.1 Cg_endo -82.83 158.83 16.04 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.088 1.858 . . . . 0.0 110.388 164.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.913 HD13 ' HB2' ' A' ' 91' ' ' ASP . 3.5 tp -56.08 -36.34 44.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.573 0.701 . . . . 0.0 110.456 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.2 pt20 -61.5 -32.85 72.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.064 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.892 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.6 tmtp? -82.12 -36.48 27.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.83 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.656 HG22 HG11 ' A' ' 142' ' ' VAL . 3.1 t -67.28 -33.53 63.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.701 171.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.655 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.75 -42.49 71.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.541 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.73 ' C ' HG21 ' A' ' 31' ' ' THR . 10.3 tp10 -67.23 -29.42 69.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.889 173.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.614 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.0 m -101.34 -8.85 21.7 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.872 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.3 m -131.23 -64.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 121.796 2.089 . . . . 0.0 113.784 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB3' HD12 ' A' ' 74' ' ' LEU . 33.8 p -97.11 65.41 2.03 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.981 -1.074 . . . . 0.0 109.156 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.73 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -155.62 -177.75 6.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.047 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.0 m -63.67 171.23 2.77 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.166 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -49.2 -3.34 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.265 1.826 . . . . 0.0 114.836 -161.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.21 -35.28 69.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.608 169.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.872 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -68.34 -36.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.766 0.793 . . . . 0.0 111.302 170.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.747 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.09 102.91 3.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 117.826 -1.55 . . . . 0.0 109.003 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 70.2 mttt -133.09 152.54 51.95 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.514 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG3' HG12 ' A' ' 68' ' ' VAL . 25.5 mt-10 -124.66 131.77 53.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 119.107 0.867 . . . . 0.0 112.897 174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.62 34.54 60.57 Favored Glycine 0 C--N 1.328 0.128 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.224 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.671 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.4 pm0 -106.93 173.27 6.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.442 1.097 . . . . 0.0 108.59 -173.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 7.7 mp0 . . . . . 0 C--N 1.306 -1.301 0 C-N-CA 118.566 -1.253 . . . . 0.0 109.111 157.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 8.8 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.8 OUTLIER -141.31 132.41 26.29 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -173.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.671 ' N ' HE22 ' A' ' 50' ' ' GLN . 55.9 t -82.89 125.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.703 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.629 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -61.45 -54.67 40.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.765 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.19 145.3 16.49 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.527 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -134.89 129.35 51.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.106 0.955 . . . . 0.0 110.453 173.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -134.55 139.36 45.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.789 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.48 122.87 78.7 Favored Pre-proline 0 CA--C 1.506 -0.749 0 O-C-N 123.711 0.632 . . . . 0.0 109.428 -165.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.02 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.6 60.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.196 1 C-N-CA 126.78 4.987 . . . . 0.0 115.684 -158.525 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -132.71 -45.41 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.53 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.59 132.85 23.17 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.369 0.604 . . . . 0.0 109.932 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.7 tt -129.78 125.63 36.25 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.6 m -138.38 124.9 20.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.009 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.572 ' HB3' HG22 ' A' ' 65' ' ' VAL . 12.2 p90 -152.31 157.53 41.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 43.0 mt-10 . . . . . 0 C--N 1.313 -0.994 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.431 -1.403 0 CA-C-O 121.525 0.678 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.757 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 90.4 m -121.1 133.17 55.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.794 -168.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.675 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -112.9 132.8 55.16 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.551 -0.718 . . . . 0.0 109.835 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -122.29 125.9 46.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.761 0.791 . . . . 0.0 110.43 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.02 HD23 ' HB3' ' A' ' 71' ' ' PRO . 63.1 tp -124.78 144.64 50.15 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.672 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -110.53 123.4 49.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.66 0.384 . . . . 0.0 110.453 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.913 ' HB2' HD13 ' A' ' 22' ' ' ILE . 8.5 t70 . . . . . 0 CA--C 1.505 -0.77 0 CA-C-O 121.234 0.54 . . . . 0.0 110.882 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.813 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.541 ' HB ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -106.44 126.05 51.76 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 119.777 1.171 . . . . 0.0 109.005 -164.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.68 117.43 5.65 Favored Glycine 0 CA--C 1.491 -1.455 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.503 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.685 ' HE2' HD12 ' A' ' 100' ' ' LEU . 13.8 t80 -103.66 126.74 50.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.803 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.4 m -122.34 115.36 22.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.039 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.685 HD12 ' HE2' ' A' ' 98' ' ' PHE . 6.2 tt -107.51 137.31 45.77 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.104 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.757 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -120.05 125.96 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.727 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' HD21 ' A' ' 100' ' ' LEU . 1.9 m170 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 8.6 p . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HA ' HD11 ' A' ' 12' ' ' ILE . 15.0 ttp85 -63.16 -31.14 72.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -73.94 -34.37 55.95 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.013 175.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 30.7 mmmt -60.6 -42.32 96.55 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.011 0.91 . . . . 0.0 109.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.621 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 3.7 mmt -81.63 -24.61 36.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.911 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.417 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 19.4 t70 -76.7 -14.98 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.763 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -129.12 -51.97 0.11 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.894 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.92 -32.02 82.54 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.774 -0.713 . . . . 0.0 113.148 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.705 ' HA ' ' CE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -62.65 -55.72 24.35 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 118.138 0.969 . . . . 0.0 110.513 -175.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.3 p -62.47 -28.95 70.17 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.513 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.2 -63.56 5.06 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 118.828 -1.653 . . . . 0.0 111.173 169.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 pt -77.16 -49.56 22.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.797 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.0 p -79.45 -43.4 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 112.436 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.694 ' HB3' ' O ' ' A' ' 131' ' ' THR . 1.1 t30 -74.84 -40.83 60.8 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.993 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.749 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 3.6 tp10 -95.82 -46.16 6.68 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.857 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.069 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 13.8 tpp180 -82.75 -32.02 28.06 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.797 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 49.0 tp -64.38 -40.49 95.92 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.7 tmm_? -65.59 -29.95 70.62 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.175 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 1.069 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -71.37 -46.59 60.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 177.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.56 -28.84 68.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.194 0.521 . . . . 0.0 109.668 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 24.1 m -94.05 -15.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.64 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -149.7 -58.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.278 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.735 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 9.9 tt0 . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 124.563 1.145 . . . . 0.0 112.925 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.672 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.93 134.33 55.28 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.892 ' HD3' HG23 ' A' ' 131' ' ' THR . 8.9 mmpt? -123.49 131.5 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.2 133.74 54.72 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.396 1.093 . . . . 0.0 111.566 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.735 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.8 148.19 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.814 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.735 ' N ' HG12 ' A' ' 16' ' ' ILE . 15.6 m -97.25 120.01 36.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 23.3 mt -90.02 107.65 19.25 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -76.83 87.28 3.42 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 116.641 -2.024 . . . . 0.0 107.044 177.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.787 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.65 165.39 18.52 Favored Pre-proline 0 C--O 1.213 -0.839 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.937 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 80.4 Cg_endo -75.7 157.71 39.75 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 120.752 0.968 . . . . 0.0 110.193 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.857 HD12 ' HB3' ' A' ' 91' ' ' ASP . 2.5 tt -52.67 -35.75 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.842 0.83 . . . . 0.0 111.108 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 2.1 pt20 -68.63 -29.66 68.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.355 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -75.6 -40.58 56.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.042 0.925 . . . . 0.0 109.421 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.652 HG22 HG11 ' A' ' 142' ' ' VAL . 8.5 t -66.45 -35.43 74.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.133 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.5 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 1.9 t90 -55.72 -43.75 76.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.96 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.764 ' C ' HG21 ' A' ' 31' ' ' THR . 37.7 tt0 -67.98 -28.75 67.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.889 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 141' ' ' ALA . 7.0 m -101.55 -9.02 21.37 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.894 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -131.07 -65.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 121.174 1.807 . . . . 0.0 113.811 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.612 ' HB3' HD12 ' A' ' 74' ' ' LEU . 21.9 p -97.49 68.34 2.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.505 -1.372 . . . . 0.0 109.057 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.2 t -156.32 -177.44 6.59 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.154 -169.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.758 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 17.4 m -62.25 170.52 2.26 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.293 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.75 -8.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 126.092 1.757 . . . . 0.0 114.435 -156.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.78 -33.91 75.18 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.08 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.81 -44.53 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 121.679 0.752 . . . . 0.0 112.398 173.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 121.54 0.686 . . . . 0.0 110.03 178.674 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.758 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 72.5 mt-30 . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.5 pt? -72.29 101.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 123.388 1.566 . . . . 0.0 109.834 -172.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HB3' ' CG ' ' A' ' 50' ' ' GLN . 4.4 mptp? -132.08 153.79 50.1 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 112.233 -2.258 . . . . 0.0 107.193 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.691 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.3 mt-10 -122.48 134.96 54.56 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 119.265 0.938 . . . . 0.0 112.345 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.06 35.99 42.49 Favored Glycine 0 N--CA 1.462 0.405 0 O-C-N 124.057 0.848 . . . . 0.0 112.121 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.667 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.2 pm0 -108.1 173.32 6.37 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.188 -1.006 . . . . 0.0 108.502 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 17.5 mp0 . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.431 156.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 31.9 m . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.554 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -148.28 129.28 14.44 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.667 ' N ' HE22 ' A' ' 50' ' ' GLN . 59.2 t -83.21 131.32 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.052 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -66.78 -54.54 21.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.626 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.04 146.14 17.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.294 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -138.17 136.16 44.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.934 176.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 57.9 mt-30 -141.28 137.4 32.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.329 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 134.24 94.0 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.767 ' C ' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -4.55 64.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.306 1 C-N-CA 125.872 4.381 . . . . 0.0 115.665 -157.782 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.488 ' N ' ' HB2' ' A' ' 89' ' ' LEU . 6.5 p -137.83 -49.56 0.58 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.561 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -147.97 144.19 27.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 110.271 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.719 HD13 ' HD2' ' A' ' 87' ' ' PHE . 8.7 tt -142.84 125.34 15.73 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 65' ' ' VAL . 74.2 m -136.92 124.12 21.78 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.544 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 65' ' ' VAL . 9.2 p90 -152.7 156.41 39.11 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.594 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 51.8 mt-10 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 121.493 0.663 . . . . 0.0 109.645 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.427 -1.611 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.717 HG22 HD13 ' A' ' 101' ' ' ILE . 85.6 m -120.85 138.28 54.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.325 -169.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 74' ' ' LEU . 18.9 m-30 -111.61 130.87 55.61 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -116.49 125.57 52.13 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.929 1.347 . . . . 0.0 109.778 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.767 ' HB2' ' C ' ' A' ' 71' ' ' PRO . 1.8 mt -122.21 139.43 53.78 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.813 -158.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 96' ' ' THR . 3.6 tp10 -115.5 132.2 56.7 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 122.189 -0.32 . . . . 0.0 111.083 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.857 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.066 0 O-C-N 124.317 1.011 . . . . 0.0 109.819 -173.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.939 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.35 136.35 49.66 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.645 0.736 . . . . 0.0 110.962 -157.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 90' ' ' GLU . . . -96.65 115.26 5.17 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 118.9 -1.619 . . . . 0.0 110.06 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 12.7 t80 -108.21 125.95 52.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.643 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -123.78 116.19 22.6 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.595 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.033 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.2 tt -108.1 140.49 41.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.742 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' THR . 1.8 mp -119.67 124.27 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.881 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.762 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 168.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.53 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 13.0 p . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.598 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.5 ptt180 -68.52 -28.41 66.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -69.97 -29.29 70.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 13.1 mmmm -61.87 -38.9 89.99 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.264 1.03 . . . . 0.0 108.634 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.968 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 20.7 mtt -75.9 -28.08 57.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.386 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.595 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 20.0 t70 -78.01 -15.54 58.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.876 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.05 -54.44 0.21 Allowed Glycine 0 C--O 1.244 0.772 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.789 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.82 -17.14 80.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.302 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.033 ' HE1' HD22 ' A' ' 100' ' ' LEU . 43.7 t-105 -89.0 -14.19 37.08 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.706 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.892 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.2 p -82.47 -32.81 28.7 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.562 164.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.69 -53.9 36.33 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 118.24 -1.934 . . . . 0.0 109.417 168.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.9 mt -69.45 -55.76 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.982 -0.609 . . . . 0.0 112.588 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.915 HG21 HD13 ' A' ' 100' ' ' LEU . 38.6 t -84.12 -44.94 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.362 -0.836 . . . . 0.0 112.291 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.664 ' HB3' ' O ' ' A' ' 131' ' ' THR . 36.6 t-20 -72.55 -40.01 67.03 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.559 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.789 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.5 tt0 -97.26 -45.56 6.45 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.66 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 17.2 tpp180 -82.5 -31.7 29.15 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.721 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.8 tp -64.06 -40.12 95.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 120.08 1.309 . . . . 0.0 108.274 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 2.9 tmt_? -62.75 -32.18 73.27 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.805 ' HA ' ' H ' ' A' ' 144' ' ' GLU . 50.8 mtmt -74.72 -43.37 55.4 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.654 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.13 -28.79 68.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.778 -0.576 . . . . 0.0 110.229 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.652 HG11 HG22 ' A' ' 25' ' ' VAL . 32.9 m -87.32 -21.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 63.2 mm-40 -143.7 -63.57 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.131 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.805 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 35.5 tt0 . . . . . 0 N--CA 1.476 0.869 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.066 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.754 HG12 ' HG2' ' A' ' 123' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.438 -1.04 0 CA-C-O 121.172 0.511 . . . . 0.0 109.788 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -122.8 133.68 54.44 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.601 173.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -126.08 128.15 46.92 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 p -125.62 137.61 53.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.68 1.229 . . . . 0.0 112.711 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.832 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.9 149.54 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 112.687 -2.051 . . . . 0.0 108.123 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.804 ' N ' HG12 ' A' ' 16' ' ' ILE . 59.2 m -93.51 119.15 32.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 16' ' ' ILE . 16.4 mt -89.73 107.68 19.24 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 2.2 pt-20 -73.95 87.94 1.84 Allowed 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 117.145 -1.822 . . . . 0.0 106.128 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -152.3 168.89 10.43 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.284 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -80.01 150.73 20.8 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.166 1.244 . . . . 0.0 109.455 164.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 91' ' ' ASP . 14.1 tt -55.41 -32.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.737 0.78 . . . . 0.0 110.947 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.678 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 1.1 pp0? -68.88 -29.41 67.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.897 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 4.6 tppp? -79.47 -38.15 35.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.794 HG22 HG11 ' A' ' 142' ' ' VAL . 9.4 t -64.82 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.58 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.678 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -54.7 -41.52 70.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.465 173.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.794 ' C ' HG21 ' A' ' 31' ' ' THR . 33.3 mm-40 -68.58 -28.29 66.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.29 170.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 141' ' ' ALA . 3.6 m -99.95 -10.2 21.92 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.0 m -131.66 -64.19 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 121.324 1.875 . . . . 0.0 113.696 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.648 ' HB3' HD12 ' A' ' 74' ' ' LEU . 24.0 p -98.1 66.85 1.85 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.794 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.5 t -157.22 -177.36 6.55 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.6 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 35' ' ' ILE . 30.7 m -62.08 172.33 1.44 Allowed 'General case' 0 C--N 1.311 -1.079 0 O-C-N 124.025 0.828 . . . . 0.0 109.62 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 7.0 mt-10 -48.0 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.983 1.713 . . . . 0.0 114.769 -163.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.34 -34.81 68.87 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.823 169.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.24 -36.26 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 121.978 0.894 . . . . 0.0 111.124 170.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.908 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.41 101.92 3.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 117.29 -1.764 . . . . 0.0 109.774 -171.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 65' ' ' VAL . 69.6 mttt -133.36 152.88 51.95 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-N 112.048 -2.342 . . . . 0.0 107.725 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.695 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.7 mt-10 -123.48 129.35 51.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 118.937 0.789 . . . . 0.0 112.167 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.22 64.0 Favored Glycine 0 N--CA 1.461 0.349 0 CA-C-O 122.081 0.823 . . . . 0.0 111.856 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.701 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.4 pm0 -106.58 172.7 6.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.38 -1.41 . . . . 0.0 107.989 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 31.8 mt-10 . . . . . 0 C--N 1.301 -1.522 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.89 159.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 59.9 m . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' HZ2' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -143.46 131.02 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.701 ' N ' HE22 ' A' ' 50' ' ' GLN . 53.0 t -80.92 127.56 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.524 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.2 mm? -66.89 -50.73 61.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 174.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.41 142.79 15.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.667 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.695 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -136.21 132.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.553 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -137.84 138.13 38.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.743 -173.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.66 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.15 124.42 86.8 Favored Pre-proline 0 CA--C 1.507 -0.694 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.527 -167.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.62 ' C ' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.61 64.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.574 1 C-N-CA 126.085 4.523 . . . . 0.0 115.267 -158.279 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 13.4 p -133.13 -46.78 0.84 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.862 166.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -146.73 141.98 27.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.428 0.632 . . . . 0.0 110.983 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.5 tt -138.92 124.9 19.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 65' ' ' VAL . 69.4 m -137.44 125.36 22.68 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.41 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.559 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 11.4 p90 -151.77 157.27 41.75 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.553 ' HG3' HD21 ' A' ' 66' ' ' LEU . 32.7 mt-10 . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.957 0.884 . . . . 0.0 108.932 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.203 0.525 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 63.8 m -126.18 132.56 51.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.077 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.695 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.9 m-85 -111.8 131.28 55.44 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.178 0.989 . . . . 0.0 110.851 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 96' ' ' THR . 1.8 tm? -119.91 140.34 51.03 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.704 -171.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' N ' HD13 ' A' ' 89' ' ' LEU . 6.1 tp10 -119.17 139.49 51.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.798 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.769 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.5 p-10 . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt . . . . . 0 N--CA 1.431 -1.415 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.29 125.56 52.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.987 169.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.72 115.79 5.31 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.729 ' HD1' HD23 ' A' ' 89' ' ' LEU . 14.1 t80 -102.6 127.74 49.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.569 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.1 m -123.32 114.84 20.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.038 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.9 tt -106.98 136.31 47.05 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.329 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.7 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.6 mp -119.05 124.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.018 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.0 m170 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.697 HG23 ' HD2' ' A' ' 125' ' ' LYS . 8.3 p . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.702 0.763 . . . . 0.0 109.043 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.754 ' HG2' HG12 ' A' ' 12' ' ' ILE . 1.7 tmt_? -62.6 -33.85 75.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.481 172.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -72.52 -29.82 65.28 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.203 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.697 ' HD2' HG23 ' A' ' 122' ' ' VAL . 57.7 mttm -60.69 -42.83 97.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.285 1.04 . . . . 0.0 109.083 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.773 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 5.9 mmt -78.99 -20.91 47.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.8 t70 -76.47 -15.42 59.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.311 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.0 -52.35 0.13 Allowed Glycine 0 C--O 1.249 1.06 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.555 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.6 -21.65 72.87 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.79 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.038 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -73.5 -30.72 63.31 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.79 -171.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.703 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.2 p -74.17 -39.17 63.39 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.158 171.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -52.5 -53.06 33.89 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 118.218 -1.944 . . . . 0.0 110.492 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.667 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 82.4 mt -73.18 -55.2 13.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 100' ' ' LEU . 17.5 t -84.39 -43.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 121.637 -0.664 . . . . 0.0 112.141 -177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.832 ' HA ' HG21 ' A' ' 16' ' ' ILE . 6.3 t30 -70.35 -40.02 74.32 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.321 -0.952 . . . . 0.0 108.574 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.852 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 3.5 tt0 -96.24 -45.45 6.83 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.917 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.693 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 tpp180 -82.01 -33.43 30.08 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 142' ' ' VAL . 18.5 tp -64.47 -40.15 95.15 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.465 -1.294 . . . . 0.0 107.945 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.5 tmm_? -65.36 -29.74 70.5 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.852 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 54.3 mtmt -72.59 -45.18 60.39 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -69.24 -29.87 67.89 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.794 HG11 HG22 ' A' ' 25' ' ' VAL . 23.3 m -86.63 -18.39 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 10.5 mm-40 -152.25 -51.58 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.735 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 12.3 pt-20 . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.91 0.862 . . . . 0.0 110.873 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' A' ' 126' ' ' MET . 2.1 mm . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -120.04 131.36 55.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 30.4 mmtm -127.52 128.97 46.56 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.591 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.44 135.58 54.71 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.398 1.094 . . . . 0.0 111.382 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.13 148.07 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 112.764 -2.017 . . . . 0.0 108.717 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.707 ' N ' HG12 ' A' ' 16' ' ' ILE . 2.0 m -96.17 119.35 34.51 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.091 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.1 mt -91.79 108.53 19.98 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.917 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -75.09 89.24 2.45 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.379 -2.128 . . . . 0.0 106.177 175.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.39 168.25 12.54 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.439 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.2 Cg_endo -82.74 157.97 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.334 1.356 . . . . 0.0 110.289 165.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 91' ' ' ASP . 13.5 tt -57.46 -32.49 41.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 121.967 0.889 . . . . 0.0 110.638 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -68.28 -30.96 70.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -177.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.57 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 59.6 tptt -82.34 -39.06 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.232 -0.917 . . . . 0.0 109.92 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.673 HG22 HG11 ' A' ' 142' ' ' VAL . 2.9 t -61.74 -34.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.245 166.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -55.1 -42.26 72.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.372 0.669 . . . . 0.0 109.755 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.75 ' C ' HG21 ' A' ' 31' ' ' THR . 34.1 tt0 -66.32 -28.37 68.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.463 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.84 -10.01 21.12 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.816 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.6 m -131.01 -64.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 121.56 1.982 . . . . 0.0 113.981 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.65 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 35.1 p -97.31 65.61 1.99 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.869 -1.144 . . . . 0.0 108.847 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -156.15 -177.54 6.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.641 -167.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' GLY . 23.8 m -62.99 169.92 3.03 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.656 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 3.2 mt-10 -48.51 -2.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.024 1.73 . . . . 0.0 114.612 -163.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -56.93 -31.88 61.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.987 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.816 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.45 -36.16 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.547 0.689 . . . . 0.0 111.692 170.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.311 -1.083 0 O-C-N 122.008 -0.432 . . . . 0.0 111.339 167.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.01 102.19 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 116.771 -1.972 . . . . 0.0 108.763 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 50.3 mttm -130.09 150.8 51.19 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 112.036 -2.347 . . . . 0.0 106.683 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.79 129.65 50.86 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.536 -0.866 . . . . 0.0 113.06 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.73 37.43 68.8 Favored Glycine 0 N--CA 1.463 0.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.13 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -109.35 173.52 6.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.948 0.899 . . . . 0.0 109.734 -171.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 . . . . . 0 C--N 1.303 -1.425 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.51 156.507 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.741 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 41.6 t . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 21.6 pttp -135.93 133.88 38.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 68' ' ' VAL . 71.0 t -84.16 127.38 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.908 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.78 HD13 ' OE1' ' A' ' 77' ' ' GLU . 0.9 OUTLIER -77.64 -39.28 45.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.286 179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.81 138.72 13.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.196 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -139.52 126.68 24.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.208 1.004 . . . . 0.0 110.91 174.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -137.01 139.05 41.14 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.621 -173.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.0 127.65 92.05 Favored Pre-proline 0 CA--C 1.504 -0.791 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -167.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.69 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -5.07 65.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 1 C-N-CA 126.263 4.642 . . . . 0.0 115.392 -157.861 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.8 p -135.53 -48.48 0.7 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.156 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.51 131.94 20.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 109.893 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.2 tt -131.84 124.67 30.06 Favored 'General case' 0 C--O 1.202 -1.4 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.6 m -137.92 123.49 19.71 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.269 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 11.5 p90 -154.01 153.9 32.77 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.754 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.78 ' OE1' HD13 ' A' ' 66' ' ' LEU . 3.5 mp0 . . . . . 0 N--CA 1.436 -1.136 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.61 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 121.544 0.688 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.812 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 95.7 m -120.15 136.9 54.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.832 -168.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 18.6 m-85 -115.08 131.61 56.87 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -122.06 128.85 51.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.82 0.819 . . . . 0.0 110.708 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 0.9 OUTLIER -121.71 145.07 48.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.976 -171.071 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 1.6 tt0 -109.68 120.53 42.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 1.052 ' HB2' HD12 ' A' ' 22' ' ' ILE . 2.9 t70 . . . . . 0 CA--C 1.497 -1.078 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.917 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -110.86 128.57 55.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.553 0.692 . . . . 0.0 110.274 -161.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.34 116.65 5.43 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 119.112 -1.518 . . . . 0.0 110.264 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.712 ' HE2' HD12 ' A' ' 100' ' ' LEU . 22.2 t80 -103.78 126.66 51.06 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.943 -170.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 m -123.04 115.39 21.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.443 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.04 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.8 tt -107.89 140.77 40.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.691 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.812 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.7 mp -120.41 125.82 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.975 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.3 m170 . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.591 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.2 p . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -65.1 -30.24 71.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.05 -30.73 67.35 Favored Glycine 0 C--O 1.238 0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.963 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.591 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.3 mtpp -59.78 -42.51 93.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.24 1.019 . . . . 0.0 108.796 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 1.063 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 9.8 mmt -78.22 -25.54 47.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.685 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 22.9 t0 -78.02 -13.75 59.76 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.873 -168.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.84 -53.78 0.16 Allowed Glycine 0 C--O 1.251 1.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.628 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.647 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -68.83 -27.3 73.99 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.457 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.063 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 10.7 t-105 -73.07 -30.45 63.7 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.182 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -70.32 -39.52 74.74 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.925 172.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.744 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -50.2 -50.41 34.3 Favored Glycine 0 C--N 1.308 -0.98 0 C-N-CA 118.236 -1.935 . . . . 0.0 110.933 168.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 129' ' ' GLY . 27.1 mm -73.48 -55.41 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 122.317 -0.519 . . . . 0.0 112.186 -175.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 1.4 p -83.72 -44.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 O-C-N 121.717 -0.614 . . . . 0.0 112.503 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.765 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.6 t30 -70.89 -40.84 71.98 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.744 ' HB3' ' O ' ' A' ' 132' ' ' GLY . 36.5 tt0 -96.38 -46.41 6.4 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.273 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.057 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.1 tpp180 -84.61 -31.44 24.26 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 29.7 tp -63.23 -40.0 96.2 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 118.261 -1.375 . . . . 0.0 107.779 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.697 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.1 tmm_? -66.11 -30.86 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 170.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 1.057 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 3.0 mtpt -67.73 -45.04 76.17 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.02 -29.92 65.99 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.431 -176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.673 HG11 HG22 ' A' ' 25' ' ' VAL . 27.8 m -89.67 -16.89 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.565 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 139' ' ' ARG . 9.9 mt-10 -148.23 -61.17 0.25 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.7 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 12.6 tt0 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.932 0.893 . . . . 0.0 111.801 -169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -119.51 133.31 55.74 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.572 0.701 . . . . 0.0 110.436 178.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.936 ' HD3' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.62 127.7 31.69 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.407 ' C ' ' HZ2' ' A' ' 14' ' ' LYS . 2.9 m -124.55 150.41 45.9 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.363 1.078 . . . . 0.0 112.103 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.75 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -153.11 148.12 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 113.142 -1.844 . . . . 0.0 108.541 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.74 ' N ' HG12 ' A' ' 16' ' ' ILE . 29.6 m -95.01 119.6 33.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.008 172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 17.6 mt -90.55 108.51 19.84 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.899 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.1 pt-20 -73.54 88.71 1.66 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 116.848 -1.941 . . . . 0.0 106.87 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.94 165.99 17.32 Favored Pre-proline 0 C--O 1.215 -0.763 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.506 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.0 Cg_endo -78.23 155.34 29.12 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.256 1.304 . . . . 0.0 110.359 168.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.722 HD12 ' HB3' ' A' ' 91' ' ' ASP . 8.6 tt -52.73 -37.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.681 0.753 . . . . 0.0 111.029 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 11.0 pt20 -60.2 -32.15 70.82 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.33 -1.304 . . . . 0.0 114.061 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -79.92 -38.05 33.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.845 0.831 . . . . 0.0 110.097 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.682 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.8 -33.12 59.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.225 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -54.69 -43.15 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.8 172.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.767 ' C ' HG21 ' A' ' 31' ' ' THR . 24.6 tt0 -68.45 -28.59 67.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.52 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.618 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.45 -9.38 21.13 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 117.63 2.456 . . . . 0.0 117.63 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.939 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.6 m -132.09 -64.61 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.318 1.872 . . . . 0.0 113.89 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.614 ' HB3' HD12 ' A' ' 74' ' ' LEU . 17.1 p -97.19 66.85 2.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.679 -1.263 . . . . 0.0 108.702 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.767 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.7 t -157.62 -174.64 4.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.811 -167.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.4 p -60.35 169.41 1.68 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 10.7 mt-10 -49.9 -8.01 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.805 1.642 . . . . 0.0 114.004 -161.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.39 -36.73 85.3 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.16 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.939 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.34 -41.38 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 117.642 0.721 . . . . 0.0 112.168 173.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 -177.833 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' THR . 39.2 mt-30 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.4 pt? -73.31 103.32 3.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 116.882 -1.927 . . . . 0.0 108.505 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -130.71 150.24 51.98 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.407 -2.179 . . . . 0.0 106.972 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -123.45 131.72 53.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.05 40.8 59.18 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.106 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.741 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.3 pm0 -109.46 174.4 5.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.494 1.118 . . . . 0.0 109.426 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 49.0 mt-10 . . . . . 0 C--N 1.308 -1.209 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.468 155.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.427 -1.607 0 CA-C-O 120.519 0.2 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.95 140.14 38.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.741 ' N ' HE22 ' A' ' 50' ' ' GLN . 54.1 t -79.95 131.99 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.068 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -77.88 -44.93 25.64 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.486 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.34 135.8 11.3 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.544 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -130.44 127.41 62.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.904 174.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -134.35 138.3 44.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.61 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.97 93.43 Favored Pre-proline 0 CA--C 1.502 -0.865 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.986 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.54 62.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 1 C-N-CA 126.274 4.649 . . . . 0.0 115.583 -159.35 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -133.65 -52.67 0.87 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.394 169.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -143.18 132.92 23.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.502 0.667 . . . . 0.0 110.29 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.692 HD13 ' HD2' ' A' ' 87' ' ' PHE . 8.8 tt -129.21 125.88 37.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.577 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 m -137.98 126.37 23.28 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 12.2 p90 -151.19 155.64 39.28 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.31 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.513 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 43.0 mt-10 . . . . . 0 C--N 1.313 -1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 121.235 0.541 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 80.1 m -126.53 136.2 52.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.829 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.692 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.3 m-85 -111.09 130.51 55.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.0 mm100 -115.66 127.73 55.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.742 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mt -123.74 144.64 49.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.188 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.12 120.19 41.49 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.276 0 O-C-N 123.822 0.701 . . . . 0.0 110.254 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.899 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.22 129.65 56.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.444 -0.785 . . . . 0.0 110.585 -160.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.38 115.1 5.04 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 118.443 -1.837 . . . . 0.0 110.442 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HE2' ' CD2' ' A' ' 100' ' ' LEU . 11.9 t80 -105.65 130.98 53.57 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.588 -171.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -122.03 122.43 39.29 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.588 170.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.687 ' HG ' ' NE1' ' A' ' 130' ' ' TRP . 0.1 OUTLIER -104.85 136.63 43.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 86' ' ' THR . 3.5 mt -127.2 122.78 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.056 176.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.481 ' NE2' ' HZ2' ' A' ' 130' ' ' TRP . 1.3 m170 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -28.46 67.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.67 76.2 Favored Glycine 0 C--O 1.24 0.511 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.338 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.6 mtpp -60.21 -42.26 94.76 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.061 0.934 . . . . 0.0 109.415 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.938 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 11.3 mmt -76.89 -23.94 52.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.501 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.87 -14.43 58.66 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.314 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.96 -50.56 0.24 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.189 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -28.12 69.34 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.74 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.938 ' HB2' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -69.85 -26.62 64.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.936 HG23 ' HD3' ' A' ' 14' ' ' LYS . 2.0 p -81.73 -39.42 24.24 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.186 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.54 -52.95 48.74 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.083 -2.008 . . . . 0.0 109.897 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 66.2 mt -75.69 -55.59 10.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 114.741 -0.729 . . . . 0.0 112.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.633 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 22.0 t -82.54 -43.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 121.424 -0.797 . . . . 0.0 111.011 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.755 ' HB3' ' O ' ' A' ' 131' ' ' THR . 2.3 t30 -72.75 -40.31 66.13 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.071 -172.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.871 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.3 tt0 -97.54 -45.65 6.33 Favored 'General case' 0 N--CA 1.42 -1.947 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.664 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.609 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.8 tpp180 -81.98 -33.03 30.39 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 19.2 tp -63.2 -40.56 97.84 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.367 -1.333 . . . . 0.0 107.626 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.832 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.0 tmm_? -65.18 -30.9 71.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.428 171.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.871 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 53.0 mtmt -73.76 -45.98 48.5 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -68.18 -29.55 68.44 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.704 -0.622 . . . . 0.0 109.934 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 25' ' ' VAL . 25.4 m -84.79 -21.85 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.406 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 13.4 mm-40 -147.29 -60.83 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.66 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 29.9 tt0 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.767 0.794 . . . . 0.0 111.461 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 126' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.099 0.476 . . . . 0.0 110.603 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.1 p -117.49 134.1 55.22 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 121.197 0.522 . . . . 0.0 109.785 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -125.49 129.81 50.51 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -121.51 137.68 54.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.014 0.911 . . . . 0.0 110.857 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.769 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.1 148.52 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.177 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.769 ' N ' HG12 ' A' ' 16' ' ' ILE . 18.9 m -95.98 118.47 32.65 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.2 mt -91.12 110.32 21.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.881 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.4 pt-20 -75.06 88.42 2.41 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 116.871 -1.932 . . . . 0.0 106.993 175.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.28 167.15 14.94 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.721 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -81.94 156.31 17.82 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.348 1.365 . . . . 0.0 110.005 166.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.969 HD12 ' HB2' ' A' ' 91' ' ' ASP . 14.0 tt -54.43 -33.59 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.632 0.729 . . . . 0.0 110.747 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.7 pt20 -64.12 -31.05 72.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.865 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 1.077 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 4.4 tmtm? -81.76 -37.8 26.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.163 0.982 . . . . 0.0 109.071 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.582 HG22 HG11 ' A' ' 142' ' ' VAL . 3.2 t -64.4 -33.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.661 169.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CZ2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 t-105 -55.1 -42.66 73.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.927 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.736 ' C ' HG21 ' A' ' 31' ' ' THR . 34.8 tt0 -68.18 -28.33 67.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.167 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.1 -10.13 20.74 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.882 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -130.91 -65.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.348 1.885 . . . . 0.0 113.98 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.695 ' HB3' HD12 ' A' ' 74' ' ' LEU . 1.3 p -98.41 66.0 1.69 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.669 -1.269 . . . . 0.0 109.43 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.6 t -156.06 -174.97 5.19 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.583 -166.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.1 m -60.99 169.04 2.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.161 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.08 -7.88 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 125.934 1.693 . . . . 0.0 114.387 -157.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.53 -36.04 83.03 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.288 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.882 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -62.13 -39.91 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.764 0.792 . . . . 0.0 112.147 174.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.542 -178.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 104.77 4.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.655 1.693 . . . . 0.0 110.007 -171.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' O ' HG21 ' A' ' 65' ' ' VAL . 69.4 mttt -134.06 153.29 51.9 Favored 'General case' 0 C--O 1.202 -1.408 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.295 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.684 ' HG3' HG12 ' A' ' 68' ' ' VAL . 23.6 mt-10 -123.13 131.28 53.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 119.251 0.932 . . . . 0.0 112.771 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.15 34.63 62.78 Favored Glycine 0 CA--C 1.509 -0.301 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.827 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -106.76 173.23 6.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.073 -1.064 . . . . 0.0 108.943 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.509 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.996 157.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 25.1 pttm -140.11 131.09 26.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' SER . 51.2 t -82.75 128.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.9 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -68.43 -48.46 64.53 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.849 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.34 145.84 16.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.639 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -141.91 132.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.451 173.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -141.25 138.85 33.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.473 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.91 127.74 93.34 Favored Pre-proline 0 N--CA 1.444 -0.774 0 O-C-N 123.751 0.657 . . . . 0.0 109.531 -167.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.623 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -3.26 62.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 1 C-N-CA 126.181 4.587 . . . . 0.0 115.744 -156.446 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.6 p -130.23 -52.55 1.11 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.592 166.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.06 135.34 29.09 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.29 0.567 . . . . 0.0 109.959 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.7 tt -136.17 125.73 25.25 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.63 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.4 m -137.49 125.16 22.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 74' ' ' LEU . 11.7 p90 -150.74 158.0 43.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' HG3' HD21 ' A' ' 66' ' ' LEU . 23.4 mt-10 . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.34 0.59 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 HD13 ' A' ' 101' ' ' ILE . 92.8 m -121.38 136.5 54.95 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.318 -171.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.737 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -112.07 131.65 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.503 ' CG ' HD11 ' A' ' 101' ' ' ILE . 4.5 mm100 -115.87 121.9 43.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD23 ' HD1' ' A' ' 98' ' ' PHE . 3.4 tm? -125.28 142.82 51.28 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.714 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.575 ' H ' HD22 ' A' ' 89' ' ' LEU . 2.8 tp10 -110.84 134.12 52.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.969 ' HB2' HD12 ' A' ' 22' ' ' ILE . 1.2 t70 . . . . . 0 CA--C 1.476 -1.903 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.847 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.881 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.54 136.61 48.64 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.099 -1.001 . . . . 0.0 111.16 -156.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 114.36 4.96 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 119.208 -1.472 . . . . 0.0 109.986 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.923 ' HD1' HD23 ' A' ' 89' ' ' LEU . 15.3 t80 -105.22 127.16 52.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.191 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -123.98 116.67 23.24 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.119 HD22 ' HE1' ' A' ' 130' ' ' TRP . 5.0 tt -106.37 136.37 46.24 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.144 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -114.23 123.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.871 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.661 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.9 p . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.491 0.662 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -33.33 74.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.336 170.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -70.39 -30.66 68.95 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.661 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.5 mtpp -60.5 -42.01 95.5 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 122.076 0.941 . . . . 0.0 109.355 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.712 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 8.7 mmt -80.91 -20.83 41.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.106 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.587 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.7 t70 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.693 -170.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.22 -50.52 0.11 Allowed Glycine 0 C--O 1.246 0.876 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.221 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.629 ' O ' HG13 ' A' ' 133' ' ' ILE . . . -65.92 -22.37 70.31 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.988 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.119 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -70.94 -33.74 70.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.593 -173.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -71.06 -39.32 72.31 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.104 172.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.48 -55.4 13.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 118.938 -1.601 . . . . 0.0 111.17 174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 129' ' ' GLY . 1.3 mt -81.85 -48.71 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.362 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.876 HG21 HD13 ' A' ' 100' ' ' LEU . 35.5 t -80.03 -44.08 22.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 121.177 -0.952 . . . . 0.0 111.368 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.743 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.0 t30 -72.45 -40.37 67.07 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.761 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.794 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 5.3 tt0 -95.82 -46.0 6.75 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 118.216 -1.393 . . . . 0.0 111.609 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.0 tpp180 -83.11 -33.82 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 27.9 tp -63.01 -39.86 96.03 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.1 tmm_? -66.17 -30.33 70.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.679 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.961 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -68.95 -48.08 64.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.796 -0.565 . . . . 0.0 112.33 175.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -66.29 -28.42 68.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.129 0.49 . . . . 0.0 110.188 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 1.077 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 28.7 m -95.64 -15.11 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.995 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -149.48 -54.2 0.17 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.122 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.65 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 68.7 tt0 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.72 HG22 ' CH2' ' A' ' 130' ' ' TRP . 5.4 mm . . . . . 0 N--CA 1.441 -0.894 0 CA-C-O 120.412 0.149 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -131.68 145.82 51.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.143 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 1.127 ' HB2' ' HE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -137.95 150.87 47.42 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -127.04 138.02 53.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.853 0.835 . . . . 0.0 111.861 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.706 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -150.79 147.74 15.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.194 173.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.706 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.2 m -96.24 119.83 35.45 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.327 172.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 16' ' ' ILE . 20.5 mt -90.35 107.76 19.35 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.966 ' HG3' ' HE ' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -74.03 88.03 1.88 Allowed 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 116.8 -1.96 . . . . 0.0 107.11 176.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.32 168.64 11.73 Favored Pre-proline 0 C--O 1.22 -0.491 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.194 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 83.8 Cg_endo -80.49 151.54 19.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.07 1.18 . . . . 0.0 110.253 166.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.63 ' CG1' ' HB2' ' A' ' 71' ' ' PRO . 6.7 tt -54.76 -36.15 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.593 0.711 . . . . 0.0 111.078 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.731 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.1 pt20 -60.95 -32.1 71.64 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.638 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.8 mmtm -82.29 -35.54 27.92 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.343 -0.848 . . . . 0.0 110.83 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.719 HG22 HG11 ' A' ' 142' ' ' VAL . 3.0 t -67.39 -32.52 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 170.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.589 ' CE3' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.64 -42.85 71.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.746 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.748 ' C ' HG21 ' A' ' 31' ' ' THR . 9.6 tp10 -65.96 -28.44 68.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.844 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.0 m -100.06 -7.03 25.46 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.919 ' HA ' HG13 ' A' ' 35' ' ' ILE . 22.6 m -134.99 -61.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.951 -1.718 . . . . 0.0 113.596 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 74' ' ' LEU . 32.3 p -96.46 63.69 2.14 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 120.33 -1.482 . . . . 0.0 109.617 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.748 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.91 -174.4 4.83 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.236 -165.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 35' ' ' ILE . 3.5 p -61.09 173.24 0.85 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.307 1.043 . . . . 0.0 110.496 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 5.2 mt-10 -47.55 -6.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.559 . . . . 0.0 114.216 -166.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.24 -40.08 91.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.585 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.919 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.01 -36.6 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.449 0.642 . . . . 0.0 111.139 171.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.726 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.14 102.14 3.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 123.691 1.71 . . . . 0.0 109.099 -172.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 55.4 mttt -134.32 154.26 51.42 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 111.593 -2.549 . . . . 0.0 107.364 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 68' ' ' VAL . 20.5 mt-10 -122.45 125.67 46.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 119.281 0.946 . . . . 0.0 111.967 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.77 81.93 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.799 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.45 159.54 15.84 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 25.2 mp0 . . . . . 0 N--CA 1.435 -1.208 0 C-N-CA 118.482 -1.287 . . . . 0.0 108.777 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.777 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.7 OUTLIER -148.98 134.0 18.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.566 0.621 . . . . 0.0 109.718 -175.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 76' ' ' PHE . 71.4 t -74.52 127.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.228 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.476 HD23 ' HG3' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -68.11 -49.45 61.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.246 177.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.21 146.19 15.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -136.48 122.11 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.43 1.11 . . . . 0.0 110.473 173.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 71.5 mm-40 -131.48 137.5 48.59 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.266 -172.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.81 123.99 83.46 Favored Pre-proline 0 CA--C 1.501 -0.919 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -166.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.56 65.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.34 1 C-N-CA 126.487 4.791 . . . . 0.0 115.248 -160.146 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -135.42 -46.85 0.69 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.713 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 28.4 tt0 -146.35 130.68 17.6 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.783 HD13 HG23 ' A' ' 68' ' ' VAL . 1.9 tp -130.74 127.66 39.23 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.6 t -137.55 127.53 25.79 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.951 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CB ' HG22 ' A' ' 65' ' ' VAL . 13.8 p90 -148.98 144.2 26.62 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.969 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HG3' HD23 ' A' ' 66' ' ' LEU . 47.9 mt-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-O 122.135 0.969 . . . . 0.0 112.651 -168.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' NE2' ' A' ' 102' ' ' HIS . 33.3 m . . . . . 0 N--CA 1.403 -2.796 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.854 HG22 HD13 ' A' ' 101' ' ' ILE . 29.3 m -117.53 129.2 55.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.96 -175.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.597 ' HD2' HD23 ' A' ' 74' ' ' LEU . 44.9 m-85 -118.66 128.32 54.41 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.806 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -117.0 125.59 51.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.818 0.818 . . . . 0.0 109.801 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.907 HD13 ' HB3' ' A' ' 71' ' ' PRO . 3.4 mt -124.04 144.18 49.99 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.05 -169.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 121.09 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.549 ' OD2' HD13 ' A' ' 22' ' ' ILE . 9.9 t0 . . . . . 0 CA--C 1.493 -1.236 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.2 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.869 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.103 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -108.57 127.97 54.42 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 -162.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.1 115.68 5.17 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 118.466 -1.826 . . . . 0.0 110.665 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 19.8 t80 -106.39 130.7 54.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.18 0.991 . . . . 0.0 113.223 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.3 m -124.28 122.11 36.84 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.769 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD13 HG21 ' A' ' 134' ' ' VAL . 5.9 tt -104.67 136.55 43.99 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.496 -0.881 . . . . 0.0 111.114 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.854 HD13 HG22 ' A' ' 86' ' ' THR . 2.4 mp -118.11 127.25 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.346 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.685 ' CG ' ' HZ2' ' A' ' 130' ' ' TRP . 13.4 m170 . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 160.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.749 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 9.8 p . . . . . 0 N--CA 1.443 -0.775 0 CA-C-O 121.088 0.471 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 123' ' ' ARG . 42.3 ttp180 -62.31 -35.41 78.97 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.19 -31.61 69.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.461 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.749 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 36.7 mtpt -62.9 -43.89 97.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 121.614 0.721 . . . . 0.0 110.599 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 6.9 mmt -81.97 -27.83 33.0 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.84 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.93 -16.06 58.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.882 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.61 -36.13 0.11 Allowed Glycine 0 C--O 1.243 0.695 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.397 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.662 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -69.03 -22.82 76.08 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.987 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 1.127 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 4.0 m0 -68.04 -33.22 74.18 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 117.922 0.861 . . . . 0.0 112.635 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.6 p -74.94 -33.15 61.92 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.81 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.809 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.67 -68.28 1.78 Allowed Glycine 0 C--N 1.312 -0.782 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.13 168.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 129' ' ' GLY . 15.9 pt -71.0 -50.26 43.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 121.513 -0.992 . . . . 0.0 112.184 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 5.7 t -81.1 -42.99 20.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 O-C-N 121.64 -0.662 . . . . 0.0 112.047 -176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.795 ' HB3' ' O ' ' A' ' 131' ' ' THR . 20.0 t-20 -75.56 -42.99 50.85 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 117.482 -1.687 . . . . 0.0 108.152 -174.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.91 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 11.3 tp10 -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.579 -169.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.072 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.0 tpp180 -83.71 -31.97 25.77 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.782 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.4 tp -66.53 -39.64 88.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 117.854 -1.538 . . . . 0.0 107.288 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.966 ' HE ' ' HG3' ' A' ' 19' ' ' GLU . 2.6 tmt_? -63.55 -32.79 74.36 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.302 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 1.072 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.58 -45.16 72.75 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.567 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -73.56 -28.75 62.02 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 110.141 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.719 HG11 HG22 ' A' ' 25' ' ' VAL . 25.5 m -86.73 -19.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 19.6 mm-40 -143.7 -64.8 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.288 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.561 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 71.5 tt0 . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.028 -165.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.31 97.71 2.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -90.44 -37.51 13.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.676 0.75 . . . . 0.0 109.331 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -112.3 163.54 14.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.776 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -93.04 121.45 34.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.916 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 9.6 tt0 -104.45 -47.02 4.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.188 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -152.55 -69.83 0.16 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.547 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.829 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . 60.22 -168.59 0.16 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -164.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.767 ' HB3' HG13 ' A' ' 122' ' ' VAL . 3.8 pp -74.91 121.88 86.25 Favored Pre-proline 0 C--N 1.307 -1.253 0 C-N-CA 117.619 -1.633 . . . . 0.0 107.394 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.726 ' HD2' ' HD3' ' A' ' 123' ' ' ARG . 64.5 Cg_exo -52.27 151.7 16.82 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.076 1.851 . . . . 0.0 109.638 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -53.27 112.89 0.97 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.696 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 123' ' ' ARG . 4.7 mm -103.22 124.96 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.208 -173.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.84 132.69 55.65 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.496 177.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 131' ' ' THR . 16.3 mmtm -126.86 129.15 47.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.83 136.27 54.81 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.05 0.929 . . . . 0.0 110.698 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.782 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.94 148.66 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.092 178.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.782 ' N ' HG12 ' A' ' 16' ' ' ILE . 77.3 m -94.89 119.25 33.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 172.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.627 HD23 ' CD1' ' A' ' 16' ' ' ILE . 22.7 mt -91.06 108.57 19.95 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -74.95 87.88 2.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 C-N-CA 116.647 -2.021 . . . . 0.0 106.709 176.087 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.76 167.26 14.6 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.165 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 98.1 Cg_endo -82.14 158.56 17.8 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.364 1.376 . . . . 0.0 110.198 167.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.045 HD12 ' HB2' ' A' ' 91' ' ' ASP . 10.8 tt -54.63 -32.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.684 0.754 . . . . 0.0 110.986 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 5.7 pt20 -68.42 -31.41 70.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.223 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 142' ' ' VAL . 82.5 mttt -81.92 -37.04 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.965 -1.085 . . . . 0.0 110.418 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG22 HG11 ' A' ' 142' ' ' VAL . 6.2 t -62.5 -34.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.612 167.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 71' ' ' PRO . 1.2 t-105 -55.21 -43.39 74.4 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.765 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.745 ' C ' HG21 ' A' ' 31' ' ' THR . 27.4 tp10 -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.929 173.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.9 -9.34 21.67 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -171.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.877 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.0 m -131.75 -63.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.64 2.018 . . . . 0.0 114.316 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.606 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 32.0 p -97.38 63.31 1.79 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 109.646 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.745 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.5 t -157.56 -174.61 4.95 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.238 -164.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 1.9 p -62.45 175.31 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.644 1.177 . . . . 0.0 110.918 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.045 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 14.4 mt-10 -47.42 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.341 1.457 . . . . 0.0 113.594 -165.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.06 -40.79 93.99 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.975 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.877 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.5 -39.73 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 122.221 1.01 . . . . 0.0 110.727 172.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . . . -55.91 -32.65 63.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.423 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -50.96 -49.84 59.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.796 ' HB2' HG23 ' A' ' 133' ' ' ILE . 11.4 p-90 -80.31 -37.01 33.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.362 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.89 -72.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.772 0.32 . . . . 0.0 111.549 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.439 ' HG3' ' HD2' ' A' ' 41' ' ' PRO . 27.9 ttt 178.35 139.7 0.26 Allowed Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 40' ' ' MET . 69.9 Cg_exo -40.63 101.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.772 2.981 . . . . 0.0 114.034 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -158.13 163.37 37.66 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.236 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.045 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 10.9 p-10 -114.64 51.84 0.87 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 32' ' ' SER . 16.3 t80 -40.96 138.77 0.99 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.303 169.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -135.17 139.24 44.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.5 pt? -73.67 100.74 3.45 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 116.932 -1.907 . . . . 0.0 108.116 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 49.2 mttm -132.33 153.0 51.17 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 111.53 -2.577 . . . . 0.0 107.434 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.793 ' HG3' HG12 ' A' ' 68' ' ' VAL . 22.7 mt-10 -123.27 130.55 52.89 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.867 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.93 40.17 71.64 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.809 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.786 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.3 pm0 -108.01 172.42 6.84 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.2 mt-10 -124.8 128.16 48.3 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.402 161.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -132.74 138.78 47.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 62' ' ' PRO . 81.3 t60 -139.6 157.26 46.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.827 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HA ' ' OD1' ' A' ' 43' ' ' ASP . 6.5 mp -68.77 15.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 53' ' ' HIS . 39.6 mt-30 -139.97 157.73 45.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.862 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 19.7 m -58.33 -55.22 47.89 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.862 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 12.5 Cg_exo -71.23 111.33 3.06 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.975 1.784 . . . . 0.0 110.497 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -70.11 -30.36 67.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.052 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.3 -115.84 4.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -81.51 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.552 2.168 . . . . 0.0 111.3 173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -73.4 115.49 41.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 55.1 Cg_endo -88.63 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.284 1.989 . . . . 0.0 112.374 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.602 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 34.5 m -129.86 154.1 47.62 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 20.9 pttp -145.87 128.75 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -173.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.786 ' N ' HE22 ' A' ' 50' ' ' GLN . 70.6 t -82.55 130.09 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.6 HD11 ' OE2' ' A' ' 77' ' ' GLU . 5.1 mp -70.15 -50.14 43.49 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.719 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.42 15.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.765 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.793 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -138.65 135.27 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.879 0.847 . . . . 0.0 110.747 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.81 140.33 32.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.139 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.87 128.07 93.3 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -166.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.691 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -4.63 68.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 125.963 4.442 . . . . 0.0 115.012 -156.831 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' GLN . 4.6 p -139.29 -50.06 0.51 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.924 171.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.68 133.15 25.0 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.148 0.499 . . . . 0.0 109.715 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.6 tt -131.84 125.77 32.63 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.4 m -137.64 123.66 20.26 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.131 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.0 p90 -152.34 158.19 42.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.789 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 27.2 mt-10 -114.79 131.31 56.85 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.501 ' HB3' ' NE1' ' A' ' 83' ' ' TRP . 56.9 t-105 -94.01 117.23 29.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.0 -1.454 . . . . 0.0 113.122 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 80' ' ' THR . 2.2 t70 41.62 -106.15 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 113.599 -1.637 . . . . 0.0 114.913 167.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.506 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 2.6 t -89.09 -29.95 19.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.47 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.999 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.3 mp0 -91.41 154.29 19.27 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -90.89 32.51 5.07 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.635 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.789 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.78 117.6 21.58 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.132 -177.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 43.1 t -80.75 80.51 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.058 166.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.774 HG13 ' HB2' ' A' ' 83' ' ' TRP . 17.3 m -83.07 124.03 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.857 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.69 HG22 HD13 ' A' ' 101' ' ' ILE . 90.8 m -120.5 136.92 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.55 -170.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.64 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.2 m-30 -112.27 131.07 55.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.459 ' CG ' HD11 ' A' ' 101' ' ' ILE . 8.3 mm100 -116.37 125.62 52.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.287 0.565 . . . . 0.0 109.601 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 ' HD1' ' A' ' 98' ' ' PHE . 1.5 tm? -121.53 142.77 49.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -172.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.435 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -110.1 119.57 39.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.045 ' HB2' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -81.6 111.65 18.09 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 121.896 0.855 . . . . 0.0 110.028 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 52.4 mt -125.24 123.45 39.56 Favored 'General case' 0 N--CA 1.399 -3.004 0 CA-C-N 113.264 -1.789 . . . . 0.0 106.643 162.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.89 -26.87 8.86 Favored Glycine 0 N--CA 1.479 1.554 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 159.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 4.6 tp10 -52.65 -154.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 111.499 -2.35 . . . . 0.0 109.254 150.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.04 175.76 6.2 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -177.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -111.92 128.44 56.15 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.502 -0.749 . . . . 0.0 109.949 -163.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.0 115.48 5.25 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 118.418 -1.849 . . . . 0.0 110.087 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.799 ' HD1' HD23 ' A' ' 89' ' ' LEU . 27.5 t80 -104.26 127.15 51.86 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.898 0.856 . . . . 0.0 111.882 -170.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.3 m -123.18 117.08 24.53 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.315 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.071 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.6 tt -107.27 138.37 43.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.238 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.198 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.1 m170 -117.54 114.36 23.33 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 166.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.7 t -143.99 165.38 27.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.79 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 83' ' ' TRP . . . -170.89 150.81 14.54 Favored Glycine 0 C--N 1.312 -0.781 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -121.09 142.21 50.06 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' A' ' 106' ' ' LYS . 11.8 ttpp 90.66 34.55 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.833 1.333 . . . . 0.0 112.756 171.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.957 ' HG2' ' HA ' ' A' ' 112' ' ' ILE . 10.3 mp0 -121.6 163.12 32.71 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 122.217 -0.302 . . . . 0.0 110.488 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.916 ' HA ' ' HB3' ' A' ' 6' ' ' GLU . 88.1 Cg_endo -92.67 -153.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.433 2.755 . . . . 0.0 112.92 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.01 -16.51 62.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.96 0.886 . . . . 0.0 110.291 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 119' ' ' SER . 41.2 tt0 -74.75 162.29 28.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.577 166.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 113' ' ' GLY . 14.8 m -74.79 -179.87 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-O 123.638 1.685 . . . . 0.0 112.117 -168.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.999 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -52.17 -30.95 13.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 110.213 -3.176 . . . . 0.0 112.602 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.695 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . 145.87 74.99 0.02 OUTLIER Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.494 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 97.2 mttt 77.43 16.13 1.63 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.467 0.707 . . . . 0.0 110.77 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.88 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -64.61 -28.62 69.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.884 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.426 HD22 ' C ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -179.47 -70.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.539 ' C ' HG13 ' A' ' 111' ' ' VAL . 38.3 tt0 -172.63 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.324 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.725 ' HB2' HG13 ' A' ' 121' ' ' VAL . 48.5 mmtm -91.46 138.06 31.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.225 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.693 ' HB2' ' C ' ' A' ' 8' ' ' ALA . 98.4 p -58.92 -35.19 72.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.966 0.888 . . . . 0.0 109.393 174.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.55 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 6.0 p -67.44 -40.5 85.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.764 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.725 HG13 ' HB2' ' A' ' 118' ' ' LYS . 16.7 m -70.5 -35.93 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.159 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' A' ' 9' ' ' LEU . 14.1 p -66.86 -38.14 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.098 0.475 . . . . 0.0 110.678 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.726 ' HD3' ' HD2' ' A' ' 10' ' ' PRO . 8.9 ptt180 -66.38 -29.89 70.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.16 -28.38 70.29 Favored Glycine 0 C--O 1.24 0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.679 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.9 mtpp -61.37 -43.27 99.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.073 0.94 . . . . 0.0 108.722 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 1.044 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 10.8 mmt -76.08 -23.51 55.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.043 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.619 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 14.9 t70 -76.62 -15.5 59.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.722 -171.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.54 -58.02 0.19 Allowed Glycine 0 C--O 1.244 0.723 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.717 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.86 -16.24 76.31 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.919 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.071 ' HE1' HD22 ' A' ' 100' ' ' LEU . 6.6 t-105 -82.19 -24.12 35.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.505 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -78.83 -34.2 45.41 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.751 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -53.99 -54.98 28.24 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 118.249 -1.929 . . . . 0.0 110.057 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 38' ' ' TRP . 53.1 mt -70.55 -54.55 17.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 100' ' ' LEU . 21.8 t -83.37 -44.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 121.36 -0.838 . . . . 0.0 112.331 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.728 ' HA ' HG21 ' A' ' 16' ' ' ILE . 40.4 t-20 -72.93 -39.94 65.84 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.736 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.742 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 2.2 tt0 -95.49 -45.82 6.93 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.687 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.7 tpp180 -83.07 -31.79 27.14 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.699 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 21.0 tp -64.54 -40.31 95.36 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 118.626 -1.229 . . . . 0.0 107.713 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.6 tmm_? -66.33 -30.23 70.59 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -68.65 -46.12 70.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.631 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.76 -28.72 63.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.792 -0.568 . . . . 0.0 110.183 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 25' ' ' VAL . 33.1 m -85.88 -21.61 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 9.6 mm-40 -148.17 -56.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.651 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 21.7 pt-20 42.61 -152.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.021 0.928 . . . . 0.0 112.024 -169.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.7 tt -153.7 -51.15 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.31 147.84 50.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.769 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -116.61 -45.64 2.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.551 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -119.77 100.16 7.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -67.46 -7.26 24.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -135.03 -73.44 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.753 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -142.06 151.74 42.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.954 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 C--O 1.245 0.834 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.25 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.565 0.221 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.87 -67.51 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.903 0.382 . . . . 0.0 111.778 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -76.26 -38.55 56.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -112.63 152.76 28.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.6 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 21.5 m-80 -74.97 122.78 24.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 5.5 tp10 -85.05 -109.09 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.608 -163.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.836 ' HB3' ' HA ' ' A' ' 110' ' ' GLN . 41.9 t-20 -104.46 -45.86 4.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.67 0.271 . . . . 0.0 110.595 -172.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.862 ' HA ' ' HA ' ' A' ' 112' ' ' ILE . . . 72.19 155.85 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.919 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -73.44 142.96 82.0 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.758 -174.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 31.7 Cg_exo -59.76 142.0 97.89 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.504 2.136 . . . . 0.0 109.924 171.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.64 122.2 8.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 112.325 -163.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.572 HG21 ' CB ' ' A' ' 126' ' ' MET . 1.5 tp -106.57 129.74 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -127.37 134.68 49.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.838 ' HB3' ' CZ2' ' A' ' 130' ' ' TRP . 20.8 tptt -138.73 152.03 47.63 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.665 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -124.42 141.87 51.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.079 0.943 . . . . 0.0 112.083 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.835 HD11 HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -142.02 148.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.593 171.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.69 ' N ' HG13 ' A' ' 16' ' ' ILE . 33.5 m -98.57 117.68 33.55 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 162.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.835 HD23 HD11 ' A' ' 16' ' ' ILE . 28.1 mt -93.59 109.4 21.02 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.673 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -75.35 88.26 2.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 117.158 -1.817 . . . . 0.0 106.84 177.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.45 166.16 17.1 Favored Pre-proline 0 C--O 1.217 -0.625 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.241 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 92.3 Cg_endo -78.88 157.15 27.34 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.232 1.288 . . . . 0.0 109.783 167.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.82 HD13 ' HA ' ' A' ' 91' ' ' ASP . 4.5 tp -53.24 -36.82 26.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.756 0.788 . . . . 0.0 110.673 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.3 pt20 -61.57 -32.41 72.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.2 -1.364 . . . . 0.0 114.073 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' GLU . 54.3 mtpt -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.721 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.548 HG22 HG11 ' A' ' 142' ' ' VAL . 2.7 t -66.97 -34.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.296 169.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.711 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.82 -41.91 71.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.586 172.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.723 ' C ' HG21 ' A' ' 31' ' ' THR . 6.0 tp10 -66.89 -29.97 70.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.931 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.699 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.2 m -101.67 -9.55 20.81 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 -170.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.865 ' HA ' HG13 ' A' ' 35' ' ' ILE . 28.3 m -130.13 -64.3 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.47 1.941 . . . . 0.0 113.916 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.647 ' HB3' HD12 ' A' ' 74' ' ' LEU . 30.8 p -97.58 65.29 1.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.852 -1.155 . . . . 0.0 109.132 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.723 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -156.77 -176.37 5.94 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.649 -166.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 35' ' ' ILE . 16.9 m -63.19 173.64 1.42 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.687 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.1 mt-10 -47.88 -5.31 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.905 1.682 . . . . 0.0 114.612 -164.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.52 -37.59 83.16 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.804 -1.188 . . . . 0.0 110.613 170.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.865 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.45 -37.57 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.771 0.796 . . . . 0.0 110.62 170.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB1' ' C ' ' A' ' 42' ' ' ASN . . . -53.97 -30.77 48.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.571 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -46.27 -49.6 17.15 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 1.028 ' HB2' HG23 ' A' ' 133' ' ' ILE . 7.1 p-90 -92.61 129.57 38.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.256 -0.277 . . . . 0.0 110.335 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' TRP . 69.6 t80 81.56 95.63 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.098 0.874 . . . . 0.0 112.412 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.1 mmt 67.27 161.95 0.14 Allowed Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.276 169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.05 116.88 3.75 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 C-N-CA 122.776 2.317 . . . . 0.0 110.437 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 12.6 t-20 -154.67 165.54 36.22 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.738 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 3.5 p-10 -155.65 39.52 0.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.47 0.652 . . . . 0.0 110.15 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 74' ' ' LEU . 21.4 t80 -46.83 142.55 3.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.375 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -138.77 141.26 38.83 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.6 pt? -73.05 102.15 3.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.976 -1.89 . . . . 0.0 108.911 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -131.13 150.6 52.07 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.062 -2.335 . . . . 0.0 106.91 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.603 ' HG3' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.5 131.74 54.0 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.55 39.54 45.52 Favored Glycine 0 N--CA 1.463 0.476 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.831 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 47' ' ' LYS . 2.2 pm0 -107.63 173.95 6.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 124.427 1.091 . . . . 0.0 109.579 -171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.035 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 78.7 mt-10 -123.53 127.04 47.77 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.234 158.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.667 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -134.24 127.14 31.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 62' ' ' PRO . 1.4 p80 -149.56 136.67 19.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.041 163.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.0 tp -105.69 -28.27 10.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HG3' ' OG ' ' A' ' 56' ' ' SER . 8.5 pt20 -101.16 -162.4 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.93 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.444 ' OG ' ' HG3' ' A' ' 55' ' ' GLN . 16.0 m 70.92 136.12 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.251 0 O-C-N 123.945 0.778 . . . . 0.0 112.811 168.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 58' ' ' PHE . 83.6 Cg_endo -83.66 -142.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.138 2.559 . . . . 0.0 110.81 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.432 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 48.1 t80 77.15 -47.13 0.5 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.222 0.609 . . . . 0.0 111.243 172.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 60' ' ' PRO . . . 105.0 -116.66 5.35 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.361 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 59' ' ' GLY . 19.7 Cg_exo -67.27 151.12 81.34 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.143 2.562 . . . . 0.0 112.365 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.5 m 61.58 66.05 1.64 Allowed Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.499 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 1.035 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 48.6 Cg_endo -74.69 -80.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.943 1.762 . . . . 0.0 111.372 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.847 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 31.2 t -126.12 151.6 47.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.666 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.17 126.84 23.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 76' ' ' PHE . 40.4 t -79.9 127.26 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.178 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.614 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.5 mm? -71.06 -46.14 62.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.132 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.532 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.41 140.51 15.3 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.281 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -139.06 127.57 28.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.007 172.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -141.95 139.81 32.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.564 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.07 127.92 91.54 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -168.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.999 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.21 60.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 1 C-N-CA 126.869 5.046 . . . . 0.0 116.066 -162.403 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -136.86 -44.48 0.58 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.245 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 30.8 tt0 -144.19 134.4 24.33 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.558 0.694 . . . . 0.0 110.584 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -137.38 126.41 24.35 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 m -139.43 126.25 20.8 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.191 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.847 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 21.4 p90 -152.32 155.09 36.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.817 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 47.7 mt-10 -117.96 128.71 55.06 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.382 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -102.24 118.8 37.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.39 -1.277 . . . . 0.0 113.847 -161.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.73 -146.05 0.59 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.846 169.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 81' ' ' GLU . 4.4 t -61.98 -28.92 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.683 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.987 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 1.9 mp0 -83.4 141.82 31.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.532 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -95.98 44.05 2.09 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.286 -170.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.817 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -92.02 119.58 31.87 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.258 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' CA ' ' HG2' ' A' ' 77' ' ' GLU . 4.3 p -84.68 95.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.093 166.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 75' ' ' SER . 0.7 OUTLIER -85.1 129.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.898 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 93.0 m -121.38 131.67 54.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.678 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -111.22 124.44 52.22 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -114.86 126.91 55.35 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 122.424 1.107 . . . . 0.0 109.668 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 71' ' ' PRO . 22.6 tp -128.61 144.38 51.14 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.673 -165.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.722 ' H ' HD12 ' A' ' 89' ' ' LEU . 4.0 tp10 -110.71 130.41 55.58 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.535 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.82 ' HA ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -96.29 106.45 18.66 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 124.203 0.939 . . . . 0.0 110.132 -170.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.067 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 15.6 mt -126.48 134.73 50.86 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.79 -24.12 67.93 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 160.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 1.067 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 6.7 tp10 -54.85 -158.86 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.251 -2.474 . . . . 0.0 109.024 152.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.787 ' H ' ' HG3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -96.72 169.18 10.05 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.83 131.59 54.92 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.454 0.645 . . . . 0.0 109.979 -158.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.76 113.35 4.62 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.861 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.85 ' HD1' HD13 ' A' ' 89' ' ' LEU . 6.5 t80 -104.89 129.94 53.14 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.848 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.8 m -122.47 116.09 23.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.022 ' HB3' ' HZ2' ' A' ' 130' ' ' TRP . 7.2 tt -110.62 139.23 46.08 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.285 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.8 mp -115.99 124.91 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.365 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.596 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -118.02 112.83 20.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -142.71 165.76 26.5 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -167.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.793 ' HA3' ' HB1' ' A' ' 8' ' ' ALA . . . -160.26 131.99 2.82 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.838 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.422 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 4.5 m0 -129.94 131.24 45.91 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.793 0.797 . . . . 0.0 111.913 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 23.3 tttm -174.22 -104.73 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 165.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.946 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.6 pt-20 -124.65 -175.42 0.39 Allowed Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.679 -169.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.946 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 67.5 Cg_endo -73.26 -173.25 1.22 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.606 2.204 . . . . 0.0 115.221 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 59.22 96.53 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.864 0.866 . . . . 0.0 110.584 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.836 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 3.4 pm0 -105.63 114.74 29.09 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -156.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 3.6 p -146.65 176.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 141.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.987 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -61.78 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 118.951 0.796 . . . . 0.0 111.871 178.006 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -168.32 -88.86 0.07 OUTLIER Glycine 0 C--O 1.222 -0.64 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.531 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 73.9 tttt -125.92 45.63 2.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 163.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -68.05 -39.97 82.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.209 -1.814 . . . . 0.0 111.618 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.4 -65.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.04 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.682 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 7.8 tp10 -167.31 -81.19 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.763 ' HB2' HG13 ' A' ' 121' ' ' VAL . 34.5 mmtp -94.96 154.67 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.764 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.864 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 89.8 p -65.78 -35.05 79.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.798 0.808 . . . . 0.0 109.196 168.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 4.3 m -66.04 -41.2 91.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG13 ' HB2' ' A' ' 118' ' ' LYS . 13.9 m -71.82 -36.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.987 -176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.825 HG11 HD11 ' A' ' 112' ' ' ILE . 7.8 p -69.68 -36.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.574 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 120' ' ' SER . 28.0 ptt180 -68.1 -28.29 67.21 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -65.43 -32.0 82.1 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 39.1 mmtm -62.48 -38.04 88.28 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.729 0.776 . . . . 0.0 109.237 172.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 102' ' ' HIS . 19.9 mtt -82.01 -7.73 59.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.541 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.495 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 31.0 t70 -92.57 -15.3 27.11 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.042 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -133.47 -53.96 0.08 OUTLIER Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.734 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.35 -18.76 73.69 Favored Glycine 0 CA--C 1.499 -0.957 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.022 ' HZ2' ' HB3' ' A' ' 100' ' ' LEU . 21.1 t90 -55.6 -63.86 1.03 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.678 -1.261 . . . . 0.0 110.913 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.9 p -63.8 -28.31 69.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.009 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -55.95 -59.28 10.89 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 118.494 -1.812 . . . . 0.0 110.289 168.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.028 HG23 ' HB2' ' A' ' 38' ' ' TRP . 1.7 mp -72.41 -54.46 16.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.824 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.8 t -81.16 -44.2 20.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 O-C-N 121.561 -0.712 . . . . 0.0 112.017 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 131' ' ' THR . 44.1 t30 -79.12 -38.11 36.94 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 117.92 -1.512 . . . . 0.0 108.735 -171.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.942 ' HG2' ' HE2' ' A' ' 140' ' ' LYS . 15.4 tt0 -94.82 -45.53 7.27 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 118.385 -1.326 . . . . 0.0 110.785 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.4 tpp180 -83.43 -33.0 25.8 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.824 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 34.5 tp -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.059 -1.456 . . . . 0.0 107.098 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HA ' HG22 ' A' ' 142' ' ' VAL . 4.4 tmm_? -65.8 -30.76 71.44 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.09 -47.51 68.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.187 0.517 . . . . 0.0 112.366 176.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -70.1 -27.44 64.6 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.782 -0.574 . . . . 0.0 109.771 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 138' ' ' LEU . 28.9 m -94.12 -12.78 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -153.24 -56.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.599 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 18.3 pt-20 35.18 77.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.496 1.118 . . . . 0.0 113.338 -169.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 145' ' ' LEU . 2.1 pp -68.27 125.69 27.21 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 169.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.19 162.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.389 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.2 t60 174.68 -24.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -85.87 -48.42 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.226 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -86.01 105.24 16.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.543 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -125.89 18.39 7.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.978 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.7 m80 56.62 -149.93 0.45 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.382 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.165 -0.921 . . . . 0.0 109.339 172.057 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.613 0.244 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.9 -45.39 4.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.065 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.87 -38.83 92.29 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.51 0.671 . . . . 0.0 109.692 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -112.47 145.69 39.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -75.84 130.54 38.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.657 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -42.02 -62.74 0.86 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.53 1.144 . . . . 0.0 112.45 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -140.02 -60.43 0.53 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -143.72 -52.32 0.34 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.006 168.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.843 HD21 ' HE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -86.14 105.06 6.48 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.43 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 39.5 Cg_exo -58.59 152.77 53.17 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.308 2.005 . . . . 0.0 111.778 -175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.79 121.71 17.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.81 0.814 . . . . 0.0 110.996 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -107.73 136.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -113.38 134.05 54.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.844 174.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.808 ' HD3' HG23 ' A' ' 131' ' ' THR . 7.8 mmpt? -122.01 130.9 53.68 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.25 54.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.129 0.966 . . . . 0.0 111.437 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -153.49 149.06 13.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.687 178.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' HG12 ' A' ' 16' ' ' ILE . 28.1 m -95.06 121.1 36.33 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 16' ' ' ILE . 96.1 mt -91.65 108.34 19.84 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 1.3 mt-10 -77.58 87.15 3.89 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 116.62 -2.032 . . . . 0.0 106.768 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.807 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -158.47 169.03 11.25 Favored Pre-proline 0 C--O 1.214 -0.811 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.639 -176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 95.7 Cg_endo -83.62 152.61 13.38 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.749 0.966 . . . . 0.0 109.9 163.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.733 HG21 ' OD2' ' A' ' 91' ' ' ASP . 7.3 tt -55.02 -32.1 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.829 0.823 . . . . 0.0 111.289 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.677 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 4.6 pt20 -66.56 -30.48 70.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.953 -1.476 . . . . 0.0 113.407 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.593 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 58.1 tptt -81.69 -35.99 29.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 122.066 0.936 . . . . 0.0 110.011 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' A' ' 89' ' ' LEU . 2.7 t -66.04 -33.64 64.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.641 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.195 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.816 ' C ' HG21 ' A' ' 31' ' ' THR . 23.4 tt0 -66.64 -28.28 68.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.106 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.556 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.4 m -100.21 -9.35 22.54 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.884 ' HA ' HG13 ' A' ' 35' ' ' ILE . 32.9 m -131.08 -63.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.334 1.879 . . . . 0.0 113.415 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 27.7 p -96.74 65.54 2.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.56 -1.338 . . . . 0.0 108.663 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.816 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.97 -174.7 4.96 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.729 -165.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 1.3 p -60.68 171.78 1.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.022 0.929 . . . . 0.0 110.315 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.024 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 4.1 mt-10 -47.76 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.571 1.549 . . . . 0.0 113.698 -162.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.02 -36.41 81.14 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.256 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.884 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.79 -44.22 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 121.718 0.77 . . . . 0.0 111.639 173.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.4 -32.74 65.12 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.773 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.9 -14.43 53.43 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.838 ' HZ2' HG12 ' A' ' 29' ' ' VAL . 8.0 p-90 -98.68 22.42 10.0 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.154 0.888 . . . . 0.0 110.872 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 130' ' ' TRP . 6.7 p90 -174.22 67.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.554 167.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.468 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 0.9 OUTLIER 77.78 120.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.379 173.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 40' ' ' MET . 3.1 Cg_endo -51.03 120.43 6.7 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.111 3.208 . . . . 0.0 114.526 -177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -156.41 142.06 17.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.563 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.024 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.2 p-10 -84.25 55.98 3.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.735 0.779 . . . . 0.0 111.02 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.685 ' HE2' HD11 ' A' ' 74' ' ' LEU . 19.4 t80 -63.55 139.39 58.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.41 164.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 20.9 mp0 -139.89 147.55 40.78 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 168.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.618 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -71.72 103.55 3.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.754 1.74 . . . . 0.0 109.369 -172.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.686 ' HB3' ' CB ' ' A' ' 50' ' ' GLN . 6.5 mmtp -131.62 154.71 48.62 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 111.625 -2.534 . . . . 0.0 107.514 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' CD ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -120.42 134.15 55.32 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.375 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.98 38.95 61.57 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.441 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -109.94 151.52 26.99 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.361 -168.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -113.98 128.86 56.57 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 160.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.906 ' HZ ' HG23 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -95.55 114.86 26.66 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.083 -167.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -135.77 139.04 43.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.6 tp 52.52 64.08 1.99 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.643 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.424 ' HG2' ' CD ' ' A' ' 45' ' ' GLN . 6.7 tp-100 -111.02 -67.42 1.0 Allowed 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.193 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.743 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 20.3 m -121.24 -54.21 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.476 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 11.0 Cg_endo -91.11 -75.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.358 2.038 . . . . 0.0 112.511 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.733 ' HD1' ' HB2' ' A' ' 57' ' ' PRO . 1.0 OUTLIER -159.24 -61.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.68 81.08 0.08 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.857 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 58' ' ' PHE . 94.0 Cg_endo -89.53 62.32 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.907 2.405 . . . . 0.0 112.031 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t 57.57 65.65 3.37 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.547 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.576 ' O ' ' HA ' ' A' ' 79' ' ' ASP . 79.7 Cg_endo -91.42 -89.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.704 2.269 . . . . 0.0 113.299 -175.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.89 ' HB3' ' HA ' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -100.85 165.88 11.13 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.432 -170.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.6 pttt -143.27 141.62 31.1 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.906 HG23 ' HZ ' ' A' ' 52' ' ' PHE . 95.9 t -83.54 132.16 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.316 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.819 HD23 ' OE1' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -82.84 -39.79 21.2 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.378 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . . . -157.85 140.76 14.95 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.17 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -140.21 132.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.16 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -141.68 138.65 32.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.942 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.77 123.02 82.24 Favored Pre-proline 0 CA--C 1.503 -0.847 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -168.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 0.02 62.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.602 1 C-N-CA 126.322 4.681 . . . . 0.0 115.732 -159.845 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 p -133.21 -41.99 0.88 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.727 167.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -144.78 133.27 21.98 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -129.48 128.65 43.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 169.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 49.1 m -138.06 121.93 17.69 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.247 168.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.639 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 p90 -154.35 151.1 28.66 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.712 0.768 . . . . 0.0 111.378 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.819 ' OE1' HD23 ' A' ' 66' ' ' LEU . 25.6 mp0 -126.11 134.51 51.32 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.904 -173.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.89 ' HA ' ' HB3' ' A' ' 63' ' ' CYS . 8.7 t-105 -79.66 125.05 29.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.43 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER 53.74 -146.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.164 175.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.535 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.0 t -78.31 -38.36 42.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.646 1.212 . . . . 0.0 108.841 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.619 ' OE2' ' HA2' ' A' ' 113' ' ' GLY . 1.7 pt-20 -142.5 142.33 32.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.567 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . 126.52 30.43 0.84 Allowed Glycine 0 C--N 1.29 -1.996 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -160.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.843 ' HE3' HD21 ' A' ' 9' ' ' LEU . 31.1 m0 -65.03 144.45 57.27 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 113.471 -1.365 . . . . 0.0 108.016 -174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -126.88 -32.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.606 172.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.898 HG21 ' HB3' ' A' ' 103' ' ' SER . 53.3 t 73.81 -108.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.133 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 14.4 m -121.52 135.78 55.0 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 122.102 2.228 . . . . 0.0 115.441 -158.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.5 m-30 -110.07 131.93 54.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -121.26 128.09 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.864 0.84 . . . . 0.0 110.631 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 71' ' ' PRO . 2.5 tt -121.28 143.29 49.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.636 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 89' ' ' LEU . 5.2 tp10 -110.53 130.83 55.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.788 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.733 ' OD2' HG21 ' A' ' 22' ' ' ILE . 8.5 t70 -94.74 109.12 21.11 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.968 -176.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.905 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 12.9 mt -122.92 131.37 53.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 167.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.28 -27.15 38.8 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 160.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.905 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.3 tp10 -55.11 -158.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 111.442 -2.379 . . . . 0.0 109.84 153.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.807 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -100.88 -179.15 3.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -177.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -106.71 131.34 53.94 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.274 -0.891 . . . . 0.0 111.041 -154.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.69 113.58 4.75 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.125 -1.512 . . . . 0.0 109.887 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.7 t80 -105.35 128.96 53.76 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.434 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 m -122.07 114.7 21.28 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 134' ' ' VAL . 6.0 tt -105.55 136.21 45.55 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 118.589 -1.245 . . . . 0.0 110.777 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.742 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.5 mp -110.29 121.32 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.807 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.31 109.24 15.57 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.618 170.256 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.898 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.8 t -99.23 122.88 43.0 Favored 'General case' 0 N--CA 1.4 -2.969 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 146.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 83' ' ' TRP . . . -174.36 173.21 45.92 Favored Glycine 0 C--N 1.277 -2.748 0 C-N-CA 115.355 -3.307 . . . . 0.0 118.475 -158.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 1.026 ' HB2' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -112.12 155.57 23.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.171 -2.015 . . . . 0.0 110.214 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 53.6 tptt -123.78 -65.08 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 31.7 tt0 172.1 -65.02 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 O-C-N 123.952 0.782 . . . . 0.0 112.277 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 7.1 Cg_exo -73.19 139.08 28.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 115.339 -163.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 70.47 -163.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.141 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 1.02 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -57.92 120.18 8.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.402 0.62 . . . . 0.0 109.474 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.909 HG22 ' H ' ' A' ' 112' ' ' ILE . 2.7 p -158.58 -168.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.318 -171.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.076 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -44.42 -34.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 123.99 0.806 . . . . 0.0 109.911 169.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.904 ' H ' HG13 ' A' ' 111' ' ' VAL . . . -54.92 89.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 164.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HD2' ' C ' ' A' ' 113' ' ' GLY . 1.1 mptp? 62.34 60.48 1.41 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 1.076 ' HB2' ' HA ' ' A' ' 112' ' ' ILE . . . -54.26 -10.48 0.38 Allowed 'General case' 0 C--N 1.352 0.687 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -172.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -63.18 -19.28 64.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.038 0.381 . . . . 0.0 110.869 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 1.02 ' HB3' ' HB2' ' A' ' 110' ' ' GLN . 14.4 mm-40 -79.64 -150.11 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.888 ' HB2' ' HG3' ' A' ' 110' ' ' GLN . 9.8 mmtm -81.25 90.46 6.1 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 124.336 2.017 . . . . 0.0 113.389 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.866 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -68.61 -29.33 67.82 Favored 'General case' 0 C--N 1.269 -2.891 0 CA-C-N 110.918 -2.855 . . . . 0.0 108.978 154.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -61.74 -34.53 76.0 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.008 -1.058 . . . . 0.0 111.184 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 118' ' ' LYS . 27.7 m -72.9 -36.83 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.631 -176.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.866 HG12 ' O ' ' A' ' 119' ' ' SER . 10.0 p -60.88 -36.22 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.554 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 48.0 ttt180 -63.66 -33.12 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.414 0.626 . . . . 0.0 109.415 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.14 -30.81 67.05 Favored Glycine 0 C--O 1.24 0.487 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.266 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.658 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 50.6 mttm -62.84 -34.88 78.26 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.409 0.623 . . . . 0.0 109.42 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.904 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 13.9 mtt -75.17 -27.38 59.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.939 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 7.2 t70 -75.97 -14.79 60.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.788 -169.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.52 -57.37 0.2 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.897 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -70.95 -19.63 77.17 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.77 -171.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.904 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -74.43 -33.39 62.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.264 0.532 . . . . 0.0 111.351 -171.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.808 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.4 p -74.65 -33.99 62.63 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.274 171.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.76 -52.1 26.46 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.752 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 38' ' ' TRP . 1.1 mm -85.54 -48.01 16.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.302 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 100' ' ' LEU . 25.6 t -78.81 -42.52 24.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 O-C-N 120.689 -1.257 . . . . 0.0 111.488 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.607 ' HB3' ' O ' ' A' ' 131' ' ' THR . 43.0 t-20 -76.56 -39.55 52.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.933 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.851 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 4.0 tt0 -93.61 -46.97 7.03 Favored 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.947 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.804 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.9 tpp180 -81.6 -33.23 31.64 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.673 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.2 tp -65.01 -40.61 95.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 120.579 1.536 . . . . 0.0 107.401 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.924 ' HB2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.87 -36.77 82.23 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 169.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 15.6 mtmt -69.09 -43.8 73.8 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.04 -28.33 64.3 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.894 -0.504 . . . . 0.0 110.491 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 138' ' ' LEU . 30.0 m -93.44 -17.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -149.1 -58.61 0.21 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.497 -174.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.82 ' HG3' ' H ' ' A' ' 145' ' ' LEU . 11.3 pt-20 34.37 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.537 1.135 . . . . 0.0 112.972 -161.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.82 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 2.6 mm? 53.5 35.0 19.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.205 0.526 . . . . 0.0 110.457 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.49 119.88 9.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.716 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -86.14 94.68 9.34 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.713 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -50.8 -58.28 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.376 -166.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.415 ' HB3' ' H ' ' A' ' 150' ' ' HIS . 68.3 m80 57.18 -151.65 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.654 0.596 . . . . 0.0 109.653 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' H ' ' HB3' ' A' ' 149' ' ' HIS . 22.5 m-70 69.75 91.9 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 111.085 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -118.83 136.7 53.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.061 -177.323 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.2 28.64 7.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.125 0.488 . . . . 0.0 110.256 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -65.68 -48.5 71.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -137.07 174.03 11.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.094 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.18 119.23 24.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 7' ' ' ASN . 3.7 tt0 -88.86 -62.0 1.58 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.068 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 2.5 p30 -107.14 -26.56 11.05 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.518 -169.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . . . -69.27 152.88 44.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 160.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.801 ' HB3' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -66.49 128.43 93.85 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.62 156.72 59.49 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.008 1.805 . . . . 0.0 109.928 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -55.29 120.47 7.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.703 0.763 . . . . 0.0 110.47 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 123' ' ' ARG . 86.8 mt -104.39 126.07 59.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.094 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.66 132.29 53.42 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 130' ' ' TRP . 26.9 tptt -128.88 133.64 47.99 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -122.51 136.96 55.01 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.241 1.019 . . . . 0.0 112.203 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.745 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.57 148.47 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.665 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.745 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.9 m -96.95 120.58 37.57 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.405 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG21 ' A' ' 142' ' ' VAL . 22.4 mt -91.03 108.31 19.78 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.813 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -74.51 89.09 2.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 116.64 -2.024 . . . . 0.0 106.852 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.56 169.46 10.32 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.34 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 93.1 Cg_endo -82.83 158.83 16.04 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.088 1.858 . . . . 0.0 110.388 164.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.913 HD13 ' HB2' ' A' ' 91' ' ' ASP . 3.5 tp -56.08 -36.34 44.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.573 0.701 . . . . 0.0 110.456 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.2 pt20 -61.5 -32.85 72.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.064 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.892 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.6 tmtp? -82.12 -36.48 27.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.83 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.656 HG22 HG11 ' A' ' 142' ' ' VAL . 3.1 t -67.28 -33.53 63.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.701 171.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.655 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.75 -42.49 71.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.541 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.73 ' C ' HG21 ' A' ' 31' ' ' THR . 10.3 tp10 -67.23 -29.42 69.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.889 173.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.614 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.0 m -101.34 -8.85 21.7 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.872 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.3 m -131.23 -64.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 121.796 2.089 . . . . 0.0 113.784 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB3' HD12 ' A' ' 74' ' ' LEU . 33.8 p -97.11 65.41 2.03 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.981 -1.074 . . . . 0.0 109.156 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.73 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -155.62 -177.75 6.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.047 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.0 m -63.67 171.23 2.77 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.166 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -49.2 -3.34 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.265 1.826 . . . . 0.0 114.836 -161.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.21 -35.28 69.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.608 169.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.872 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -68.34 -36.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.766 0.793 . . . . 0.0 111.302 170.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -53.36 -29.34 33.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.747 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -54.73 -41.39 70.31 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.801 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 9.5 p-90 -91.02 33.67 0.94 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.512 -0.742 . . . . 0.0 109.83 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HD1' ' O ' ' A' ' 40' ' ' MET . 2.7 t80 -141.67 144.89 34.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.682 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 22.2 mmt -73.21 158.87 86.25 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 30.7 Cg_exo -12.2 98.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 125.348 4.032 . . . . 0.0 115.17 -163.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 20.5 t-20 -156.32 153.86 29.71 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.1 -170.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HB2' HD12 ' A' ' 54' ' ' LEU . 1.8 p30 -152.93 42.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.59 0.709 . . . . 0.0 110.385 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 74' ' ' LEU . 39.9 t80 -49.32 143.01 6.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.919 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -138.8 143.5 38.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.09 102.91 3.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 117.826 -1.55 . . . . 0.0 109.003 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 70.2 mttt -133.09 152.54 51.95 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.514 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG3' HG12 ' A' ' 68' ' ' VAL . 25.5 mt-10 -124.66 131.77 53.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 119.107 0.867 . . . . 0.0 112.897 174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.62 34.54 60.57 Favored Glycine 0 C--N 1.328 0.128 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.224 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.671 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.4 pm0 -106.93 173.27 6.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.442 1.097 . . . . 0.0 108.59 -173.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.929 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 7.7 mp0 -118.06 129.11 55.36 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.566 -1.253 . . . . 0.0 109.111 157.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.676 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.68 131.99 41.9 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.546 ' HE1' ' HA ' ' A' ' 57' ' ' PRO . 4.9 p80 -148.2 139.17 23.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.066 165.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 43' ' ' ASP . 81.1 mt -109.58 -19.51 13.18 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.68 171.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -102.6 146.77 27.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.267 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.577 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 70.8 m 53.48 90.33 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.546 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 97.1 Cg_endo -84.3 66.34 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.683 2.256 . . . . 0.0 112.749 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 56' ' ' SER . 5.0 p90 -134.27 26.62 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.343 0.592 . . . . 0.0 110.542 173.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.44 132.66 7.02 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.24 -63.94 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.587 2.191 . . . . 0.0 111.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.899 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.7 m -128.59 114.58 19.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.929 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 70.2 Cg_endo -75.37 -111.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 123.038 2.492 . . . . 0.0 113.874 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 8.8 m -101.93 157.48 16.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.928 -172.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.8 OUTLIER -141.31 132.41 26.29 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -173.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.671 ' N ' HE22 ' A' ' 50' ' ' GLN . 55.9 t -82.89 125.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.703 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.629 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -61.45 -54.67 40.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.765 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.19 145.3 16.49 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.527 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -134.89 129.35 51.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.106 0.955 . . . . 0.0 110.453 173.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -134.55 139.36 45.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.789 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.48 122.87 78.7 Favored Pre-proline 0 CA--C 1.506 -0.749 0 O-C-N 123.711 0.632 . . . . 0.0 109.428 -165.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.02 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.6 60.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.196 1 C-N-CA 126.78 4.987 . . . . 0.0 115.684 -158.525 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -132.71 -45.41 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.53 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.59 132.85 23.17 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.369 0.604 . . . . 0.0 109.932 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 44' ' ' PHE . 8.7 tt -129.78 125.63 36.25 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.6 m -138.38 124.9 20.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.009 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.597 ' HE2' ' HE3' ' A' ' 78' ' ' TRP . 12.2 p90 -152.31 157.53 41.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.783 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 43.0 mt-10 -118.49 132.46 56.23 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.597 ' HE3' ' HE2' ' A' ' 76' ' ' PHE . 69.0 t-105 -104.7 130.77 52.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.935 -167.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 57.06 -153.54 0.37 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.367 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.5 t -54.15 -33.45 57.98 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.48 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.854 ' HG3' ' HA ' ' A' ' 112' ' ' ILE . 13.5 mm-40 -90.61 172.4 8.71 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.422 -167.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.909 ' HA2' ' HE2' ' A' ' 106' ' ' LYS . . . -105.66 22.3 32.49 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.534 -163.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.851 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -72.72 112.61 8.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.089 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.55 88.07 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.868 161.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 83' ' ' TRP . 14.3 m -86.67 119.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.545 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.757 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 90.4 m -121.1 133.17 55.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.794 -168.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.675 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -112.9 132.8 55.16 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.551 -0.718 . . . . 0.0 109.835 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -122.29 125.9 46.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.761 0.791 . . . . 0.0 110.43 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.02 HD23 ' HB3' ' A' ' 71' ' ' PRO . 63.1 tp -124.78 144.64 50.15 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.672 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -110.53 123.4 49.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.66 0.384 . . . . 0.0 110.453 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.913 ' HB2' HD13 ' A' ' 22' ' ' ILE . 8.5 t70 -94.61 111.27 23.04 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.234 0.54 . . . . 0.0 110.882 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.682 ' CB ' ' HB3' ' A' ' 94' ' ' GLU . 19.4 mt -120.36 152.86 37.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.372 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.4 -23.36 68.36 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 163.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.965 ' HG2' ' HD3' ' A' ' 95' ' ' LYS . 17.8 tt0 -58.9 -160.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 111.086 -2.557 . . . . 0.0 108.698 155.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.965 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -100.44 -175.97 3.07 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -173.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.541 ' HB ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -106.44 126.05 51.76 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 119.777 1.171 . . . . 0.0 109.005 -164.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.68 117.43 5.65 Favored Glycine 0 CA--C 1.491 -1.455 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.503 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.685 ' HE2' HD12 ' A' ' 100' ' ' LEU . 13.8 t80 -103.66 126.74 50.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.803 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.4 m -122.34 115.36 22.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.039 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.685 HD12 ' HE2' ' A' ' 98' ' ' PHE . 6.2 tt -107.51 137.31 45.77 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.104 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.757 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -120.05 125.96 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.727 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' HD21 ' A' ' 100' ' ' LEU . 1.9 m170 -119.25 113.66 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -131.46 160.93 33.72 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.675 ' HA3' HD11 ' A' ' 9' ' ' LEU . . . -140.7 128.78 3.89 Favored Glycine 0 C--N 1.314 -0.691 0 O-C-N 124.046 0.841 . . . . 0.0 111.952 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -132.77 125.36 29.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.909 ' HE2' ' HA2' ' A' ' 82' ' ' GLY . 3.7 tppt? -177.34 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.75 0.31 . . . . 0.0 110.773 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.492 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 41.2 mm-40 -118.19 130.19 24.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.171 -174.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 3.1 Cg_exo -81.18 62.19 8.4 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.165 2.576 . . . . 0.0 111.999 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.476 ' HB2' ' H ' ' A' ' 110' ' ' GLN . 3.9 m120 -120.71 -85.88 0.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.476 ' H ' ' HB2' ' A' ' 109' ' ' ASN . 4.3 pm0 -140.77 152.72 45.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.011 HG12 ' HA ' ' A' ' 119' ' ' SER . 0.4 OUTLIER -107.92 -177.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.46 -1.296 . . . . 0.0 112.816 -171.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.96 HD11 HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.65 -45.72 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 111.78 -2.464 . . . . 0.0 114.774 -160.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.995 ' HA2' ' HB ' ' A' ' 122' ' ' VAL . . . 59.93 -127.41 44.15 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -164.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.632 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 12.9 ptmm? -82.68 128.79 34.69 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 146.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.816 ' HB2' ' CZ2' ' A' ' 83' ' ' TRP . . . -48.37 -11.39 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 -142.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 114' ' ' LYS . 18.6 p30 -101.61 29.84 4.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 120.036 1.289 . . . . 0.0 111.627 169.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.765 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 46.8 mm-40 -116.76 -157.29 0.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.781 0.432 . . . . 0.0 111.793 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.9 mttt -99.31 161.94 13.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 1.011 ' HA ' HG12 ' A' ' 111' ' ' VAL . 2.7 p -71.79 -45.24 62.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.257 -1.338 . . . . 0.0 114.374 173.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 m -65.99 -31.47 72.38 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.407 1.099 . . . . 0.0 108.044 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 118' ' ' LYS . 12.7 t -71.7 -45.59 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.421 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.995 ' HB ' ' HA2' ' A' ' 113' ' ' GLY . 8.6 p -60.27 -40.48 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HA ' HD11 ' A' ' 12' ' ' ILE . 15.0 ttp85 -63.16 -31.14 72.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -73.94 -34.37 55.95 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.013 175.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 30.7 mmmt -60.6 -42.32 96.55 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.011 0.91 . . . . 0.0 109.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.621 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 3.7 mmt -81.63 -24.61 36.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.911 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.417 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 19.4 t70 -76.7 -14.98 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.763 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -129.12 -51.97 0.11 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.894 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.92 -32.02 82.54 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.774 -0.713 . . . . 0.0 113.148 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.705 ' CE3' ' HA ' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -62.65 -55.72 24.35 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 118.138 0.969 . . . . 0.0 110.513 -175.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.3 p -62.47 -28.95 70.17 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.513 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.2 -63.56 5.06 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 118.828 -1.653 . . . . 0.0 111.173 169.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 pt -77.16 -49.56 22.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.797 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.0 p -79.45 -43.4 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 112.436 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.694 ' HB3' ' O ' ' A' ' 131' ' ' THR . 1.1 t30 -74.84 -40.83 60.8 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.993 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.749 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 3.6 tp10 -95.82 -46.16 6.68 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.857 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.069 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 13.8 tpp180 -82.75 -32.02 28.06 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.797 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 49.0 tp -64.38 -40.49 95.92 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.7 tmm_? -65.59 -29.95 70.62 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.175 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.069 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -71.37 -46.59 60.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 177.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.56 -28.84 68.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.194 0.521 . . . . 0.0 109.668 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 24.1 m -94.05 -15.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.64 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -149.7 -58.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.278 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.735 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 9.9 tt0 52.13 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.563 1.145 . . . . 0.0 112.925 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 53.5 tp 173.64 -75.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -167.55 88.64 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.944 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -131.59 99.29 4.75 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -65.22 -25.22 67.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.017 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 51.17 26.65 3.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.937 1.295 . . . . 0.0 112.234 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -166.64 64.64 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.69 -31.85 52.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.49 175.577 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 107.93 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.305 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -62.43 -44.36 96.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.785 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 80' ' ' THR . 57.4 t30 -173.21 127.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 174.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.52 129.01 55.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.0 111.08 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 5.5 tp10 -105.64 -67.19 0.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.918 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 110' ' ' GLN . 12.3 t-20 -162.34 -40.92 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . 84.37 151.51 0.08 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 163.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.903 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 1.4 pp -82.51 157.63 67.2 Favored Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.193 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 123' ' ' ARG . 8.5 Cg_exo -71.23 146.72 51.95 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.027 1.818 . . . . 0.0 108.737 162.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.48 124.82 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.533 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.672 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -106.45 127.84 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.93 134.33 55.28 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.892 ' HD3' HG23 ' A' ' 131' ' ' THR . 8.9 mmpt? -123.49 131.5 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.2 133.74 54.72 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.396 1.093 . . . . 0.0 111.566 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.735 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.8 148.19 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.814 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.735 ' N ' HG12 ' A' ' 16' ' ' ILE . 15.6 m -97.25 120.01 36.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 23.3 mt -90.02 107.65 19.25 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -76.83 87.28 3.42 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 116.641 -2.024 . . . . 0.0 107.044 177.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.787 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.65 165.39 18.52 Favored Pre-proline 0 C--O 1.213 -0.839 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.937 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 80.4 Cg_endo -75.7 157.71 39.75 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 120.752 0.968 . . . . 0.0 110.193 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.857 HD12 ' HB3' ' A' ' 91' ' ' ASP . 2.5 tt -52.67 -35.75 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.842 0.83 . . . . 0.0 111.108 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 2.1 pt20 -68.63 -29.66 68.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.355 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -75.6 -40.58 56.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.042 0.925 . . . . 0.0 109.421 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.652 HG22 HG11 ' A' ' 142' ' ' VAL . 8.5 t -66.45 -35.43 74.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.133 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.5 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 1.9 t90 -55.72 -43.75 76.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.96 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.764 ' C ' HG21 ' A' ' 31' ' ' THR . 37.7 tt0 -67.98 -28.75 67.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.889 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 141' ' ' ALA . 7.0 m -101.55 -9.02 21.37 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.894 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -131.07 -65.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 121.174 1.807 . . . . 0.0 113.811 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.612 ' HB3' HD12 ' A' ' 74' ' ' LEU . 21.9 p -97.49 68.34 2.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.505 -1.372 . . . . 0.0 109.057 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.2 t -156.32 -177.44 6.59 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.154 -169.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.758 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 17.4 m -62.25 170.52 2.26 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.293 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -49.75 -8.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 126.092 1.757 . . . . 0.0 114.435 -156.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.78 -33.91 75.18 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.08 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.81 -44.53 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 121.679 0.752 . . . . 0.0 112.398 173.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.663 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . . . -56.7 -31.67 64.71 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.54 0.686 . . . . 0.0 110.03 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -78.78 50.03 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.424 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.787 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 13.8 m0 -94.72 64.63 2.98 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.725 -1.235 . . . . 0.0 108.169 168.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 38' ' ' TRP . 92.5 t80 77.35 -17.1 0.59 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.146 0.578 . . . . 0.0 110.464 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.488 ' CG ' ' HD2' ' A' ' 41' ' ' PRO . 24.7 ttt -96.41 151.63 38.18 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.47 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' CG ' ' A' ' 40' ' ' MET . 87.3 Cg_exo -47.37 149.9 3.91 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 113.041 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.663 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 9.6 p30 -99.69 155.24 17.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -177.17 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.509 0.505 . . . . 0.0 111.792 -172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.835 ' HD2' HD12 ' A' ' 35' ' ' ILE . 30.0 t80 -65.56 140.86 58.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.758 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 72.5 mt-30 -139.62 144.85 37.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.5 pt? -72.29 101.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 123.388 1.566 . . . . 0.0 109.834 -172.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HB3' ' CG ' ' A' ' 50' ' ' GLN . 4.4 mptp? -132.08 153.79 50.1 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 112.233 -2.258 . . . . 0.0 107.193 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.691 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.3 mt-10 -122.48 134.96 54.56 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 119.265 0.938 . . . . 0.0 112.345 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.06 35.99 42.49 Favored Glycine 0 N--CA 1.462 0.405 0 O-C-N 124.057 0.848 . . . . 0.0 112.121 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.667 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.2 pm0 -108.1 173.32 6.37 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.188 -1.006 . . . . 0.0 108.502 -171.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.865 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 17.5 mp0 -118.76 130.94 56.08 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.431 156.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.725 ' CE1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -128.51 128.22 43.92 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.896 0.379 . . . . 0.0 111.433 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.85 ' HB3' ' HG3' ' A' ' 62' ' ' PRO . 34.9 p-80 -140.56 140.64 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.622 -171.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.4 mt -89.05 -42.68 11.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 167.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -137.39 153.81 50.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.388 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 19.8 m -91.24 113.99 60.19 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 8.3 Cg_exo -72.03 72.2 2.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.341 2.694 . . . . 0.0 112.264 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 59.1 21.36 9.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.934 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.46 ' HA2' ' HD3' ' A' ' 60' ' ' PRO . . . -170.26 140.02 5.81 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.359 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 2.9 Cg_exo -77.21 43.13 1.24 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.59 2.86 . . . . 0.0 112.528 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.4 m -148.77 94.78 4.04 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.865 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 86.5 Cg_endo -83.21 -113.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.7 2.267 . . . . 0.0 112.85 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.725 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 31.9 m -102.0 161.36 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.472 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.554 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -148.28 129.28 14.44 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.667 ' N ' HE22 ' A' ' 50' ' ' GLN . 59.2 t -83.21 131.32 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.052 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -66.78 -54.54 21.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.626 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.04 146.14 17.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.294 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -138.17 136.16 44.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.934 176.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 57.9 mt-30 -141.28 137.4 32.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.329 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 134.24 94.0 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.767 ' C ' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -4.55 64.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.306 1 C-N-CA 125.872 4.381 . . . . 0.0 115.665 -157.782 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.488 ' N ' ' HB2' ' A' ' 89' ' ' LEU . 6.5 p -137.83 -49.56 0.58 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.561 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -147.97 144.19 27.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 110.271 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.719 HD11 ' CE2' ' A' ' 44' ' ' PHE . 8.7 tt -142.84 125.34 15.73 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 65' ' ' VAL . 74.2 m -136.92 124.12 21.78 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.544 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 65' ' ' VAL . 9.2 p90 -152.7 156.41 39.11 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.806 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 51.8 mt-10 -118.67 132.89 56.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.493 0.663 . . . . 0.0 109.645 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.412 ' HB3' ' NE1' ' A' ' 83' ' ' TRP . 1.9 t90 -107.14 130.43 54.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.925 -160.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 80' ' ' THR . 3.5 t70 51.51 -114.55 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.069 1.348 . . . . 0.0 114.408 170.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.9 t -103.5 -15.51 15.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.352 -169.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 14.2 mp0 -94.89 151.28 19.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.85 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.49 38.51 3.21 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.411 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.806 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -86.43 116.87 24.85 Favored 'General case' 0 CA--C 1.486 -1.51 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.722 -177.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 4.2 p -86.47 84.94 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.131 -1.849 . . . . 0.0 106.539 165.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.797 HG13 ' HB2' ' A' ' 83' ' ' TRP . 16.3 m -84.42 123.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.335 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.717 HG22 HD13 ' A' ' 101' ' ' ILE . 85.6 m -120.85 138.28 54.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.325 -169.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 74' ' ' LEU . 18.9 m-30 -111.61 130.87 55.61 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -116.49 125.57 52.13 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.929 1.347 . . . . 0.0 109.778 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.767 ' HB2' ' C ' ' A' ' 71' ' ' PRO . 1.8 mt -122.21 139.43 53.78 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.813 -158.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 96' ' ' THR . 3.6 tp10 -115.5 132.2 56.7 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 122.189 -0.32 . . . . 0.0 111.083 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.857 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.16 107.32 19.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.317 1.011 . . . . 0.0 109.819 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 17.9 mt -126.58 134.26 50.87 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 167.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.66 -25.44 63.44 Favored Glycine 0 N--CA 1.47 0.953 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 161.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 15.9 tt0 -55.17 -158.8 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 111.155 -2.523 . . . . 0.0 109.23 154.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.939 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -98.54 175.1 6.13 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.35 136.35 49.66 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.645 0.736 . . . . 0.0 110.962 -157.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 90' ' ' GLU . . . -96.65 115.26 5.17 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 118.9 -1.619 . . . . 0.0 110.06 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 12.7 t80 -108.21 125.95 52.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.643 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -123.78 116.19 22.6 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.595 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.033 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.2 tt -108.1 140.49 41.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.742 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' THR . 1.8 mp -119.67 124.27 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.881 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.762 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -118.78 110.31 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 168.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.887 ' HA ' HD11 ' A' ' 9' ' ' LEU . 33.9 t -144.23 163.91 32.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.782 -167.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -154.2 132.7 3.62 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.629 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 71.5 t-105 -79.42 122.52 26.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.744 0.772 . . . . 0.0 111.772 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.858 ' HG3' ' H ' ' A' ' 107' ' ' GLU . 2.9 tptm 159.42 -156.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.068 1.347 . . . . 0.0 107.748 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.858 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 40.6 mt-10 -121.33 116.25 30.98 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 117.991 0.359 . . . . 0.0 110.413 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 35.8 Cg_endo -64.28 137.32 55.57 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 124.067 3.178 . . . . 0.0 116.964 -164.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 179.61 -64.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.95 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.794 ' O ' ' HB3' ' A' ' 119' ' ' SER . 6.2 tp60 -96.4 162.11 13.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.226 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.635 HG13 ' C ' ' A' ' 117' ' ' GLU . 14.6 m -74.18 -179.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 CA-C-O 123.304 1.526 . . . . 0.0 112.101 -164.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.905 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -52.86 -45.76 51.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 111.377 -2.647 . . . . 0.0 112.036 -177.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 6' ' ' GLU . . . -161.45 -74.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.867 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 4.7 tmtt? -140.55 43.75 1.86 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 169.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.816 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -71.56 -26.18 62.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.501 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -178.93 -79.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.296 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.635 ' C ' HG13 ' A' ' 111' ' ' VAL . 1.7 tm-20 -164.48 -74.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.695 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.779 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 24.9 mttm -92.68 141.49 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 111.644 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.903 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 78.6 p -66.38 -41.48 89.33 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.447 0.642 . . . . 0.0 111.478 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.6 m -66.7 -30.3 70.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.703 0.764 . . . . 0.0 109.617 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 118' ' ' LYS . 13.8 t -71.57 -44.26 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.468 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 112' ' ' ILE . 13.0 p -65.42 -39.31 84.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.454 0.471 . . . . 0.0 111.238 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.598 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.5 ptt180 -68.52 -28.41 66.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -69.97 -29.29 70.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.705 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.1 mmmm -61.87 -38.9 89.99 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.264 1.03 . . . . 0.0 108.634 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.968 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 20.7 mtt -75.9 -28.08 57.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.386 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.595 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 20.0 t70 -78.01 -15.54 58.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.876 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.05 -54.44 0.21 Allowed Glycine 0 C--O 1.244 0.772 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.789 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.82 -17.14 80.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.302 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.033 ' HE1' HD22 ' A' ' 100' ' ' LEU . 43.7 t-105 -89.0 -14.19 37.08 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.706 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.892 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.2 p -82.47 -32.81 28.7 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.562 164.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.69 -53.9 36.33 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 118.24 -1.934 . . . . 0.0 109.417 168.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.9 mt -69.45 -55.76 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.982 -0.609 . . . . 0.0 112.588 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.915 HG21 HD13 ' A' ' 100' ' ' LEU . 38.6 t -84.12 -44.94 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.362 -0.836 . . . . 0.0 112.291 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.664 ' HB3' ' O ' ' A' ' 131' ' ' THR . 36.6 t-20 -72.55 -40.01 67.03 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.559 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.789 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.5 tt0 -97.26 -45.56 6.45 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.66 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 17.2 tpp180 -82.5 -31.7 29.15 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.721 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.8 tp -64.06 -40.12 95.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 120.08 1.309 . . . . 0.0 108.274 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 2.9 tmt_? -62.75 -32.18 73.27 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.805 ' HA ' ' H ' ' A' ' 144' ' ' GLU . 50.8 mtmt -74.72 -43.37 55.4 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.654 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.13 -28.79 68.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.778 -0.576 . . . . 0.0 110.229 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.652 HG11 HG22 ' A' ' 25' ' ' VAL . 32.9 m -87.32 -21.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 63.2 mm-40 -143.7 -63.57 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.131 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.805 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 35.5 tt0 59.72 137.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.066 -171.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.57 51.21 1.23 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.678 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 32.87 56.41 0.43 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.131 1.373 . . . . 0.0 113.792 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 69.76 -67.56 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.942 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.9 t60 73.04 129.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -166.17 127.12 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.601 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -131.93 135.26 46.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.03 106.95 7.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.4 t60 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.064 175.26 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.8 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 113' ' ' GLY . . . -140.44 82.92 1.88 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.86 -32.56 10.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.211 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 113' ' ' GLY . 4.4 p-10 -112.64 158.5 19.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.996 0.427 . . . . 0.0 111.17 -173.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.597 ' HB3' ' O ' ' A' ' 80' ' ' THR . 27.8 p-10 -98.93 144.91 27.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.608 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.67 ' HG3' ' N ' ' A' ' 7' ' ' ASN . 7.0 pt-20 -144.4 -48.06 0.26 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.371 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.67 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 9.0 p30 -116.93 -120.75 0.3 Allowed 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.703 ' HA ' HG23 ' A' ' 112' ' ' ILE . . . 164.42 166.99 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.679 -170.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.846 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -81.46 155.67 71.38 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.383 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.28 142.22 29.6 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.094 1.863 . . . . 0.0 109.805 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.92 119.39 5.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.359 0.6 . . . . 0.0 110.964 -170.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.754 HG12 ' HG2' ' A' ' 123' ' ' ARG . 0.8 OUTLIER -105.16 127.56 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.788 -177.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -122.8 133.68 54.44 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.601 173.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -126.08 128.15 46.92 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 p -125.62 137.61 53.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.68 1.229 . . . . 0.0 112.711 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.832 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.9 149.54 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 112.687 -2.051 . . . . 0.0 108.123 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.804 ' N ' HG12 ' A' ' 16' ' ' ILE . 59.2 m -93.51 119.15 32.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 16' ' ' ILE . 16.4 mt -89.73 107.68 19.24 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 2.2 pt-20 -73.95 87.94 1.84 Allowed 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 117.145 -1.822 . . . . 0.0 106.128 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -152.3 168.89 10.43 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.284 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -80.01 150.73 20.8 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.166 1.244 . . . . 0.0 109.455 164.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 91' ' ' ASP . 14.1 tt -55.41 -32.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.737 0.78 . . . . 0.0 110.947 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.678 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 1.1 pp0? -68.88 -29.41 67.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.897 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 4.6 tppp? -79.47 -38.15 35.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.794 HG22 HG11 ' A' ' 142' ' ' VAL . 9.4 t -64.82 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.58 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.678 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -54.7 -41.52 70.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.465 173.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.794 ' C ' HG21 ' A' ' 31' ' ' THR . 33.3 mm-40 -68.58 -28.29 66.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.29 170.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 141' ' ' ALA . 3.6 m -99.95 -10.2 21.92 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.0 m -131.66 -64.19 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 121.324 1.875 . . . . 0.0 113.696 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.648 ' HB3' HD12 ' A' ' 74' ' ' LEU . 24.0 p -98.1 66.85 1.85 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.794 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.5 t -157.22 -177.36 6.55 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.6 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 35' ' ' ILE . 30.7 m -62.08 172.33 1.44 Allowed 'General case' 0 C--N 1.311 -1.079 0 O-C-N 124.025 0.828 . . . . 0.0 109.62 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG2' ' HB2' ' A' ' 43' ' ' ASP . 7.0 mt-10 -48.0 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.983 1.713 . . . . 0.0 114.769 -163.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.34 -34.81 68.87 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.823 169.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.24 -36.26 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 121.978 0.894 . . . . 0.0 111.124 170.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -54.02 -29.97 45.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.908 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -46.53 -46.14 19.06 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.761 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -79.31 70.66 5.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.748 0.704 . . . . 0.0 111.674 -175.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 69.06 169.1 0.29 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.603 167.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 76.3 mtp 64.08 112.98 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.242 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.45 106.74 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.253 2.635 . . . . 0.0 112.816 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 78' ' ' TRP . 31.2 t-20 -156.43 164.95 37.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.34 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 8.4 p-10 -154.5 38.58 0.43 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.004 0.907 . . . . 0.0 108.798 173.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.73 ' CE2' HD11 ' A' ' 74' ' ' LEU . 29.2 t80 -42.41 144.29 0.53 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.282 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -140.13 141.36 36.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.41 101.92 3.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 117.29 -1.764 . . . . 0.0 109.774 -171.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 65' ' ' VAL . 69.6 mttt -133.36 152.88 51.95 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-N 112.048 -2.342 . . . . 0.0 107.725 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.695 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.7 mt-10 -123.48 129.35 51.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 118.937 0.789 . . . . 0.0 112.167 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.22 64.0 Favored Glycine 0 N--CA 1.461 0.349 0 CA-C-O 122.081 0.823 . . . . 0.0 111.856 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.701 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.4 pm0 -106.58 172.7 6.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.38 -1.41 . . . . 0.0 107.989 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.731 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 31.8 mt-10 -124.62 128.55 49.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.89 159.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.695 ' CE1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -130.62 125.73 34.85 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . 0.9 OUTLIER -146.94 139.32 24.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.381 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 54' ' ' LEU . 2.0 tm? -90.12 -11.33 41.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -70.86 -179.91 2.42 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.366 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.517 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 11.2 t -53.31 127.49 48.28 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.712 -175.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 12.0 Cg_exo -70.96 165.42 32.39 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.436 2.757 . . . . 0.0 111.666 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 59.02 26.36 14.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.657 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.81 -154.2 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.31 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.71 146.28 72.38 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.939 2.426 . . . . 0.0 112.014 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -63.97 122.96 80.29 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.718 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 72.7 Cg_endo -78.55 -86.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.534 2.156 . . . . 0.0 113.576 -171.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.695 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 59.9 m -130.37 159.59 36.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.292 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' HB2' ' HZ2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -143.46 131.02 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.701 ' N ' HE22 ' A' ' 50' ' ' GLN . 53.0 t -80.92 127.56 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.524 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.2 mm? -66.89 -50.73 61.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 174.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.41 142.79 15.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.667 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.695 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -136.21 132.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.553 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -137.84 138.13 38.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.743 -173.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.66 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.15 124.42 86.8 Favored Pre-proline 0 CA--C 1.507 -0.694 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.527 -167.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.62 ' C ' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.61 64.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.574 1 C-N-CA 126.085 4.523 . . . . 0.0 115.267 -158.279 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 13.4 p -133.13 -46.78 0.84 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.862 166.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -146.73 141.98 27.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.428 0.632 . . . . 0.0 110.983 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.5 tt -138.92 124.9 19.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 65' ' ' VAL . 69.4 m -137.44 125.36 22.68 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.41 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.559 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 11.4 p90 -151.77 157.27 41.75 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.743 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 32.7 mt-10 -116.29 131.96 56.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.957 0.884 . . . . 0.0 108.932 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.726 ' HB3' ' CE3' ' A' ' 83' ' ' TRP . 3.6 t90 -104.52 104.21 14.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.159 -1.837 . . . . 0.0 114.35 -155.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.675 ' HB2' ' HD1' ' A' ' 78' ' ' TRP . 2.0 t70 59.14 -123.14 1.23 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 161.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.881 HG21 ' HE2' ' A' ' 114' ' ' LYS . 4.6 t -81.15 -20.71 40.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.268 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.075 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.3 mp0 -97.19 172.05 8.06 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.763 ' H ' HG22 ' A' ' 112' ' ' ILE . . . -126.88 48.65 0.96 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.142 -1.504 . . . . 0.0 113.655 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.822 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.259 0.0 OUTLIER -81.32 137.84 35.74 Favored 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 117.507 -1.677 . . . . 0.0 107.476 172.594 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 17.6 t -85.97 71.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 125.126 1.516 . . . . 0.0 106.969 163.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 83' ' ' TRP . 31.6 m -65.98 130.47 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.203 0.525 . . . . 0.0 110.264 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 63.8 m -126.18 132.56 51.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.077 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.695 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.9 m-85 -111.8 131.28 55.44 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.178 0.989 . . . . 0.0 110.851 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 96' ' ' THR . 1.8 tm? -119.91 140.34 51.03 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.704 -171.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 6.1 tp10 -119.17 139.49 51.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.798 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.769 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.5 p-10 -110.74 110.55 21.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.627 ' HG ' ' HG3' ' A' ' 90' ' ' GLU . 56.1 mt -125.04 104.98 8.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.015 -0.428 . . . . 0.0 110.33 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.16 0.51 Allowed Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.69 117.47 23.55 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 118.416 -1.314 . . . . 0.0 111.437 151.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.48 ' HG3' ' HB2' ' A' ' 92' ' ' LEU . 9.2 ptmt -179.99 162.8 1.03 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 162.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.29 125.56 52.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.987 169.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.72 115.79 5.31 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.729 ' HD1' HD23 ' A' ' 89' ' ' LEU . 14.1 t80 -102.6 127.74 49.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.569 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.1 m -123.32 114.84 20.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.038 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.9 tt -106.98 136.31 47.05 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.329 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.7 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.6 mp -119.05 124.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.018 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.0 m170 -116.69 106.66 13.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -146.44 165.14 30.29 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.731 -1.577 . . . . 0.0 107.853 -171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.53 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -165.08 173.46 40.92 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -78.52 133.5 37.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 118.019 0.909 . . . . 0.0 111.016 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 7' ' ' ASN . 26.2 tptp 75.45 121.21 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.058 0.849 . . . . 0.0 110.872 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -134.43 83.24 44.0 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -175.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 33.4 Cg_endo -97.13 -105.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.756 2.971 . . . . 0.0 113.55 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.422 ' H ' ' HB2' ' A' ' 108' ' ' PRO . 27.3 p-10 -135.14 -42.5 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -175.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 119' ' ' SER . 46.6 tt0 -67.89 157.51 34.76 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.263 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' A' ' 112' ' ' ILE . 3.1 m -80.05 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.615 1.674 . . . . 0.0 112.542 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.075 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -53.98 -45.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 110.129 -3.214 . . . . 0.0 110.941 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -169.38 -85.99 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.912 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 30.9 ttpt -115.73 22.89 12.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.781 0.801 . . . . 0.0 108.852 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.728 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -63.47 -22.37 66.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER 170.52 -78.1 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' C ' HG13 ' A' ' 111' ' ' VAL . 38.4 tt0 -170.73 -55.76 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.138 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.593 ' HB2' HG13 ' A' ' 121' ' ' VAL . 64.6 mmtt -94.77 127.52 40.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.217 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.846 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 94.8 p -59.59 -32.22 70.19 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 8.9 p -63.45 -41.99 98.64 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.609 -0.682 . . . . 0.0 111.945 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 118' ' ' LYS . 20.7 m -72.08 -35.17 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 122.033 -0.417 . . . . 0.0 110.801 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.855 HG11 HD11 ' A' ' 112' ' ' ILE . 8.3 p -65.78 -33.75 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.702 0.763 . . . . 0.0 109.043 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.754 ' HG2' HG12 ' A' ' 12' ' ' ILE . 1.7 tmt_? -62.6 -33.85 75.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.481 172.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -72.52 -29.82 65.28 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.203 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.697 ' HD2' HG23 ' A' ' 122' ' ' VAL . 57.7 mttm -60.69 -42.83 97.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.285 1.04 . . . . 0.0 109.083 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.773 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 5.9 mmt -78.99 -20.91 47.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.8 t70 -76.47 -15.42 59.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.311 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.0 -52.35 0.13 Allowed Glycine 0 C--O 1.249 1.06 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.555 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.6 -21.65 72.87 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.79 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.038 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -73.5 -30.72 63.31 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.79 -171.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.703 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.2 p -74.17 -39.17 63.39 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.158 171.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -52.5 -53.06 33.89 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 118.218 -1.944 . . . . 0.0 110.492 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.667 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 82.4 mt -73.18 -55.2 13.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 100' ' ' LEU . 17.5 t -84.39 -43.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 121.637 -0.664 . . . . 0.0 112.141 -177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.832 ' HA ' HG21 ' A' ' 16' ' ' ILE . 6.3 t30 -70.35 -40.02 74.32 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.321 -0.952 . . . . 0.0 108.574 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.852 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 3.5 tt0 -96.24 -45.45 6.83 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.917 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.693 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 tpp180 -82.01 -33.43 30.08 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 142' ' ' VAL . 18.5 tp -64.47 -40.15 95.15 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.465 -1.294 . . . . 0.0 107.945 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.5 tmm_? -65.36 -29.74 70.5 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.852 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 54.3 mtmt -72.59 -45.18 60.39 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -69.24 -29.87 67.89 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.794 HG11 HG22 ' A' ' 25' ' ' VAL . 23.3 m -86.63 -18.39 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 10.5 mm-40 -152.25 -51.58 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.735 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 12.3 pt-20 40.95 47.04 2.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.91 0.862 . . . . 0.0 110.873 -169.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.83 65.34 9.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.748 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.62 141.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.184 0.992 . . . . 0.0 113.486 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -110.33 5.66 21.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -69.01 135.07 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.353 -174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 152' ' ' HIS . 12.4 m-70 -147.01 154.69 41.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 75.63 -40.92 0.43 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -171.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -87.59 1.53 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 163.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 149' ' ' HIS . 5.4 t-80 . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.213 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtm . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.99 78.94 1.26 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.73 0.3 . . . . 0.0 111.796 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -69.97 -40.26 75.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -153.34 153.29 32.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.978 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -110.38 145.39 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 7' ' ' ASN . 21.9 tt0 -66.07 -55.37 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.214 0.531 . . . . 0.0 110.08 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.71 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . 1.3 m-20 -175.36 -80.74 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.698 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.659 ' HA ' ' CB ' ' A' ' 119' ' ' SER . . . -111.14 -153.01 0.51 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 123' ' ' ARG . 2.1 tt -75.85 113.42 27.06 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.9 Cg_exo -71.76 -147.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.652 2.234 . . . . 0.0 110.124 176.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' HA ' ' OG ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -74.84 115.09 14.04 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.206 169.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' A' ' 126' ' ' MET . 2.1 mm -106.24 121.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 162.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -120.04 131.36 55.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 30.4 mmtm -127.52 128.97 46.56 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.591 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.44 135.58 54.71 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.398 1.094 . . . . 0.0 111.382 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.13 148.07 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 112.764 -2.017 . . . . 0.0 108.717 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.707 ' N ' HG12 ' A' ' 16' ' ' ILE . 2.0 m -96.17 119.35 34.51 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.091 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.1 mt -91.79 108.53 19.98 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.917 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -75.09 89.24 2.45 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.379 -2.128 . . . . 0.0 106.177 175.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.39 168.25 12.54 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.439 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.2 Cg_endo -82.74 157.97 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.334 1.356 . . . . 0.0 110.289 165.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 91' ' ' ASP . 13.5 tt -57.46 -32.49 41.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 121.967 0.889 . . . . 0.0 110.638 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -68.28 -30.96 70.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -177.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.57 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 59.6 tptt -82.34 -39.06 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.232 -0.917 . . . . 0.0 109.92 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.673 HG22 HG11 ' A' ' 142' ' ' VAL . 2.9 t -61.74 -34.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.245 166.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -55.1 -42.26 72.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.372 0.669 . . . . 0.0 109.755 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.75 ' C ' HG21 ' A' ' 31' ' ' THR . 34.1 tt0 -66.32 -28.37 68.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.463 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.84 -10.01 21.12 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.816 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.6 m -131.01 -64.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 121.56 1.982 . . . . 0.0 113.981 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.65 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 35.1 p -97.31 65.61 1.99 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.869 -1.144 . . . . 0.0 108.847 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -156.15 -177.54 6.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.641 -167.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 23.8 m -62.99 169.92 3.03 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.961 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 3.2 mt-10 -48.51 -2.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.024 1.73 . . . . 0.0 114.612 -163.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -56.93 -31.88 61.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.987 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.816 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.45 -36.16 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.547 0.689 . . . . 0.0 111.692 170.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -53.03 -33.76 53.3 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.008 -0.432 . . . . 0.0 111.339 167.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 45.6 mmtm -79.87 33.42 0.27 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.796 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 1.5 m0 -87.35 -54.53 4.24 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 163.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.83 ' HB3' HD12 ' A' ' 133' ' ' ILE . 43.5 t80 171.04 62.33 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.875 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 17.8 tpt -153.67 124.7 3.55 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 22.0 Cg_exo -67.72 106.35 1.27 Allowed 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 122.379 2.053 . . . . 0.0 113.031 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' ND2' ' HB2' ' A' ' 36' ' ' ALA . 3.1 p-10 -157.95 148.14 20.39 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.185 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.961 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 6.4 p30 -109.12 42.22 1.48 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.664 0.745 . . . . 0.0 109.01 172.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.672 ' CE2' HD11 ' A' ' 74' ' ' LEU . 25.9 t80 -60.66 141.67 56.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.7 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -138.8 144.12 39.2 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.01 102.19 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 116.771 -1.972 . . . . 0.0 108.763 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.745 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 50.3 mttm -130.09 150.8 51.19 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 112.036 -2.347 . . . . 0.0 106.683 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.79 129.65 50.86 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.536 -0.866 . . . . 0.0 113.06 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.73 37.43 68.8 Favored Glycine 0 N--CA 1.463 0.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.13 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -109.35 173.52 6.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.948 0.899 . . . . 0.0 109.734 -171.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.94 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 54.2 mp0 -118.78 130.62 55.89 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.51 156.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.745 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -130.54 129.96 43.5 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 13.0 p80 -146.46 136.75 23.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.897 171.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tt -88.17 -27.89 21.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.618 ' HG2' ' HB2' ' A' ' 53' ' ' HIS . 11.7 pt20 -59.56 136.38 57.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.844 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 57' ' ' PRO . 39.5 m -67.94 -37.41 11.54 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.304 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 56' ' ' SER . 81.5 Cg_exo -44.76 136.17 9.62 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.226 1.951 . . . . 0.0 112.803 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -76.59 78.9 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.836 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.84 112.5 3.72 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.2 -49.94 15.29 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.033 2.489 . . . . 0.0 112.545 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -138.81 94.87 9.99 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.94 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 61.8 Cg_endo -72.92 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.229 1.953 . . . . 0.0 111.599 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.741 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 41.6 t -121.79 149.51 43.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.455 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 21.6 pttp -135.93 133.88 38.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 68' ' ' VAL . 71.0 t -84.16 127.38 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.908 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.78 HD13 ' OE1' ' A' ' 77' ' ' GLU . 0.9 OUTLIER -77.64 -39.28 45.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.286 179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.81 138.72 13.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.196 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -139.52 126.68 24.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.208 1.004 . . . . 0.0 110.91 174.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -137.01 139.05 41.14 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.621 -173.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.0 127.65 92.05 Favored Pre-proline 0 CA--C 1.504 -0.791 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -167.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.69 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -5.07 65.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 1 C-N-CA 126.263 4.642 . . . . 0.0 115.392 -157.861 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.8 p -135.53 -48.48 0.7 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.156 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.51 131.94 20.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 109.893 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.2 tt -131.84 124.67 30.06 Favored 'General case' 0 C--O 1.202 -1.4 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.6 m -137.92 123.49 19.71 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.269 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 11.5 p90 -154.01 153.9 32.77 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.754 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 3.5 mp0 -118.67 126.72 52.55 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.61 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.607 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -82.35 130.63 35.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.796 -166.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 63' ' ' CYS . 11.9 t0 33.07 -108.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.943 1.402 . . . . 0.0 114.602 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 t -91.78 -31.86 15.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.123 -168.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.03 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.5 mp0 -81.75 154.34 26.04 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -94.69 33.05 5.57 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.311 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.882 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.77 114.61 21.73 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.562 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.072 HG12 ' HA2' ' A' ' 104' ' ' GLY . 6.8 p -85.14 75.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 O-C-N 125.028 1.455 . . . . 0.0 108.05 167.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.754 HG13 ' HB2' ' A' ' 83' ' ' TRP . 14.7 m -69.97 120.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.818 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.812 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 95.7 m -120.15 136.9 54.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.832 -168.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 18.6 m-85 -115.08 131.61 56.87 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -122.06 128.85 51.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.82 0.819 . . . . 0.0 110.708 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 0.9 OUTLIER -121.71 145.07 48.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.976 -171.071 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 1.6 tt0 -109.68 120.53 42.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 1.052 ' HB2' HD12 ' A' ' 22' ' ' ILE . 2.9 t70 -94.86 110.78 22.62 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 23.1 mt -120.18 144.89 47.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.851 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.78 -24.74 64.81 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 163.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.737 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 16.6 tt0 -57.31 -158.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 110.968 -2.616 . . . . 0.0 109.119 154.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.917 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -99.14 -178.48 3.94 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 -174.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -110.86 128.57 55.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.553 0.692 . . . . 0.0 110.274 -161.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.34 116.65 5.43 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 119.112 -1.518 . . . . 0.0 110.264 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.712 ' HE2' HD12 ' A' ' 100' ' ' LEU . 22.2 t80 -103.78 126.66 51.06 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.943 -170.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 m -123.04 115.39 21.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.443 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.04 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.8 tt -107.89 140.77 40.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.691 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.812 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.7 mp -120.41 125.82 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.975 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.3 m170 -118.29 110.04 17.04 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.561 ' OG ' ' HA ' ' A' ' 11' ' ' ASP . 66.3 m -146.34 164.29 32.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.575 -174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 1.072 ' HA2' HG12 ' A' ' 84' ' ' VAL . . . -170.23 176.76 43.81 Favored Glycine 0 C--N 1.312 -0.795 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -75.01 147.71 40.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.52 0.66 . . . . 0.0 110.672 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -120.67 167.49 12.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.524 -167.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.671 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -167.6 -60.45 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.983 172.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 89.9 Cg_endo -100.88 168.37 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.803 2.336 . . . . 0.0 112.796 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.27 49.85 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.179 0.99 . . . . 0.0 110.059 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.541 ' HB3' ' HG2' ' A' ' 108' ' ' PRO . 54.8 tt0 -139.64 162.32 35.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.369 -166.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 112' ' ' ILE . 1.3 p -77.22 174.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.077 0.941 . . . . 0.0 109.931 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.03 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -53.48 -31.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.78 -167.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.648 ' H ' HG13 ' A' ' 111' ' ' VAL . . . 156.0 60.18 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 67.05 31.0 7.16 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 0.0 110.683 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -68.57 -24.86 64.66 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -171.84 -67.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -169.41 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.89 ' HB2' HG13 ' A' ' 121' ' ' VAL . 50.5 mttm -93.01 147.18 23.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.324 0.583 . . . . 0.0 111.971 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.659 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p -58.38 -37.28 74.95 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.89 166.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 9.5 t -69.77 -36.06 75.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.574 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.89 HG13 ' HB2' ' A' ' 118' ' ' LYS . 11.9 m -71.29 -37.12 64.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.602 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.816 HG11 HD11 ' A' ' 112' ' ' ILE . 12.2 p -67.14 -41.84 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.717 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . 17.0 ptt180 -65.1 -30.24 71.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.05 -30.73 67.35 Favored Glycine 0 C--O 1.238 0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.963 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 25.3 mtpp -59.78 -42.51 93.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.24 1.019 . . . . 0.0 108.796 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 1.063 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 9.8 mmt -78.22 -25.54 47.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.685 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 22.9 t0 -78.02 -13.75 59.76 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.873 -168.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.84 -53.78 0.16 Allowed Glycine 0 C--O 1.251 1.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.628 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.647 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -68.83 -27.3 73.99 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.457 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.063 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 10.7 t-105 -73.07 -30.45 63.7 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.182 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -70.32 -39.52 74.74 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.925 172.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.744 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -50.2 -50.41 34.3 Favored Glycine 0 C--N 1.308 -0.98 0 C-N-CA 118.236 -1.935 . . . . 0.0 110.933 168.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 39' ' ' PHE . 27.1 mm -73.48 -55.41 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 122.317 -0.519 . . . . 0.0 112.186 -175.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.774 HG23 ' CZ3' ' A' ' 38' ' ' TRP . 1.4 p -83.72 -44.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 O-C-N 121.717 -0.614 . . . . 0.0 112.503 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.765 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.6 t30 -70.89 -40.84 71.98 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.744 ' HB3' ' O ' ' A' ' 132' ' ' GLY . 36.5 tt0 -96.38 -46.41 6.4 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.273 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.057 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.1 tpp180 -84.61 -31.44 24.26 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 29.7 tp -63.23 -40.0 96.2 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 118.261 -1.375 . . . . 0.0 107.779 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.697 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.1 tmm_? -66.11 -30.86 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 170.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.057 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 3.0 mtpt -67.73 -45.04 76.17 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.02 -29.92 65.99 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.431 -176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.673 HG11 HG22 ' A' ' 25' ' ' VAL . 27.8 m -89.67 -16.89 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.565 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 139' ' ' ARG . 9.9 mt-10 -148.23 -61.17 0.25 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.7 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 12.6 tt0 60.63 131.37 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.932 0.893 . . . . 0.0 111.801 -169.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.94 89.95 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.496 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.7 100.48 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -139.42 62.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.576 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -54.37 -49.71 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.405 0.622 . . . . 0.0 109.801 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -151.8 128.21 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.001 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -116.46 -84.9 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.58 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.835 0.709 . . . . 0.0 109.091 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.458 176.653 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 21.0 ptp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' GLU . . . -85.67 -166.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.014 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 14.5 mm100 -66.19 -47.93 72.3 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.242 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.69 128.04 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.589 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -111.49 120.44 42.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 0.0 109.652 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.4 -70.5 0.79 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.147 0.499 . . . . 0.0 111.064 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.825 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -149.39 -54.77 0.17 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 112' ' ' ILE . . . 68.44 163.5 0.22 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 160.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.789 ' HG ' ' HB3' ' A' ' 123' ' ' ARG . 0.8 OUTLIER -72.05 129.68 87.56 Favored Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.585 170.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.707 ' HD2' HD23 ' A' ' 9' ' ' LEU . 24.5 Cg_exo -63.98 -152.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.265 1.977 . . . . 0.0 111.006 167.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 103' ' ' SER . 10.3 p-10 -72.45 114.14 10.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.343 0.592 . . . . 0.0 110.642 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 168.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -119.51 133.31 55.74 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.572 0.701 . . . . 0.0 110.436 178.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.936 ' HD3' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.62 127.7 31.69 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.407 ' C ' ' HZ2' ' A' ' 14' ' ' LYS . 2.9 m -124.55 150.41 45.9 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.363 1.078 . . . . 0.0 112.103 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.75 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -153.11 148.12 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 113.142 -1.844 . . . . 0.0 108.541 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.74 ' N ' HG12 ' A' ' 16' ' ' ILE . 29.6 m -95.01 119.6 33.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.008 172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 17.6 mt -90.55 108.51 19.84 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.899 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.1 pt-20 -73.54 88.71 1.66 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 116.848 -1.941 . . . . 0.0 106.87 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.94 165.99 17.32 Favored Pre-proline 0 C--O 1.215 -0.763 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.506 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.0 Cg_endo -78.23 155.34 29.12 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.256 1.304 . . . . 0.0 110.359 168.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.722 HD12 ' HB3' ' A' ' 91' ' ' ASP . 8.6 tt -52.73 -37.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.681 0.753 . . . . 0.0 111.029 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 11.0 pt20 -60.2 -32.15 70.82 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.33 -1.304 . . . . 0.0 114.061 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -79.92 -38.05 33.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.845 0.831 . . . . 0.0 110.097 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.682 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.8 -33.12 59.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.225 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -54.69 -43.15 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.8 172.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.767 ' C ' HG21 ' A' ' 31' ' ' THR . 24.6 tt0 -68.45 -28.59 67.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.52 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.618 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.45 -9.38 21.13 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 117.63 2.456 . . . . 0.0 117.63 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.939 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.6 m -132.09 -64.61 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.318 1.872 . . . . 0.0 113.89 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.614 ' HB3' HD12 ' A' ' 74' ' ' LEU . 17.1 p -97.19 66.85 2.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.679 -1.263 . . . . 0.0 108.702 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.767 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.7 t -157.62 -174.64 4.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.811 -167.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.4 p -60.35 169.41 1.68 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 10.7 mt-10 -49.9 -8.01 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.805 1.642 . . . . 0.0 114.004 -161.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.39 -36.73 85.3 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.16 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.939 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.34 -41.38 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 117.642 0.721 . . . . 0.0 112.168 173.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . . . -56.11 -31.89 63.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -56.3 -39.55 72.9 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.849 ' HB2' HG23 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -60.45 -33.66 72.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.116 1.325 . . . . 0.0 111.594 -172.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB2' ' HZ3' ' A' ' 130' ' ' TRP . 54.7 t80 -114.64 -50.85 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 112.144 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.641 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.6 mmm -108.59 -174.12 0.29 Allowed Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.871 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 31.7 Cg_exo -63.63 -158.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.741 1.628 . . . . 0.0 110.166 163.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 5.2 p-10 -99.37 142.15 31.23 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 53' ' ' HIS . 28.7 t70 -174.69 -55.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.239 0.337 . . . . 0.0 111.144 -171.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 74' ' ' LEU . 29.5 t80 -68.11 140.21 56.21 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.797 0.808 . . . . 0.0 112.703 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' THR . 39.2 mt-30 -140.46 147.8 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 171.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.4 pt? -73.31 103.32 3.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 116.882 -1.927 . . . . 0.0 108.505 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -130.71 150.24 51.98 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.407 -2.179 . . . . 0.0 106.972 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -123.45 131.72 53.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.05 40.8 59.18 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.106 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.741 HE22 ' N ' ' A' ' 65' ' ' VAL . 2.3 pm0 -109.46 174.4 5.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.494 1.118 . . . . 0.0 109.426 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.732 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 49.0 mt-10 -123.27 128.92 50.64 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.468 155.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.551 ' O ' ' HD1' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -133.44 133.8 42.78 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.707 ' HB2' ' HG3' ' A' ' 62' ' ' PRO . 2.1 t-80 -148.22 136.96 21.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.493 170.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt 26.58 -90.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.133 1.521 . . . . 0.0 113.482 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.35 60.61 1.29 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.976 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.4 m -150.79 96.24 3.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.822 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.76 -39.95 7.88 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.604 2.203 . . . . 0.0 111.625 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -126.36 147.65 49.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.231 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 60' ' ' PRO . . . 126.42 -103.21 0.67 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 59' ' ' GLY . 5.9 Cg_exo -77.73 97.93 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.743 2.295 . . . . 0.0 111.343 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 p -62.25 110.61 3.47 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.811 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.732 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 38.2 Cg_endo -97.4 -102.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.468 2.112 . . . . 0.0 114.418 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.906 ' HB3' ' HA ' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -118.83 160.05 22.61 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.845 -169.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.95 140.14 38.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.741 ' N ' HE22 ' A' ' 50' ' ' GLN . 54.1 t -79.95 131.99 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.068 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -77.88 -44.93 25.64 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.486 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.34 135.8 11.3 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.544 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -130.44 127.41 62.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.904 174.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -134.35 138.3 44.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.61 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.97 93.43 Favored Pre-proline 0 CA--C 1.502 -0.865 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.986 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.54 62.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 1 C-N-CA 126.274 4.649 . . . . 0.0 115.583 -159.35 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -133.65 -52.67 0.87 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.394 169.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -143.18 132.92 23.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.502 0.667 . . . . 0.0 110.29 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.806 HD11 ' CE2' ' A' ' 44' ' ' PHE . 8.8 tt -129.21 125.88 37.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.577 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 m -137.98 126.37 23.28 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 12.2 p90 -151.19 155.64 39.28 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.31 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.818 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 43.0 mt-10 -118.07 131.01 56.48 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.906 ' HA ' ' HB3' ' A' ' 63' ' ' CYS . 5.8 t90 -107.8 124.45 50.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -161.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' H ' ' HB3' ' A' ' 63' ' ' CYS . 1.0 OUTLIER 43.98 -131.95 0.73 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.216 -1.356 . . . . 0.0 114.131 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.683 ' HA ' ' HB2' ' A' ' 3' ' ' GLN . 7.5 t -76.84 -29.91 56.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.076 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.956 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 6.0 mp0 -81.46 148.14 29.39 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.607 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -86.66 37.6 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.142 -173.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.911 ' HB3' HG13 ' A' ' 85' ' ' VAL . 5.0 m-90 -71.99 118.63 15.09 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.51 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.613 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 p -95.91 90.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 156.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.911 HG13 ' HB3' ' A' ' 83' ' ' TRP . 11.0 m -89.91 127.13 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.26 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 80.1 m -126.53 136.2 52.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.829 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.692 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.3 m-85 -111.09 130.51 55.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.0 mm100 -115.66 127.73 55.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.742 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mt -123.74 144.64 49.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.188 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.12 120.19 41.49 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.57 108.41 16.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 O-C-N 123.822 0.701 . . . . 0.0 110.254 -174.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 39.4 mt -127.49 136.01 51.17 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.23 -25.27 66.33 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 159.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.0 tp10 -54.53 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.328 -2.436 . . . . 0.0 108.675 152.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.899 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.92 175.73 6.04 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.22 129.65 56.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.444 -0.785 . . . . 0.0 110.585 -160.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.38 115.1 5.04 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 118.443 -1.837 . . . . 0.0 110.442 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HE2' ' CD2' ' A' ' 100' ' ' LEU . 11.9 t80 -105.65 130.98 53.57 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.588 -171.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -122.03 122.43 39.29 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.588 170.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.687 ' HG ' ' NE1' ' A' ' 130' ' ' TRP . 0.1 OUTLIER -104.85 136.63 43.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 86' ' ' THR . 3.5 mt -127.2 122.78 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.056 176.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.481 ' NE2' ' HZ2' ' A' ' 130' ' ' TRP . 1.3 m170 -119.53 112.2 19.05 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 40.3 t -137.91 162.75 33.22 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.613 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -147.24 143.27 11.11 Favored Glycine 0 C--N 1.299 -1.52 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.777 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 7.7 t-105 -79.73 120.77 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.52 1.16 . . . . 0.0 110.381 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.825 ' HB3' ' O ' ' A' ' 7' ' ' ASN . 20.8 tptt 147.67 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 O-C-N 125.062 1.476 . . . . 0.0 109.385 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -111.22 140.58 23.05 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 122.532 0.333 . . . . 0.0 111.066 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.608 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 71.3 Cg_endo -73.27 137.84 26.6 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.18 2.586 . . . . 0.0 115.194 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.495 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 28.3 t-20 171.13 -62.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.676 1.19 . . . . 0.0 108.635 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 119' ' ' SER . 9.2 tt0 -97.7 160.86 14.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.697 173.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.743 HG13 ' H ' ' A' ' 113' ' ' GLY . 0.8 OUTLIER -80.27 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 118.751 0.705 . . . . 0.0 112.189 -164.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.956 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -52.65 -41.01 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.48 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.743 ' H ' HG13 ' A' ' 111' ' ' VAL . . . -178.5 -66.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.698 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 41.7 tttm -131.96 14.31 4.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.956 0.884 . . . . 0.0 108.64 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -59.84 -42.6 93.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.057 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 2.0 t-20 174.65 40.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.016 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.716 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 34.2 tt0 69.89 -71.75 0.12 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.718 ' HB2' HG13 ' A' ' 121' ' ' VAL . 73.3 mmtt -94.93 136.49 35.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 110' ' ' GLN . 69.0 p -64.18 -35.1 79.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.617 0.722 . . . . 0.0 110.021 171.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.633 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 20.2 m -67.4 -37.56 83.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.384 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.718 HG13 ' HB2' ' A' ' 118' ' ' LYS . 15.9 m -71.67 -37.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.189 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG11 HD11 ' A' ' 112' ' ' ILE . 14.7 p -67.1 -37.14 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.789 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.33 -28.46 67.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.67 76.2 Favored Glycine 0 C--O 1.24 0.511 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.338 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.6 mtpp -60.21 -42.26 94.76 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.061 0.934 . . . . 0.0 109.415 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.938 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 11.3 mmt -76.89 -23.94 52.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.501 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.87 -14.43 58.66 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.314 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.96 -50.56 0.24 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.189 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -28.12 69.34 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.74 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.938 ' HB2' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -69.85 -26.62 64.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.936 HG23 ' HD3' ' A' ' 14' ' ' LYS . 2.0 p -81.73 -39.42 24.24 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.186 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.54 -52.95 48.74 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.083 -2.008 . . . . 0.0 109.897 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.849 HG23 ' HB2' ' A' ' 38' ' ' TRP . 66.2 mt -75.69 -55.59 10.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 114.741 -0.729 . . . . 0.0 112.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.703 HG22 ' CZ3' ' A' ' 38' ' ' TRP . 22.0 t -82.54 -43.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 121.424 -0.797 . . . . 0.0 111.011 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.755 ' HB3' ' O ' ' A' ' 131' ' ' THR . 2.3 t30 -72.75 -40.31 66.13 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.071 -172.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.871 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.3 tt0 -97.54 -45.65 6.33 Favored 'General case' 0 N--CA 1.42 -1.947 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.664 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.609 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.8 tpp180 -81.98 -33.03 30.39 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 19.2 tp -63.2 -40.56 97.84 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.367 -1.333 . . . . 0.0 107.626 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.832 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.0 tmm_? -65.18 -30.9 71.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.428 171.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.871 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 53.0 mtmt -73.76 -45.98 48.5 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -68.18 -29.55 68.44 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.704 -0.622 . . . . 0.0 109.934 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 25' ' ' VAL . 25.4 m -84.79 -21.85 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.406 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 13.4 mm-40 -147.29 -60.83 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.66 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 29.9 tt0 45.43 41.89 7.06 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.767 0.794 . . . . 0.0 111.461 -170.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 145' ' ' LEU . 3.4 mm? -85.14 139.67 31.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.806 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.13 87.05 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.759 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 152' ' ' HIS . 74.8 m80 -138.77 54.09 1.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.845 175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -167.35 12.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -81.28 -57.29 3.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 68.7 m-70 -133.31 56.47 1.85 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 85.8 t60 70.79 -1.3 2.67 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.104 0.954 . . . . 0.0 108.888 -164.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 147' ' ' HIS . 41.7 t-80 . . . . . 0 C--O 1.246 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.349 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.56 75.98 0.31 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 109.943 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -79.43 -47.81 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.155 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -124.66 128.28 48.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.165 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.704 ' HB2' ' HG2' ' A' ' 110' ' ' GLN . 25.6 p-10 -80.68 125.23 29.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.75 -157.81 0.24 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.656 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.6 t30 87.35 -16.98 0.35 Allowed 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 125.111 1.364 . . . . 0.0 111.627 166.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.622 ' C ' ' HB2' ' A' ' 119' ' ' SER . . . 60.58 -154.95 0.36 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.226 -169.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.716 HD12 HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.4 135.02 94.64 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.54 130.69 41.36 Favored 'Trans proline' 0 CA--C 1.514 -0.488 0 C-N-CA 121.911 1.741 . . . . 0.0 109.141 172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -52.35 121.41 6.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.917 0.865 . . . . 0.0 111.242 -162.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 126' ' ' MET . 0.9 OUTLIER -106.62 127.01 62.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.603 -169.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.1 p -117.49 134.1 55.22 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 121.197 0.522 . . . . 0.0 109.785 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -125.49 129.81 50.51 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -121.51 137.68 54.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.014 0.911 . . . . 0.0 110.857 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.769 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.1 148.52 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.177 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.769 ' N ' HG12 ' A' ' 16' ' ' ILE . 18.9 m -95.98 118.47 32.65 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.2 mt -91.12 110.32 21.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.881 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.4 pt-20 -75.06 88.42 2.41 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 116.871 -1.932 . . . . 0.0 106.993 175.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.28 167.15 14.94 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.721 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -81.94 156.31 17.82 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.348 1.365 . . . . 0.0 110.005 166.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.969 HD12 ' HB2' ' A' ' 91' ' ' ASP . 14.0 tt -54.43 -33.59 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.632 0.729 . . . . 0.0 110.747 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.7 pt20 -64.12 -31.05 72.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.865 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 1.077 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 4.4 tmtm? -81.76 -37.8 26.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.163 0.982 . . . . 0.0 109.071 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.582 HG22 HG11 ' A' ' 142' ' ' VAL . 3.2 t -64.4 -33.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.661 169.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CZ2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 t-105 -55.1 -42.66 73.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.927 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.736 ' C ' HG21 ' A' ' 31' ' ' THR . 34.8 tt0 -68.18 -28.33 67.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.167 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.1 -10.13 20.74 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.882 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -130.91 -65.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.348 1.885 . . . . 0.0 113.98 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.695 ' HB3' HD12 ' A' ' 74' ' ' LEU . 1.3 p -98.41 66.0 1.69 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.669 -1.269 . . . . 0.0 109.43 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.6 t -156.06 -174.97 5.19 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.583 -166.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.1 m -60.99 169.04 2.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.161 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' CB ' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -51.08 -7.88 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 125.934 1.693 . . . . 0.0 114.387 -157.249 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.53 -36.04 83.03 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.288 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.882 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -62.13 -39.91 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.764 0.792 . . . . 0.0 112.147 174.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . . . -55.54 -31.82 62.43 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.542 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -62.23 -23.46 66.68 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.761 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 8.5 p-90 -91.71 52.84 2.1 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.472 1.033 . . . . 0.0 110.982 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -179.17 -55.03 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.251 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.79 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 84.1 mtp -135.1 -174.2 0.4 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.749 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 9.8 Cg_endo -54.8 -175.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 111.436 166.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.742 ' HB2' ' CB ' ' A' ' 33' ' ' GLU . 9.1 p30 -98.06 143.14 28.92 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.683 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.424 ' N ' ' HB3' ' A' ' 33' ' ' GLU . 28.2 t70 -170.57 -56.02 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.417 -171.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.703 ' CE2' HD11 ' A' ' 74' ' ' LEU . 23.6 t80 -61.18 136.62 58.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.469 0.652 . . . . 0.0 112.694 -172.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -140.85 143.29 34.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.625 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 104.77 4.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.655 1.693 . . . . 0.0 110.007 -171.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 69.4 mttt -134.06 153.29 51.9 Favored 'General case' 0 C--O 1.202 -1.408 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.295 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.684 ' HG3' HG12 ' A' ' 68' ' ' VAL . 23.6 mt-10 -123.13 131.28 53.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 119.251 0.932 . . . . 0.0 112.771 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.15 34.63 62.78 Favored Glycine 0 CA--C 1.509 -0.301 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.827 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -106.76 173.23 6.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.073 -1.064 . . . . 0.0 108.943 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.02 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -118.7 130.15 55.67 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.996 157.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.524 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.1 136.05 48.05 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 120.936 0.398 . . . . 0.0 111.945 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' SER . 18.2 p80 -139.42 139.03 36.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.971 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -110.93 -54.69 2.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.076 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -98.82 25.42 6.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.224 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 15.1 m -125.71 89.12 53.05 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.268 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.54 -23.66 36.82 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.37 2.047 . . . . 0.0 110.898 173.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -128.87 97.94 4.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.92 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.4 79.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.391 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.56 135.3 26.0 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.685 2.257 . . . . 0.0 111.183 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.845 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 50.1 m 55.65 68.41 2.43 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.746 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 1.02 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 62.1 Cg_endo -75.05 -87.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.924 1.75 . . . . 0.0 111.911 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.721 ' HB3' ' H ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -119.68 149.47 41.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.439 -178.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 25.1 pttm -140.11 131.09 26.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' SER . 51.2 t -82.75 128.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.9 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -68.43 -48.46 64.53 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.849 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.34 145.84 16.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.639 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -141.91 132.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.451 173.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -141.25 138.85 33.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.473 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.91 127.74 93.34 Favored Pre-proline 0 N--CA 1.444 -0.774 0 O-C-N 123.751 0.657 . . . . 0.0 109.531 -167.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.623 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -3.26 62.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 1 C-N-CA 126.181 4.587 . . . . 0.0 115.744 -156.446 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.6 p -130.23 -52.55 1.11 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.592 166.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.06 135.34 29.09 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.29 0.567 . . . . 0.0 109.959 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.7 tt -136.17 125.73 25.25 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.63 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.4 m -137.49 125.16 22.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 74' ' ' LEU . 11.7 p90 -150.74 158.0 43.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.928 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 23.4 mt-10 -116.45 130.65 56.88 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.0 113.89 25.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.036 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.721 ' H ' ' HB3' ' A' ' 63' ' ' CYS . 14.5 t70 41.51 -118.59 0.4 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.465 . . . . 0.0 114.86 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 80' ' ' THR . 5.1 t -78.24 -35.82 47.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.547 -167.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.767 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 21.0 mp0 -83.1 171.32 13.86 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.07 40.87 2.33 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.296 -1.431 . . . . 0.0 111.909 -173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.928 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -71.86 112.87 8.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.053 -176.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 17.1 t -89.51 73.19 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.724 HG13 ' HB3' ' A' ' 83' ' ' TRP . 10.5 m -79.39 122.76 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.158 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 HD13 ' A' ' 101' ' ' ILE . 92.8 m -121.38 136.5 54.95 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.318 -171.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.737 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -112.07 131.65 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.503 ' CG ' HD11 ' A' ' 101' ' ' ILE . 4.5 mm100 -115.87 121.9 43.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD23 ' HD1' ' A' ' 98' ' ' PHE . 3.4 tm? -125.28 142.82 51.28 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.714 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.575 ' H ' HD22 ' A' ' 89' ' ' LEU . 2.8 tp10 -110.84 134.12 52.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.969 ' HB2' HD12 ' A' ' 22' ' ' ILE . 1.2 t70 -92.87 111.63 23.31 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.847 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.069 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 16.6 mt -123.55 124.55 43.08 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.75 -28.12 10.61 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 159.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 1.069 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 4.3 tp10 -53.49 -156.59 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 111.515 -2.343 . . . . 0.0 109.427 151.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.881 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.0 175.82 5.63 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.54 136.61 48.64 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.099 -1.001 . . . . 0.0 111.16 -156.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 114.36 4.96 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 119.208 -1.472 . . . . 0.0 109.986 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.923 ' HD1' HD23 ' A' ' 89' ' ' LEU . 15.3 t80 -105.22 127.16 52.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.191 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -123.98 116.67 23.24 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.119 HD22 ' HE1' ' A' ' 130' ' ' TRP . 5.0 tt -106.37 136.37 46.24 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.144 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -114.23 123.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.871 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.629 ' O ' HD21 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -118.28 112.2 19.76 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -142.46 159.58 41.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -141.23 150.66 22.01 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.765 -169.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.5 160.05 26.69 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -90.34 136.69 32.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.448 0.642 . . . . 0.0 112.426 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HG3' ' HD2' ' A' ' 108' ' ' PRO . 38.0 tt0 -132.42 143.55 49.28 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.577 ' HD2' ' HG3' ' A' ' 107' ' ' GLU . 73.1 Cg_exo -41.05 142.42 0.82 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.305 2.67 . . . . 0.0 113.222 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.6 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 84.6 m-20 73.19 -175.92 0.16 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -165.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.704 ' HG2' ' HB2' ' A' ' 5' ' ' ASN . 9.2 pt20 -135.39 109.07 8.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 116.398 -2.121 . . . . 0.0 113.932 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.907 HG13 ' H ' ' A' ' 113' ' ' GLY . 7.0 p -151.8 -176.41 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 153.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 2.0 mm -55.68 -36.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 119.451 1.023 . . . . 0.0 110.894 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.907 ' H ' HG13 ' A' ' 111' ' ' VAL . . . 179.1 -82.74 0.06 OUTLIER Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.743 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 2.2 mppt? -122.84 30.05 6.58 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 169.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.767 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -71.11 -41.28 70.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.887 -171.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 118' ' ' LYS . 2.2 t30 -172.02 12.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.583 ' C ' ' HB ' ' A' ' 111' ' ' VAL . 47.2 mt-10 67.75 -37.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.62 0.768 . . . . 0.0 112.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.742 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 4.3 mptp? -94.25 102.49 14.5 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.622 ' HB2' ' C ' ' A' ' 8' ' ' ALA . 88.2 p -61.23 -40.92 95.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.983 0.42 . . . . 0.0 112.007 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 p -69.01 -36.57 77.95 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.563 -0.71 . . . . 0.0 110.991 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.742 ' HB ' ' CB ' ' A' ' 118' ' ' LYS . 56.1 t -73.15 -37.1 51.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.57 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.661 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.9 p -65.99 -35.67 75.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.491 0.662 . . . . 0.0 109.691 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.64 -33.33 74.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.336 170.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -70.39 -30.66 68.95 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.661 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.5 mtpp -60.5 -42.01 95.5 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 122.076 0.941 . . . . 0.0 109.355 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.712 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 8.7 mmt -80.91 -20.83 41.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.106 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.587 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.7 t70 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.693 -170.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.22 -50.52 0.11 Allowed Glycine 0 C--O 1.246 0.876 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.221 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.629 ' O ' HG13 ' A' ' 133' ' ' ILE . . . -65.92 -22.37 70.31 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.988 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.119 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -70.94 -33.74 70.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.593 -173.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -71.06 -39.32 72.31 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.104 172.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.48 -55.4 13.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 118.938 -1.601 . . . . 0.0 111.17 174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 129' ' ' GLY . 1.3 mt -81.85 -48.71 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.362 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.876 HG21 HD13 ' A' ' 100' ' ' LEU . 35.5 t -80.03 -44.08 22.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 121.177 -0.952 . . . . 0.0 111.368 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.743 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.0 t30 -72.45 -40.37 67.07 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.761 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.794 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 5.3 tt0 -95.82 -46.0 6.75 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 118.216 -1.393 . . . . 0.0 111.609 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.0 tpp180 -83.11 -33.82 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 27.9 tp -63.01 -39.86 96.03 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.1 tmm_? -66.17 -30.33 70.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.679 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.961 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -68.95 -48.08 64.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.796 -0.565 . . . . 0.0 112.33 175.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -66.29 -28.42 68.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.129 0.49 . . . . 0.0 110.188 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 1.077 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 28.7 m -95.64 -15.11 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.995 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -149.48 -54.2 0.17 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.122 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.65 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 68.7 tt0 46.24 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 43.4 tp -165.1 107.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.914 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -4.05 11.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.405 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -53.33 -58.95 5.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.702 0.626 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -165.23 83.46 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.11 -78.41 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.23 71.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.244 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -66.71 130.97 44.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.661 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.5 p80 . . . . . 0 C--O 1.243 0.722 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.451 0.167 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.78 70.01 1.86 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.145 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.6 -44.51 6.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.891 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -153.44 140.32 19.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.408 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 5.3 m-20 -82.49 121.74 27.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -98.28 -53.27 3.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.477 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 119' ' ' SER . 33.8 t-20 -99.02 -65.44 0.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 5' ' ' ASN . . . -53.15 129.14 30.2 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 12' ' ' ILE . 53.7 tp -66.73 129.59 94.07 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 122.322 0.249 . . . . 0.0 111.001 -171.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.637 ' HD2' HD12 ' A' ' 9' ' ' LEU . 1.3 Cg_endo -81.22 -159.98 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.68 2.92 . . . . 0.0 112.709 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 7.6 p-10 -61.59 135.82 57.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.68 0.752 . . . . 0.0 110.019 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.72 HG22 ' CH2' ' A' ' 130' ' ' TRP . 5.4 mm -132.74 131.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.032 -167.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -131.68 145.82 51.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.143 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 1.127 ' HB2' ' HE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -137.95 150.87 47.42 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -127.04 138.02 53.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.853 0.835 . . . . 0.0 111.861 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.706 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -150.79 147.74 15.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.194 173.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.706 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.2 m -96.24 119.83 35.45 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.327 172.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 16' ' ' ILE . 20.5 mt -90.35 107.76 19.35 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.966 ' HG3' ' HE ' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -74.03 88.03 1.88 Allowed 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 116.8 -1.96 . . . . 0.0 107.11 176.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.32 168.64 11.73 Favored Pre-proline 0 C--O 1.22 -0.491 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.194 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 83.8 Cg_endo -80.49 151.54 19.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.07 1.18 . . . . 0.0 110.253 166.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.63 ' CG1' ' HB2' ' A' ' 71' ' ' PRO . 6.7 tt -54.76 -36.15 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.593 0.711 . . . . 0.0 111.078 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.731 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.1 pt20 -60.95 -32.1 71.64 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.638 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.8 mmtm -82.29 -35.54 27.92 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.343 -0.848 . . . . 0.0 110.83 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.719 HG22 HG11 ' A' ' 142' ' ' VAL . 3.0 t -67.39 -32.52 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 170.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.589 ' CE3' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.64 -42.85 71.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.746 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.748 ' C ' HG21 ' A' ' 31' ' ' THR . 9.6 tp10 -65.96 -28.44 68.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.844 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.0 m -100.06 -7.03 25.46 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.919 ' HA ' HG13 ' A' ' 35' ' ' ILE . 22.6 m -134.99 -61.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.951 -1.718 . . . . 0.0 113.596 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 74' ' ' LEU . 32.3 p -96.46 63.69 2.14 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 120.33 -1.482 . . . . 0.0 109.617 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.748 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.91 -174.4 4.83 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.236 -165.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 3.5 p -61.09 173.24 0.85 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.307 1.043 . . . . 0.0 110.496 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.039 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 5.2 mt-10 -47.55 -6.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.559 . . . . 0.0 114.216 -166.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.24 -40.08 91.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.585 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.919 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.01 -36.6 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.449 0.642 . . . . 0.0 111.139 171.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.87 ' HB1' ' HB3' ' A' ' 42' ' ' ASN . . . -52.78 -32.21 42.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.726 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.57 -166.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 170.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.755 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 22.2 p-90 41.8 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.314 0.578 . . . . 0.0 111.657 -167.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HZ ' HD11 ' A' ' 100' ' ' LEU . 32.8 m-85 -151.44 -95.53 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.591 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.655 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 66.5 mtm -156.94 170.63 8.63 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 73.5 Cg_exo -42.31 115.55 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.19 2.594 . . . . 0.0 113.869 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.87 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 24.9 t-20 -156.71 162.14 39.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.039 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 30.0 t0 -136.95 41.1 2.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.385 1.088 . . . . 0.0 108.829 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 32' ' ' SER . 24.7 t80 -50.75 142.43 11.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.358 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -139.43 138.01 36.11 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.14 102.14 3.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 123.691 1.71 . . . . 0.0 109.099 -172.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 55.4 mttt -134.32 154.26 51.42 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 111.593 -2.549 . . . . 0.0 107.364 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 68' ' ' VAL . 20.5 mt-10 -122.45 125.67 46.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 119.281 0.946 . . . . 0.0 111.967 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.77 81.93 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.799 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.45 159.54 15.84 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 25.2 mp0 -114.2 126.39 55.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.482 -1.287 . . . . 0.0 108.777 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -133.42 139.03 46.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -133.45 148.01 51.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.281 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -50.75 -70.11 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.184 0.516 . . . . 0.0 110.865 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -149.27 -49.4 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.25 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 m -77.87 115.54 51.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.38 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -84.26 62.01 6.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.764 2.309 . . . . 0.0 111.64 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -51.68 -42.68 62.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.863 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.05 137.07 13.76 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.67 -46.22 35.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.719 2.279 . . . . 0.0 111.711 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.9 m -113.31 105.92 54.93 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.748 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 57.8 Cg_endo -73.61 -94.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.144 1.896 . . . . 0.0 113.629 -173.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.777 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 2.0 m -130.64 163.78 26.42 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.571 -172.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.7 OUTLIER -148.98 134.0 18.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.566 0.621 . . . . 0.0 109.718 -175.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 76' ' ' PHE . 71.4 t -74.52 127.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.228 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.476 HD23 ' HG3' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -68.11 -49.45 61.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.246 177.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.21 146.19 15.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -136.48 122.11 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.43 1.11 . . . . 0.0 110.473 173.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 71.5 mm-40 -131.48 137.5 48.59 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.266 -172.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.81 123.99 83.46 Favored Pre-proline 0 CA--C 1.501 -0.919 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -166.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.56 65.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.34 1 C-N-CA 126.487 4.791 . . . . 0.0 115.248 -160.146 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -135.42 -46.85 0.69 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.713 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 28.4 tt0 -146.35 130.68 17.6 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.783 HD13 HG23 ' A' ' 68' ' ' VAL . 1.9 tp -130.74 127.66 39.23 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.6 t -137.55 127.53 25.79 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.951 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CB ' HG22 ' A' ' 65' ' ' VAL . 13.8 p90 -148.98 144.2 26.62 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.969 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.043 ' HG2' HG23 ' A' ' 84' ' ' VAL . 47.9 mt-10 -126.43 151.15 48.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.135 0.969 . . . . 0.0 112.651 -168.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.705 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 2.7 t90 -118.72 139.19 51.94 Favored 'General case' 0 C--O 1.19 -2.075 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.902 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER 32.68 -99.12 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 168.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.719 ' HA ' ' HB3' ' A' ' 105' ' ' TRP . 5.6 t -159.17 97.05 1.35 Allowed 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.044 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 43.9 mt-10 -145.16 -172.4 3.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 125.149 1.379 . . . . 0.0 110.568 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.698 ' CA ' HG22 ' A' ' 112' ' ' ILE . . . -94.65 -6.73 60.68 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.524 156.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.866 ' HE1' ' HD3' ' A' ' 106' ' ' LYS 0.277 0.4 OUTLIER -101.63 136.68 41.06 Favored 'General case' 0 C--N 1.379 1.848 0 CA-C-N 120.927 2.364 . . . . 0.0 114.362 173.816 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.103 HG12 ' H ' ' A' ' 103' ' ' SER . 6.7 p -95.29 -178.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 159.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' NE2' ' A' ' 102' ' ' HIS . 33.3 m -121.81 99.22 6.75 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.052 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 160.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.854 HG22 HD13 ' A' ' 101' ' ' ILE . 29.3 m -117.53 129.2 55.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.96 -175.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.597 ' HD2' HD23 ' A' ' 74' ' ' LEU . 44.9 m-85 -118.66 128.32 54.41 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.806 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -117.0 125.59 51.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.818 0.818 . . . . 0.0 109.801 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.907 HD13 ' HB3' ' A' ' 71' ' ' PRO . 3.4 mt -124.04 144.18 49.99 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.05 -169.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 121.09 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.586 ' O ' HD23 ' A' ' 92' ' ' LEU . 9.9 t0 -80.88 110.3 16.27 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.2 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.839 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 45.6 mt -125.02 139.36 53.88 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 165.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.03 61.3 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.839 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.0 tp10 -56.65 -157.91 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 111.319 -2.441 . . . . 0.0 109.423 153.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.869 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -99.57 -179.44 4.2 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -173.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -108.57 127.97 54.42 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 -162.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.1 115.68 5.17 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 118.466 -1.826 . . . . 0.0 110.665 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 19.8 t80 -106.39 130.7 54.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.18 0.991 . . . . 0.0 113.223 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.3 m -124.28 122.11 36.84 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.769 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD13 HG21 ' A' ' 134' ' ' VAL . 5.9 tt -104.67 136.55 43.99 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.496 -0.881 . . . . 0.0 111.114 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.854 HD13 HG22 ' A' ' 86' ' ' THR . 2.4 mp -118.11 127.25 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.346 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.746 ' HB3' ' HB2' ' A' ' 83' ' ' TRP . 13.4 m170 -115.29 104.74 12.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 160.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 1.103 ' H ' HG12 ' A' ' 84' ' ' VAL . 3.3 t -148.05 120.41 8.43 Favored 'General case' 0 C--O 1.206 -1.228 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.984 ' HA3' ' N ' ' A' ' 84' ' ' VAL . . . 177.43 -166.49 36.99 Favored Glycine 0 C--N 1.28 -2.574 0 C-N-CA 116.606 -2.711 . . . . 0.0 118.894 -149.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.911 ' HA ' ' H ' ' A' ' 81' ' ' GLU . 64.7 m95 -127.92 156.99 41.75 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 112.324 -1.938 . . . . 0.0 111.188 164.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.866 ' HD3' ' HE1' ' A' ' 83' ' ' TRP . 37.4 tttm 179.45 147.26 0.22 Allowed 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 166.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.0 mt-10 50.39 -173.18 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 168.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 114' ' ' LYS . 68.5 Cg_endo -116.66 132.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.079 0 C-N-CA 125.036 3.824 . . . . 0.0 117.178 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 14.7 t-20 160.02 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 125.641 1.576 . . . . 0.0 109.26 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -99.99 112.2 24.49 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 123.625 1.679 . . . . 0.0 110.937 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.037 HG22 ' H ' ' A' ' 112' ' ' ILE . 11.0 p -165.34 -156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.98 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.037 ' H ' HG22 ' A' ' 111' ' ' VAL 0.253 1.4 mt -42.13 -45.39 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.24 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 1.044 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -146.92 -69.94 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 167.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 1.022 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 56.5 mttp -151.66 38.24 0.6 Allowed 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.892 0.853 . . . . 0.0 109.98 173.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.718 ' H ' ' CG1' ' A' ' 111' ' ' VAL . . . -54.02 -41.34 67.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.533 1.533 . . . . 0.0 114.628 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 62.6 t30 137.62 -35.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.486 1.116 . . . . 0.0 108.098 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.683 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 5.1 mm-40 -87.97 -169.12 2.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.962 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' HG13 ' A' ' 121' ' ' VAL . 73.2 mmtt -91.28 151.81 20.74 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.446 168.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.652 ' N ' ' HA ' ' A' ' 111' ' ' VAL . 5.0 p -57.38 -42.51 82.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.016 0.436 . . . . 0.0 111.347 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 t -67.99 -43.61 78.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 118' ' ' LYS . 5.6 m -72.5 -36.56 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.229 0.538 . . . . 0.0 109.61 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.749 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 9.8 p -66.52 -36.63 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.066 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.551 ' HA ' HD22 ' A' ' 9' ' ' LEU . 42.3 ttp180 -62.31 -35.41 78.97 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.19 -31.61 69.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.461 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.749 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 36.7 mtpt -62.9 -43.89 97.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 121.614 0.721 . . . . 0.0 110.599 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 6.9 mmt -81.97 -27.83 33.0 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.84 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.93 -16.06 58.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.882 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.61 -36.13 0.11 Allowed Glycine 0 C--O 1.243 0.695 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.397 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.662 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -69.03 -22.82 76.08 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.987 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 1.127 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 4.0 m0 -68.04 -33.22 74.18 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 117.922 0.861 . . . . 0.0 112.635 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.6 p -74.94 -33.15 61.92 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.81 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.809 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.67 -68.28 1.78 Allowed Glycine 0 C--N 1.312 -0.782 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.13 168.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 129' ' ' GLY . 15.9 pt -71.0 -50.26 43.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 121.513 -0.992 . . . . 0.0 112.184 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 5.7 t -81.1 -42.99 20.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 O-C-N 121.64 -0.662 . . . . 0.0 112.047 -176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.795 ' HB3' ' O ' ' A' ' 131' ' ' THR . 20.0 t-20 -75.56 -42.99 50.85 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 117.482 -1.687 . . . . 0.0 108.152 -174.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.91 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 11.3 tp10 -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.579 -169.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.072 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.0 tpp180 -83.71 -31.97 25.77 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.782 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.4 tp -66.53 -39.64 88.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 117.854 -1.538 . . . . 0.0 107.288 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.966 ' HE ' ' HG3' ' A' ' 19' ' ' GLU . 2.6 tmt_? -63.55 -32.79 74.36 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.302 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.072 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.58 -45.16 72.75 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.567 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -73.56 -28.75 62.02 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 110.141 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.719 HG11 HG22 ' A' ' 25' ' ' VAL . 25.5 m -86.73 -19.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 19.6 mm-40 -143.7 -64.8 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.288 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.561 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 71.5 tt0 43.88 -106.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.028 -165.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 22.0 tp 50.65 21.86 0.98 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -84.88 -62.2 1.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.845 -0.534 . . . . 0.0 110.02 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.54 120.7 24.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -121.12 -23.97 5.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' A' ' 150' ' ' HIS . 19.2 t-80 -66.37 129.79 41.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.658 172.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 10.8 t-80 75.54 -55.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.765 0.666 . . . . 0.0 111.111 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -160.59 148.45 16.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.8 p80 . . . . . 0 C--O 1.244 0.77 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.563 174.238 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 123' ' ' ARG . 4.7 mm . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.84 132.69 55.65 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.496 177.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 131' ' ' THR . 16.3 mmtm -126.86 129.15 47.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.83 136.27 54.81 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.05 0.929 . . . . 0.0 110.698 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.782 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.94 148.66 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.092 178.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.782 ' N ' HG12 ' A' ' 16' ' ' ILE . 77.3 m -94.89 119.25 33.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 172.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.627 HD23 ' CD1' ' A' ' 16' ' ' ILE . 22.7 mt -91.06 108.57 19.95 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -74.95 87.88 2.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 C-N-CA 116.647 -2.021 . . . . 0.0 106.709 176.087 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.76 167.26 14.6 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.165 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 98.1 Cg_endo -82.14 158.56 17.8 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.364 1.376 . . . . 0.0 110.198 167.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.045 HD12 ' HB2' ' A' ' 91' ' ' ASP . 10.8 tt -54.63 -32.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.684 0.754 . . . . 0.0 110.986 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 5.7 pt20 -68.42 -31.41 70.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.223 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 142' ' ' VAL . 82.5 mttt -81.92 -37.04 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.965 -1.085 . . . . 0.0 110.418 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG22 HG11 ' A' ' 142' ' ' VAL . 6.2 t -62.5 -34.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.612 167.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 71' ' ' PRO . 1.2 t-105 -55.21 -43.39 74.4 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.765 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.745 ' C ' HG21 ' A' ' 31' ' ' THR . 27.4 tp10 -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.929 173.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.9 -9.34 21.67 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -171.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.877 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.0 m -131.75 -63.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.64 2.018 . . . . 0.0 114.316 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.606 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 32.0 p -97.38 63.31 1.79 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 109.646 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.745 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.5 t -157.56 -174.61 4.95 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.238 -164.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.9 p -62.45 175.31 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.644 1.177 . . . . 0.0 110.918 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 14.4 mt-10 -47.42 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.341 1.457 . . . . 0.0 113.594 -165.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.06 -40.79 93.99 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.975 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.877 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.5 -39.73 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 122.221 1.01 . . . . 0.0 110.727 172.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.423 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.5 pt? -73.67 100.74 3.45 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 116.932 -1.907 . . . . 0.0 108.116 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 49.2 mttm -132.33 153.0 51.17 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 111.53 -2.577 . . . . 0.0 107.434 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.793 ' HG3' HG12 ' A' ' 68' ' ' VAL . 22.7 mt-10 -123.27 130.55 52.89 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.867 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.93 40.17 71.64 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.809 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.906 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.01 172.42 6.84 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 48.2 mt-10 . . . . . 0 C--N 1.302 -1.489 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.402 161.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 34.5 m . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.87 128.75 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.906 ' HB ' HE22 ' A' ' 50' ' ' GLN . 70.6 t -82.55 130.09 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.6 HD11 ' OE2' ' A' ' 77' ' ' GLU . 5.1 mp -70.15 -50.14 43.49 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.719 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.42 15.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.765 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.793 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -138.65 135.27 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.879 0.847 . . . . 0.0 110.747 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.81 140.33 32.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.139 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.87 128.07 93.3 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -166.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.691 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -4.63 68.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 125.963 4.442 . . . . 0.0 115.012 -156.831 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' GLN . 4.6 p -139.29 -50.06 0.51 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.924 171.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.68 133.15 25.0 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.148 0.499 . . . . 0.0 109.715 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.6 tt -131.84 125.77 32.63 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.4 m -137.64 123.66 20.26 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.131 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.0 p90 -152.34 158.19 42.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.6 ' OE2' HD11 ' A' ' 66' ' ' LEU . 27.2 mt-10 . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.434 -1.27 0 CA-C-O 121.441 0.638 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.69 HG22 HD13 ' A' ' 101' ' ' ILE . 90.8 m -120.5 136.92 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.55 -170.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.64 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.2 m-30 -112.27 131.07 55.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.459 ' CG ' HD11 ' A' ' 101' ' ' ILE . 8.3 mm100 -116.37 125.62 52.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.287 0.565 . . . . 0.0 109.601 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 ' HD1' ' A' ' 98' ' ' PHE . 1.5 tm? -121.53 142.77 49.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -172.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.435 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -110.1 119.57 39.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.045 ' HB2' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.472 -2.042 0 CA-C-O 121.896 0.855 . . . . 0.0 110.028 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.682 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.266 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -111.92 128.44 56.15 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.502 -0.749 . . . . 0.0 109.949 -163.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.0 115.48 5.25 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 118.418 -1.849 . . . . 0.0 110.087 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.799 ' HD1' HD23 ' A' ' 89' ' ' LEU . 27.5 t80 -104.26 127.15 51.86 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.898 0.856 . . . . 0.0 111.882 -170.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.3 m -123.18 117.08 24.53 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.315 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.071 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.6 tt -107.27 138.37 43.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.238 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.198 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.1 m170 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 166.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.648 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 14.1 p . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.098 0.475 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HB2' ' CG1' ' A' ' 12' ' ' ILE . 8.9 ptt180 -66.38 -29.89 70.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.16 -28.38 70.29 Favored Glycine 0 C--O 1.24 0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.679 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.9 mtpp -61.37 -43.27 99.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.073 0.94 . . . . 0.0 108.722 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 1.044 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 10.8 mmt -76.08 -23.51 55.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.043 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.619 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 14.9 t70 -76.62 -15.5 59.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.722 -171.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.54 -58.02 0.19 Allowed Glycine 0 C--O 1.244 0.723 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.717 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.86 -16.24 76.31 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.919 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.071 ' HE1' HD22 ' A' ' 100' ' ' LEU . 6.6 t-105 -82.19 -24.12 35.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.505 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -78.83 -34.2 45.41 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.751 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -53.99 -54.98 28.24 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 118.249 -1.929 . . . . 0.0 110.057 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 53.1 mt -70.55 -54.55 17.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 100' ' ' LEU . 21.8 t -83.37 -44.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 121.36 -0.838 . . . . 0.0 112.331 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.728 ' HA ' HG21 ' A' ' 16' ' ' ILE . 40.4 t-20 -72.93 -39.94 65.84 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.736 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.742 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 2.2 tt0 -95.49 -45.82 6.93 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.687 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.7 tpp180 -83.07 -31.79 27.14 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.699 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 21.0 tp -64.54 -40.31 95.36 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 118.626 -1.229 . . . . 0.0 107.713 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.6 tmm_? -66.33 -30.23 70.59 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -68.65 -46.12 70.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.631 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.76 -28.72 63.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.792 -0.568 . . . . 0.0 110.183 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 25' ' ' VAL . 33.1 m -85.88 -21.61 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 9.6 mm-40 -148.17 -56.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.651 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 21.7 pt-20 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 124.021 0.928 . . . . 0.0 112.024 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.572 HG21 ' CB ' ' A' ' 126' ' ' MET . 1.5 tp . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -127.37 134.68 49.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.838 ' HB3' ' CZ2' ' A' ' 130' ' ' TRP . 20.8 tptt -138.73 152.03 47.63 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.665 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -124.42 141.87 51.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.079 0.943 . . . . 0.0 112.083 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.835 HD11 HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -142.02 148.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.593 171.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.69 ' N ' HG13 ' A' ' 16' ' ' ILE . 33.5 m -98.57 117.68 33.55 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 162.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.835 HD23 HD11 ' A' ' 16' ' ' ILE . 28.1 mt -93.59 109.4 21.02 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.673 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -75.35 88.26 2.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 117.158 -1.817 . . . . 0.0 106.84 177.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.45 166.16 17.1 Favored Pre-proline 0 C--O 1.217 -0.625 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.241 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 92.3 Cg_endo -78.88 157.15 27.34 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.232 1.288 . . . . 0.0 109.783 167.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.82 HD13 ' HA ' ' A' ' 91' ' ' ASP . 4.5 tp -53.24 -36.82 26.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.756 0.788 . . . . 0.0 110.673 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.3 pt20 -61.57 -32.41 72.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.2 -1.364 . . . . 0.0 114.073 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' GLU . 54.3 mtpt -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.721 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.548 HG22 HG11 ' A' ' 142' ' ' VAL . 2.7 t -66.97 -34.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.296 169.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.711 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.82 -41.91 71.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.586 172.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.723 ' C ' HG21 ' A' ' 31' ' ' THR . 6.0 tp10 -66.89 -29.97 70.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.931 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.699 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.2 m -101.67 -9.55 20.81 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 -170.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.865 ' HA ' HG13 ' A' ' 35' ' ' ILE . 28.3 m -130.13 -64.3 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.47 1.941 . . . . 0.0 113.916 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.647 ' HB3' HD12 ' A' ' 74' ' ' LEU . 30.8 p -97.58 65.29 1.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.852 -1.155 . . . . 0.0 109.132 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.723 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -156.77 -176.37 5.94 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.649 -166.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 35' ' ' ILE . 16.9 m -63.19 173.64 1.42 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.687 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.1 mt-10 -47.88 -5.31 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.905 1.682 . . . . 0.0 114.612 -164.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.52 -37.59 83.16 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.804 -1.188 . . . . 0.0 110.613 170.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.865 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.45 -37.57 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.771 0.796 . . . . 0.0 110.62 170.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.571 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.6 pt? -73.05 102.15 3.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.976 -1.89 . . . . 0.0 108.911 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -131.13 150.6 52.07 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.062 -2.335 . . . . 0.0 106.91 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.603 ' HG3' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.5 131.74 54.0 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.55 39.54 45.52 Favored Glycine 0 N--CA 1.463 0.476 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.831 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 47' ' ' LYS . 2.2 pm0 -107.63 173.95 6.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 124.427 1.091 . . . . 0.0 109.579 -171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 78.7 mt-10 . . . . . 0 C--N 1.307 -1.255 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.234 158.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.847 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 31.2 t . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.17 126.84 23.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 76' ' ' PHE . 40.4 t -79.9 127.26 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.178 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.614 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.5 mm? -71.06 -46.14 62.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.132 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.532 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.41 140.51 15.3 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.281 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -139.06 127.57 28.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.007 172.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -141.95 139.81 32.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.564 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.07 127.92 91.54 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -168.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.999 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.21 60.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 1 C-N-CA 126.869 5.046 . . . . 0.0 116.066 -162.403 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -136.86 -44.48 0.58 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.245 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 30.8 tt0 -144.19 134.4 24.33 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.558 0.694 . . . . 0.0 110.584 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -137.38 126.41 24.35 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 m -139.43 126.25 20.8 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.191 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.847 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 21.4 p90 -152.32 155.09 36.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.614 ' HG3' HD21 ' A' ' 66' ' ' LEU . 47.7 mt-10 . . . . . 0 CA--C 1.5 -0.96 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.382 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 102' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.427 -1.616 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.898 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 93.0 m -121.38 131.67 54.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.678 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -111.22 124.44 52.22 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -114.86 126.91 55.35 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 122.424 1.107 . . . . 0.0 109.668 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 71' ' ' PRO . 22.6 tp -128.61 144.38 51.14 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.673 -165.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.722 ' H ' HD12 ' A' ' 89' ' ' LEU . 4.0 tp10 -110.71 130.41 55.58 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.535 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.82 ' HA ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.497 -1.087 0 O-C-N 124.203 0.939 . . . . 0.0 110.132 -170.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.584 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.83 131.59 54.92 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.454 0.645 . . . . 0.0 109.979 -158.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.76 113.35 4.62 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.861 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.85 ' HD1' HD13 ' A' ' 89' ' ' LEU . 6.5 t80 -104.89 129.94 53.14 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.848 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.8 m -122.47 116.09 23.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.022 ' HB3' ' HZ2' ' A' ' 130' ' ' TRP . 7.2 tt -110.62 139.23 46.08 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.285 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.8 mp -115.99 124.91 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.365 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.632 ' CD2' HD21 ' A' ' 100' ' ' LEU . 4.7 m170 . . . . . 0 C--N 1.299 -1.616 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 7.8 p . . . . . 0 N--CA 1.443 -0.817 0 CA-C-O 120.874 0.369 . . . . 0.0 111.574 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' HB2' HD13 ' A' ' 12' ' ' ILE . 28.0 ptt180 -68.1 -28.29 67.21 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -65.43 -32.0 82.1 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 39.1 mmtm -62.48 -38.04 88.28 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.729 0.776 . . . . 0.0 109.237 172.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 102' ' ' HIS . 19.9 mtt -82.01 -7.73 59.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.541 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.495 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 31.0 t70 -92.57 -15.3 27.11 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.042 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -133.47 -53.96 0.08 OUTLIER Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.734 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.35 -18.76 73.69 Favored Glycine 0 CA--C 1.499 -0.957 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.022 ' HZ2' ' HB3' ' A' ' 100' ' ' LEU . 21.1 t90 -55.6 -63.86 1.03 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.678 -1.261 . . . . 0.0 110.913 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.9 p -63.8 -28.31 69.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.009 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -55.95 -59.28 10.89 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 118.494 -1.812 . . . . 0.0 110.289 168.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.511 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 1.7 mp -72.41 -54.46 16.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.824 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.8 t -81.16 -44.2 20.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 O-C-N 121.561 -0.712 . . . . 0.0 112.017 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 131' ' ' THR . 44.1 t30 -79.12 -38.11 36.94 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 117.92 -1.512 . . . . 0.0 108.735 -171.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.942 ' HG2' ' HE2' ' A' ' 140' ' ' LYS . 15.4 tt0 -94.82 -45.53 7.27 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 118.385 -1.326 . . . . 0.0 110.785 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.4 tpp180 -83.43 -33.0 25.8 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.824 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 34.5 tp -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.059 -1.456 . . . . 0.0 107.098 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HA ' HG22 ' A' ' 142' ' ' VAL . 4.4 tmm_? -65.8 -30.76 71.44 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.09 -47.51 68.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.187 0.517 . . . . 0.0 112.366 176.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -70.1 -27.44 64.6 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.782 -0.574 . . . . 0.0 109.771 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 138' ' ' LEU . 28.9 m -94.12 -12.78 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -153.24 -56.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.599 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 18.3 pt-20 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 124.496 1.118 . . . . 0.0 113.338 -169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -113.38 134.05 54.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.844 174.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.808 ' HD3' HG23 ' A' ' 131' ' ' THR . 7.8 mmpt? -122.01 130.9 53.68 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.25 54.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.129 0.966 . . . . 0.0 111.437 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -153.49 149.06 13.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.687 178.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' HG12 ' A' ' 16' ' ' ILE . 28.1 m -95.06 121.1 36.33 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 16' ' ' ILE . 96.1 mt -91.65 108.34 19.84 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 1.3 mt-10 -77.58 87.15 3.89 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 116.62 -2.032 . . . . 0.0 106.768 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.807 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -158.47 169.03 11.25 Favored Pre-proline 0 C--O 1.214 -0.811 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.639 -176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 95.7 Cg_endo -83.62 152.61 13.38 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.749 0.966 . . . . 0.0 109.9 163.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.733 HG21 ' OD2' ' A' ' 91' ' ' ASP . 7.3 tt -55.02 -32.1 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.829 0.823 . . . . 0.0 111.289 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.677 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 4.6 pt20 -66.56 -30.48 70.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.953 -1.476 . . . . 0.0 113.407 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.593 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 58.1 tptt -81.69 -35.99 29.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 122.066 0.936 . . . . 0.0 110.011 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' A' ' 89' ' ' LEU . 2.7 t -66.04 -33.64 64.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.641 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.195 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.816 ' C ' HG21 ' A' ' 31' ' ' THR . 23.4 tt0 -66.64 -28.28 68.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.106 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.556 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.4 m -100.21 -9.35 22.54 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.884 ' HA ' HG13 ' A' ' 35' ' ' ILE . 32.9 m -131.08 -63.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.334 1.879 . . . . 0.0 113.415 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 27.7 p -96.74 65.54 2.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.56 -1.338 . . . . 0.0 108.663 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.816 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.97 -174.7 4.96 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.729 -165.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.3 p -60.68 171.78 1.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.022 0.929 . . . . 0.0 110.315 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' A' ' 33' ' ' GLU . 4.1 mt-10 -47.76 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.571 1.549 . . . . 0.0 113.698 -162.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.02 -36.41 81.14 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.256 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.884 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.79 -44.22 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 121.718 0.77 . . . . 0.0 111.639 173.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.773 -178.65 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.618 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -71.72 103.55 3.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.754 1.74 . . . . 0.0 109.369 -172.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.686 ' HB3' ' CB ' ' A' ' 50' ' ' GLN . 6.5 mmtp -131.62 154.71 48.62 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 111.625 -2.534 . . . . 0.0 107.514 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' CD ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -120.42 134.15 55.32 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.375 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.98 38.95 61.57 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.441 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -109.94 151.52 26.99 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.361 -168.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 160.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 120.494 0.188 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.6 pttt -143.27 141.62 31.1 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.647 HG11 ' HB ' ' A' ' 68' ' ' VAL . 95.9 t -83.54 132.16 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.316 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.819 HD23 ' OE1' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -82.84 -39.79 21.2 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.378 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . . . -157.85 140.76 14.95 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.17 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -140.21 132.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.16 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -141.68 138.65 32.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.942 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.77 123.02 82.24 Favored Pre-proline 0 CA--C 1.503 -0.847 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -168.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 0.02 62.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.602 1 C-N-CA 126.322 4.681 . . . . 0.0 115.732 -159.845 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 p -133.21 -41.99 0.88 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.727 167.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -144.78 133.27 21.98 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -129.48 128.65 43.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 169.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 49.1 m -138.06 121.93 17.69 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.247 168.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.629 ' HD1' HD21 ' A' ' 74' ' ' LEU . 2.3 p90 -154.35 151.1 28.66 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.712 0.768 . . . . 0.0 111.378 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.819 ' OE1' HD23 ' A' ' 66' ' ' LEU . 25.6 mp0 . . . . . 0 N--CA 1.425 -1.686 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.904 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.878 ' O ' ' HA ' ' A' ' 75' ' ' SER . 53.3 t . . . . . 0 N--CA 1.424 -1.761 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 14.4 m -121.52 135.78 55.0 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 122.102 2.228 . . . . 0.0 115.441 -158.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.5 m-30 -110.07 131.93 54.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.26 128.09 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.864 0.84 . . . . 0.0 110.631 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 71' ' ' PRO . 2.5 tt -121.28 143.29 49.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.636 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 89' ' ' LEU . 5.2 tp10 -110.53 130.83 55.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.788 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.733 ' OD2' HG21 ' A' ' 22' ' ' ILE . 8.5 t70 . . . . . 0 CA--C 1.487 -1.448 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.968 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.807 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -106.71 131.34 53.94 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.274 -0.891 . . . . 0.0 111.041 -154.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.69 113.58 4.75 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.125 -1.512 . . . . 0.0 109.887 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.7 t80 -105.35 128.96 53.76 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.434 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 m -122.07 114.7 21.28 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 134' ' ' VAL . 6.0 tt -105.55 136.21 45.55 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 118.589 -1.245 . . . . 0.0 110.777 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.742 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.5 mp -110.29 121.32 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.807 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.278 -2.512 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.618 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.604 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.645 0.26 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.554 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 48.0 ttt180 -63.66 -33.12 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.414 0.626 . . . . 0.0 109.415 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.14 -30.81 67.05 Favored Glycine 0 C--O 1.24 0.487 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.266 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.604 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 50.6 mttm -62.84 -34.88 78.26 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.409 0.623 . . . . 0.0 109.42 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.904 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 13.9 mtt -75.17 -27.38 59.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.939 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 7.2 t70 -75.97 -14.79 60.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.788 -169.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.52 -57.37 0.2 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.897 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -70.95 -19.63 77.17 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.77 -171.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.904 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -74.43 -33.39 62.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.264 0.532 . . . . 0.0 111.351 -171.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.808 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.4 p -74.65 -33.99 62.63 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.274 171.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.76 -52.1 26.46 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.752 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 mm -85.54 -48.01 16.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.302 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 100' ' ' LEU . 25.6 t -78.81 -42.52 24.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 O-C-N 120.689 -1.257 . . . . 0.0 111.488 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.607 ' HB3' ' O ' ' A' ' 131' ' ' THR . 43.0 t-20 -76.56 -39.55 52.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.933 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.851 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 4.0 tt0 -93.61 -46.97 7.03 Favored 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.947 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.804 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.9 tpp180 -81.6 -33.23 31.64 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.673 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.2 tp -65.01 -40.61 95.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 120.579 1.536 . . . . 0.0 107.401 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.924 ' HB2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.87 -36.77 82.23 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 169.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 15.6 mtmt -69.09 -43.8 73.8 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.04 -28.33 64.3 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.894 -0.504 . . . . 0.0 110.491 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 138' ' ' LEU . 30.0 m -93.44 -17.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -149.1 -58.61 0.21 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.497 -174.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.647 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 11.3 pt-20 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.537 1.135 . . . . 0.0 112.972 -161.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 123' ' ' ARG . 86.8 mt . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.66 132.29 53.42 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 130' ' ' TRP . 26.9 tptt -128.88 133.64 47.99 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -122.51 136.96 55.01 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.241 1.019 . . . . 0.0 112.203 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.775 ' HB ' HD22 ' A' ' 135' ' ' ASN . 0.0 OUTLIER -152.57 148.47 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.665 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.745 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.9 m -96.95 120.58 37.57 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.405 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG21 ' A' ' 142' ' ' VAL . 22.4 mt -91.03 108.31 19.78 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.813 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -74.51 89.09 2.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 116.64 -2.024 . . . . 0.0 106.852 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.56 169.46 10.32 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.34 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 93.1 Cg_endo -82.83 158.83 16.04 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.088 1.858 . . . . 0.0 110.388 164.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.913 HD13 ' HB2' ' A' ' 91' ' ' ASP . 3.5 tp -56.08 -36.34 44.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.573 0.701 . . . . 0.0 110.456 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.2 pt20 -61.5 -32.85 72.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.064 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.892 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.6 tmtp? -82.12 -36.48 27.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.83 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.656 HG22 HG11 ' A' ' 142' ' ' VAL . 3.1 t -67.28 -33.53 63.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.701 171.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.655 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.75 -42.49 71.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.541 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.73 ' C ' HG21 ' A' ' 31' ' ' THR . 10.3 tp10 -67.23 -29.42 69.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.889 173.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.614 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.0 m -101.34 -8.85 21.7 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.872 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.3 m -131.23 -64.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 121.796 2.089 . . . . 0.0 113.784 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB3' HD12 ' A' ' 74' ' ' LEU . 33.8 p -97.11 65.41 2.03 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.981 -1.074 . . . . 0.0 109.156 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.73 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -155.62 -177.75 6.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.047 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.0 m -63.67 171.23 2.77 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.166 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -49.2 -3.34 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.265 1.826 . . . . 0.0 114.836 -161.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.21 -35.28 69.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.608 169.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.872 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -68.34 -36.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.766 0.793 . . . . 0.0 111.302 170.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.747 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.09 102.91 3.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 117.826 -1.55 . . . . 0.0 109.003 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 70.2 mttt -133.09 152.54 51.95 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.514 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG3' HG12 ' A' ' 68' ' ' VAL . 25.5 mt-10 -124.66 131.77 53.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 119.107 0.867 . . . . 0.0 112.897 174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.62 34.54 60.57 Favored Glycine 0 C--N 1.328 0.128 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.224 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.937 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.93 173.27 6.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.442 1.097 . . . . 0.0 108.59 -173.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 7.7 mp0 . . . . . 0 C--N 1.306 -1.301 0 C-N-CA 118.566 -1.253 . . . . 0.0 109.111 157.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 8.8 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.8 OUTLIER -141.31 132.41 26.29 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -173.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.937 ' HB ' HE22 ' A' ' 50' ' ' GLN . 55.9 t -82.89 125.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.703 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.629 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -61.45 -54.67 40.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.765 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.19 145.3 16.49 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.527 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -134.89 129.35 51.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.106 0.955 . . . . 0.0 110.453 173.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -134.55 139.36 45.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.789 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.48 122.87 78.7 Favored Pre-proline 0 CA--C 1.506 -0.749 0 O-C-N 123.711 0.632 . . . . 0.0 109.428 -165.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.02 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.6 60.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.196 1 C-N-CA 126.78 4.987 . . . . 0.0 115.684 -158.525 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -132.71 -45.41 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.53 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.59 132.85 23.17 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.369 0.604 . . . . 0.0 109.932 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.7 tt -129.78 125.63 36.25 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.6 m -138.38 124.9 20.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.009 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.572 ' HB3' HG22 ' A' ' 65' ' ' VAL . 12.2 p90 -152.31 157.53 41.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 43.0 mt-10 . . . . . 0 C--N 1.313 -0.994 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.431 -1.403 0 CA-C-O 121.525 0.678 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.757 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 90.4 m -121.1 133.17 55.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.794 -168.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.675 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -112.9 132.8 55.16 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.551 -0.718 . . . . 0.0 109.835 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.41 HE21 HD11 ' A' ' 101' ' ' ILE . 16.9 mt-30 -122.29 125.9 46.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.761 0.791 . . . . 0.0 110.43 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.02 HD23 ' HB3' ' A' ' 71' ' ' PRO . 63.1 tp -124.78 144.64 50.15 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.672 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -110.53 123.4 49.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.66 0.384 . . . . 0.0 110.453 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.913 ' HB2' HD13 ' A' ' 22' ' ' ILE . 8.5 t70 . . . . . 0 CA--C 1.505 -0.77 0 CA-C-O 121.234 0.54 . . . . 0.0 110.882 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.813 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.541 ' HB ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -106.44 126.05 51.76 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 119.777 1.171 . . . . 0.0 109.005 -164.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.68 117.43 5.65 Favored Glycine 0 CA--C 1.491 -1.455 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.503 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.685 ' HE2' HD12 ' A' ' 100' ' ' LEU . 13.8 t80 -103.66 126.74 50.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.803 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.4 m -122.34 115.36 22.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.039 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.685 HD12 ' HE2' ' A' ' 98' ' ' PHE . 6.2 tt -107.51 137.31 45.77 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.104 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.757 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -120.05 125.96 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.727 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' HD21 ' A' ' 100' ' ' LEU . 1.9 m170 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.686 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 8.6 p . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HA ' HD11 ' A' ' 12' ' ' ILE . 15.0 ttp85 -63.16 -31.14 72.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -73.94 -34.37 55.95 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.013 175.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 30.7 mmmt -60.6 -42.32 96.55 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.011 0.91 . . . . 0.0 109.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.621 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 3.7 mmt -81.63 -24.61 36.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.911 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.417 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 19.4 t70 -76.7 -14.98 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.763 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -129.12 -51.97 0.11 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.894 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.92 -32.02 82.54 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.774 -0.713 . . . . 0.0 113.148 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.705 ' HA ' ' CE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -62.65 -55.72 24.35 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 118.138 0.969 . . . . 0.0 110.513 -175.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.3 p -62.47 -28.95 70.17 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.513 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.2 -63.56 5.06 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 118.828 -1.653 . . . . 0.0 111.173 169.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 pt -77.16 -49.56 22.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.797 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.0 p -79.45 -43.4 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 112.436 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.775 HD22 ' HB ' ' A' ' 16' ' ' ILE . 10.7 t-20 -74.84 -40.83 60.8 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.993 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.749 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 3.6 tp10 -95.82 -46.16 6.68 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.857 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.069 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 13.8 tpp180 -82.75 -32.02 28.06 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.797 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 49.0 tp -64.38 -40.49 95.92 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.7 tmm_? -65.59 -29.95 70.62 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.175 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 1.069 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -71.37 -46.59 60.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 177.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.56 -28.84 68.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.194 0.521 . . . . 0.0 109.668 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 24.1 m -94.05 -15.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.64 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -149.7 -58.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.278 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.735 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 9.9 tt0 . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 124.563 1.145 . . . . 0.0 112.925 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.672 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.93 134.33 55.28 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.892 ' HD3' HG23 ' A' ' 131' ' ' THR . 8.9 mmpt? -123.49 131.5 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.2 133.74 54.72 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.396 1.093 . . . . 0.0 111.566 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.735 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.8 148.19 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.814 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.735 ' N ' HG12 ' A' ' 16' ' ' ILE . 15.6 m -97.25 120.01 36.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 23.3 mt -90.02 107.65 19.25 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -76.83 87.28 3.42 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 116.641 -2.024 . . . . 0.0 107.044 177.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.787 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.65 165.39 18.52 Favored Pre-proline 0 C--O 1.213 -0.839 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.937 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 80.4 Cg_endo -75.7 157.71 39.75 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 120.752 0.968 . . . . 0.0 110.193 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.857 HD12 ' HB3' ' A' ' 91' ' ' ASP . 2.5 tt -52.67 -35.75 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.842 0.83 . . . . 0.0 111.108 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 2.1 pt20 -68.63 -29.66 68.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.355 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -75.6 -40.58 56.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.042 0.925 . . . . 0.0 109.421 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.652 HG22 HG11 ' A' ' 142' ' ' VAL . 8.5 t -66.45 -35.43 74.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.133 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.5 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 1.9 t90 -55.72 -43.75 76.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.96 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.764 ' C ' HG21 ' A' ' 31' ' ' THR . 37.7 tt0 -67.98 -28.75 67.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.889 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 141' ' ' ALA . 7.0 m -101.55 -9.02 21.37 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.894 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -131.07 -65.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 121.174 1.807 . . . . 0.0 113.811 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.612 ' HB3' HD12 ' A' ' 74' ' ' LEU . 21.9 p -97.49 68.34 2.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.505 -1.372 . . . . 0.0 109.057 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.2 t -156.32 -177.44 6.59 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.154 -169.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.758 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 17.4 m -62.25 170.52 2.26 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.293 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.75 -8.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 126.092 1.757 . . . . 0.0 114.435 -156.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.78 -33.91 75.18 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.08 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.81 -44.53 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 121.679 0.752 . . . . 0.0 112.398 173.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 121.54 0.686 . . . . 0.0 110.03 178.674 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.758 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 20.2 mt-30 . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.5 pt? -72.29 101.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 123.388 1.566 . . . . 0.0 109.834 -172.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HB3' ' CG ' ' A' ' 50' ' ' GLN . 4.4 mptp? -132.08 153.79 50.1 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 112.233 -2.258 . . . . 0.0 107.193 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.691 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.3 mt-10 -122.48 134.96 54.56 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 119.265 0.938 . . . . 0.0 112.345 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.06 35.99 42.49 Favored Glycine 0 N--CA 1.462 0.405 0 O-C-N 124.057 0.848 . . . . 0.0 112.121 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.933 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.1 173.32 6.37 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.188 -1.006 . . . . 0.0 108.502 -171.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 17.5 mp0 . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.431 156.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 31.9 m . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -148.28 129.28 14.44 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.933 ' HB ' HE22 ' A' ' 50' ' ' GLN . 59.2 t -83.21 131.32 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.052 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -66.78 -54.54 21.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.626 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.04 146.14 17.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.294 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -138.17 136.16 44.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.934 176.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 20.9 mt-30 -141.28 137.4 32.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.329 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 134.24 94.0 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.767 ' C ' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -4.55 64.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.306 1 C-N-CA 125.872 4.381 . . . . 0.0 115.665 -157.782 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.488 ' N ' ' HB2' ' A' ' 89' ' ' LEU . 6.5 p -137.83 -49.56 0.58 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.561 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -147.97 144.19 27.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 110.271 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.719 HD13 ' HD2' ' A' ' 87' ' ' PHE . 8.7 tt -142.84 125.34 15.73 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 65' ' ' VAL . 74.2 m -136.92 124.12 21.78 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.544 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 65' ' ' VAL . 9.2 p90 -152.7 156.41 39.11 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.594 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 51.8 mt-10 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 121.493 0.663 . . . . 0.0 109.645 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.427 -1.611 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.717 HG22 HD13 ' A' ' 101' ' ' ILE . 85.6 m -120.85 138.28 54.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.325 -169.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 74' ' ' LEU . 18.9 m-30 -111.61 130.87 55.61 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -116.49 125.57 52.13 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.929 1.347 . . . . 0.0 109.778 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.767 ' HB2' ' C ' ' A' ' 71' ' ' PRO . 1.8 mt -122.21 139.43 53.78 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.813 -158.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 96' ' ' THR . 3.6 tp10 -115.5 132.2 56.7 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 122.189 -0.32 . . . . 0.0 111.083 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.857 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.066 0 O-C-N 124.317 1.011 . . . . 0.0 109.819 -173.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.939 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.35 136.35 49.66 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.645 0.736 . . . . 0.0 110.962 -157.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 90' ' ' GLU . . . -96.65 115.26 5.17 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 118.9 -1.619 . . . . 0.0 110.06 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 12.7 t80 -108.21 125.95 52.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.643 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -123.78 116.19 22.6 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.595 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.033 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.2 tt -108.1 140.49 41.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.742 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' THR . 1.8 mp -119.67 124.27 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.881 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.762 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 168.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.53 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 13.0 p . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.598 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.5 ptt180 -68.52 -28.41 66.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -69.97 -29.29 70.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 13.1 mmmm -61.87 -38.9 89.99 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.264 1.03 . . . . 0.0 108.634 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.968 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 20.7 mtt -75.9 -28.08 57.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.386 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.595 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 20.0 t70 -78.01 -15.54 58.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.876 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.05 -54.44 0.21 Allowed Glycine 0 C--O 1.244 0.772 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.789 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.82 -17.14 80.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.302 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.033 ' HE1' HD22 ' A' ' 100' ' ' LEU . 43.7 t-105 -89.0 -14.19 37.08 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.706 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.892 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.2 p -82.47 -32.81 28.7 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.562 164.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.69 -53.9 36.33 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 118.24 -1.934 . . . . 0.0 109.417 168.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.9 mt -69.45 -55.76 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.982 -0.609 . . . . 0.0 112.588 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.915 HG21 HD13 ' A' ' 100' ' ' LEU . 38.6 t -84.12 -44.94 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.362 -0.836 . . . . 0.0 112.291 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.664 ' HB3' ' O ' ' A' ' 131' ' ' THR . 36.6 t-20 -72.55 -40.01 67.03 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.559 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.789 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.5 tt0 -97.26 -45.56 6.45 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.66 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 17.2 tpp180 -82.5 -31.7 29.15 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.721 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.8 tp -64.06 -40.12 95.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 120.08 1.309 . . . . 0.0 108.274 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 2.9 tmt_? -62.75 -32.18 73.27 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.805 ' HA ' ' H ' ' A' ' 144' ' ' GLU . 50.8 mtmt -74.72 -43.37 55.4 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.654 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.13 -28.79 68.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.778 -0.576 . . . . 0.0 110.229 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.652 HG11 HG22 ' A' ' 25' ' ' VAL . 32.9 m -87.32 -21.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 63.2 mm-40 -143.7 -63.57 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.131 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.805 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 35.5 tt0 . . . . . 0 N--CA 1.476 0.869 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.066 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.754 HG12 ' HG2' ' A' ' 123' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.438 -1.04 0 CA-C-O 121.172 0.511 . . . . 0.0 109.788 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -122.8 133.68 54.44 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.601 173.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.668 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -126.08 128.15 46.92 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 p -125.62 137.61 53.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.68 1.229 . . . . 0.0 112.711 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.832 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.9 149.54 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 112.687 -2.051 . . . . 0.0 108.123 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.804 ' N ' HG12 ' A' ' 16' ' ' ILE . 59.2 m -93.51 119.15 32.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 16' ' ' ILE . 16.4 mt -89.73 107.68 19.24 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 2.2 pt-20 -73.95 87.94 1.84 Allowed 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 117.145 -1.822 . . . . 0.0 106.128 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -152.3 168.89 10.43 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.284 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -80.01 150.73 20.8 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.166 1.244 . . . . 0.0 109.455 164.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 91' ' ' ASP . 14.1 tt -55.41 -32.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.737 0.78 . . . . 0.0 110.947 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.678 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 1.1 pp0? -68.88 -29.41 67.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.897 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 4.6 tppp? -79.47 -38.15 35.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.794 HG22 HG11 ' A' ' 142' ' ' VAL . 9.4 t -64.82 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.58 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.678 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -54.7 -41.52 70.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.465 173.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.794 ' C ' HG21 ' A' ' 31' ' ' THR . 33.3 mm-40 -68.58 -28.29 66.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.29 170.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 141' ' ' ALA . 3.6 m -99.95 -10.2 21.92 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.0 m -131.66 -64.19 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 121.324 1.875 . . . . 0.0 113.696 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.648 ' HB3' HD12 ' A' ' 74' ' ' LEU . 24.0 p -98.1 66.85 1.85 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.794 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.5 t -157.22 -177.36 6.55 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.6 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 35' ' ' ILE . 30.7 m -62.08 172.33 1.44 Allowed 'General case' 0 C--N 1.311 -1.079 0 O-C-N 124.025 0.828 . . . . 0.0 109.62 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 7.0 mt-10 -48.0 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.983 1.713 . . . . 0.0 114.769 -163.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.34 -34.81 68.87 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.823 169.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.24 -36.26 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 121.978 0.894 . . . . 0.0 111.124 170.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.908 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.41 101.92 3.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 117.29 -1.764 . . . . 0.0 109.774 -171.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 65' ' ' VAL . 69.6 mttt -133.36 152.88 51.95 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-N 112.048 -2.342 . . . . 0.0 107.725 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.695 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.7 mt-10 -123.48 129.35 51.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 118.937 0.789 . . . . 0.0 112.167 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.22 64.0 Favored Glycine 0 N--CA 1.461 0.349 0 CA-C-O 122.081 0.823 . . . . 0.0 111.856 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.878 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.58 172.7 6.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.38 -1.41 . . . . 0.0 107.989 -177.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 31.8 mt-10 . . . . . 0 C--N 1.301 -1.522 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.89 159.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 59.9 m . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' HB2' ' HZ2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -143.46 131.02 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.878 ' HB ' HE22 ' A' ' 50' ' ' GLN . 53.0 t -80.92 127.56 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.524 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.2 mm? -66.89 -50.73 61.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 174.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.41 142.79 15.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.667 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.695 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -136.21 132.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.553 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -137.84 138.13 38.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.743 -173.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.66 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.15 124.42 86.8 Favored Pre-proline 0 CA--C 1.507 -0.694 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.527 -167.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.62 ' C ' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.61 64.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.574 1 C-N-CA 126.085 4.523 . . . . 0.0 115.267 -158.279 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 13.4 p -133.13 -46.78 0.84 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.862 166.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -146.73 141.98 27.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.428 0.632 . . . . 0.0 110.983 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.5 tt -138.92 124.9 19.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 65' ' ' VAL . 69.4 m -137.44 125.36 22.68 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.41 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.559 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 11.4 p90 -151.77 157.27 41.75 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.553 ' HG3' HD21 ' A' ' 66' ' ' LEU . 32.7 mt-10 . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.957 0.884 . . . . 0.0 108.932 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 121.203 0.525 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 63.8 m -126.18 132.56 51.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.077 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.695 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.9 m-85 -111.8 131.28 55.44 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.178 0.989 . . . . 0.0 110.851 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 96' ' ' THR . 1.8 tm? -119.91 140.34 51.03 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.704 -171.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' N ' HD13 ' A' ' 89' ' ' LEU . 6.1 tp10 -119.17 139.49 51.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.798 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.769 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.5 p-10 . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt . . . . . 0 N--CA 1.431 -1.415 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.29 125.56 52.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.987 169.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.72 115.79 5.31 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.729 ' HD1' HD23 ' A' ' 89' ' ' LEU . 14.1 t80 -102.6 127.74 49.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.569 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.1 m -123.32 114.84 20.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.038 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.9 tt -106.98 136.31 47.05 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.329 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.7 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.6 mp -119.05 124.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.018 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.0 m170 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.697 HG23 ' HD2' ' A' ' 125' ' ' LYS . 8.3 p . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.702 0.763 . . . . 0.0 109.043 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.754 ' HG2' HG12 ' A' ' 12' ' ' ILE . 1.7 tmt_? -62.6 -33.85 75.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.481 172.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -72.52 -29.82 65.28 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.203 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.697 ' HD2' HG23 ' A' ' 122' ' ' VAL . 57.7 mttm -60.69 -42.83 97.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.285 1.04 . . . . 0.0 109.083 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.773 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 5.9 mmt -78.99 -20.91 47.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.8 t70 -76.47 -15.42 59.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.311 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.0 -52.35 0.13 Allowed Glycine 0 C--O 1.249 1.06 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.555 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.6 -21.65 72.87 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.79 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.038 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -73.5 -30.72 63.31 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.79 -171.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.703 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.2 p -74.17 -39.17 63.39 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.158 171.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -52.5 -53.06 33.89 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 118.218 -1.944 . . . . 0.0 110.492 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.667 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 82.4 mt -73.18 -55.2 13.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 100' ' ' LEU . 17.5 t -84.39 -43.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 121.637 -0.664 . . . . 0.0 112.141 -177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.832 ' HA ' HG21 ' A' ' 16' ' ' ILE . 6.3 t30 -70.35 -40.02 74.32 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.321 -0.952 . . . . 0.0 108.574 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.852 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 3.5 tt0 -96.24 -45.45 6.83 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.917 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.693 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 tpp180 -82.01 -33.43 30.08 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 142' ' ' VAL . 18.5 tp -64.47 -40.15 95.15 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.465 -1.294 . . . . 0.0 107.945 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.5 tmm_? -65.36 -29.74 70.5 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.852 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 54.3 mtmt -72.59 -45.18 60.39 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -69.24 -29.87 67.89 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.794 HG11 HG22 ' A' ' 25' ' ' VAL . 23.3 m -86.63 -18.39 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 10.5 mm-40 -152.25 -51.58 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.735 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 12.3 pt-20 . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.91 0.862 . . . . 0.0 110.873 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' A' ' 126' ' ' MET . 2.1 mm . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -120.04 131.36 55.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 30.4 mmtm -127.52 128.97 46.56 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.591 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.44 135.58 54.71 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.398 1.094 . . . . 0.0 111.382 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.13 148.07 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 112.764 -2.017 . . . . 0.0 108.717 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.707 ' N ' HG12 ' A' ' 16' ' ' ILE . 2.0 m -96.17 119.35 34.51 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.091 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.1 mt -91.79 108.53 19.98 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.917 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -75.09 89.24 2.45 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.379 -2.128 . . . . 0.0 106.177 175.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.39 168.25 12.54 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.439 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.2 Cg_endo -82.74 157.97 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.334 1.356 . . . . 0.0 110.289 165.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 91' ' ' ASP . 13.5 tt -57.46 -32.49 41.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 121.967 0.889 . . . . 0.0 110.638 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -68.28 -30.96 70.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -177.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.57 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 59.6 tptt -82.34 -39.06 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.232 -0.917 . . . . 0.0 109.92 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.673 HG22 HG11 ' A' ' 142' ' ' VAL . 2.9 t -61.74 -34.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.245 166.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -55.1 -42.26 72.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.372 0.669 . . . . 0.0 109.755 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.75 ' C ' HG21 ' A' ' 31' ' ' THR . 34.1 tt0 -66.32 -28.37 68.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.463 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.84 -10.01 21.12 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.816 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.6 m -131.01 -64.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 121.56 1.982 . . . . 0.0 113.981 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.65 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 35.1 p -97.31 65.61 1.99 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.869 -1.144 . . . . 0.0 108.847 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -156.15 -177.54 6.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.641 -167.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' GLY . 23.8 m -62.99 169.92 3.03 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.656 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 3.2 mt-10 -48.51 -2.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.024 1.73 . . . . 0.0 114.612 -163.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -56.93 -31.88 61.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.987 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.816 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.45 -36.16 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.547 0.689 . . . . 0.0 111.692 170.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.311 -1.083 0 O-C-N 122.008 -0.432 . . . . 0.0 111.339 167.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.01 102.19 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 116.771 -1.972 . . . . 0.0 108.763 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' CB ' ' HG3' ' A' ' 50' ' ' GLN . 50.3 mttm -130.09 150.8 51.19 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 112.036 -2.347 . . . . 0.0 106.683 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.79 129.65 50.86 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.536 -0.866 . . . . 0.0 113.06 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.73 37.43 68.8 Favored Glycine 0 N--CA 1.463 0.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.13 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -109.35 173.52 6.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.948 0.899 . . . . 0.0 109.734 -171.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 . . . . . 0 C--N 1.303 -1.425 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.51 156.507 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.741 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 41.6 t . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 21.6 pttp -135.93 133.88 38.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 68' ' ' VAL . 71.0 t -84.16 127.38 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.908 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.78 HD13 ' OE1' ' A' ' 77' ' ' GLU . 0.9 OUTLIER -77.64 -39.28 45.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.286 179.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.81 138.72 13.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.196 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -139.52 126.68 24.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.208 1.004 . . . . 0.0 110.91 174.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -137.01 139.05 41.14 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.621 -173.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.0 127.65 92.05 Favored Pre-proline 0 CA--C 1.504 -0.791 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -167.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.69 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -5.07 65.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 1 C-N-CA 126.263 4.642 . . . . 0.0 115.392 -157.861 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.8 p -135.53 -48.48 0.7 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.156 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.51 131.94 20.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 109.893 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.2 tt -131.84 124.67 30.06 Favored 'General case' 0 C--O 1.202 -1.4 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.6 m -137.92 123.49 19.71 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.269 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 11.5 p90 -154.01 153.9 32.77 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.754 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.78 ' OE1' HD13 ' A' ' 66' ' ' LEU . 3.5 mp0 . . . . . 0 N--CA 1.436 -1.136 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.61 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 121.544 0.688 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.812 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 95.7 m -120.15 136.9 54.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.832 -168.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 18.6 m-85 -115.08 131.61 56.87 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -122.06 128.85 51.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.82 0.819 . . . . 0.0 110.708 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 0.9 OUTLIER -121.71 145.07 48.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.976 -171.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 1.6 tt0 -109.68 120.53 42.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 1.052 ' HB2' HD12 ' A' ' 22' ' ' ILE . 2.9 t70 . . . . . 0 CA--C 1.497 -1.078 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.917 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -110.86 128.57 55.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.553 0.692 . . . . 0.0 110.274 -161.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.34 116.65 5.43 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 119.112 -1.518 . . . . 0.0 110.264 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.712 ' HE2' HD12 ' A' ' 100' ' ' LEU . 22.2 t80 -103.78 126.66 51.06 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.943 -170.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 m -123.04 115.39 21.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.443 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.04 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.8 tt -107.89 140.77 40.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.691 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.812 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.7 mp -120.41 125.82 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.975 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.3 m170 . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.591 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.2 p . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -65.1 -30.24 71.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.05 -30.73 67.35 Favored Glycine 0 C--O 1.238 0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.963 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.591 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.3 mtpp -59.78 -42.51 93.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.24 1.019 . . . . 0.0 108.796 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 1.063 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 9.8 mmt -78.22 -25.54 47.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.685 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 22.9 t0 -78.02 -13.75 59.76 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.873 -168.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.84 -53.78 0.16 Allowed Glycine 0 C--O 1.251 1.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.628 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.647 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -68.83 -27.3 73.99 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.457 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.063 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 10.7 t-105 -73.07 -30.45 63.7 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.182 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -70.32 -39.52 74.74 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.925 172.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.744 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -50.2 -50.41 34.3 Favored Glycine 0 C--N 1.308 -0.98 0 C-N-CA 118.236 -1.935 . . . . 0.0 110.933 168.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 129' ' ' GLY . 27.1 mm -73.48 -55.41 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 122.317 -0.519 . . . . 0.0 112.186 -175.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 1.4 p -83.72 -44.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 O-C-N 121.717 -0.614 . . . . 0.0 112.503 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.765 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.6 t30 -70.89 -40.84 71.98 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.744 ' HB3' ' O ' ' A' ' 132' ' ' GLY . 36.5 tt0 -96.38 -46.41 6.4 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.273 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.057 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.1 tpp180 -84.61 -31.44 24.26 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 29.7 tp -63.23 -40.0 96.2 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 118.261 -1.375 . . . . 0.0 107.779 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.697 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.1 tmm_? -66.11 -30.86 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 170.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 1.057 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 3.0 mtpt -67.73 -45.04 76.17 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.02 -29.92 65.99 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.431 -176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.673 HG11 HG22 ' A' ' 25' ' ' VAL . 27.8 m -89.67 -16.89 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.565 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 139' ' ' ARG . 9.9 mt-10 -148.23 -61.17 0.25 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.7 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 12.6 tt0 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.932 0.893 . . . . 0.0 111.801 -169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -119.51 133.31 55.74 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.572 0.701 . . . . 0.0 110.436 178.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.936 ' HD3' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.62 127.7 31.69 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.407 ' C ' ' HZ2' ' A' ' 14' ' ' LYS . 2.9 m -124.55 150.41 45.9 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.363 1.078 . . . . 0.0 112.103 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.75 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -153.11 148.12 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 113.142 -1.844 . . . . 0.0 108.541 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.74 ' N ' HG12 ' A' ' 16' ' ' ILE . 29.6 m -95.01 119.6 33.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.008 172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 17.6 mt -90.55 108.51 19.84 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.899 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.1 pt-20 -73.54 88.71 1.66 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 116.848 -1.941 . . . . 0.0 106.87 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.94 165.99 17.32 Favored Pre-proline 0 C--O 1.215 -0.763 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.506 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.0 Cg_endo -78.23 155.34 29.12 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.256 1.304 . . . . 0.0 110.359 168.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.722 HD12 ' HB3' ' A' ' 91' ' ' ASP . 8.6 tt -52.73 -37.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.681 0.753 . . . . 0.0 111.029 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 11.0 pt20 -60.2 -32.15 70.82 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.33 -1.304 . . . . 0.0 114.061 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -79.92 -38.05 33.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.845 0.831 . . . . 0.0 110.097 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.682 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.8 -33.12 59.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.225 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -54.69 -43.15 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.8 172.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.767 ' C ' HG21 ' A' ' 31' ' ' THR . 24.6 tt0 -68.45 -28.59 67.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.52 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.618 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.45 -9.38 21.13 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 117.63 2.456 . . . . 0.0 117.63 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.939 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.6 m -132.09 -64.61 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.318 1.872 . . . . 0.0 113.89 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.614 ' HB3' HD12 ' A' ' 74' ' ' LEU . 17.1 p -97.19 66.85 2.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.679 -1.263 . . . . 0.0 108.702 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.767 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.7 t -157.62 -174.64 4.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.811 -167.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.4 p -60.35 169.41 1.68 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 10.7 mt-10 -49.9 -8.01 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.805 1.642 . . . . 0.0 114.004 -161.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.39 -36.73 85.3 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.16 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.939 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.34 -41.38 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 117.642 0.721 . . . . 0.0 112.168 173.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 -177.833 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' THR . 39.2 mt-30 . . . . . 0 CA--C 1.51 -0.566 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.4 pt? -73.31 103.32 3.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 116.882 -1.927 . . . . 0.0 108.505 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -130.71 150.24 51.98 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.407 -2.179 . . . . 0.0 106.972 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -123.45 131.72 53.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.05 40.8 59.18 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.106 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.851 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -109.46 174.4 5.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.494 1.118 . . . . 0.0 109.426 -172.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 49.0 mt-10 . . . . . 0 C--N 1.308 -1.209 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.468 155.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.427 -1.607 0 CA-C-O 120.519 0.2 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -138.95 140.14 38.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.851 ' HB ' HE22 ' A' ' 50' ' ' GLN . 54.1 t -79.95 131.99 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.068 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -77.88 -44.93 25.64 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.486 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.34 135.8 11.3 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.544 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -130.44 127.41 62.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.904 174.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.35 138.3 44.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.61 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.97 93.43 Favored Pre-proline 0 CA--C 1.502 -0.865 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.986 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.54 62.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 1 C-N-CA 126.274 4.649 . . . . 0.0 115.583 -159.35 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -133.65 -52.67 0.87 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.394 169.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -143.18 132.92 23.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.502 0.667 . . . . 0.0 110.29 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.692 HD13 ' HD2' ' A' ' 87' ' ' PHE . 8.8 tt -129.21 125.88 37.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.577 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 m -137.98 126.37 23.28 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 12.2 p90 -151.19 155.64 39.28 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.31 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.513 ' HG3' ' CD2' ' A' ' 66' ' ' LEU . 43.0 mt-10 . . . . . 0 C--N 1.313 -1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 121.235 0.541 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 80.1 m -126.53 136.2 52.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.829 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.692 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.3 m-85 -111.09 130.51 55.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.0 mm100 -115.66 127.73 55.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.742 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mt -123.74 144.64 49.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.188 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.12 120.19 41.49 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.276 0 O-C-N 123.822 0.701 . . . . 0.0 110.254 -174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.899 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.22 129.65 56.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.444 -0.785 . . . . 0.0 110.585 -160.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.38 115.1 5.04 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 118.443 -1.837 . . . . 0.0 110.442 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HE2' ' CD2' ' A' ' 100' ' ' LEU . 11.9 t80 -105.65 130.98 53.57 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.588 -171.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -122.03 122.43 39.29 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.588 170.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.687 ' HG ' ' NE1' ' A' ' 130' ' ' TRP . 0.1 OUTLIER -104.85 136.63 43.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 86' ' ' THR . 3.5 mt -127.2 122.78 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.056 176.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.481 ' NE2' ' HZ2' ' A' ' 130' ' ' TRP . 1.3 m170 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -28.46 67.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.67 76.2 Favored Glycine 0 C--O 1.24 0.511 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.338 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.6 mtpp -60.21 -42.26 94.76 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.061 0.934 . . . . 0.0 109.415 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.938 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 11.3 mmt -76.89 -23.94 52.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.501 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.87 -14.43 58.66 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.314 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.96 -50.56 0.24 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.189 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -28.12 69.34 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.74 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.938 ' HB2' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -69.85 -26.62 64.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.936 HG23 ' HD3' ' A' ' 14' ' ' LYS . 2.0 p -81.73 -39.42 24.24 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.186 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.54 -52.95 48.74 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.083 -2.008 . . . . 0.0 109.897 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 66.2 mt -75.69 -55.59 10.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 114.741 -0.729 . . . . 0.0 112.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.633 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 22.0 t -82.54 -43.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 121.424 -0.797 . . . . 0.0 111.011 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.755 ' HB3' ' O ' ' A' ' 131' ' ' THR . 15.3 t-20 -72.75 -40.31 66.13 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.071 -172.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.871 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.3 tt0 -97.54 -45.65 6.33 Favored 'General case' 0 N--CA 1.42 -1.947 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.664 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.609 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.8 tpp180 -81.98 -33.03 30.39 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 19.2 tp -63.2 -40.56 97.84 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.367 -1.333 . . . . 0.0 107.626 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.832 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.0 tmm_? -65.18 -30.9 71.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.428 171.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.871 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 53.0 mtmt -73.76 -45.98 48.5 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -68.18 -29.55 68.44 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.704 -0.622 . . . . 0.0 109.934 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 25' ' ' VAL . 25.4 m -84.79 -21.85 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.406 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 13.4 mm-40 -147.29 -60.83 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.66 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 29.9 tt0 . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.767 0.794 . . . . 0.0 111.461 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 126' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.099 0.476 . . . . 0.0 110.603 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.1 p -117.49 134.1 55.22 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 121.197 0.522 . . . . 0.0 109.785 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -125.49 129.81 50.51 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -121.51 137.68 54.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.014 0.911 . . . . 0.0 110.857 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.769 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.1 148.52 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.177 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.769 ' N ' HG12 ' A' ' 16' ' ' ILE . 18.9 m -95.98 118.47 32.65 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.2 mt -91.12 110.32 21.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.881 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.4 pt-20 -75.06 88.42 2.41 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 116.871 -1.932 . . . . 0.0 106.993 175.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.28 167.15 14.94 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.721 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -81.94 156.31 17.82 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.348 1.365 . . . . 0.0 110.005 166.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.969 HD12 ' HB2' ' A' ' 91' ' ' ASP . 14.0 tt -54.43 -33.59 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.632 0.729 . . . . 0.0 110.747 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.7 pt20 -64.12 -31.05 72.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.865 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 1.077 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 4.4 tmtm? -81.76 -37.8 26.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.163 0.982 . . . . 0.0 109.071 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.582 HG22 HG11 ' A' ' 142' ' ' VAL . 3.2 t -64.4 -33.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.661 169.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CZ2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 t-105 -55.1 -42.66 73.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.927 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.736 ' C ' HG21 ' A' ' 31' ' ' THR . 34.8 tt0 -68.18 -28.33 67.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.167 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.1 -10.13 20.74 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.882 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -130.91 -65.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.348 1.885 . . . . 0.0 113.98 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.695 ' HB3' HD12 ' A' ' 74' ' ' LEU . 1.3 p -98.41 66.0 1.69 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.669 -1.269 . . . . 0.0 109.43 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.6 t -156.06 -174.97 5.19 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.583 -166.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.1 m -60.99 169.04 2.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.161 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.08 -7.88 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 125.934 1.693 . . . . 0.0 114.387 -157.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.53 -36.04 83.03 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.288 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.882 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -62.13 -39.91 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.764 0.792 . . . . 0.0 112.147 174.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.542 -178.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.625 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 104.77 4.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.655 1.693 . . . . 0.0 110.007 -171.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' O ' HG21 ' A' ' 65' ' ' VAL . 69.4 mttt -134.06 153.29 51.9 Favored 'General case' 0 C--O 1.202 -1.408 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.295 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.684 ' HG3' HG12 ' A' ' 68' ' ' VAL . 23.6 mt-10 -123.13 131.28 53.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 119.251 0.932 . . . . 0.0 112.771 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.15 34.63 62.78 Favored Glycine 0 CA--C 1.509 -0.301 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.827 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -106.76 173.23 6.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.073 -1.064 . . . . 0.0 108.943 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.509 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.996 157.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 25.1 pttm -140.11 131.09 26.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' SER . 51.2 t -82.75 128.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.9 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -68.43 -48.46 64.53 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.849 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.34 145.84 16.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.639 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -141.91 132.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.451 173.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -141.25 138.85 33.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.473 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.91 127.74 93.34 Favored Pre-proline 0 N--CA 1.444 -0.774 0 O-C-N 123.751 0.657 . . . . 0.0 109.531 -167.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.623 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -3.26 62.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 1 C-N-CA 126.181 4.587 . . . . 0.0 115.744 -156.446 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.6 p -130.23 -52.55 1.11 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.592 166.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.06 135.34 29.09 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.29 0.567 . . . . 0.0 109.959 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.7 tt -136.17 125.73 25.25 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.63 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.4 m -137.49 125.16 22.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 74' ' ' LEU . 11.7 p90 -150.74 158.0 43.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' HG3' HD21 ' A' ' 66' ' ' LEU . 23.4 mt-10 . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.34 0.59 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 HD13 ' A' ' 101' ' ' ILE . 92.8 m -121.38 136.5 54.95 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.318 -171.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.737 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -112.07 131.65 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.503 ' CG ' HD11 ' A' ' 101' ' ' ILE . 7.2 mm-40 -115.87 121.9 43.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD23 ' HD1' ' A' ' 98' ' ' PHE . 3.4 tm? -125.28 142.82 51.28 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.714 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.575 ' H ' HD22 ' A' ' 89' ' ' LEU . 2.8 tp10 -110.84 134.12 52.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.969 ' HB2' HD12 ' A' ' 22' ' ' ILE . 1.2 t70 . . . . . 0 CA--C 1.476 -1.903 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.847 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.881 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.54 136.61 48.64 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.099 -1.001 . . . . 0.0 111.16 -156.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 114.36 4.96 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 119.208 -1.472 . . . . 0.0 109.986 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.923 ' HD1' HD23 ' A' ' 89' ' ' LEU . 15.3 t80 -105.22 127.16 52.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.191 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -123.98 116.67 23.24 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.119 HD22 ' HE1' ' A' ' 130' ' ' TRP . 5.0 tt -106.37 136.37 46.24 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.144 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -114.23 123.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.871 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.661 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.9 p . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 121.491 0.662 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -33.33 74.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.336 170.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -70.39 -30.66 68.95 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.661 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.5 mtpp -60.5 -42.01 95.5 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 122.076 0.941 . . . . 0.0 109.355 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.712 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 8.7 mmt -80.91 -20.83 41.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.106 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.587 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.7 t70 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.693 -170.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.22 -50.52 0.11 Allowed Glycine 0 C--O 1.246 0.876 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.221 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.629 ' O ' HG13 ' A' ' 133' ' ' ILE . . . -65.92 -22.37 70.31 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.988 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.119 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -70.94 -33.74 70.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.593 -173.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -71.06 -39.32 72.31 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.104 172.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.48 -55.4 13.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 118.938 -1.601 . . . . 0.0 111.17 174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 129' ' ' GLY . 1.3 mt -81.85 -48.71 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.362 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.876 HG21 HD13 ' A' ' 100' ' ' LEU . 35.5 t -80.03 -44.08 22.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 121.177 -0.952 . . . . 0.0 111.368 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.743 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.0 t30 -72.45 -40.37 67.07 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.761 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.794 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 5.3 tt0 -95.82 -46.0 6.75 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 118.216 -1.393 . . . . 0.0 111.609 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.0 tpp180 -83.11 -33.82 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 27.9 tp -63.01 -39.86 96.03 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.1 tmm_? -66.17 -30.33 70.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.679 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.961 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -68.95 -48.08 64.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.796 -0.565 . . . . 0.0 112.33 175.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -66.29 -28.42 68.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.129 0.49 . . . . 0.0 110.188 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 1.077 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 28.7 m -95.64 -15.11 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.995 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -149.48 -54.2 0.17 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.65 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 68.7 tt0 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.72 HG22 ' CH2' ' A' ' 130' ' ' TRP . 5.4 mm . . . . . 0 N--CA 1.441 -0.894 0 CA-C-O 120.412 0.149 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -131.68 145.82 51.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 1.127 ' HB2' ' HE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -137.95 150.87 47.42 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -127.04 138.02 53.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.853 0.835 . . . . 0.0 111.861 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.706 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -150.79 147.74 15.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.194 173.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.706 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.2 m -96.24 119.83 35.45 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.327 172.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 16' ' ' ILE . 20.5 mt -90.35 107.76 19.35 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.966 ' HG3' ' HE ' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -74.03 88.03 1.88 Allowed 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 116.8 -1.96 . . . . 0.0 107.11 176.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.32 168.64 11.73 Favored Pre-proline 0 C--O 1.22 -0.491 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.194 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 83.8 Cg_endo -80.49 151.54 19.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.07 1.18 . . . . 0.0 110.253 166.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.63 ' CG1' ' HB2' ' A' ' 71' ' ' PRO . 6.7 tt -54.76 -36.15 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.593 0.711 . . . . 0.0 111.078 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.731 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 1.1 pt20 -60.95 -32.1 71.64 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.638 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.8 mmtm -82.29 -35.54 27.92 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.343 -0.848 . . . . 0.0 110.83 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.719 HG22 HG11 ' A' ' 142' ' ' VAL . 3.0 t -67.39 -32.52 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 170.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.589 ' CE3' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.64 -42.85 71.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.746 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.748 ' C ' HG21 ' A' ' 31' ' ' THR . 9.6 tp10 -65.96 -28.44 68.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.844 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.0 m -100.06 -7.03 25.46 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.919 ' HA ' HG13 ' A' ' 35' ' ' ILE . 22.6 m -134.99 -61.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.951 -1.718 . . . . 0.0 113.596 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 74' ' ' LEU . 32.3 p -96.46 63.69 2.14 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 120.33 -1.482 . . . . 0.0 109.617 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.748 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.91 -174.4 4.83 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.236 -165.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 35' ' ' ILE . 3.5 p -61.09 173.24 0.85 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.307 1.043 . . . . 0.0 110.496 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 5.2 mt-10 -47.55 -6.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.559 . . . . 0.0 114.216 -166.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.24 -40.08 91.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.585 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.919 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.01 -36.6 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.449 0.642 . . . . 0.0 111.139 171.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.726 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.14 102.14 3.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 123.691 1.71 . . . . 0.0 109.099 -172.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 55.4 mttt -134.32 154.26 51.42 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 111.593 -2.549 . . . . 0.0 107.364 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 68' ' ' VAL . 20.5 mt-10 -122.45 125.67 46.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 119.281 0.946 . . . . 0.0 111.967 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.77 81.93 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.799 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.45 159.54 15.84 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 25.2 mp0 . . . . . 0 N--CA 1.435 -1.208 0 C-N-CA 118.482 -1.287 . . . . 0.0 108.777 172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.777 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.7 OUTLIER -148.98 134.0 18.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.566 0.621 . . . . 0.0 109.718 -175.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 76' ' ' PHE . 71.4 t -74.52 127.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.228 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.476 HD23 ' HG3' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -68.11 -49.45 61.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.246 177.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.21 146.19 15.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -136.48 122.11 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.43 1.11 . . . . 0.0 110.473 173.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 11.7 mm100 -131.48 137.5 48.59 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.266 -172.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.81 123.99 83.46 Favored Pre-proline 0 CA--C 1.501 -0.919 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -166.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.56 65.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.34 1 C-N-CA 126.487 4.791 . . . . 0.0 115.248 -160.146 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -135.42 -46.85 0.69 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.713 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 28.4 tt0 -146.35 130.68 17.6 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.783 HD13 HG23 ' A' ' 68' ' ' VAL . 1.9 tp -130.74 127.66 39.23 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.6 t -137.55 127.53 25.79 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.951 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CB ' HG22 ' A' ' 65' ' ' VAL . 13.8 p90 -148.98 144.2 26.62 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.969 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HG3' HD23 ' A' ' 66' ' ' LEU . 47.9 mt-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-O 122.135 0.969 . . . . 0.0 112.651 -168.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' NE2' ' A' ' 102' ' ' HIS . 33.3 m . . . . . 0 N--CA 1.403 -2.796 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.854 HG22 HD13 ' A' ' 101' ' ' ILE . 29.3 m -117.53 129.2 55.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.96 -175.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.597 ' HD2' HD23 ' A' ' 74' ' ' LEU . 44.9 m-85 -118.66 128.32 54.41 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.806 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -117.0 125.59 51.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.818 0.818 . . . . 0.0 109.801 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.907 HD13 ' HB3' ' A' ' 71' ' ' PRO . 3.4 mt -124.04 144.18 49.99 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.05 -169.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 121.09 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.549 ' OD2' HD13 ' A' ' 22' ' ' ILE . 9.9 t0 . . . . . 0 CA--C 1.493 -1.236 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.2 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.869 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.103 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -108.57 127.97 54.42 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 -162.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.1 115.68 5.17 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 118.466 -1.826 . . . . 0.0 110.665 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 19.8 t80 -106.39 130.7 54.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.18 0.991 . . . . 0.0 113.223 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.3 m -124.28 122.11 36.84 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.769 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD13 HG21 ' A' ' 134' ' ' VAL . 5.9 tt -104.67 136.55 43.99 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.496 -0.881 . . . . 0.0 111.114 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.854 HD13 HG22 ' A' ' 86' ' ' THR . 2.4 mp -118.11 127.25 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.346 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.685 ' CG ' ' HZ2' ' A' ' 130' ' ' TRP . 13.4 m170 . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 160.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.749 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 9.8 p . . . . . 0 N--CA 1.443 -0.775 0 CA-C-O 121.088 0.471 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 123' ' ' ARG . 42.3 ttp180 -62.31 -35.41 78.97 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.19 -31.61 69.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.461 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.749 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 36.7 mtpt -62.9 -43.89 97.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 121.614 0.721 . . . . 0.0 110.599 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 6.9 mmt -81.97 -27.83 33.0 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.84 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.93 -16.06 58.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.882 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.61 -36.13 0.11 Allowed Glycine 0 C--O 1.243 0.695 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.397 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.662 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -69.03 -22.82 76.08 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.987 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 1.127 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 4.0 m0 -68.04 -33.22 74.18 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 117.922 0.861 . . . . 0.0 112.635 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.6 p -74.94 -33.15 61.92 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.81 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.809 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.67 -68.28 1.78 Allowed Glycine 0 C--N 1.312 -0.782 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.13 168.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 129' ' ' GLY . 15.9 pt -71.0 -50.26 43.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 121.513 -0.992 . . . . 0.0 112.184 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 5.7 t -81.1 -42.99 20.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 O-C-N 121.64 -0.662 . . . . 0.0 112.047 -176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.795 ' HB3' ' O ' ' A' ' 131' ' ' THR . 20.0 t-20 -75.56 -42.99 50.85 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 117.482 -1.687 . . . . 0.0 108.152 -174.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.91 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 11.3 tp10 -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.579 -169.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.072 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.0 tpp180 -83.71 -31.97 25.77 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.782 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.4 tp -66.53 -39.64 88.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 117.854 -1.538 . . . . 0.0 107.288 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.966 ' HE ' ' HG3' ' A' ' 19' ' ' GLU . 2.6 tmt_? -63.55 -32.79 74.36 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.302 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 1.072 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.58 -45.16 72.75 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.567 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -73.56 -28.75 62.02 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 110.141 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.719 HG11 HG22 ' A' ' 25' ' ' VAL . 25.5 m -86.73 -19.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 19.6 mm-40 -143.7 -64.8 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.288 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.561 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 71.5 tt0 . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.028 -165.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.31 97.71 2.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.331 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -90.44 -37.51 13.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.676 0.75 . . . . 0.0 109.331 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -112.3 163.54 14.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.776 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -93.04 121.45 34.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.916 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 9.6 tt0 -104.45 -47.02 4.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.188 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.416 HD21 ' HG3' ' A' ' 10' ' ' PRO . 3.2 t-20 -152.55 -69.83 0.16 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.547 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.829 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . 60.22 -168.59 0.16 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -164.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.767 ' HB3' HG13 ' A' ' 122' ' ' VAL . 3.8 pp -74.91 121.88 86.25 Favored Pre-proline 0 C--N 1.307 -1.253 0 C-N-CA 117.619 -1.633 . . . . 0.0 107.394 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.726 ' HD2' ' HD3' ' A' ' 123' ' ' ARG . 64.5 Cg_exo -52.27 151.7 16.82 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.076 1.851 . . . . 0.0 109.638 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -53.27 112.89 0.97 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.696 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 123' ' ' ARG . 4.7 mm -103.22 124.96 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.208 -173.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.84 132.69 55.65 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.496 177.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 131' ' ' THR . 16.3 mmtm -126.86 129.15 47.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.83 136.27 54.81 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.05 0.929 . . . . 0.0 110.698 -172.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.782 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.94 148.66 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-N 113.569 -1.651 . . . . 0.0 109.092 178.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.782 ' N ' HG12 ' A' ' 16' ' ' ILE . 77.3 m -94.89 119.25 33.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 172.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.627 HD23 ' CD1' ' A' ' 16' ' ' ILE . 22.7 mt -91.06 108.57 19.95 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -74.95 87.88 2.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 C-N-CA 116.647 -2.021 . . . . 0.0 106.709 176.087 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.76 167.26 14.6 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.165 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 98.1 Cg_endo -82.14 158.56 17.8 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.364 1.376 . . . . 0.0 110.198 167.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.045 HD12 ' HB2' ' A' ' 91' ' ' ASP . 10.8 tt -54.63 -32.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.684 0.754 . . . . 0.0 110.986 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 5.7 pt20 -68.42 -31.41 70.73 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.223 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 142' ' ' VAL . 82.5 mttt -81.92 -37.04 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.965 -1.085 . . . . 0.0 110.418 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG22 HG11 ' A' ' 142' ' ' VAL . 6.2 t -62.5 -34.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.612 167.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 71' ' ' PRO . 1.2 t-105 -55.21 -43.39 74.4 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.765 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.745 ' C ' HG21 ' A' ' 31' ' ' THR . 27.4 tp10 -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.929 173.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.631 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.9 -9.34 21.67 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -171.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.877 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.0 m -131.75 -63.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 121.64 2.018 . . . . 0.0 114.316 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.606 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 32.0 p -97.38 63.31 1.79 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 109.646 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.745 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.5 t -157.56 -174.61 4.95 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.238 -164.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 1.9 p -62.45 175.31 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.644 1.177 . . . . 0.0 110.918 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.045 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 14.4 mt-10 -47.42 -8.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.341 1.457 . . . . 0.0 113.594 -165.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.06 -40.79 93.99 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.975 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.877 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.5 -39.73 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 122.221 1.01 . . . . 0.0 110.727 172.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . . . -55.91 -32.65 63.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.423 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -50.96 -49.84 59.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.796 ' HB2' HG23 ' A' ' 133' ' ' ILE . 11.4 p-90 -80.31 -37.01 33.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.362 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.89 -72.08 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.772 0.32 . . . . 0.0 111.549 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.439 ' HG3' ' HD2' ' A' ' 41' ' ' PRO . 27.9 ttt 178.35 139.7 0.26 Allowed Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' A' ' 40' ' ' MET . 69.9 Cg_exo -40.63 101.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.772 2.981 . . . . 0.0 114.034 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -158.13 163.37 37.66 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.236 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.045 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 10.9 p-10 -114.64 51.84 0.87 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 32' ' ' SER . 16.3 t80 -40.96 138.77 0.99 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.303 169.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -135.17 139.24 44.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.5 pt? -73.67 100.74 3.45 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 116.932 -1.907 . . . . 0.0 108.116 -176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 49.2 mttm -132.33 153.0 51.17 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 111.53 -2.577 . . . . 0.0 107.434 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.793 ' HG3' HG12 ' A' ' 68' ' ' VAL . 22.7 mt-10 -123.27 130.55 52.89 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.867 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 54.93 40.17 71.64 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.809 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.906 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.01 172.42 6.84 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.2 mt-10 -124.8 128.16 48.3 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.464 -1.294 . . . . 0.0 109.402 161.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.602 ' CD1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -132.74 138.78 47.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 62' ' ' PRO . 81.3 t60 -139.6 157.26 46.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.827 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HA ' ' OD1' ' A' ' 43' ' ' ASP . 6.5 mp -68.77 15.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 53' ' ' HIS . 39.6 mt-30 -139.97 157.73 45.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.862 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 19.7 m -58.33 -55.22 47.89 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.862 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 12.5 Cg_exo -71.23 111.33 3.06 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.975 1.784 . . . . 0.0 110.497 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -70.11 -30.36 67.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.052 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.3 -115.84 4.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -81.51 -165.44 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.552 2.168 . . . . 0.0 111.3 173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -73.4 115.49 41.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 55.1 Cg_endo -88.63 -90.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.284 1.989 . . . . 0.0 112.374 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.602 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 34.5 m -129.86 154.1 47.62 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.87 128.75 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.906 ' HB ' HE22 ' A' ' 50' ' ' GLN . 70.6 t -82.55 130.09 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.6 HD11 ' OE2' ' A' ' 77' ' ' GLU . 5.1 mp -70.15 -50.14 43.49 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.719 173.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.26 142.42 15.79 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.765 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.793 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -138.65 135.27 43.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.879 0.847 . . . . 0.0 110.747 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.81 140.33 32.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.139 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.87 128.07 93.3 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -166.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.691 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -4.63 68.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 125.963 4.442 . . . . 0.0 115.012 -156.831 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 69' ' ' GLN . 4.6 p -139.29 -50.06 0.51 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 113.537 -1.665 . . . . 0.0 108.924 171.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.68 133.15 25.0 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.148 0.499 . . . . 0.0 109.715 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.6 tt -131.84 125.77 32.63 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.4 m -137.64 123.66 20.26 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.131 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 3.0 p90 -152.34 158.19 42.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.789 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 27.2 mt-10 -114.79 131.31 56.85 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.501 ' HB3' ' NE1' ' A' ' 83' ' ' TRP . 56.9 t-105 -94.01 117.23 29.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.0 -1.454 . . . . 0.0 113.122 -166.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 80' ' ' THR . 2.2 t70 41.62 -106.15 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 113.599 -1.637 . . . . 0.0 114.913 167.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.506 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 2.6 t -89.09 -29.95 19.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.47 -167.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.999 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.3 mp0 -91.41 154.29 19.27 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -90.89 32.51 5.07 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.635 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.789 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.78 117.6 21.58 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.132 -177.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 43.1 t -80.75 80.51 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 112.789 -2.005 . . . . 0.0 107.058 166.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.774 HG13 ' HB2' ' A' ' 83' ' ' TRP . 17.3 m -83.07 124.03 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.857 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.69 HG22 HD13 ' A' ' 101' ' ' ILE . 90.8 m -120.5 136.92 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.55 -170.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.64 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.2 m-30 -112.27 131.07 55.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.459 ' CG ' HD11 ' A' ' 101' ' ' ILE . 8.3 mm100 -116.37 125.62 52.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.287 0.565 . . . . 0.0 109.601 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 ' HD1' ' A' ' 98' ' ' PHE . 1.5 tm? -121.53 142.77 49.74 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -172.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.435 ' N ' HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -110.1 119.57 39.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.045 ' HB2' HD12 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -81.6 111.65 18.09 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 121.896 0.855 . . . . 0.0 110.028 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 52.4 mt -125.24 123.45 39.56 Favored 'General case' 0 N--CA 1.399 -3.004 0 CA-C-N 113.264 -1.789 . . . . 0.0 106.643 162.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.89 -26.87 8.86 Favored Glycine 0 N--CA 1.479 1.554 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 159.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 4.6 tp10 -52.65 -154.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 111.499 -2.35 . . . . 0.0 109.254 150.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.04 175.76 6.2 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -177.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -111.92 128.44 56.15 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.502 -0.749 . . . . 0.0 109.949 -163.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.0 115.48 5.25 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 118.418 -1.849 . . . . 0.0 110.087 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.799 ' HD1' HD23 ' A' ' 89' ' ' LEU . 27.5 t80 -104.26 127.15 51.86 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.898 0.856 . . . . 0.0 111.882 -170.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.3 m -123.18 117.08 24.53 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.315 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.071 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.6 tt -107.27 138.37 43.58 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.238 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.198 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.1 m170 -117.54 114.36 23.33 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 166.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.7 t -143.99 165.38 27.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.79 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 83' ' ' TRP . . . -170.89 150.81 14.54 Favored Glycine 0 C--N 1.312 -0.781 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -121.09 142.21 50.06 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' A' ' 106' ' ' LYS . 11.8 ttpp 90.66 34.55 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.833 1.333 . . . . 0.0 112.756 171.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.957 ' HG2' ' HA ' ' A' ' 112' ' ' ILE . 10.3 mp0 -121.6 163.12 32.71 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 122.217 -0.302 . . . . 0.0 110.488 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.916 ' HA ' ' HB3' ' A' ' 6' ' ' GLU . 88.1 Cg_endo -92.67 -153.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.433 2.755 . . . . 0.0 112.92 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.01 -16.51 62.06 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.96 0.886 . . . . 0.0 110.291 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 119' ' ' SER . 41.2 tt0 -74.75 162.29 28.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.577 166.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 113' ' ' GLY . 14.8 m -74.79 -179.87 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.199 0 CA-C-O 123.638 1.685 . . . . 0.0 112.117 -168.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.999 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -52.17 -30.95 13.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 110.213 -3.176 . . . . 0.0 112.602 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.695 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . 145.87 74.99 0.02 OUTLIER Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.494 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 97.2 mttt 77.43 16.13 1.63 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.467 0.707 . . . . 0.0 110.77 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.88 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -64.61 -28.62 69.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.884 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.426 ' C ' HD22 ' A' ' 116' ' ' ASN . 0.2 OUTLIER -179.47 -70.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.539 ' C ' HG13 ' A' ' 111' ' ' VAL . 38.3 tt0 -172.63 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.324 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.725 ' HB2' HG13 ' A' ' 121' ' ' VAL . 48.5 mmtm -91.46 138.06 31.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.225 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.693 ' HB2' ' C ' ' A' ' 8' ' ' ALA . 98.4 p -58.92 -35.19 72.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.966 0.888 . . . . 0.0 109.393 174.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.55 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 6.0 p -67.44 -40.5 85.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.764 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.725 HG13 ' HB2' ' A' ' 118' ' ' LYS . 16.7 m -70.5 -35.93 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.159 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' A' ' 9' ' ' LEU . 14.1 p -66.86 -38.14 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.098 0.475 . . . . 0.0 110.678 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.726 ' HD3' ' HD2' ' A' ' 10' ' ' PRO . 8.9 ptt180 -66.38 -29.89 70.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.16 -28.38 70.29 Favored Glycine 0 C--O 1.24 0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.679 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.9 mtpp -61.37 -43.27 99.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 122.073 0.94 . . . . 0.0 108.722 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 1.044 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 10.8 mmt -76.08 -23.51 55.01 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.043 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.619 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 14.9 t70 -76.62 -15.5 59.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.722 -171.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.54 -58.02 0.19 Allowed Glycine 0 C--O 1.244 0.723 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.717 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.86 -16.24 76.31 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.919 -172.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.071 ' HE1' HD22 ' A' ' 100' ' ' LEU . 6.6 t-105 -82.19 -24.12 35.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.505 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -78.83 -34.2 45.41 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.751 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -53.99 -54.98 28.24 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 118.249 -1.929 . . . . 0.0 110.057 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 38' ' ' TRP . 53.1 mt -70.55 -54.55 17.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.878 HG21 HD13 ' A' ' 100' ' ' LEU . 21.8 t -83.37 -44.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 121.36 -0.838 . . . . 0.0 112.331 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.728 ' HA ' HG21 ' A' ' 16' ' ' ILE . 40.4 t-20 -72.93 -39.94 65.84 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.736 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.742 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 2.2 tt0 -95.49 -45.82 6.93 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.687 -176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.7 tpp180 -83.07 -31.79 27.14 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.699 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 21.0 tp -64.54 -40.31 95.36 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 118.626 -1.229 . . . . 0.0 107.713 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.6 tmm_? -66.33 -30.23 70.59 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -68.65 -46.12 70.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 176.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.631 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.76 -28.72 63.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.792 -0.568 . . . . 0.0 110.183 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 25' ' ' VAL . 33.1 m -85.88 -21.61 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 9.6 mm-40 -148.17 -56.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.651 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 21.7 pt-20 42.61 -152.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.021 0.928 . . . . 0.0 112.024 -169.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.7 tt -153.7 -51.15 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.31 147.84 50.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.769 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -116.61 -45.64 2.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.551 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -119.77 100.16 7.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -67.46 -7.26 24.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -135.03 -73.44 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.753 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -142.06 151.74 42.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.954 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 C--O 1.245 0.834 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.25 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.565 0.221 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.87 -67.51 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.903 0.382 . . . . 0.0 111.778 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.26 -38.55 56.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -112.63 152.76 28.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.6 -175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 12.8 m120 -74.97 122.78 24.01 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 5.5 tp10 -85.05 -109.09 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.608 -163.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.836 ' HB3' ' HA ' ' A' ' 110' ' ' GLN . 0.1 OUTLIER -104.46 -45.86 4.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.67 0.271 . . . . 0.0 110.595 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.862 ' HA ' ' HA ' ' A' ' 112' ' ' ILE . . . 72.19 155.85 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.919 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -73.44 142.96 82.0 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.758 -174.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 31.7 Cg_exo -59.76 142.0 97.89 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.504 2.136 . . . . 0.0 109.924 171.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.64 122.2 8.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 112.325 -163.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.572 HG21 ' CB ' ' A' ' 126' ' ' MET . 1.5 tp -106.57 129.74 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.549 HG23 HG13 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -127.37 134.68 49.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.838 ' HB3' ' CZ2' ' A' ' 130' ' ' TRP . 20.8 tptt -138.73 152.03 47.63 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.665 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -124.42 141.87 51.74 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 122.079 0.943 . . . . 0.0 112.083 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.835 HD11 HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -142.02 148.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.593 171.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.69 ' N ' HG13 ' A' ' 16' ' ' ILE . 33.5 m -98.57 117.68 33.55 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 162.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.835 HD23 HD11 ' A' ' 16' ' ' ILE . 28.1 mt -93.59 109.4 21.02 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.673 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -75.35 88.26 2.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 117.158 -1.817 . . . . 0.0 106.84 177.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.45 166.16 17.1 Favored Pre-proline 0 C--O 1.217 -0.625 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.241 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 92.3 Cg_endo -78.88 157.15 27.34 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.232 1.288 . . . . 0.0 109.783 167.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.82 HD13 ' HA ' ' A' ' 91' ' ' ASP . 4.5 tp -53.24 -36.82 26.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.756 0.788 . . . . 0.0 110.673 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.3 pt20 -61.57 -32.41 72.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.2 -1.364 . . . . 0.0 114.073 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' GLU . 54.3 mtpt -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.721 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.548 HG22 HG11 ' A' ' 142' ' ' VAL . 2.7 t -66.97 -34.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.296 169.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.711 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.82 -41.91 71.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.586 172.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.723 ' C ' HG21 ' A' ' 31' ' ' THR . 6.0 tp10 -66.89 -29.97 70.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.931 172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.699 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.2 m -101.67 -9.55 20.81 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 -170.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.865 ' HA ' HG13 ' A' ' 35' ' ' ILE . 28.3 m -130.13 -64.3 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.47 1.941 . . . . 0.0 113.916 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.647 ' HB3' HD12 ' A' ' 74' ' ' LEU . 30.8 p -97.58 65.29 1.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 120.852 -1.155 . . . . 0.0 109.132 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.723 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -156.77 -176.37 5.94 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.649 -166.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 35' ' ' ILE . 16.9 m -63.19 173.64 1.42 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.687 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.1 mt-10 -47.88 -5.31 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.905 1.682 . . . . 0.0 114.612 -164.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.52 -37.59 83.16 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.804 -1.188 . . . . 0.0 110.613 170.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.865 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.45 -37.57 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.771 0.796 . . . . 0.0 110.62 170.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HB1' ' C ' ' A' ' 42' ' ' ASN . . . -53.97 -30.77 48.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.571 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -46.27 -49.6 17.15 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 1.028 ' HB2' HG23 ' A' ' 133' ' ' ILE . 7.1 p-90 -92.61 129.57 38.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.256 -0.277 . . . . 0.0 110.335 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' TRP . 69.6 t80 81.56 95.63 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.098 0.874 . . . . 0.0 112.412 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.1 mmt 67.27 161.95 0.14 Allowed Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.276 169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.05 116.88 3.75 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 C-N-CA 122.776 2.317 . . . . 0.0 110.437 168.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 12.6 t-20 -154.67 165.54 36.22 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.738 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 3.5 p-10 -155.65 39.52 0.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.47 0.652 . . . . 0.0 110.15 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 74' ' ' LEU . 21.4 t80 -46.83 142.55 3.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.375 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -138.77 141.26 38.83 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 174.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.6 pt? -73.05 102.15 3.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 116.976 -1.89 . . . . 0.0 108.911 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -131.13 150.6 52.07 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.062 -2.335 . . . . 0.0 106.91 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.603 ' HG3' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.5 131.74 54.0 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.55 39.54 45.52 Favored Glycine 0 N--CA 1.463 0.476 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.831 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 47' ' ' LYS . 2.2 pm0 -107.63 173.95 6.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 124.427 1.091 . . . . 0.0 109.579 -171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.035 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 78.7 mt-10 -123.53 127.04 47.77 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.234 158.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.667 ' HE1' ' SG ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -134.24 127.14 31.28 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 62' ' ' PRO . 1.4 p80 -149.56 136.67 19.76 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.041 163.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.0 tp -105.69 -28.27 10.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HG3' ' OG ' ' A' ' 56' ' ' SER . 8.5 pt20 -101.16 -162.4 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.93 171.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.444 ' OG ' ' HG3' ' A' ' 55' ' ' GLN . 16.0 m 70.92 136.12 0.05 OUTLIER Pre-proline 0 C--O 1.234 0.251 0 O-C-N 123.945 0.778 . . . . 0.0 112.811 168.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 58' ' ' PHE . 83.6 Cg_endo -83.66 -142.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.138 2.559 . . . . 0.0 110.81 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.432 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 48.1 t80 77.15 -47.13 0.5 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.222 0.609 . . . . 0.0 111.243 172.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 60' ' ' PRO . . . 105.0 -116.66 5.35 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.361 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 59' ' ' GLY . 19.7 Cg_exo -67.27 151.12 81.34 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.143 2.562 . . . . 0.0 112.365 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.5 m 61.58 66.05 1.64 Allowed Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.499 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 1.035 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 48.6 Cg_endo -74.69 -80.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.943 1.762 . . . . 0.0 111.372 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.847 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 31.2 t -126.12 151.6 47.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.666 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -138.17 126.84 23.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 76' ' ' PHE . 40.4 t -79.9 127.26 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.178 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.614 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.5 mm? -71.06 -46.14 62.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.132 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.532 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.41 140.51 15.3 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.281 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -139.06 127.57 28.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.007 172.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -141.95 139.81 32.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.564 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.07 127.92 91.54 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -168.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.999 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.21 60.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 1 C-N-CA 126.869 5.046 . . . . 0.0 116.066 -162.403 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -136.86 -44.48 0.58 Allowed 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.245 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 30.8 tt0 -144.19 134.4 24.33 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.558 0.694 . . . . 0.0 110.584 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.76 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -137.38 126.41 24.35 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 m -139.43 126.25 20.8 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.191 174.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.847 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 21.4 p90 -152.32 155.09 36.98 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.817 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 47.7 mt-10 -117.96 128.71 55.06 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.382 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -102.24 118.8 37.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.39 -1.277 . . . . 0.0 113.847 -161.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.73 -146.05 0.59 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.846 169.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 81' ' ' GLU . 4.4 t -61.98 -28.92 69.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.683 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.987 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 1.9 mp0 -83.4 141.82 31.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.532 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.602 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -95.98 44.05 2.09 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.286 -170.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.817 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -92.02 119.58 31.87 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.258 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' CA ' ' HG2' ' A' ' 77' ' ' GLU . 4.3 p -84.68 95.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.093 166.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -85.1 129.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.898 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 93.0 m -121.38 131.67 54.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.678 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -111.22 124.44 52.22 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -114.86 126.91 55.35 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 122.424 1.107 . . . . 0.0 109.668 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.999 HD23 ' HB3' ' A' ' 71' ' ' PRO . 22.6 tp -128.61 144.38 51.14 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.673 -165.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.722 ' H ' HD12 ' A' ' 89' ' ' LEU . 4.0 tp10 -110.71 130.41 55.58 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.535 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.82 ' HA ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -96.29 106.45 18.66 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 124.203 0.939 . . . . 0.0 110.132 -170.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.067 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 15.6 mt -126.48 134.73 50.86 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.79 -24.12 67.93 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 160.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 1.067 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 6.7 tp10 -54.85 -158.86 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.251 -2.474 . . . . 0.0 109.024 152.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.787 ' H ' ' HG3' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -96.72 169.18 10.05 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.83 131.59 54.92 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.454 0.645 . . . . 0.0 109.979 -158.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.76 113.35 4.62 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 118.581 -1.771 . . . . 0.0 109.861 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.85 ' HD1' HD13 ' A' ' 89' ' ' LEU . 6.5 t80 -104.89 129.94 53.14 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.848 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.8 m -122.47 116.09 23.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.022 ' HB3' ' HZ2' ' A' ' 130' ' ' TRP . 7.2 tt -110.62 139.23 46.08 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.285 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.8 mp -115.99 124.91 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.365 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.632 ' CD2' HD21 ' A' ' 100' ' ' LEU . 4.7 m170 -118.02 112.83 20.77 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -142.71 165.76 26.5 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -167.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.793 ' HA3' ' HB1' ' A' ' 8' ' ' ALA . . . -160.26 131.99 2.82 Favored Glycine 0 C--N 1.311 -0.824 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.838 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.422 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 4.5 m0 -129.94 131.24 45.91 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.793 0.797 . . . . 0.0 111.913 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 23.3 tttm -174.22 -104.73 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 165.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.946 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.6 pt-20 -124.65 -175.42 0.39 Allowed Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.679 -169.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.946 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 67.5 Cg_endo -73.26 -173.25 1.22 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 122.606 2.204 . . . . 0.0 115.221 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.401 ' HA ' HD22 ' A' ' 109' ' ' ASN . 9.4 m120 59.22 96.53 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.864 0.866 . . . . 0.0 110.584 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.836 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -105.63 114.74 29.09 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -156.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 117' ' ' GLU . 3.6 p -146.65 176.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 103.373 -2.825 . . . . 0.0 103.373 141.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.987 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -61.78 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 118.951 0.796 . . . . 0.0 111.871 178.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -168.32 -88.86 0.07 OUTLIER Glycine 0 C--O 1.222 -0.64 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.531 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 73.9 tttt -125.92 45.63 2.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 163.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -68.05 -39.97 82.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.209 -1.814 . . . . 0.0 111.618 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.4 -65.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.04 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.682 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 7.8 tp10 -167.31 -81.19 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.763 ' HB2' HG13 ' A' ' 121' ' ' VAL . 34.5 mmtp -94.96 154.67 17.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.764 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.864 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 89.8 p -65.78 -35.05 79.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.798 0.808 . . . . 0.0 109.196 168.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 4.3 m -66.04 -41.2 91.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG13 ' HB2' ' A' ' 118' ' ' LYS . 13.9 m -71.82 -36.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.987 -176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.825 HG11 HD11 ' A' ' 112' ' ' ILE . 7.8 p -69.68 -36.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.574 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 120' ' ' SER . 28.0 ptt180 -68.1 -28.29 67.21 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -65.43 -32.0 82.1 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 39.1 mmtm -62.48 -38.04 88.28 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.729 0.776 . . . . 0.0 109.237 172.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 102' ' ' HIS . 19.9 mtt -82.01 -7.73 59.63 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.541 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.495 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 31.0 t70 -92.57 -15.3 27.11 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.042 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -133.47 -53.96 0.08 OUTLIER Glycine 0 C--O 1.248 0.993 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.734 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.35 -18.76 73.69 Favored Glycine 0 CA--C 1.499 -0.957 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.022 ' HZ2' ' HB3' ' A' ' 100' ' ' LEU . 21.1 t90 -55.6 -63.86 1.03 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.678 -1.261 . . . . 0.0 110.913 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.9 p -63.8 -28.31 69.78 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.009 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -55.95 -59.28 10.89 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 118.494 -1.812 . . . . 0.0 110.289 168.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.028 HG23 ' HB2' ' A' ' 38' ' ' TRP . 1.7 mp -72.41 -54.46 16.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.824 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.8 t -81.16 -44.2 20.73 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 O-C-N 121.561 -0.712 . . . . 0.0 112.017 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 131' ' ' THR . 44.1 t30 -79.12 -38.11 36.94 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 117.92 -1.512 . . . . 0.0 108.735 -171.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.942 ' HG2' ' HE2' ' A' ' 140' ' ' LYS . 15.4 tt0 -94.82 -45.53 7.27 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 118.385 -1.326 . . . . 0.0 110.785 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.05 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.4 tpp180 -83.43 -33.0 25.8 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.824 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 34.5 tp -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 118.059 -1.456 . . . . 0.0 107.098 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HA ' HG22 ' A' ' 142' ' ' VAL . 4.4 tmm_? -65.8 -30.76 71.44 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.09 -47.51 68.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.187 0.517 . . . . 0.0 112.366 176.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -70.1 -27.44 64.6 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.782 -0.574 . . . . 0.0 109.771 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 138' ' ' LEU . 28.9 m -94.12 -12.78 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -153.24 -56.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.599 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 18.3 pt-20 35.18 77.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.496 1.118 . . . . 0.0 113.338 -169.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 145' ' ' LEU . 2.1 pp -68.27 125.69 27.21 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 169.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 68.19 162.78 0.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.389 -167.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.2 t60 174.68 -24.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -172.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -85.87 -48.42 8.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.226 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -86.01 105.24 16.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.543 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -125.89 18.39 7.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.978 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.7 m80 56.62 -149.93 0.45 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.382 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.165 -0.921 . . . . 0.0 109.339 172.057 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.613 0.244 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.9 -45.39 4.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.065 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.87 -38.83 92.29 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.51 0.671 . . . . 0.0 109.692 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -112.47 145.69 39.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 169.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -75.84 130.54 38.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.657 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -42.02 -62.74 0.86 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.53 1.144 . . . . 0.0 112.45 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -140.02 -60.43 0.53 Allowed 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -143.72 -52.32 0.34 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.006 168.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.843 HD21 ' HE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -86.14 105.06 6.48 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.43 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 39.5 Cg_exo -58.59 152.77 53.17 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.308 2.005 . . . . 0.0 111.778 -175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.79 121.71 17.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.81 0.814 . . . . 0.0 110.996 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -107.73 136.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -113.38 134.05 54.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.844 174.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.808 ' HD3' HG23 ' A' ' 131' ' ' THR . 7.8 mmpt? -122.01 130.9 53.68 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 135.25 54.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.129 0.966 . . . . 0.0 111.437 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -153.49 149.06 13.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.687 178.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.853 ' N ' HG12 ' A' ' 16' ' ' ILE . 28.1 m -95.06 121.1 36.33 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 16' ' ' ILE . 96.1 mt -91.65 108.34 19.84 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 1.3 mt-10 -77.58 87.15 3.89 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 116.62 -2.032 . . . . 0.0 106.768 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.807 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -158.47 169.03 11.25 Favored Pre-proline 0 C--O 1.214 -0.811 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.639 -176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 95.7 Cg_endo -83.62 152.61 13.38 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.749 0.966 . . . . 0.0 109.9 163.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.733 HG21 ' OD2' ' A' ' 91' ' ' ASP . 7.3 tt -55.02 -32.1 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.829 0.823 . . . . 0.0 111.289 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.677 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 4.6 pt20 -66.56 -30.48 70.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.953 -1.476 . . . . 0.0 113.407 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.593 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 58.1 tptt -81.69 -35.99 29.22 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 122.066 0.936 . . . . 0.0 110.011 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.659 ' HB ' HD11 ' A' ' 89' ' ' LEU . 2.7 t -66.04 -33.64 64.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.641 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.74 -42.33 71.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.195 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.816 ' C ' HG21 ' A' ' 31' ' ' THR . 23.4 tt0 -66.64 -28.28 68.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.106 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.556 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.4 m -100.21 -9.35 22.54 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.884 ' HA ' HG13 ' A' ' 35' ' ' ILE . 32.9 m -131.08 -63.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 121.334 1.879 . . . . 0.0 113.415 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 27.7 p -96.74 65.54 2.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.56 -1.338 . . . . 0.0 108.663 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.816 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.97 -174.7 4.96 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.729 -165.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 1.3 p -60.68 171.78 1.07 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.022 0.929 . . . . 0.0 110.315 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.024 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 4.1 mt-10 -47.76 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.571 1.549 . . . . 0.0 113.698 -162.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.02 -36.41 81.14 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.256 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.884 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.79 -44.22 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 121.718 0.77 . . . . 0.0 111.639 173.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.4 -32.74 65.12 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.773 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -63.9 -14.43 53.43 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.838 ' HZ2' HG12 ' A' ' 29' ' ' VAL . 8.0 p-90 -98.68 22.42 10.0 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.154 0.888 . . . . 0.0 110.872 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 130' ' ' TRP . 6.7 p90 -174.22 67.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.554 167.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.468 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 0.9 OUTLIER 77.78 120.57 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.379 173.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 40' ' ' MET . 3.1 Cg_endo -51.03 120.43 6.7 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.111 3.208 . . . . 0.0 114.526 -177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -156.41 142.06 17.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.563 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.024 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.2 p-10 -84.25 55.98 3.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.735 0.779 . . . . 0.0 111.02 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.685 ' HE2' HD11 ' A' ' 74' ' ' LEU . 19.4 t80 -63.55 139.39 58.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.41 164.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 45' ' ' GLN . 1.5 mp0 -139.89 147.55 40.78 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 168.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.618 ' HB3' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -71.72 103.55 3.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.754 1.74 . . . . 0.0 109.369 -172.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.686 ' HB3' ' CB ' ' A' ' 50' ' ' GLN . 6.5 mmtp -131.62 154.71 48.62 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 111.625 -2.534 . . . . 0.0 107.514 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' CD ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -120.42 134.15 55.32 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.375 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.98 38.95 61.57 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.441 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -109.94 151.52 26.99 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.361 -168.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -113.98 128.86 56.57 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 160.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.906 ' HZ ' HG23 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -95.55 114.86 26.66 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.083 -167.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -135.77 139.04 43.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.6 tp 52.52 64.08 1.99 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.643 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.424 ' HG2' ' CD ' ' A' ' 45' ' ' GLN . 6.7 tp-100 -111.02 -67.42 1.0 Allowed 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.193 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.743 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 20.3 m -121.24 -54.21 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.476 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 56' ' ' SER . 11.0 Cg_endo -91.11 -75.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.358 2.038 . . . . 0.0 112.511 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.733 ' HD1' ' HB2' ' A' ' 57' ' ' PRO . 1.0 OUTLIER -159.24 -61.28 0.07 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.68 81.08 0.08 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.857 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 58' ' ' PHE . 94.0 Cg_endo -89.53 62.32 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.907 2.405 . . . . 0.0 112.031 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t 57.57 65.65 3.37 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.547 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.576 ' O ' ' HA ' ' A' ' 79' ' ' ASP . 79.7 Cg_endo -91.42 -89.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.704 2.269 . . . . 0.0 113.299 -175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.89 ' HB3' ' HA ' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -100.85 165.88 11.13 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.432 -170.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 53.6 pttt -143.27 141.62 31.1 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.906 HG23 ' HZ ' ' A' ' 52' ' ' PHE . 95.9 t -83.54 132.16 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.316 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.819 HD23 ' OE1' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -82.84 -39.79 21.2 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.378 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 48' ' ' GLU . . . -157.85 140.76 14.95 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.17 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -140.21 132.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.16 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -141.68 138.65 32.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.942 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.77 123.02 82.24 Favored Pre-proline 0 CA--C 1.503 -0.847 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -168.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 0.02 62.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.602 1 C-N-CA 126.322 4.681 . . . . 0.0 115.732 -159.845 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.3 p -133.21 -41.99 0.88 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.727 167.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -144.78 133.27 21.98 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.529 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.2 tt -129.48 128.65 43.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 169.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 49.1 m -138.06 121.93 17.69 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.247 168.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.639 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 p90 -154.35 151.1 28.66 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.712 0.768 . . . . 0.0 111.378 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.819 ' OE1' HD23 ' A' ' 66' ' ' LEU . 25.6 mp0 -126.11 134.51 51.32 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.904 -173.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.89 ' HA ' ' HB3' ' A' ' 63' ' ' CYS . 8.7 t-105 -79.66 125.05 29.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.43 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER 53.74 -146.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.164 175.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.535 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.0 t -78.31 -38.36 42.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.646 1.212 . . . . 0.0 108.841 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.619 ' OE2' ' HA2' ' A' ' 113' ' ' GLY . 1.7 pt-20 -142.5 142.33 32.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.388 -2.187 . . . . 0.0 105.567 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . 126.52 30.43 0.84 Allowed Glycine 0 C--N 1.29 -1.996 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 -160.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.843 ' HE3' HD21 ' A' ' 9' ' ' LEU . 31.1 m0 -65.03 144.45 57.27 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 113.471 -1.365 . . . . 0.0 108.016 -174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -126.88 -32.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.606 172.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.898 HG21 ' HB3' ' A' ' 103' ' ' SER . 53.3 t 73.81 -108.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.133 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.742 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 14.4 m -121.52 135.78 55.0 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 122.102 2.228 . . . . 0.0 115.441 -158.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.702 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . 21.5 m-30 -110.07 131.93 54.62 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.26 128.09 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.864 0.84 . . . . 0.0 110.631 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.998 HD13 ' HB3' ' A' ' 71' ' ' PRO . 2.5 tt -121.28 143.29 49.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.636 -168.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' N ' HD23 ' A' ' 89' ' ' LEU . 5.2 tp10 -110.53 130.83 55.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.788 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.733 ' OD2' HG21 ' A' ' 22' ' ' ILE . 8.5 t70 -94.74 109.12 21.11 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.968 -176.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.905 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 12.9 mt -122.92 131.37 53.7 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 167.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.28 -27.15 38.8 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 160.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.905 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.3 tp10 -55.11 -158.68 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 111.442 -2.379 . . . . 0.0 109.84 153.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.807 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -100.88 -179.15 3.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -177.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -106.71 131.34 53.94 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.274 -0.891 . . . . 0.0 111.041 -154.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.69 113.58 4.75 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.125 -1.512 . . . . 0.0 109.887 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.59 ' HE2' HD12 ' A' ' 100' ' ' LEU . 17.7 t80 -105.35 128.96 53.76 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.434 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.2 m -122.07 114.7 21.28 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 HG21 ' A' ' 134' ' ' VAL . 6.0 tt -105.55 136.21 45.55 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 118.589 -1.245 . . . . 0.0 110.777 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.742 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 2.5 mp -110.29 121.32 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.807 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -119.31 109.24 15.57 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 117.292 -1.763 . . . . 0.0 109.618 170.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.898 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.8 t -99.23 122.88 43.0 Favored 'General case' 0 N--CA 1.4 -2.969 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 146.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 83' ' ' TRP . . . -174.36 173.21 45.92 Favored Glycine 0 C--N 1.277 -2.748 0 C-N-CA 115.355 -3.307 . . . . 0.0 118.475 -158.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 1.026 ' HB2' HG13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -112.12 155.57 23.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 112.171 -2.015 . . . . 0.0 110.214 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 53.6 tptt -123.78 -65.08 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 31.7 tt0 172.1 -65.02 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 O-C-N 123.952 0.782 . . . . 0.0 112.277 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 7.1 Cg_exo -73.19 139.08 28.87 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.689 2.259 . . . . 0.0 115.339 -163.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 70.47 -163.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.141 166.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 1.02 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -57.92 120.18 8.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.402 0.62 . . . . 0.0 109.474 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.909 HG22 ' H ' ' A' ' 112' ' ' ILE . 2.7 p -158.58 -168.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.318 -171.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.076 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -44.42 -34.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 123.99 0.806 . . . . 0.0 109.911 169.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.904 ' H ' HG13 ' A' ' 111' ' ' VAL . . . -54.92 89.29 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 164.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.526 ' HD2' ' C ' ' A' ' 113' ' ' GLY . 1.1 mptp? 62.34 60.48 1.41 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -162.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 1.076 ' HB2' ' HA ' ' A' ' 112' ' ' ILE . . . -54.26 -10.48 0.38 Allowed 'General case' 0 C--N 1.352 0.687 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -172.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -63.18 -19.28 64.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.038 0.381 . . . . 0.0 110.869 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 1.02 ' HB3' ' HB2' ' A' ' 110' ' ' GLN . 14.4 mm-40 -79.64 -150.11 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.888 ' HB2' ' HG3' ' A' ' 110' ' ' GLN . 9.8 mmtm -81.25 90.46 6.1 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 124.336 2.017 . . . . 0.0 113.389 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.866 ' O ' HG12 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -68.61 -29.33 67.82 Favored 'General case' 0 C--N 1.269 -2.891 0 CA-C-N 110.918 -2.855 . . . . 0.0 108.978 154.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -61.74 -34.53 76.0 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.008 -1.058 . . . . 0.0 111.184 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 118' ' ' LYS . 27.7 m -72.9 -36.83 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.631 -176.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.866 HG12 ' O ' ' A' ' 119' ' ' SER . 10.0 p -60.88 -36.22 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.559 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.554 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 48.0 ttt180 -63.66 -33.12 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.414 0.626 . . . . 0.0 109.415 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -71.14 -30.81 67.05 Favored Glycine 0 C--O 1.24 0.487 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.266 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.658 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 50.6 mttm -62.84 -34.88 78.26 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.409 0.623 . . . . 0.0 109.42 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.904 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 13.9 mtt -75.17 -27.38 59.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.939 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 7.2 t70 -75.97 -14.79 60.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.788 -169.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.52 -57.37 0.2 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.897 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -70.95 -19.63 77.17 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.77 -171.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.904 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -74.43 -33.39 62.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.264 0.532 . . . . 0.0 111.351 -171.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.808 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.4 p -74.65 -33.99 62.63 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.274 171.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.76 -52.1 26.46 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 118.835 -1.65 . . . . 0.0 110.752 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 38' ' ' TRP . 1.1 mm -85.54 -48.01 16.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.302 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.897 HG21 HD13 ' A' ' 100' ' ' LEU . 25.6 t -78.81 -42.52 24.78 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 O-C-N 120.689 -1.257 . . . . 0.0 111.488 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.607 ' HB3' ' O ' ' A' ' 131' ' ' THR . 43.0 t-20 -76.56 -39.55 52.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.837 -1.145 . . . . 0.0 108.933 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.851 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 4.0 tt0 -93.61 -46.97 7.03 Favored 'General case' 0 N--CA 1.408 -2.553 0 C-N-CA 117.709 -1.596 . . . . 0.0 109.947 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.804 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.9 tpp180 -81.6 -33.23 31.64 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.673 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.2 tp -65.01 -40.61 95.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 120.579 1.536 . . . . 0.0 107.401 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.924 ' HB2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.87 -36.77 82.23 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 169.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 15.6 mtmt -69.09 -43.8 73.8 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.04 -28.33 64.3 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.894 -0.504 . . . . 0.0 110.491 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 138' ' ' LEU . 30.0 m -93.44 -17.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -149.1 -58.61 0.21 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.497 -174.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.82 ' HG3' ' H ' ' A' ' 145' ' ' LEU . 11.3 pt-20 34.37 -87.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.537 1.135 . . . . 0.0 112.972 -161.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.82 ' H ' ' HG3' ' A' ' 144' ' ' GLU . 2.6 mm? 53.5 35.0 19.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.205 0.526 . . . . 0.0 110.457 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.49 119.88 9.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.716 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -86.14 94.68 9.34 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.713 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -50.8 -58.28 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.376 -166.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.415 ' HB3' ' H ' ' A' ' 150' ' ' HIS . 95.5 m-70 57.18 -151.65 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.654 0.596 . . . . 0.0 109.653 -172.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' H ' ' HB3' ' A' ' 149' ' ' HIS . 22.5 m-70 69.75 91.9 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.335 0.588 . . . . 0.0 111.085 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -118.83 136.7 53.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.061 -177.323 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.2 28.64 7.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.125 0.488 . . . . 0.0 110.256 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -65.68 -48.5 71.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.809 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -137.07 174.03 11.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.094 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -84.18 119.23 24.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 7' ' ' ASN . 3.7 tt0 -88.86 -62.0 1.58 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.068 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 2.5 p30 -107.14 -26.56 11.05 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.518 -169.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . . . -69.27 152.88 44.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 160.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.801 ' HB3' HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -66.49 128.43 93.85 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.62 156.72 59.49 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.008 1.805 . . . . 0.0 109.928 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -55.29 120.47 7.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.703 0.763 . . . . 0.0 110.47 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 123' ' ' ARG . 86.8 mt -104.39 126.07 59.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.094 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -124.66 132.29 53.42 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 130' ' ' TRP . 26.9 tptt -128.88 133.64 47.99 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -122.51 136.96 55.01 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.241 1.019 . . . . 0.0 112.203 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.775 ' HB ' HD22 ' A' ' 135' ' ' ASN . 0.0 OUTLIER -152.57 148.47 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 113.277 -1.783 . . . . 0.0 109.665 177.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.745 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.9 m -96.95 120.58 37.57 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.405 171.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG21 ' A' ' 142' ' ' VAL . 22.4 mt -91.03 108.31 19.78 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.813 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -74.51 89.09 2.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 116.64 -2.024 . . . . 0.0 106.852 176.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.56 169.46 10.32 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.34 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 93.1 Cg_endo -82.83 158.83 16.04 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.088 1.858 . . . . 0.0 110.388 164.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.913 HD13 ' HB2' ' A' ' 91' ' ' ASP . 3.5 tp -56.08 -36.34 44.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.573 0.701 . . . . 0.0 110.456 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 8.2 pt20 -61.5 -32.85 72.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.549 -1.205 . . . . 0.0 114.064 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.892 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 5.6 tmtp? -82.12 -36.48 27.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.83 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.656 HG22 HG11 ' A' ' 142' ' ' VAL . 3.1 t -67.28 -33.53 63.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.701 171.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.655 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.75 -42.49 71.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.541 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.73 ' C ' HG21 ' A' ' 31' ' ' THR . 10.3 tp10 -67.23 -29.42 69.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.889 173.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.614 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.0 m -101.34 -8.85 21.7 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -171.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.872 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.3 m -131.23 -64.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 121.796 2.089 . . . . 0.0 113.784 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.621 ' HB3' HD12 ' A' ' 74' ' ' LEU . 33.8 p -97.11 65.41 2.03 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.981 -1.074 . . . . 0.0 109.156 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.73 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -155.62 -177.75 6.79 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.047 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.0 m -63.67 171.23 2.77 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.166 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -49.2 -3.34 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.265 1.826 . . . . 0.0 114.836 -161.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.21 -35.28 69.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.608 169.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.872 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -68.34 -36.72 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.766 0.793 . . . . 0.0 111.302 170.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -53.36 -29.34 33.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.747 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -54.73 -41.39 70.31 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.801 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 9.5 p-90 -91.02 33.67 0.94 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.512 -0.742 . . . . 0.0 109.83 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HD1' ' O ' ' A' ' 40' ' ' MET . 2.7 t80 -141.67 144.89 34.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.682 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 22.2 mmt -73.21 158.87 86.25 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 30.7 Cg_exo -12.2 98.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 1 C-N-CA 125.348 4.032 . . . . 0.0 115.17 -163.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 20.5 t-20 -156.32 153.86 29.71 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.1 -170.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' HB2' HD12 ' A' ' 54' ' ' LEU . 1.8 p30 -152.93 42.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.59 0.709 . . . . 0.0 110.385 174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 74' ' ' LEU . 39.9 t80 -49.32 143.01 6.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.919 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -138.8 143.5 38.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.09 102.91 3.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 117.826 -1.55 . . . . 0.0 109.003 -174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 70.2 mttt -133.09 152.54 51.95 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-N 112.003 -2.362 . . . . 0.0 107.514 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.641 ' HG3' HG12 ' A' ' 68' ' ' VAL . 25.5 mt-10 -124.66 131.77 53.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 119.107 0.867 . . . . 0.0 112.897 174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.62 34.54 60.57 Favored Glycine 0 C--N 1.328 0.128 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.224 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.937 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.93 173.27 6.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.442 1.097 . . . . 0.0 108.59 -173.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.929 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 7.7 mp0 -118.06 129.11 55.36 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.566 -1.253 . . . . 0.0 109.111 157.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.676 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -132.68 131.99 41.9 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.546 ' HE1' ' HA ' ' A' ' 57' ' ' PRO . 4.9 p80 -148.2 139.17 23.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.066 165.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 43' ' ' ASP . 81.1 mt -109.58 -19.51 13.18 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.306 0.574 . . . . 0.0 109.68 171.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -102.6 146.77 27.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.267 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.577 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 70.8 m 53.48 90.33 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.546 ' HA ' ' HE1' ' A' ' 53' ' ' HIS . 97.1 Cg_endo -84.3 66.34 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.683 2.256 . . . . 0.0 112.749 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 56' ' ' SER . 5.0 p90 -134.27 26.62 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.343 0.592 . . . . 0.0 110.542 173.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.44 132.66 7.02 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.24 -63.94 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.587 2.191 . . . . 0.0 111.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.899 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 44.7 m -128.59 114.58 19.45 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.929 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 70.2 Cg_endo -75.37 -111.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 123.038 2.492 . . . . 0.0 113.874 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 8.8 m -101.93 157.48 16.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.928 -172.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.8 OUTLIER -141.31 132.41 26.29 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -173.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.937 ' HB ' HE22 ' A' ' 50' ' ' GLN . 55.9 t -82.89 125.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.703 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.629 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -61.45 -54.67 40.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.765 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.19 145.3 16.49 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.527 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -134.89 129.35 51.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.106 0.955 . . . . 0.0 110.453 173.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -134.55 139.36 45.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.789 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.48 122.87 78.7 Favored Pre-proline 0 CA--C 1.506 -0.749 0 O-C-N 123.711 0.632 . . . . 0.0 109.428 -165.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.02 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.6 60.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.196 1 C-N-CA 126.78 4.987 . . . . 0.0 115.684 -158.525 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -132.71 -45.41 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.53 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.59 132.85 23.17 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.369 0.604 . . . . 0.0 109.932 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 44' ' ' PHE . 8.7 tt -129.78 125.63 36.25 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.6 m -138.38 124.9 20.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.009 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.597 ' HE2' ' HE3' ' A' ' 78' ' ' TRP . 12.2 p90 -152.31 157.53 41.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.783 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 43.0 mt-10 -118.49 132.46 56.23 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.597 ' HE3' ' HE2' ' A' ' 76' ' ' PHE . 69.0 t-105 -104.7 130.77 52.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.935 -167.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 57.06 -153.54 0.37 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.367 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.5 t -54.15 -33.45 57.98 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.48 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.854 ' HG3' ' HA ' ' A' ' 112' ' ' ILE . 13.5 mm-40 -90.61 172.4 8.71 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.422 -167.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.909 ' HA2' ' HE2' ' A' ' 106' ' ' LYS . . . -105.66 22.3 32.49 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.534 -163.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.851 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -72.72 112.61 8.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.089 179.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.55 88.07 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.958 -1.928 . . . . 0.0 105.868 161.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 83' ' ' TRP . 14.3 m -86.67 119.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.545 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.757 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 90.4 m -121.1 133.17 55.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.794 -168.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.675 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -112.9 132.8 55.16 Favored 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.551 -0.718 . . . . 0.0 109.835 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.41 HE21 HD11 ' A' ' 101' ' ' ILE . 16.9 mt-30 -122.29 125.9 46.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.761 0.791 . . . . 0.0 110.43 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.02 HD23 ' HB3' ' A' ' 71' ' ' PRO . 63.1 tp -124.78 144.64 50.15 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.672 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -110.53 123.4 49.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.66 0.384 . . . . 0.0 110.453 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.913 ' HB2' HD13 ' A' ' 22' ' ' ILE . 8.5 t70 -94.61 111.27 23.04 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.234 0.54 . . . . 0.0 110.882 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.682 ' CB ' ' HB3' ' A' ' 94' ' ' GLU . 19.4 mt -120.36 152.86 37.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.372 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.4 -23.36 68.36 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 163.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.965 ' HG2' ' HD3' ' A' ' 95' ' ' LYS . 17.8 tt0 -58.9 -160.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 111.086 -2.557 . . . . 0.0 108.698 155.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.965 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -100.44 -175.97 3.07 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -173.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.541 ' HB ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -106.44 126.05 51.76 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 119.777 1.171 . . . . 0.0 109.005 -164.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.68 117.43 5.65 Favored Glycine 0 CA--C 1.491 -1.455 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.503 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.685 ' HE2' HD12 ' A' ' 100' ' ' LEU . 13.8 t80 -103.66 126.74 50.99 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.803 -171.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.4 m -122.34 115.36 22.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.039 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.685 HD12 ' HE2' ' A' ' 98' ' ' PHE . 6.2 tt -107.51 137.31 45.77 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.104 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.757 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.8 mp -120.05 125.96 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.727 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' HD21 ' A' ' 100' ' ' LEU . 1.9 m170 -119.25 113.66 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -131.46 160.93 33.72 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.675 ' HA3' HD11 ' A' ' 9' ' ' LEU . . . -140.7 128.78 3.89 Favored Glycine 0 C--N 1.314 -0.691 0 O-C-N 124.046 0.841 . . . . 0.0 111.952 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -132.77 125.36 29.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.909 ' HE2' ' HA2' ' A' ' 82' ' ' GLY . 3.7 tppt? -177.34 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.75 0.31 . . . . 0.0 110.773 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.492 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 41.2 mm-40 -118.19 130.19 24.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.171 -174.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 3.1 Cg_exo -81.18 62.19 8.4 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.165 2.576 . . . . 0.0 111.999 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.476 ' HB2' ' H ' ' A' ' 110' ' ' GLN . 3.9 m120 -120.71 -85.88 0.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.476 ' H ' ' HB2' ' A' ' 109' ' ' ASN . 4.3 pm0 -140.77 152.72 45.45 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.011 HG12 ' HA ' ' A' ' 119' ' ' SER . 0.4 OUTLIER -107.92 -177.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 118.46 -1.296 . . . . 0.0 112.816 -171.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.96 HD11 HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -60.65 -45.72 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 111.78 -2.464 . . . . 0.0 114.774 -160.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.995 ' HA2' ' HB ' ' A' ' 122' ' ' VAL . . . 59.93 -127.41 44.15 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -164.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.632 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 12.9 ptmm? -82.68 128.79 34.69 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 146.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.816 ' HB2' ' CZ2' ' A' ' 83' ' ' TRP . . . -48.37 -11.39 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 -142.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 114' ' ' LYS . 18.6 p30 -101.61 29.84 4.64 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 120.036 1.289 . . . . 0.0 111.627 169.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.765 ' HB2' ' HA3' ' A' ' 113' ' ' GLY . 46.8 mm-40 -116.76 -157.29 0.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.781 0.432 . . . . 0.0 111.793 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.9 mttt -99.31 161.94 13.33 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 1.011 ' HA ' HG12 ' A' ' 111' ' ' VAL . 2.7 p -71.79 -45.24 62.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.257 -1.338 . . . . 0.0 114.374 173.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 m -65.99 -31.47 72.38 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.407 1.099 . . . . 0.0 108.044 175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 118' ' ' LYS . 12.7 t -71.7 -45.59 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.421 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.995 ' HB ' ' HA2' ' A' ' 113' ' ' GLY . 8.6 p -60.27 -40.48 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HA ' HD11 ' A' ' 12' ' ' ILE . 15.0 ttp85 -63.16 -31.14 72.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -73.94 -34.37 55.95 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.013 175.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 122' ' ' VAL . 30.7 mmmt -60.6 -42.32 96.55 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.011 0.91 . . . . 0.0 109.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.621 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 3.7 mmt -81.63 -24.61 36.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.911 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.417 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 19.4 t70 -76.7 -14.98 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.763 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -129.12 -51.97 0.11 Allowed Glycine 0 C--O 1.247 0.939 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.894 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -62.92 -32.02 82.54 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.774 -0.713 . . . . 0.0 113.148 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.705 ' CE3' ' HA ' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -62.65 -55.72 24.35 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 118.138 0.969 . . . . 0.0 110.513 -175.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.3 p -62.47 -28.95 70.17 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.513 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.2 -63.56 5.06 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 118.828 -1.653 . . . . 0.0 111.173 169.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 129' ' ' GLY . 1.1 pt -77.16 -49.56 22.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.797 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 11.0 p -79.45 -43.4 23.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 120.825 -1.172 . . . . 0.0 112.436 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.775 HD22 ' HB ' ' A' ' 16' ' ' ILE . 10.7 t-20 -74.84 -40.83 60.8 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.993 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.749 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 3.6 tp10 -95.82 -46.16 6.68 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.857 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.069 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 13.8 tpp180 -82.75 -32.02 28.06 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.797 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 49.0 tp -64.38 -40.49 95.92 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.7 tmm_? -65.59 -29.95 70.62 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.175 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.069 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -71.37 -46.59 60.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 177.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.56 -28.84 68.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.194 0.521 . . . . 0.0 109.668 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.892 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 24.1 m -94.05 -15.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.64 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -149.7 -58.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.278 -179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.735 ' HA ' ' HG3' ' A' ' 140' ' ' LYS . 9.9 tt0 52.13 -74.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.563 1.145 . . . . 0.0 112.925 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 53.5 tp 173.64 -75.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -167.55 88.64 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.944 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -131.59 99.29 4.75 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -65.22 -25.22 67.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.017 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 51.17 26.65 3.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.937 1.295 . . . . 0.0 112.234 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -166.64 64.64 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.524 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.69 -31.85 52.68 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.49 175.577 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 107.93 11.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.305 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -62.43 -44.36 96.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.785 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 80' ' ' THR . 57.4 t30 -173.21 127.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 174.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.52 129.01 55.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.037 0.446 . . . . 0.0 111.08 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 5.5 tp10 -105.64 -67.19 0.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.918 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 110' ' ' GLN . 12.3 t-20 -162.34 -40.92 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.01 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . 84.37 151.51 0.08 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 163.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.903 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 1.4 pp -82.51 157.63 67.2 Favored Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.193 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 123' ' ' ARG . 8.5 Cg_exo -71.23 146.72 51.95 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.027 1.818 . . . . 0.0 108.737 162.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.48 124.82 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.533 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.672 HG21 ' CB ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -106.45 127.84 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.93 134.33 55.28 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.892 ' HD3' HG23 ' A' ' 131' ' ' THR . 8.9 mmpt? -123.49 131.5 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.2 133.74 54.72 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.396 1.093 . . . . 0.0 111.566 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.735 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -153.8 148.19 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.814 178.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.735 ' N ' HG12 ' A' ' 16' ' ' ILE . 15.6 m -97.25 120.01 36.82 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 23.3 mt -90.02 107.65 19.25 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.939 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -76.83 87.28 3.42 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 116.641 -2.024 . . . . 0.0 107.044 177.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.787 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.65 165.39 18.52 Favored Pre-proline 0 C--O 1.213 -0.839 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.937 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 80.4 Cg_endo -75.7 157.71 39.75 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 120.752 0.968 . . . . 0.0 110.193 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.857 HD12 ' HB3' ' A' ' 91' ' ' ASP . 2.5 tt -52.67 -35.75 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.842 0.83 . . . . 0.0 111.108 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 2.1 pt20 -68.63 -29.66 68.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.355 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -75.6 -40.58 56.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.042 0.925 . . . . 0.0 109.421 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.652 HG22 HG11 ' A' ' 142' ' ' VAL . 8.5 t -66.45 -35.43 74.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.133 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.5 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 1.9 t90 -55.72 -43.75 76.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.96 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.764 ' C ' HG21 ' A' ' 31' ' ' THR . 37.7 tt0 -67.98 -28.75 67.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.889 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 141' ' ' ALA . 7.0 m -101.55 -9.02 21.37 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.894 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -131.07 -65.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 121.174 1.807 . . . . 0.0 113.811 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.612 ' HB3' HD12 ' A' ' 74' ' ' LEU . 21.9 p -97.49 68.34 2.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.505 -1.372 . . . . 0.0 109.057 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.2 t -156.32 -177.44 6.59 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.154 -169.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.758 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 17.4 m -62.25 170.52 2.26 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.293 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -49.75 -8.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 126.092 1.757 . . . . 0.0 114.435 -156.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.78 -33.91 75.18 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.08 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.81 -44.53 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 121.679 0.752 . . . . 0.0 112.398 173.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.663 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . . . -56.7 -31.67 64.71 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.54 0.686 . . . . 0.0 110.03 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -78.78 50.03 0.96 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.92 -1.037 . . . . 0.0 113.424 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.787 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 13.8 m0 -94.72 64.63 2.98 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.725 -1.235 . . . . 0.0 108.169 168.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 38' ' ' TRP . 92.5 t80 77.35 -17.1 0.59 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.146 0.578 . . . . 0.0 110.464 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.488 ' CG ' ' HD2' ' A' ' 41' ' ' PRO . 24.7 ttt -96.41 151.63 38.18 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.47 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD2' ' CG ' ' A' ' 40' ' ' MET . 87.3 Cg_exo -47.37 149.9 3.91 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 113.041 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.663 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 9.6 p30 -99.69 155.24 17.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -177.17 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.509 0.505 . . . . 0.0 111.792 -172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.835 ' HD2' HD12 ' A' ' 35' ' ' ILE . 30.0 t80 -65.56 140.86 58.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -173.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.758 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 20.2 mt-30 -139.62 144.85 37.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.5 pt? -72.29 101.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 123.388 1.566 . . . . 0.0 109.834 -172.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HB3' ' CG ' ' A' ' 50' ' ' GLN . 4.4 mptp? -132.08 153.79 50.1 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 112.233 -2.258 . . . . 0.0 107.193 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.691 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.3 mt-10 -122.48 134.96 54.56 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 119.265 0.938 . . . . 0.0 112.345 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.06 35.99 42.49 Favored Glycine 0 N--CA 1.462 0.405 0 O-C-N 124.057 0.848 . . . . 0.0 112.121 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.933 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.1 173.32 6.37 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.188 -1.006 . . . . 0.0 108.502 -171.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.865 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 17.5 mp0 -118.76 130.94 56.08 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.431 156.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.725 ' CE1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -128.51 128.22 43.92 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.896 0.379 . . . . 0.0 111.433 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.85 ' HB3' ' HG3' ' A' ' 62' ' ' PRO . 34.9 p-80 -140.56 140.64 35.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.622 -171.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.4 mt -89.05 -42.68 11.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 167.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -137.39 153.81 50.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.388 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 19.8 m -91.24 113.99 60.19 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 8.3 Cg_exo -72.03 72.2 2.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.341 2.694 . . . . 0.0 112.264 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 59.1 21.36 9.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.934 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.46 ' HA2' ' HD3' ' A' ' 60' ' ' PRO . . . -170.26 140.02 5.81 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.359 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 2.9 Cg_exo -77.21 43.13 1.24 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.59 2.86 . . . . 0.0 112.528 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.4 m -148.77 94.78 4.04 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.865 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 86.5 Cg_endo -83.21 -113.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.7 2.267 . . . . 0.0 112.85 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.725 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 31.9 m -102.0 161.36 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.472 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -148.28 129.28 14.44 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.933 ' HB ' HE22 ' A' ' 50' ' ' GLN . 59.2 t -83.21 131.32 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.052 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -66.78 -54.54 21.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.626 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.04 146.14 17.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.294 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -138.17 136.16 44.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.934 176.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.465 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 20.9 mt-30 -141.28 137.4 32.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.329 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 134.24 94.0 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.767 ' C ' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -4.55 64.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.306 1 C-N-CA 125.872 4.381 . . . . 0.0 115.665 -157.782 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.488 ' N ' ' HB2' ' A' ' 89' ' ' LEU . 6.5 p -137.83 -49.56 0.58 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.561 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -147.97 144.19 27.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 110.271 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.719 HD11 ' CE2' ' A' ' 44' ' ' PHE . 8.7 tt -142.84 125.34 15.73 Favored 'General case' 0 C--O 1.202 -1.416 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 65' ' ' VAL . 74.2 m -136.92 124.12 21.78 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.544 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 65' ' ' VAL . 9.2 p90 -152.7 156.41 39.11 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.806 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 51.8 mt-10 -118.67 132.89 56.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.493 0.663 . . . . 0.0 109.645 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.412 ' HB3' ' NE1' ' A' ' 83' ' ' TRP . 1.9 t90 -107.14 130.43 54.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.348 -1.296 . . . . 0.0 113.925 -160.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 80' ' ' THR . 3.5 t70 51.51 -114.55 0.81 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.069 1.348 . . . . 0.0 114.408 170.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 79' ' ' ASP . 4.9 t -103.5 -15.51 15.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.352 -169.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 14.2 mp0 -94.89 151.28 19.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.85 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.49 38.51 3.21 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.411 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.806 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -86.43 116.87 24.85 Favored 'General case' 0 CA--C 1.486 -1.51 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.722 -177.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 4.2 p -86.47 84.94 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.131 -1.849 . . . . 0.0 106.539 165.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.797 HG13 ' HB2' ' A' ' 83' ' ' TRP . 16.3 m -84.42 123.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.335 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.717 HG22 HD13 ' A' ' 101' ' ' ILE . 85.6 m -120.85 138.28 54.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.325 -169.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 74' ' ' LEU . 18.9 m-30 -111.61 130.87 55.61 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -116.49 125.57 52.13 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.929 1.347 . . . . 0.0 109.778 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.767 ' HB2' ' C ' ' A' ' 71' ' ' PRO . 1.8 mt -122.21 139.43 53.78 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.813 -158.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 96' ' ' THR . 3.6 tp10 -115.5 132.2 56.7 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 122.189 -0.32 . . . . 0.0 111.083 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.857 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.16 107.32 19.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 124.317 1.011 . . . . 0.0 109.819 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 17.9 mt -126.58 134.26 50.87 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 167.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.66 -25.44 63.44 Favored Glycine 0 N--CA 1.47 0.953 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 161.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.97 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 15.9 tt0 -55.17 -158.8 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 111.155 -2.523 . . . . 0.0 109.23 154.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.939 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -98.54 175.1 6.13 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.35 136.35 49.66 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.645 0.736 . . . . 0.0 110.962 -157.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 90' ' ' GLU . . . -96.65 115.26 5.17 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 118.9 -1.619 . . . . 0.0 110.06 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 12.7 t80 -108.21 125.95 52.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.643 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -123.78 116.19 22.6 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.595 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.033 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.2 tt -108.1 140.49 41.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.742 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' THR . 1.8 mp -119.67 124.27 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.881 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.762 ' HB3' ' SD ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -118.78 110.31 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 168.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.887 ' HA ' HD11 ' A' ' 9' ' ' LEU . 33.9 t -144.23 163.91 32.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.782 -167.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -154.2 132.7 3.62 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.629 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 71.5 t-105 -79.42 122.52 26.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.744 0.772 . . . . 0.0 111.772 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.858 ' HG3' ' H ' ' A' ' 107' ' ' GLU . 2.9 tptm 159.42 -156.48 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.068 1.347 . . . . 0.0 107.748 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.858 ' H ' ' HG3' ' A' ' 106' ' ' LYS . 40.6 mt-10 -121.33 116.25 30.98 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 117.991 0.359 . . . . 0.0 110.413 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 35.8 Cg_endo -64.28 137.32 55.57 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 124.067 3.178 . . . . 0.0 116.964 -164.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 179.61 -64.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.95 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.794 ' O ' ' HB3' ' A' ' 119' ' ' SER . 6.2 tp60 -96.4 162.11 13.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.226 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.635 HG13 ' C ' ' A' ' 117' ' ' GLU . 14.6 m -74.18 -179.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 CA-C-O 123.304 1.526 . . . . 0.0 112.101 -164.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.905 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -52.86 -45.76 51.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 111.377 -2.647 . . . . 0.0 112.036 -177.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 6' ' ' GLU . . . -161.45 -74.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.867 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 4.7 tmtt? -140.55 43.75 1.86 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 169.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.816 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -71.56 -26.18 62.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.501 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -178.93 -79.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.296 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.635 ' C ' HG13 ' A' ' 111' ' ' VAL . 1.7 tm-20 -164.48 -74.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.695 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.779 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 24.9 mttm -92.68 141.49 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 111.644 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.903 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 78.6 p -66.38 -41.48 89.33 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.447 0.642 . . . . 0.0 111.478 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.6 m -66.7 -30.3 70.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.703 0.764 . . . . 0.0 109.617 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 118' ' ' LYS . 13.8 t -71.57 -44.26 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.468 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 112' ' ' ILE . 13.0 p -65.42 -39.31 84.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.454 0.471 . . . . 0.0 111.238 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.598 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.5 ptt180 -68.52 -28.41 66.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -69.97 -29.29 70.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.705 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.1 mmmm -61.87 -38.9 89.99 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.264 1.03 . . . . 0.0 108.634 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.968 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 20.7 mtt -75.9 -28.08 57.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.386 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.595 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 20.0 t70 -78.01 -15.54 58.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.876 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.05 -54.44 0.21 Allowed Glycine 0 C--O 1.244 0.772 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.789 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.82 -17.14 80.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.302 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.033 ' HE1' HD22 ' A' ' 100' ' ' LEU . 43.7 t-105 -89.0 -14.19 37.08 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.706 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.892 HG23 ' HD3' ' A' ' 14' ' ' LYS . 1.2 p -82.47 -32.81 28.7 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.562 164.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -54.69 -53.9 36.33 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 118.24 -1.934 . . . . 0.0 109.417 168.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.9 mt -69.45 -55.76 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.982 -0.609 . . . . 0.0 112.588 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.915 HG21 HD13 ' A' ' 100' ' ' LEU . 38.6 t -84.12 -44.94 18.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 121.362 -0.836 . . . . 0.0 112.291 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.664 ' HB3' ' O ' ' A' ' 131' ' ' THR . 36.6 t-20 -72.55 -40.01 67.03 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.559 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.789 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.5 tt0 -97.26 -45.56 6.45 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.66 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 17.2 tpp180 -82.5 -31.7 29.15 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.721 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 18.8 tp -64.06 -40.12 95.57 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 120.08 1.309 . . . . 0.0 108.274 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.544 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 2.9 tmt_? -62.75 -32.18 73.27 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.805 ' HA ' ' H ' ' A' ' 144' ' ' GLU . 50.8 mtmt -74.72 -43.37 55.4 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.654 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -67.13 -28.79 68.43 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.778 -0.576 . . . . 0.0 110.229 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.652 HG11 HG22 ' A' ' 25' ' ' VAL . 32.9 m -87.32 -21.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 63.2 mm-40 -143.7 -63.57 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.131 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.805 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 35.5 tt0 59.72 137.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.066 -171.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 29.6 tp -79.57 51.21 1.23 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.678 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 32.87 56.41 0.43 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.131 1.373 . . . . 0.0 113.792 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 69.76 -67.56 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.942 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.9 t60 73.04 129.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -166.17 127.12 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.601 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -131.93 135.26 46.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.03 106.95 7.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.4 t60 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.064 175.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.8 mtm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 113' ' ' GLY . . . -140.44 82.92 1.88 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -99.86 -32.56 10.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.211 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 113' ' ' GLY . 4.4 p-10 -112.64 158.5 19.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.996 0.427 . . . . 0.0 111.17 -173.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.597 ' HB3' ' O ' ' A' ' 80' ' ' THR . 27.8 p-10 -98.93 144.91 27.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.608 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.67 ' HG3' ' N ' ' A' ' 7' ' ' ASN . 7.0 pt-20 -144.4 -48.06 0.26 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.371 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.67 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 9.0 p30 -116.93 -120.75 0.3 Allowed 'General case' 0 N--CA 1.408 -2.543 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.703 ' HA ' HG23 ' A' ' 112' ' ' ILE . . . 164.42 166.99 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.679 -170.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.846 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -81.46 155.67 71.38 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.383 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.28 142.22 29.6 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.094 1.863 . . . . 0.0 109.805 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.92 119.39 5.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.359 0.6 . . . . 0.0 110.964 -170.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.754 HG12 ' HG2' ' A' ' 123' ' ' ARG . 0.8 OUTLIER -105.16 127.56 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.788 -177.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -122.8 133.68 54.44 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.601 173.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -126.08 128.15 46.92 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 p -125.62 137.61 53.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 122.68 1.229 . . . . 0.0 112.711 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.832 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -150.9 149.54 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 112.687 -2.051 . . . . 0.0 108.123 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.804 ' N ' HG12 ' A' ' 16' ' ' ILE . 59.2 m -93.51 119.15 32.23 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.699 HD23 ' CD1' ' A' ' 16' ' ' ILE . 16.4 mt -89.73 107.68 19.24 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 2.2 pt-20 -73.95 87.94 1.84 Allowed 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 117.145 -1.822 . . . . 0.0 106.128 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -152.3 168.89 10.43 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.284 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB2' ' HG3' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -80.01 150.73 20.8 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 121.166 1.244 . . . . 0.0 109.455 164.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.769 HD12 ' HB3' ' A' ' 91' ' ' ASP . 14.1 tt -55.41 -32.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.737 0.78 . . . . 0.0 110.947 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.678 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 1.1 pp0? -68.88 -29.41 67.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.897 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 142' ' ' VAL . 4.6 tppp? -79.47 -38.15 35.19 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.794 HG22 HG11 ' A' ' 142' ' ' VAL . 9.4 t -64.82 -33.44 63.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.58 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.678 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -54.7 -41.52 70.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.465 173.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.794 ' C ' HG21 ' A' ' 31' ' ' THR . 33.3 mm-40 -68.58 -28.29 66.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.29 170.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 141' ' ' ALA . 3.6 m -99.95 -10.2 21.92 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.0 m -131.66 -64.19 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 121.324 1.875 . . . . 0.0 113.696 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.648 ' HB3' HD12 ' A' ' 74' ' ' LEU . 24.0 p -98.1 66.85 1.85 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 120.894 -1.129 . . . . 0.0 109.425 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.794 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.5 t -157.22 -177.36 6.55 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.6 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 35' ' ' ILE . 30.7 m -62.08 172.33 1.44 Allowed 'General case' 0 C--N 1.311 -1.079 0 O-C-N 124.025 0.828 . . . . 0.0 109.62 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG2' ' HB2' ' A' ' 43' ' ' ASP . 7.0 mt-10 -48.0 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.983 1.713 . . . . 0.0 114.769 -163.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.34 -34.81 68.87 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.823 169.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.24 -36.26 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 121.978 0.894 . . . . 0.0 111.124 170.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -54.02 -29.97 45.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.908 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -46.53 -46.14 19.06 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.761 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -79.31 70.66 5.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.748 0.704 . . . . 0.0 111.674 -175.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 69.06 169.1 0.29 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.603 167.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 76.3 mtp 64.08 112.98 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.242 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.45 106.74 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.253 2.635 . . . . 0.0 112.816 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 78' ' ' TRP . 31.2 t-20 -156.43 164.95 37.65 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.34 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 8.4 p-10 -154.5 38.58 0.43 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 122.004 0.907 . . . . 0.0 108.798 173.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.73 ' CE2' HD11 ' A' ' 74' ' ' LEU . 29.2 t80 -42.41 144.29 0.53 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.282 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -140.13 141.36 36.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.41 101.92 3.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 117.29 -1.764 . . . . 0.0 109.774 -171.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 65' ' ' VAL . 69.6 mttt -133.36 152.88 51.95 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-N 112.048 -2.342 . . . . 0.0 107.725 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.695 ' HG3' HG12 ' A' ' 68' ' ' VAL . 24.7 mt-10 -123.48 129.35 51.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 118.937 0.789 . . . . 0.0 112.167 175.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.22 64.0 Favored Glycine 0 N--CA 1.461 0.349 0 CA-C-O 122.081 0.823 . . . . 0.0 111.856 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.878 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -106.58 172.7 6.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 113.38 -1.41 . . . . 0.0 107.989 -177.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.731 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 31.8 mt-10 -124.62 128.55 49.03 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.89 159.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.695 ' CE1' ' HB2' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -130.62 125.73 34.85 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -175.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -146.94 139.32 24.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.381 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 54' ' ' LEU . 2.0 tm? -90.12 -11.33 41.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -70.86 -179.91 2.42 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.366 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.517 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 11.2 t -53.31 127.49 48.28 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.712 -175.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 12.0 Cg_exo -70.96 165.42 32.39 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.436 2.757 . . . . 0.0 111.666 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 59.02 26.36 14.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.657 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.81 -154.2 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.31 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.71 146.28 72.38 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.939 2.426 . . . . 0.0 112.014 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -63.97 122.96 80.29 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.718 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 72.7 Cg_endo -78.55 -86.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.534 2.156 . . . . 0.0 113.576 -171.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.695 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 59.9 m -130.37 159.59 36.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.292 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' HZ2' ' HB2' ' A' ' 64' ' ' LYS . 4.4 ttmp? -143.46 131.02 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.878 ' HB ' HE22 ' A' ' 50' ' ' GLN . 53.0 t -80.92 127.56 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.524 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.2 mm? -66.89 -50.73 61.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 174.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.41 142.79 15.9 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.667 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.695 HG12 ' HG3' ' A' ' 48' ' ' GLU . 1.2 p -136.21 132.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.553 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -137.84 138.13 38.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.743 -173.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.66 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.15 124.42 86.8 Favored Pre-proline 0 CA--C 1.507 -0.694 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.527 -167.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.62 ' C ' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.61 64.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.574 1 C-N-CA 126.085 4.523 . . . . 0.0 115.267 -158.279 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 13.4 p -133.13 -46.78 0.84 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.862 166.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -146.73 141.98 27.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.428 0.632 . . . . 0.0 110.983 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 86' ' ' THR . 8.5 tt -138.92 124.9 19.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 65' ' ' VAL . 69.4 m -137.44 125.36 22.68 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.41 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.559 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 11.4 p90 -151.77 157.27 41.75 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.743 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 32.7 mt-10 -116.29 131.96 56.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.957 0.884 . . . . 0.0 108.932 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.726 ' HB3' ' CE3' ' A' ' 83' ' ' TRP . 3.6 t90 -104.52 104.21 14.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.159 -1.837 . . . . 0.0 114.35 -155.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.675 ' HB2' ' HD1' ' A' ' 78' ' ' TRP . 2.0 t70 59.14 -123.14 1.23 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 161.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.881 HG21 ' HE2' ' A' ' 114' ' ' LYS . 4.6 t -81.15 -20.71 40.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.268 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.075 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.3 mp0 -97.19 172.05 8.06 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.763 ' H ' HG22 ' A' ' 112' ' ' ILE . . . -126.88 48.65 0.96 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.142 -1.504 . . . . 0.0 113.655 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.822 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.259 0.0 OUTLIER -81.32 137.84 35.74 Favored 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 117.507 -1.677 . . . . 0.0 107.476 172.594 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 17.6 t -85.97 71.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 125.126 1.516 . . . . 0.0 106.969 163.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 83' ' ' TRP . 31.6 m -65.98 130.47 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.203 0.525 . . . . 0.0 110.264 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 63.8 m -126.18 132.56 51.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.077 -175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.695 ' HD2' HD13 ' A' ' 74' ' ' LEU . 19.9 m-85 -111.8 131.28 55.44 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.178 0.989 . . . . 0.0 110.851 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 96' ' ' THR . 1.8 tm? -119.91 140.34 51.03 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.704 -171.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' HG3' ' HG ' ' A' ' 92' ' ' LEU . 6.1 tp10 -119.17 139.49 51.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.798 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.769 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.5 p-10 -110.74 110.55 21.25 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.627 ' HG ' ' HG3' ' A' ' 90' ' ' GLU . 56.1 mt -125.04 104.98 8.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.015 -0.428 . . . . 0.0 110.33 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.16 0.51 Allowed Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.69 117.47 23.55 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 118.416 -1.314 . . . . 0.0 111.437 151.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.48 ' HG3' ' HB2' ' A' ' 92' ' ' LEU . 9.2 ptmt -179.99 162.8 1.03 Allowed 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 162.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.29 125.56 52.34 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.987 169.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.72 115.79 5.31 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.729 ' HD1' HD23 ' A' ' 89' ' ' LEU . 14.1 t80 -102.6 127.74 49.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.569 -170.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.1 m -123.32 114.84 20.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.038 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.9 tt -106.98 136.31 47.05 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.329 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.7 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.6 mp -119.05 124.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.018 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.0 m170 -116.69 106.66 13.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 165.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -146.44 165.14 30.29 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.731 -1.577 . . . . 0.0 107.853 -171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.53 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -165.08 173.46 40.92 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -78.52 133.5 37.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 118.019 0.909 . . . . 0.0 111.016 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HB3' ' HA ' ' A' ' 7' ' ' ASN . 26.2 tptp 75.45 121.21 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.058 0.849 . . . . 0.0 110.872 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -134.43 83.24 44.0 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -175.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 33.4 Cg_endo -97.13 -105.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.756 2.971 . . . . 0.0 113.55 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.422 ' H ' ' HB2' ' A' ' 108' ' ' PRO . 27.3 p-10 -135.14 -42.5 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -175.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.58 ' O ' ' HB3' ' A' ' 119' ' ' SER . 8.0 tt0 -67.89 157.51 34.76 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.263 172.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' A' ' 112' ' ' ILE . 3.1 m -80.05 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 CA-C-O 123.615 1.674 . . . . 0.0 112.542 -172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.075 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -53.98 -45.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 110.129 -3.214 . . . . 0.0 110.941 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -169.38 -85.99 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.912 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 30.9 ttpt -115.73 22.89 12.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.781 0.801 . . . . 0.0 108.852 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.728 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -63.47 -22.37 66.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER 170.52 -78.1 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' C ' HG13 ' A' ' 111' ' ' VAL . 38.4 tt0 -170.73 -55.76 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.138 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.593 ' HB2' HG13 ' A' ' 121' ' ' VAL . 64.6 mmtt -94.77 127.52 40.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.217 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.846 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 94.8 p -59.59 -32.22 70.19 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 123' ' ' ARG . 8.9 p -63.45 -41.99 98.64 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.609 -0.682 . . . . 0.0 111.945 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 118' ' ' LYS . 20.7 m -72.08 -35.17 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 O-C-N 122.033 -0.417 . . . . 0.0 110.801 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.855 HG11 HD11 ' A' ' 112' ' ' ILE . 8.3 p -65.78 -33.75 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.702 0.763 . . . . 0.0 109.043 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.754 ' HG2' HG12 ' A' ' 12' ' ' ILE . 1.7 tmt_? -62.6 -33.85 75.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.481 172.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -72.52 -29.82 65.28 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.203 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.697 ' HD2' HG23 ' A' ' 122' ' ' VAL . 57.7 mttm -60.69 -42.83 97.93 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.285 1.04 . . . . 0.0 109.083 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.773 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 5.9 mmt -78.99 -20.91 47.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.8 t70 -76.47 -15.42 59.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.311 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -128.0 -52.35 0.13 Allowed Glycine 0 C--O 1.249 1.06 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.555 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.6 -21.65 72.87 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.79 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.038 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -73.5 -30.72 63.31 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.061 -0.655 . . . . 0.0 111.79 -171.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.703 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 1.2 p -74.17 -39.17 63.39 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.158 171.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -52.5 -53.06 33.89 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 118.218 -1.944 . . . . 0.0 110.492 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.667 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 82.4 mt -73.18 -55.2 13.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 100' ' ' LEU . 17.5 t -84.39 -43.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 O-C-N 121.637 -0.664 . . . . 0.0 112.141 -177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.832 ' HA ' HG21 ' A' ' 16' ' ' ILE . 6.3 t30 -70.35 -40.02 74.32 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.321 -0.952 . . . . 0.0 108.574 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.852 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 3.5 tt0 -96.24 -45.45 6.83 Favored 'General case' 0 N--CA 1.418 -2.054 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.917 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.693 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.7 tpp180 -82.01 -33.43 30.08 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 142' ' ' VAL . 18.5 tp -64.47 -40.15 95.15 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.465 -1.294 . . . . 0.0 107.945 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 2.5 tmm_? -65.36 -29.74 70.5 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.852 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 54.3 mtmt -72.59 -45.18 60.39 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -69.24 -29.87 67.89 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.794 HG11 HG22 ' A' ' 25' ' ' VAL . 23.3 m -86.63 -18.39 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 10.5 mm-40 -152.25 -51.58 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.735 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 12.3 pt-20 40.95 47.04 2.54 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.91 0.862 . . . . 0.0 110.873 -169.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.83 65.34 9.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.748 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.62 141.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 122.184 0.992 . . . . 0.0 113.486 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -110.33 5.66 21.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 169.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -69.01 135.07 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.353 -174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 152' ' ' HIS . 12.4 m-70 -147.01 154.69 41.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 75.63 -40.92 0.43 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -171.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -87.59 1.53 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 163.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 149' ' ' HIS . 5.4 t-80 . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.213 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtm . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.99 78.94 1.26 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.73 0.3 . . . . 0.0 111.796 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -69.97 -40.26 75.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -153.34 153.29 32.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.978 171.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -110.38 145.39 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 7' ' ' ASN . 21.9 tt0 -66.07 -55.37 16.9 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.214 0.531 . . . . 0.0 110.08 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.71 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . 1.3 m-20 -175.36 -80.74 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.698 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.659 ' HA ' ' CB ' ' A' ' 119' ' ' SER . . . -111.14 -153.01 0.51 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 123' ' ' ARG . 2.1 tt -75.85 113.42 27.06 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.9 Cg_exo -71.76 -147.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.652 2.234 . . . . 0.0 110.124 176.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' HA ' ' OG ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -74.84 115.09 14.04 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.206 169.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' A' ' 126' ' ' MET . 2.1 mm -106.24 121.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 162.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -120.04 131.36 55.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 30.4 mmtm -127.52 128.97 46.56 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.591 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.44 135.58 54.71 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.398 1.094 . . . . 0.0 111.382 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.731 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -151.13 148.07 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-N 112.764 -2.017 . . . . 0.0 108.717 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.707 ' N ' HG12 ' A' ' 16' ' ' ILE . 2.0 m -96.17 119.35 34.51 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.091 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.1 mt -91.79 108.53 19.98 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.917 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -75.09 89.24 2.45 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.379 -2.128 . . . . 0.0 106.177 175.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.39 168.25 12.54 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.439 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.2 Cg_endo -82.74 157.97 16.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.334 1.356 . . . . 0.0 110.289 165.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 91' ' ' ASP . 13.5 tt -57.46 -32.49 41.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 121.967 0.889 . . . . 0.0 110.638 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -68.28 -30.96 70.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.93 -1.486 . . . . 0.0 114.152 -177.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.57 ' HG3' ' HA ' ' A' ' 142' ' ' VAL . 59.6 tptt -82.34 -39.06 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.232 -0.917 . . . . 0.0 109.92 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.673 HG22 HG11 ' A' ' 142' ' ' VAL . 2.9 t -61.74 -34.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.245 166.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 23' ' ' GLN . 1.2 t-105 -55.1 -42.26 72.64 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.372 0.669 . . . . 0.0 109.755 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.75 ' C ' HG21 ' A' ' 31' ' ' THR . 34.1 tt0 -66.32 -28.37 68.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.463 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.7 m -100.84 -10.01 21.12 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.816 ' HA ' HG13 ' A' ' 35' ' ' ILE . 27.6 m -131.01 -64.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 121.56 1.982 . . . . 0.0 113.981 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.65 ' OG ' ' HD3' ' A' ' 71' ' ' PRO . 35.1 p -97.31 65.61 1.99 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.869 -1.144 . . . . 0.0 108.847 -177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.75 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.0 t -156.15 -177.54 6.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.641 -167.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 23.8 m -62.99 169.92 3.03 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.961 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 3.2 mt-10 -48.51 -2.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.024 1.73 . . . . 0.0 114.612 -163.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -56.93 -31.88 61.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.987 169.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.816 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -67.45 -36.16 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.547 0.689 . . . . 0.0 111.692 170.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . -53.03 -33.76 53.3 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 122.008 -0.432 . . . . 0.0 111.339 167.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 45.6 mmtm -79.87 33.42 0.27 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.796 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 1.5 m0 -87.35 -54.53 4.24 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 163.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.83 ' HB3' HD12 ' A' ' 133' ' ' ILE . 43.5 t80 171.04 62.33 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.875 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 17.8 tpt -153.67 124.7 3.55 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 40' ' ' MET . 22.0 Cg_exo -67.72 106.35 1.27 Allowed 'Trans proline' 0 CA--C 1.515 -0.45 0 C-N-CA 122.379 2.053 . . . . 0.0 113.031 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.602 HD21 ' HA ' ' A' ' 36' ' ' ALA . 7.1 p30 -157.95 148.14 20.39 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.185 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.961 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 6.4 p30 -109.12 42.22 1.48 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.664 0.745 . . . . 0.0 109.01 172.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.672 ' CE2' HD11 ' A' ' 74' ' ' LEU . 25.9 t80 -60.66 141.67 56.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.7 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -138.8 144.12 39.2 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 172.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.01 102.19 3.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 116.771 -1.972 . . . . 0.0 108.763 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.745 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 50.3 mttm -130.09 150.8 51.19 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 112.036 -2.347 . . . . 0.0 106.683 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.79 129.65 50.86 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.536 -0.866 . . . . 0.0 113.06 178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.73 37.43 68.8 Favored Glycine 0 N--CA 1.463 0.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.13 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -109.35 173.52 6.28 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.948 0.899 . . . . 0.0 109.734 -171.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.94 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 54.2 mp0 -118.78 130.62 55.89 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.51 156.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.745 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -130.54 129.96 43.5 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 13.0 p80 -146.46 136.75 23.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.897 171.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tt -88.17 -27.89 21.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.618 ' HG2' ' HB2' ' A' ' 53' ' ' HIS . 11.7 pt20 -59.56 136.38 57.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.844 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 57' ' ' PRO . 39.5 m -67.94 -37.41 11.54 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.304 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 56' ' ' SER . 81.5 Cg_exo -44.76 136.17 9.62 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.226 1.951 . . . . 0.0 112.803 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -76.59 78.9 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.836 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.84 112.5 3.72 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.2 -49.94 15.29 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.033 2.489 . . . . 0.0 112.545 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 p -138.81 94.87 9.99 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.94 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 61.8 Cg_endo -72.92 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.229 1.953 . . . . 0.0 111.599 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.741 ' SG ' ' HD2' ' A' ' 76' ' ' PHE . 41.6 t -121.79 149.51 43.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.455 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 21.6 pttp -135.93 133.88 38.11 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 68' ' ' VAL . 71.0 t -84.16 127.38 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.908 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.78 HD13 ' OE1' ' A' ' 77' ' ' GLU . 0.9 OUTLIER -77.64 -39.28 45.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.286 179.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.81 138.72 13.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.196 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -139.52 126.68 24.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.208 1.004 . . . . 0.0 110.91 174.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -137.01 139.05 41.14 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.621 -173.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -64.0 127.65 92.05 Favored Pre-proline 0 CA--C 1.504 -0.791 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -167.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.69 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -5.07 65.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 1 C-N-CA 126.263 4.642 . . . . 0.0 115.392 -157.861 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.8 p -135.53 -48.48 0.7 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.156 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.51 131.94 20.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 109.893 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.2 tt -131.84 124.67 30.06 Favored 'General case' 0 C--O 1.202 -1.4 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.6 m -137.92 123.49 19.71 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.269 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 11.5 p90 -154.01 153.9 32.77 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.754 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 3.5 mp0 -118.67 126.72 52.55 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.61 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.607 ' HA ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -82.35 130.63 35.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.983 -1.462 . . . . 0.0 112.796 -166.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 63' ' ' CYS . 11.9 t0 33.07 -108.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.943 1.402 . . . . 0.0 114.602 168.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 t -91.78 -31.86 15.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.123 -168.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.03 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 10.5 mp0 -81.75 154.34 26.04 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -94.69 33.05 5.57 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.87 -1.157 . . . . 0.0 113.311 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.882 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.77 114.61 21.73 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.562 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.072 HG12 ' HA2' ' A' ' 104' ' ' GLY . 6.8 p -85.14 75.37 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 O-C-N 125.028 1.455 . . . . 0.0 108.05 167.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.754 HG13 ' HB2' ' A' ' 83' ' ' TRP . 14.7 m -69.97 120.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.818 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.812 ' HB ' ' HB ' ' A' ' 101' ' ' ILE . 95.7 m -120.15 136.9 54.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.832 -168.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 100' ' ' LEU . 18.6 m-85 -115.08 131.61 56.87 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -122.06 128.85 51.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.82 0.819 . . . . 0.0 110.708 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 0.9 OUTLIER -121.71 145.07 48.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.976 -171.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 97' ' ' GLY . 1.6 tt0 -109.68 120.53 42.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 1.052 ' HB2' HD12 ' A' ' 22' ' ' ILE . 2.9 t70 -94.86 110.78 22.62 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.653 0.74 . . . . 0.0 110.93 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 23.1 mt -120.18 144.89 47.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.851 170.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.78 -24.74 64.81 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 163.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.737 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 16.6 tt0 -57.31 -158.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 110.968 -2.616 . . . . 0.0 109.119 154.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.917 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -99.14 -178.48 3.94 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 -174.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -110.86 128.57 55.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.553 0.692 . . . . 0.0 110.274 -161.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLU . . . -95.34 116.65 5.43 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 119.112 -1.518 . . . . 0.0 110.264 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.712 ' HE2' HD12 ' A' ' 100' ' ' LEU . 22.2 t80 -103.78 126.66 51.06 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.943 -170.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 m -123.04 115.39 21.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.443 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.04 HD22 ' HE1' ' A' ' 130' ' ' TRP . 4.8 tt -107.89 140.77 40.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.691 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.812 ' HB ' ' HB ' ' A' ' 86' ' ' THR . 1.7 mp -120.41 125.82 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.975 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.3 m170 -118.29 110.04 17.04 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 166.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.561 ' OG ' ' HA ' ' A' ' 11' ' ' ASP . 66.3 m -146.34 164.29 32.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.575 -174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 1.072 ' HA2' HG12 ' A' ' 84' ' ' VAL . . . -170.23 176.76 43.81 Favored Glycine 0 C--N 1.312 -0.795 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -75.01 147.71 40.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.52 0.66 . . . . 0.0 110.672 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -120.67 167.49 12.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.524 -167.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.671 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -167.6 -60.45 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.983 172.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 89.9 Cg_endo -100.88 168.37 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.803 2.336 . . . . 0.0 112.796 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.27 49.85 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.179 0.99 . . . . 0.0 110.059 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.541 ' HB3' ' HG2' ' A' ' 108' ' ' PRO . 8.7 tt0 -139.64 162.32 35.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.369 -166.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 112' ' ' ILE . 1.3 p -77.22 174.04 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.077 0.941 . . . . 0.0 109.931 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.03 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -53.48 -31.57 19.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.78 -167.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.648 ' H ' HG13 ' A' ' 111' ' ' VAL . . . 156.0 60.18 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 67.05 31.0 7.16 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 0.0 110.683 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -68.57 -24.86 64.66 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -171.84 -67.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -169.41 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.89 ' HB2' HG13 ' A' ' 121' ' ' VAL . 50.5 mttm -93.01 147.18 23.05 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.324 0.583 . . . . 0.0 111.971 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.659 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 5.2 p -58.38 -37.28 74.95 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.89 166.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 9.5 t -69.77 -36.06 75.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.574 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.89 HG13 ' HB2' ' A' ' 118' ' ' LYS . 11.9 m -71.29 -37.12 64.42 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.602 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.816 HG11 HD11 ' A' ' 112' ' ' ILE . 12.2 p -67.14 -41.84 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.064 0.459 . . . . 0.0 111.074 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.717 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . 17.0 ptt180 -65.1 -30.24 71.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.05 -30.73 67.35 Favored Glycine 0 C--O 1.238 0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.963 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 25.3 mtpp -59.78 -42.51 93.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 122.24 1.019 . . . . 0.0 108.796 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 1.063 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 9.8 mmt -78.22 -25.54 47.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.685 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 22.9 t0 -78.02 -13.75 59.76 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.873 -168.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.84 -53.78 0.16 Allowed Glycine 0 C--O 1.251 1.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.628 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.647 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -68.83 -27.3 73.99 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.457 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.063 ' HB2' ' HA ' ' A' ' 126' ' ' MET . 10.7 t-105 -73.07 -30.45 63.7 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.182 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -70.32 -39.52 74.74 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.925 172.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.744 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -50.2 -50.41 34.3 Favored Glycine 0 C--N 1.308 -0.98 0 C-N-CA 118.236 -1.935 . . . . 0.0 110.933 168.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 39' ' ' PHE . 27.1 mm -73.48 -55.41 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 122.317 -0.519 . . . . 0.0 112.186 -175.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.774 HG23 ' CZ3' ' A' ' 38' ' ' TRP . 1.4 p -83.72 -44.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 O-C-N 121.717 -0.614 . . . . 0.0 112.503 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.765 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.6 t30 -70.89 -40.84 71.98 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.744 ' HB3' ' O ' ' A' ' 132' ' ' GLY . 36.5 tt0 -96.38 -46.41 6.4 Favored 'General case' 0 N--CA 1.415 -2.196 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.273 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.057 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 15.1 tpp180 -84.61 -31.44 24.26 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 29.7 tp -63.23 -40.0 96.2 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 118.261 -1.375 . . . . 0.0 107.779 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.697 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.1 tmm_? -66.11 -30.86 71.43 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 170.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.057 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 3.0 mtpt -67.73 -45.04 76.17 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -71.02 -29.92 65.99 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.431 -176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.673 HG11 HG22 ' A' ' 25' ' ' VAL . 27.8 m -89.67 -16.89 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.565 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 139' ' ' ARG . 9.9 mt-10 -148.23 -61.17 0.25 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.7 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 12.6 tt0 60.63 131.37 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.932 0.893 . . . . 0.0 111.801 -169.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.94 89.95 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.496 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -79.7 100.48 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -139.42 62.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.576 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -54.37 -49.71 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.405 0.622 . . . . 0.0 109.801 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -151.8 128.21 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.001 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -116.46 -84.9 0.63 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.58 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.835 0.709 . . . . 0.0 109.091 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.458 176.653 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG3' ' HD3' ' A' ' 64' ' ' LYS . 21.0 ptp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' GLU . . . -85.67 -166.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.014 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB2' ' HA ' ' A' ' 80' ' ' THR . 14.5 mm100 -66.19 -47.93 72.3 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.242 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.69 128.04 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.589 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -111.49 120.44 42.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 0.0 109.652 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.4 -70.5 0.79 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.147 0.499 . . . . 0.0 111.064 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.825 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -149.39 -54.77 0.17 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 112' ' ' ILE . . . 68.44 163.5 0.22 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 160.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.789 ' HG ' ' HB3' ' A' ' 123' ' ' ARG . 0.8 OUTLIER -72.05 129.68 87.56 Favored Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 113.057 -1.883 . . . . 0.0 108.585 170.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.707 ' HD2' HD23 ' A' ' 9' ' ' LEU . 24.5 Cg_exo -63.98 -152.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.265 1.977 . . . . 0.0 111.006 167.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 103' ' ' SER . 10.3 p-10 -72.45 114.14 10.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.343 0.592 . . . . 0.0 110.642 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 168.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -119.51 133.31 55.74 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.572 0.701 . . . . 0.0 110.436 178.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.936 ' HD3' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.62 127.7 31.69 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.407 ' C ' ' HZ2' ' A' ' 14' ' ' LYS . 2.9 m -124.55 150.41 45.9 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.363 1.078 . . . . 0.0 112.103 -173.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.75 HG21 ' HA ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -153.11 148.12 14.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 113.142 -1.844 . . . . 0.0 108.541 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.74 ' N ' HG12 ' A' ' 16' ' ' ILE . 29.6 m -95.01 119.6 33.8 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.008 172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 16' ' ' ILE . 17.6 mt -90.55 108.51 19.84 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.899 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.1 pt-20 -73.54 88.71 1.66 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 116.848 -1.941 . . . . 0.0 106.87 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.94 165.99 17.32 Favored Pre-proline 0 C--O 1.215 -0.763 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.506 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 88.0 Cg_endo -78.23 155.34 29.12 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.256 1.304 . . . . 0.0 110.359 168.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.722 HD12 ' HB3' ' A' ' 91' ' ' ASP . 8.6 tt -52.73 -37.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.681 0.753 . . . . 0.0 111.029 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 11.0 pt20 -60.2 -32.15 70.82 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.33 -1.304 . . . . 0.0 114.061 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -79.92 -38.05 33.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.845 0.831 . . . . 0.0 110.097 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.682 ' CG1' HD11 ' A' ' 89' ' ' LEU . 3.0 t -67.8 -33.12 59.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.225 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.624 ' CE3' HG12 ' A' ' 22' ' ' ILE . 1.2 t-105 -54.69 -43.15 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.8 172.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.767 ' C ' HG21 ' A' ' 31' ' ' THR . 24.6 tt0 -68.45 -28.59 67.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.52 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.618 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.45 -9.38 21.13 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 117.63 2.456 . . . . 0.0 117.63 -172.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.939 ' HA ' HG13 ' A' ' 35' ' ' ILE . 34.6 m -132.09 -64.61 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.318 1.872 . . . . 0.0 113.89 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.614 ' HB3' HD12 ' A' ' 74' ' ' LEU . 17.1 p -97.19 66.85 2.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.679 -1.263 . . . . 0.0 108.702 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.767 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.7 t -157.62 -174.64 4.97 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.811 -167.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.4 p -60.35 169.41 1.68 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 10.7 mt-10 -49.9 -8.01 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.805 1.642 . . . . 0.0 114.004 -161.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.39 -36.73 85.3 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.16 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.939 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -63.34 -41.38 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 117.642 0.721 . . . . 0.0 112.168 173.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . . . -56.11 -31.89 63.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -56.3 -39.55 72.9 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.849 ' HB2' HG23 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -60.45 -33.66 72.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.116 1.325 . . . . 0.0 111.594 -172.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB2' ' HZ3' ' A' ' 130' ' ' TRP . 54.7 t80 -114.64 -50.85 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 112.144 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.641 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.6 mmm -108.59 -174.12 0.29 Allowed Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.871 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 31.7 Cg_exo -63.63 -158.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.741 1.628 . . . . 0.0 110.166 163.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.954 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 5.2 p-10 -99.37 142.15 31.23 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 53' ' ' HIS . 28.7 t70 -174.69 -55.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.239 0.337 . . . . 0.0 111.144 -171.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 74' ' ' LEU . 29.5 t80 -68.11 140.21 56.21 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.797 0.808 . . . . 0.0 112.703 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' THR . 39.2 mt-30 -140.46 147.8 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 171.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 31' ' ' THR . 2.4 pt? -73.31 103.32 3.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 116.882 -1.927 . . . . 0.0 108.505 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.518 ' HD3' ' HG3' ' A' ' 50' ' ' GLN . 36.5 mttp -130.71 150.24 51.98 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 112.407 -2.179 . . . . 0.0 106.972 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.71 ' OE2' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -123.45 131.72 53.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 53.05 40.8 59.18 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.106 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.851 HE22 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -109.46 174.4 5.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.494 1.118 . . . . 0.0 109.426 -172.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.732 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 49.0 mt-10 -123.27 128.92 50.64 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.468 155.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.551 ' HD1' ' O ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -133.44 133.8 42.78 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.707 ' HB2' ' HG3' ' A' ' 62' ' ' PRO . 2.1 t-80 -148.22 136.96 21.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.493 170.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt 26.58 -90.03 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.133 1.521 . . . . 0.0 113.482 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.35 60.61 1.29 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.976 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.4 m -150.79 96.24 3.36 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.822 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.76 -39.95 7.88 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.604 2.203 . . . . 0.0 111.625 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -126.36 147.65 49.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.231 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 60' ' ' PRO . . . 126.42 -103.21 0.67 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 59' ' ' GLY . 5.9 Cg_exo -77.73 97.93 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.743 2.295 . . . . 0.0 111.343 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 p -62.25 110.61 3.47 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.811 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.732 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 38.2 Cg_endo -97.4 -102.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.468 2.112 . . . . 0.0 114.418 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.906 ' HB3' ' HA ' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -118.83 160.05 22.61 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.845 -169.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HD3' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -138.95 140.14 38.17 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.851 ' HB ' HE22 ' A' ' 50' ' ' GLN . 54.1 t -79.95 131.99 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.068 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' CD2' ' HG3' ' A' ' 77' ' ' GLU . 3.8 mm? -77.88 -44.93 25.64 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.486 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . . . -157.34 135.8 11.3 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.544 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -130.44 127.41 62.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.904 174.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.35 138.3 44.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.61 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 127.97 93.43 Favored Pre-proline 0 CA--C 1.502 -0.865 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.986 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -1.54 62.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.513 1 C-N-CA 126.274 4.649 . . . . 0.0 115.583 -159.35 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -133.65 -52.67 0.87 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.394 169.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -143.18 132.92 23.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.502 0.667 . . . . 0.0 110.29 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.806 HD11 ' CE2' ' A' ' 44' ' ' PHE . 8.8 tt -129.21 125.88 37.93 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.577 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 m -137.98 126.37 23.28 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.0 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . 12.2 p90 -151.19 155.64 39.28 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.31 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.818 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 43.0 mt-10 -118.07 131.01 56.48 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.906 ' HA ' ' HB3' ' A' ' 63' ' ' CYS . 5.8 t90 -107.8 124.45 50.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -161.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' H ' ' HB3' ' A' ' 63' ' ' CYS . 1.0 OUTLIER 43.98 -131.95 0.73 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.216 -1.356 . . . . 0.0 114.131 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.683 ' HA ' ' HB2' ' A' ' 3' ' ' GLN . 7.5 t -76.84 -29.91 56.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.076 -171.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.956 ' HB3' ' HB ' ' A' ' 112' ' ' ILE . 6.0 mp0 -81.46 148.14 29.39 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.607 ' N ' HG22 ' A' ' 112' ' ' ILE . . . -86.66 37.6 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.142 -173.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.911 ' HB3' HG13 ' A' ' 85' ' ' VAL . 5.0 m-90 -71.99 118.63 15.09 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.51 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.613 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 p -95.91 90.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 156.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.911 HG13 ' HB3' ' A' ' 83' ' ' TRP . 11.0 m -89.91 127.13 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.26 -177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 74' ' ' LEU . 80.1 m -126.53 136.2 52.27 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.829 -172.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.692 ' HD2' HD13 ' A' ' 74' ' ' LEU . 21.3 m-85 -111.09 130.51 55.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 99' ' ' THR . 5.0 mm100 -115.66 127.73 55.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.742 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mt -123.74 144.64 49.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.188 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.12 120.19 41.49 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HB3' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.57 108.41 16.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 O-C-N 123.822 0.701 . . . . 0.0 110.254 -174.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 39.4 mt -127.49 136.01 51.17 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.23 -25.27 66.33 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 159.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.0 tp10 -54.53 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 111.328 -2.436 . . . . 0.0 108.675 152.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.899 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -97.92 175.73 6.04 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.22 129.65 56.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.444 -0.785 . . . . 0.0 110.585 -160.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.38 115.1 5.04 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 118.443 -1.837 . . . . 0.0 110.442 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.566 ' HE2' ' CD2' ' A' ' 100' ' ' LEU . 11.9 t80 -105.65 130.98 53.57 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.588 -171.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -122.03 122.43 39.29 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.588 170.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.687 ' HG ' ' NE1' ' A' ' 130' ' ' TRP . 0.1 OUTLIER -104.85 136.63 43.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 86' ' ' THR . 3.5 mt -127.2 122.78 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.056 176.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.481 ' NE2' ' HZ2' ' A' ' 130' ' ' TRP . 1.3 m170 -119.53 112.2 19.05 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 40.3 t -137.91 162.75 33.22 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.613 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -147.24 143.27 11.11 Favored Glycine 0 C--N 1.299 -1.52 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.777 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 7.7 t-105 -79.73 120.77 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.52 1.16 . . . . 0.0 110.381 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.825 ' HB3' ' O ' ' A' ' 7' ' ' ASN . 20.8 tptt 147.67 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 O-C-N 125.062 1.476 . . . . 0.0 109.385 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -111.22 140.58 23.05 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 122.532 0.333 . . . . 0.0 111.066 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.608 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 71.3 Cg_endo -73.27 137.84 26.6 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.18 2.586 . . . . 0.0 115.194 -169.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.495 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 28.3 t-20 171.13 -62.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.676 1.19 . . . . 0.0 108.635 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 119' ' ' SER . 9.2 tt0 -97.7 160.86 14.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.697 173.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.743 HG13 ' H ' ' A' ' 113' ' ' GLY . 0.8 OUTLIER -80.27 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 118.751 0.705 . . . . 0.0 112.189 -164.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.956 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -52.65 -41.01 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.48 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.743 ' H ' HG13 ' A' ' 111' ' ' VAL . . . -178.5 -66.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.698 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 41.7 tttm -131.96 14.31 4.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.956 0.884 . . . . 0.0 108.64 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -59.84 -42.6 93.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.057 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 2.0 t-20 174.65 40.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.016 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.716 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 34.2 tt0 69.89 -71.75 0.12 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.718 ' HB2' HG13 ' A' ' 121' ' ' VAL . 73.3 mmtt -94.93 136.49 35.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 110' ' ' GLN . 69.0 p -64.18 -35.1 79.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.617 0.722 . . . . 0.0 110.021 171.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.633 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 20.2 m -67.4 -37.56 83.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.384 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.718 HG13 ' HB2' ' A' ' 118' ' ' LYS . 15.9 m -71.67 -37.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.189 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG11 HD11 ' A' ' 112' ' ' ILE . 14.7 p -67.1 -37.14 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.789 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.33 -28.46 67.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.67 76.2 Favored Glycine 0 C--O 1.24 0.511 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.338 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.618 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 25.6 mtpp -60.21 -42.26 94.76 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.061 0.934 . . . . 0.0 109.415 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.938 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 11.3 mmt -76.89 -23.94 52.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.501 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.87 -14.43 58.66 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.314 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.96 -50.56 0.24 Allowed Glycine 0 C--O 1.247 0.91 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.189 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.65 -28.12 69.34 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.74 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.938 ' HB2' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -69.85 -26.62 64.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.936 HG23 ' HD3' ' A' ' 14' ' ' LYS . 2.0 p -81.73 -39.42 24.24 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.186 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.54 -52.95 48.74 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.083 -2.008 . . . . 0.0 109.897 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.849 HG23 ' HB2' ' A' ' 38' ' ' TRP . 66.2 mt -75.69 -55.59 10.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 114.741 -0.729 . . . . 0.0 112.855 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.703 HG22 ' CZ3' ' A' ' 38' ' ' TRP . 22.0 t -82.54 -43.41 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 O-C-N 121.424 -0.797 . . . . 0.0 111.011 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.755 ' HB3' ' O ' ' A' ' 131' ' ' THR . 15.3 t-20 -72.75 -40.31 66.13 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.114 -1.035 . . . . 0.0 109.071 -172.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.871 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 6.3 tt0 -97.54 -45.65 6.33 Favored 'General case' 0 N--CA 1.42 -1.947 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.664 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.609 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.8 tpp180 -81.98 -33.03 30.39 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 19.2 tp -63.2 -40.56 97.84 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.367 -1.333 . . . . 0.0 107.626 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.832 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 2.0 tmm_? -65.18 -30.9 71.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.428 171.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.871 ' HG3' ' O ' ' A' ' 136' ' ' GLU . 53.0 mtmt -73.76 -45.98 48.5 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -68.18 -29.55 68.44 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.704 -0.622 . . . . 0.0 109.934 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 25' ' ' VAL . 25.4 m -84.79 -21.85 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.406 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 13.4 mm-40 -147.29 -60.83 0.28 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.66 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 29.9 tt0 45.43 41.89 7.06 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.767 0.794 . . . . 0.0 111.461 -170.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 147' ' ' HIS . 3.4 mm? -85.14 139.67 31.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.806 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.13 87.05 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.759 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 152' ' ' HIS . 94.9 m-70 -138.77 54.09 1.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.845 175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -167.35 12.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -81.28 -57.29 3.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 68.7 m-70 -133.31 56.47 1.85 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 85.8 t60 70.79 -1.3 2.67 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.104 0.954 . . . . 0.0 108.888 -164.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 147' ' ' HIS . 41.7 t-80 . . . . . 0 C--O 1.246 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.349 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.56 75.98 0.31 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 109.943 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -79.43 -47.81 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.155 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -124.66 128.28 48.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.165 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.704 ' HB2' ' HG2' ' A' ' 110' ' ' GLN . 25.6 p-10 -80.68 125.23 29.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.75 -157.81 0.24 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.656 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.6 t30 87.35 -16.98 0.35 Allowed 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 125.111 1.364 . . . . 0.0 111.627 166.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.622 ' C ' ' HB2' ' A' ' 119' ' ' SER . . . 60.58 -154.95 0.36 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.226 -169.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.716 HD12 HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.4 135.02 94.64 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.54 130.69 41.36 Favored 'Trans proline' 0 CA--C 1.514 -0.488 0 C-N-CA 121.911 1.741 . . . . 0.0 109.141 172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -52.35 121.41 6.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.917 0.865 . . . . 0.0 111.242 -162.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 126' ' ' MET . 0.9 OUTLIER -106.62 127.01 62.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.603 -169.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 1.1 p -117.49 134.1 55.22 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 121.197 0.522 . . . . 0.0 109.785 172.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.902 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -125.49 129.81 50.51 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -121.51 137.68 54.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.014 0.911 . . . . 0.0 110.857 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.769 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.1 148.52 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 113.495 -1.684 . . . . 0.0 109.177 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.769 ' N ' HG12 ' A' ' 16' ' ' ILE . 18.9 m -95.98 118.47 32.65 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 16' ' ' ILE . 25.2 mt -91.12 110.32 21.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.881 ' HA ' ' HB2' ' A' ' 95' ' ' LYS . 2.4 pt-20 -75.06 88.42 2.41 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 116.871 -1.932 . . . . 0.0 106.993 175.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -156.28 167.15 14.94 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.721 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 90.6 Cg_endo -81.94 156.31 17.82 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.348 1.365 . . . . 0.0 110.005 166.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.969 HD12 ' HB2' ' A' ' 91' ' ' ASP . 14.0 tt -54.43 -33.59 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.632 0.729 . . . . 0.0 110.747 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.668 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 7.7 pt20 -64.12 -31.05 72.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.865 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 1.077 ' HD2' ' HA ' ' A' ' 142' ' ' VAL . 4.4 tmtm? -81.76 -37.8 26.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.163 0.982 . . . . 0.0 109.071 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.582 HG22 HG11 ' A' ' 142' ' ' VAL . 3.2 t -64.4 -33.8 65.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.661 169.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CZ2' ' HB1' ' A' ' 70' ' ' ALA . 1.2 t-105 -55.1 -42.66 73.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.927 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.736 ' C ' HG21 ' A' ' 31' ' ' THR . 34.8 tt0 -68.18 -28.33 67.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.167 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 141' ' ' ALA . 4.5 m -101.1 -10.13 20.74 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.882 ' HA ' HG13 ' A' ' 35' ' ' ILE . 33.8 m -130.91 -65.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 121.348 1.885 . . . . 0.0 113.98 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.695 ' HB3' HD12 ' A' ' 74' ' ' LEU . 1.3 p -98.41 66.0 1.69 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.669 -1.269 . . . . 0.0 109.43 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.736 HG21 ' C ' ' A' ' 27' ' ' GLU . 4.6 t -156.06 -174.97 5.19 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.583 -166.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' GLY . 18.1 m -60.99 169.04 2.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.161 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' CB ' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -51.08 -7.88 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 125.934 1.693 . . . . 0.0 114.387 -157.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -58.53 -36.04 83.03 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.288 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.882 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -62.13 -39.91 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.764 0.792 . . . . 0.0 112.147 174.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . . . -55.54 -31.82 62.43 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.542 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -62.23 -23.46 66.68 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.761 ' CZ2' HG12 ' A' ' 29' ' ' VAL . 8.5 p-90 -91.71 52.84 2.1 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.472 1.033 . . . . 0.0 110.982 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -179.17 -55.03 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.251 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.79 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 84.1 mtp -135.1 -174.2 0.4 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.749 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 9.8 Cg_endo -54.8 -175.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 111.436 166.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.742 ' HB2' ' CB ' ' A' ' 33' ' ' GLU . 9.1 p30 -98.06 143.14 28.92 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.683 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.424 ' N ' ' HB3' ' A' ' 33' ' ' GLU . 28.2 t70 -170.57 -56.02 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.417 -171.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.703 ' CE2' HD11 ' A' ' 74' ' ' LEU . 23.6 t80 -61.18 136.62 58.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.469 0.652 . . . . 0.0 112.694 -172.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -140.85 143.29 34.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -72.86 104.77 4.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.655 1.693 . . . . 0.0 110.007 -171.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' HD2' ' A' ' 52' ' ' PHE . 69.4 mttt -134.06 153.29 51.9 Favored 'General case' 0 C--O 1.202 -1.408 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.295 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.684 ' HG3' HG12 ' A' ' 68' ' ' VAL . 23.6 mt-10 -123.13 131.28 53.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 119.251 0.932 . . . . 0.0 112.771 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 56.15 34.63 62.78 Favored Glycine 0 CA--C 1.509 -0.301 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.827 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 64' ' ' LYS . 2.1 pm0 -106.76 173.23 6.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.073 -1.064 . . . . 0.0 108.943 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.02 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -118.7 130.15 55.67 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.996 157.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.524 ' HD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.1 136.05 48.05 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 120.936 0.398 . . . . 0.0 111.945 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' SER . 18.2 p80 -139.42 139.03 36.99 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.971 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -110.93 -54.69 2.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.076 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -98.82 25.42 6.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.224 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 15.1 m -125.71 89.12 53.05 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.268 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.54 -23.66 36.82 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.37 2.047 . . . . 0.0 110.898 173.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -128.87 97.94 4.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.92 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.4 79.36 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.391 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.56 135.3 26.0 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.685 2.257 . . . . 0.0 111.183 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.845 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 50.1 m 55.65 68.41 2.43 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.746 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 1.02 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 62.1 Cg_endo -75.05 -87.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.924 1.75 . . . . 0.0 111.911 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.721 ' HB3' ' H ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -119.68 149.47 41.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.439 -178.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.577 ' HA ' ' NE2' ' A' ' 50' ' ' GLN . 25.1 pttm -140.11 131.09 26.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' SER . 51.2 t -82.75 128.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.9 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD21 ' HG3' ' A' ' 77' ' ' GLU . 4.1 mm? -68.43 -48.46 64.53 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.849 175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.34 145.84 16.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.639 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG12 ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -141.91 132.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.451 173.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -141.25 138.85 33.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.473 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -65.91 127.74 93.34 Favored Pre-proline 0 N--CA 1.444 -0.774 0 O-C-N 123.751 0.657 . . . . 0.0 109.531 -167.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.623 ' HB2' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -3.26 62.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 1 C-N-CA 126.181 4.587 . . . . 0.0 115.744 -156.446 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.6 p -130.23 -52.55 1.11 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.592 166.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.06 135.34 29.09 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.29 0.567 . . . . 0.0 109.959 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 86' ' ' THR . 7.7 tt -136.17 125.73 25.25 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.63 ' O ' HG13 ' A' ' 65' ' ' VAL . 67.4 m -137.49 125.16 22.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.547 ' CD1' HD21 ' A' ' 74' ' ' LEU . 11.7 p90 -150.74 158.0 43.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.928 ' HA ' ' O ' ' A' ' 83' ' ' TRP . 23.4 mt-10 -116.45 130.65 56.88 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.0 113.89 25.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.036 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.721 ' H ' ' HB3' ' A' ' 63' ' ' CYS . 14.5 t70 41.51 -118.59 0.4 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.465 . . . . 0.0 114.86 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 80' ' ' THR . 5.1 t -78.24 -35.82 47.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.547 -167.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.767 ' HG2' ' HB2' ' A' ' 115' ' ' ALA . 21.0 mp0 -83.1 171.32 13.86 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.07 40.87 2.33 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.296 -1.431 . . . . 0.0 111.909 -173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.928 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -71.86 112.87 8.32 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.053 -176.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 17.1 t -89.51 73.19 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 162.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.724 HG13 ' HB3' ' A' ' 83' ' ' TRP . 10.5 m -79.39 122.76 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.158 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 HD13 ' A' ' 101' ' ' ILE . 92.8 m -121.38 136.5 54.95 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.318 -171.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.737 ' HD2' HD13 ' A' ' 74' ' ' LEU . 22.1 m-30 -112.07 131.65 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.503 ' CG ' HD11 ' A' ' 101' ' ' ILE . 7.2 mm-40 -115.87 121.9 43.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD23 ' HD1' ' A' ' 98' ' ' PHE . 3.4 tm? -125.28 142.82 51.28 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.714 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.575 ' H ' HD22 ' A' ' 89' ' ' LEU . 2.8 tp10 -110.84 134.12 52.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.694 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.969 ' HB2' HD12 ' A' ' 22' ' ' ILE . 1.2 t70 -92.87 111.63 23.31 Favored 'General case' 0 CA--C 1.476 -1.903 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.847 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.069 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 16.6 mt -123.55 124.55 43.08 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.75 -28.12 10.61 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 159.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 1.069 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 4.3 tp10 -53.49 -156.59 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 111.515 -2.343 . . . . 0.0 109.427 151.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.881 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -100.0 175.82 5.63 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.54 136.61 48.64 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.099 -1.001 . . . . 0.0 111.16 -156.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 114.36 4.96 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 119.208 -1.472 . . . . 0.0 109.986 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.923 ' HD1' HD23 ' A' ' 89' ' ' LEU . 15.3 t80 -105.22 127.16 52.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.191 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 26.9 m -123.98 116.67 23.24 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.119 HD22 ' HE1' ' A' ' 130' ' ' TRP . 5.0 tt -106.37 136.37 46.24 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.144 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 86' ' ' THR . 1.6 mp -114.23 123.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.871 176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.629 ' O ' HD21 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -118.28 112.2 19.76 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -142.46 159.58 41.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA2' ' H ' ' A' ' 84' ' ' VAL . . . -141.23 150.66 22.01 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.765 -169.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.5 160.05 26.69 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -90.34 136.69 32.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.448 0.642 . . . . 0.0 112.426 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HG3' ' HD2' ' A' ' 108' ' ' PRO . 38.0 tt0 -132.42 143.55 49.28 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.577 ' HD2' ' HG3' ' A' ' 107' ' ' GLU . 73.1 Cg_exo -41.05 142.42 0.82 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.305 2.67 . . . . 0.0 113.222 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.6 ' HA ' ' ND2' ' A' ' 5' ' ' ASN . 84.6 m-20 73.19 -175.92 0.16 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -165.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.704 ' HG2' ' HB2' ' A' ' 5' ' ' ASN . 3.7 pt20 -135.39 109.07 8.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 116.398 -2.121 . . . . 0.0 113.932 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.907 HG13 ' H ' ' A' ' 113' ' ' GLY . 7.0 p -151.8 -176.41 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 153.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 81' ' ' GLU . 2.0 mm -55.68 -36.21 41.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 119.451 1.023 . . . . 0.0 110.894 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.907 ' H ' HG13 ' A' ' 111' ' ' VAL . . . 179.1 -82.74 0.06 OUTLIER Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.743 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 2.2 mppt? -122.84 30.05 6.58 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 169.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.767 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -71.11 -41.28 70.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.887 -171.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 118' ' ' LYS . 2.2 t30 -172.02 12.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.204 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.583 ' C ' ' HB ' ' A' ' 111' ' ' VAL . 47.2 mt-10 67.75 -37.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.62 0.768 . . . . 0.0 112.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.742 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 4.3 mptp? -94.25 102.49 14.5 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.622 ' HB2' ' C ' ' A' ' 8' ' ' ALA . 88.2 p -61.23 -40.92 95.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.983 0.42 . . . . 0.0 112.007 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.4 p -69.01 -36.57 77.95 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 121.563 -0.71 . . . . 0.0 110.991 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.742 ' HB ' ' CB ' ' A' ' 118' ' ' LYS . 56.1 t -73.15 -37.1 51.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.57 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.661 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 12.9 p -65.99 -35.67 75.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.491 0.662 . . . . 0.0 109.691 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -62.64 -33.33 74.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.336 170.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . -70.39 -30.66 68.95 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.661 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 26.5 mtpp -60.5 -42.01 95.5 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 122.076 0.941 . . . . 0.0 109.355 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.712 ' HA ' ' HB2' ' A' ' 130' ' ' TRP . 8.7 mmt -80.91 -20.83 41.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.106 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.587 ' HB3' ' HA2' ' A' ' 124' ' ' GLY . 18.7 t70 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.693 -170.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.22 -50.52 0.11 Allowed Glycine 0 C--O 1.246 0.876 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.221 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.629 ' O ' HG13 ' A' ' 133' ' ' ILE . . . -65.92 -22.37 70.31 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.988 -175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.119 ' HE1' HD22 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -70.94 -33.74 70.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.593 -173.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.902 HG23 ' HD2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -71.06 -39.32 72.31 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.104 172.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -49.48 -55.4 13.42 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 118.938 -1.601 . . . . 0.0 111.17 174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 129' ' ' GLY . 1.3 mt -81.85 -48.71 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.362 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.876 HG21 HD13 ' A' ' 100' ' ' LEU . 35.5 t -80.03 -44.08 22.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 121.177 -0.952 . . . . 0.0 111.368 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.743 ' HB3' ' O ' ' A' ' 131' ' ' THR . 5.0 t30 -72.45 -40.37 67.07 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.761 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.794 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 5.3 tt0 -95.82 -46.0 6.75 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 118.216 -1.393 . . . . 0.0 111.609 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.961 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 14.0 tpp180 -83.11 -33.82 26.25 Favored 'General case' 0 C--O 1.21 -0.974 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 27.9 tp -63.01 -39.86 96.03 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HD11 ' A' ' 16' ' ' ILE . 3.1 tmm_? -66.17 -30.33 70.79 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.679 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.961 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -68.95 -48.08 64.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 121.796 -0.565 . . . . 0.0 112.33 175.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -66.29 -28.42 68.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.129 0.49 . . . . 0.0 110.188 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 1.077 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 28.7 m -95.64 -15.11 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.995 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -149.48 -54.2 0.17 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.65 ' CA ' ' HA ' ' A' ' 140' ' ' LYS . 68.7 tt0 46.24 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.609 ' HB3' ' HD2' ' A' ' 149' ' ' HIS . 43.4 tp -165.1 107.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.914 169.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -4.05 11.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.405 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -53.33 -58.95 5.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.702 0.626 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -165.23 83.46 0.36 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.609 ' HD2' ' HB3' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -104.11 -78.41 0.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.23 71.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.244 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -66.71 130.97 44.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.661 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.5 p80 . . . . . 0 C--O 1.243 0.722 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.168 177.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.451 0.167 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.78 70.01 1.86 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.145 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.6 -44.51 6.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.891 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -153.44 140.32 19.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.408 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 5.3 m-20 -82.49 121.74 27.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -98.28 -53.27 3.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.477 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 119' ' ' SER . 33.8 t-20 -99.02 -65.44 0.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 5' ' ' ASN . . . -53.15 129.14 30.2 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 12' ' ' ILE . 53.7 tp -66.73 129.59 94.07 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 122.322 0.249 . . . . 0.0 111.001 -171.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.637 ' HD2' HD12 ' A' ' 9' ' ' LEU . 1.3 Cg_endo -81.22 -159.98 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.68 2.92 . . . . 0.0 112.709 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' CB ' ' HB2' ' A' ' 103' ' ' SER . 7.6 p-10 -61.59 135.82 57.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.68 0.752 . . . . 0.0 110.019 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.72 HG22 ' CH2' ' A' ' 130' ' ' TRP . 5.4 mm -132.74 131.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.032 -167.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -131.68 145.82 51.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 1.127 ' HB2' ' HE3' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -137.95 150.87 47.42 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -127.04 138.02 53.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.853 0.835 . . . . 0.0 111.861 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.706 HG12 ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -150.79 147.74 15.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.194 173.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.706 ' N ' HG12 ' A' ' 16' ' ' ILE . 23.2 m -96.24 119.83 35.45 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.327 172.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 16' ' ' ILE . 20.5 mt -90.35 107.76 19.35 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.966 ' HG3' ' HE ' ' A' ' 139' ' ' ARG . 0.7 OUTLIER -74.03 88.03 1.88 Allowed 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 116.8 -1.96 . . . . 0.0 107.11 176.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 95' ' ' LYS . . . -155.32 168.64 11.73 Favored Pre-proline 0 C--O 1.22 -0.491 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.194 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 83.8 Cg_endo -80.49 151.54 19.88 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.07 1.18 . . . . 0.0 110.253 166.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.63 ' CG1' ' HB2' ' A' ' 71' ' ' PRO . 6.7 tt -54.76 -36.15 35.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.593 0.711 . . . . 0.0 111.078 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.731 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 1.1 pt20 -60.95 -32.1 71.64 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.638 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.8 mmtm -82.29 -35.54 27.92 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.343 -0.848 . . . . 0.0 110.83 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.719 HG22 HG11 ' A' ' 142' ' ' VAL . 3.0 t -67.39 -32.52 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 170.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.589 ' CE3' ' HG2' ' A' ' 71' ' ' PRO . 1.2 t-105 -54.64 -42.85 71.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.746 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.748 ' C ' HG21 ' A' ' 31' ' ' THR . 9.6 tp10 -65.96 -28.44 68.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.844 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 141' ' ' ALA . 5.0 m -100.06 -7.03 25.46 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -173.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.919 ' HA ' HG13 ' A' ' 35' ' ' ILE . 22.6 m -134.99 -61.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.951 -1.718 . . . . 0.0 113.596 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 74' ' ' LEU . 32.3 p -96.46 63.69 2.14 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 120.33 -1.482 . . . . 0.0 109.617 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.748 HG21 ' C ' ' A' ' 27' ' ' GLU . 2.8 t -157.91 -174.4 4.83 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.236 -165.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 3.5 p -61.09 173.24 0.85 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.307 1.043 . . . . 0.0 110.496 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.039 ' HG2' ' HA ' ' A' ' 43' ' ' ASP . 5.2 mt-10 -47.55 -6.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.599 1.559 . . . . 0.0 114.216 -166.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' SER . . . -57.24 -40.08 91.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.585 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.919 HG13 ' HA ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -70.01 -36.6 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.449 0.642 . . . . 0.0 111.139 171.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.87 ' HB1' ' HB3' ' A' ' 42' ' ' ASN . . . -52.78 -32.21 42.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.726 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.57 -166.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 170.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.755 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 22.2 p-90 41.8 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.314 0.578 . . . . 0.0 111.657 -167.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' HZ ' HD11 ' A' ' 100' ' ' LEU . 32.8 m-85 -151.44 -95.53 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.591 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.655 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 66.5 mtm -156.94 170.63 8.63 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 40' ' ' MET . 73.5 Cg_exo -42.31 115.55 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.19 2.594 . . . . 0.0 113.869 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.87 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 24.9 t-20 -156.71 162.14 39.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.039 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 30.0 t0 -136.95 41.1 2.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.385 1.088 . . . . 0.0 108.829 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 32' ' ' SER . 24.7 t80 -50.75 142.43 11.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.358 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -139.43 138.01 36.11 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 2.5 pt? -73.14 102.14 3.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 123.691 1.71 . . . . 0.0 109.099 -172.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 55.4 mttt -134.32 154.26 51.42 Favored 'General case' 0 C--O 1.194 -1.843 0 CA-C-N 111.593 -2.549 . . . . 0.0 107.364 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 68' ' ' VAL . 20.5 mt-10 -122.45 125.67 46.32 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 119.281 0.946 . . . . 0.0 111.967 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.77 81.93 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.799 ' O ' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.45 159.54 15.84 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 63' ' ' CYS . 25.2 mp0 -114.2 126.39 55.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.482 -1.287 . . . . 0.0 108.777 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -133.42 139.03 46.5 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -133.45 148.01 51.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.281 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -50.75 -70.11 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.184 0.516 . . . . 0.0 110.865 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -149.27 -49.4 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.25 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 m -77.87 115.54 51.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.38 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -84.26 62.01 6.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.764 2.309 . . . . 0.0 111.64 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -51.68 -42.68 62.34 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.863 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.05 137.07 13.76 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.67 -46.22 35.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.719 2.279 . . . . 0.0 111.711 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.9 m -113.31 105.92 54.93 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.748 ' HD2' ' HB3' ' A' ' 51' ' ' GLU . 57.8 Cg_endo -73.61 -94.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.144 1.896 . . . . 0.0 113.629 -173.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.777 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 2.0 m -130.64 163.78 26.42 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.571 -172.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 0.7 OUTLIER -148.98 134.0 18.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.566 0.621 . . . . 0.0 109.718 -175.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 76' ' ' PHE . 71.4 t -74.52 127.92 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.228 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.476 HD23 ' HG3' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -68.11 -49.45 61.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.246 177.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.21 146.19 15.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.783 HG23 HD13 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -136.48 122.11 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.43 1.11 . . . . 0.0 110.473 173.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 11.7 mm100 -131.48 137.5 48.59 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.266 -172.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' CZ2' ' A' ' 26' ' ' TRP . . . -63.81 123.99 83.46 Favored Pre-proline 0 CA--C 1.501 -0.919 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -166.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.907 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -2.56 65.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.34 1 C-N-CA 126.487 4.791 . . . . 0.0 115.248 -160.146 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 p -135.42 -46.85 0.69 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.713 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 28.4 tt0 -146.35 130.68 17.6 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.783 HD13 HG23 ' A' ' 68' ' ' VAL . 1.9 tp -130.74 127.66 39.23 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.6 t -137.55 127.53 25.79 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.951 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CB ' HG22 ' A' ' 65' ' ' VAL . 13.8 p90 -148.98 144.2 26.62 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.969 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.043 ' HG2' HG23 ' A' ' 84' ' ' VAL . 47.9 mt-10 -126.43 151.15 48.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.135 0.969 . . . . 0.0 112.651 -168.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.705 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 2.7 t90 -118.72 139.19 51.94 Favored 'General case' 0 C--O 1.19 -2.075 0 CA-C-N 113.266 -1.788 . . . . 0.0 107.902 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER 32.68 -99.12 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 168.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.719 ' HA ' ' HB3' ' A' ' 105' ' ' TRP . 5.6 t -159.17 97.05 1.35 Allowed 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.044 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 43.9 mt-10 -145.16 -172.4 3.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 125.149 1.379 . . . . 0.0 110.568 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.698 ' CA ' HG22 ' A' ' 112' ' ' ILE . . . -94.65 -6.73 60.68 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.524 156.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.866 ' HE1' ' HD3' ' A' ' 106' ' ' LYS 0.277 0.4 OUTLIER -101.63 136.68 41.06 Favored 'General case' 0 C--N 1.379 1.848 0 CA-C-N 120.927 2.364 . . . . 0.0 114.362 173.816 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.103 HG12 ' H ' ' A' ' 103' ' ' SER . 6.7 p -95.29 -178.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 159.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' NE2' ' A' ' 102' ' ' HIS . 33.3 m -121.81 99.22 6.75 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.052 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 160.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.854 HG22 HD13 ' A' ' 101' ' ' ILE . 29.3 m -117.53 129.2 55.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.96 -175.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.597 ' HD2' HD23 ' A' ' 74' ' ' LEU . 44.9 m-85 -118.66 128.32 54.41 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.806 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -117.0 125.59 51.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.818 0.818 . . . . 0.0 109.801 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.907 HD13 ' HB3' ' A' ' 71' ' ' PRO . 3.4 mt -124.04 144.18 49.99 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.05 -169.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 121.09 44.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.586 ' O ' HD23 ' A' ' 92' ' ' LEU . 9.9 t0 -80.88 110.3 16.27 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.2 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.839 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 45.6 mt -125.02 139.36 53.88 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 165.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.03 61.3 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 161.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.839 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 5.0 tp10 -56.65 -157.91 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 111.319 -2.441 . . . . 0.0 109.423 153.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.869 ' HB2' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -99.57 -179.44 4.2 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -173.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -108.57 127.97 54.42 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 -162.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.1 115.68 5.17 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 118.466 -1.826 . . . . 0.0 110.665 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.418 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 19.8 t80 -106.39 130.7 54.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.18 0.991 . . . . 0.0 113.223 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.3 m -124.28 122.11 36.84 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.769 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD13 HG21 ' A' ' 134' ' ' VAL . 5.9 tt -104.67 136.55 43.99 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 119.496 -0.881 . . . . 0.0 111.114 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.854 HD13 HG22 ' A' ' 86' ' ' THR . 2.4 mp -118.11 127.25 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.346 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.746 ' HB3' ' HB2' ' A' ' 83' ' ' TRP . 13.4 m170 -115.29 104.74 12.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 160.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 1.103 ' H ' HG12 ' A' ' 84' ' ' VAL . 3.3 t -148.05 120.41 8.43 Favored 'General case' 0 C--O 1.206 -1.228 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.984 ' HA3' ' N ' ' A' ' 84' ' ' VAL . . . 177.43 -166.49 36.99 Favored Glycine 0 C--N 1.28 -2.574 0 C-N-CA 116.606 -2.711 . . . . 0.0 118.894 -149.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.911 ' HA ' ' H ' ' A' ' 81' ' ' GLU . 64.7 m95 -127.92 156.99 41.75 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 112.324 -1.938 . . . . 0.0 111.188 164.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.866 ' HD3' ' HE1' ' A' ' 83' ' ' TRP . 37.4 tttm 179.45 147.26 0.22 Allowed 'General case' 0 N--CA 1.513 2.675 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 166.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 13.0 mt-10 50.39 -173.18 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 168.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 114' ' ' LYS . 68.5 Cg_endo -116.66 132.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.079 0 C-N-CA 125.036 3.824 . . . . 0.0 117.178 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 14.7 t-20 160.02 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.671 0 C-N-CA 125.641 1.576 . . . . 0.0 109.26 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -99.99 112.2 24.49 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 123.625 1.679 . . . . 0.0 110.937 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.037 HG22 ' H ' ' A' ' 112' ' ' ILE . 11.0 p -165.34 -156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.98 -165.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.037 ' H ' HG22 ' A' ' 111' ' ' VAL 0.253 1.4 mt -42.13 -45.39 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.24 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 1.044 ' HA3' ' HA ' ' A' ' 81' ' ' GLU . . . -146.92 -69.94 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 167.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 1.022 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 56.5 mttp -151.66 38.24 0.6 Allowed 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.892 0.853 . . . . 0.0 109.98 173.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.718 ' H ' ' CG1' ' A' ' 111' ' ' VAL . . . -54.02 -41.34 67.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.533 1.533 . . . . 0.0 114.628 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 115' ' ' ALA . 62.6 t30 137.62 -35.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.486 1.116 . . . . 0.0 108.098 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.683 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 5.1 mm-40 -87.97 -169.12 2.45 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.962 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' HG13 ' A' ' 121' ' ' VAL . 73.2 mmtt -91.28 151.81 20.74 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.446 168.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.652 ' N ' ' HA ' ' A' ' 111' ' ' VAL . 5.0 p -57.38 -42.51 82.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.016 0.436 . . . . 0.0 111.347 176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.5 t -67.99 -43.61 78.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.906 0.384 . . . . 0.0 111.13 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 118' ' ' LYS . 5.6 m -72.5 -36.56 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.229 0.538 . . . . 0.0 109.61 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.749 ' HA ' ' HG3' ' A' ' 125' ' ' LYS . 9.8 p -66.52 -36.63 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.066 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.551 ' HA ' HD22 ' A' ' 9' ' ' LEU . 42.3 ttp180 -62.31 -35.41 78.97 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.19 -31.61 69.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.461 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.749 ' HG3' ' HA ' ' A' ' 122' ' ' VAL . 36.7 mtpt -62.9 -43.89 97.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 121.614 0.721 . . . . 0.0 110.599 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 6.9 mmt -81.97 -27.83 33.0 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.84 -177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.93 -16.06 58.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.882 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.61 -36.13 0.11 Allowed Glycine 0 C--O 1.243 0.695 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.397 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.662 ' O ' HG12 ' A' ' 133' ' ' ILE . . . -69.03 -22.82 76.08 Favored Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.987 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 1.127 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 4.0 m0 -68.04 -33.22 74.18 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 117.922 0.861 . . . . 0.0 112.635 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.795 ' O ' ' HB3' ' A' ' 135' ' ' ASN . 6.6 p -74.94 -33.15 61.92 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.81 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.809 ' O ' ' HB3' ' A' ' 136' ' ' GLU . . . -57.67 -68.28 1.78 Allowed Glycine 0 C--N 1.312 -0.782 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.13 168.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 129' ' ' GLY . 15.9 pt -71.0 -50.26 43.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 121.513 -0.992 . . . . 0.0 112.184 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 5.7 t -81.1 -42.99 20.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 O-C-N 121.64 -0.662 . . . . 0.0 112.047 -176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.795 ' HB3' ' O ' ' A' ' 131' ' ' THR . 20.0 t-20 -75.56 -42.99 50.85 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 117.482 -1.687 . . . . 0.0 108.152 -174.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.91 ' HG3' ' HE2' ' A' ' 140' ' ' LYS . 11.3 tp10 -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.579 -169.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.072 ' HA ' ' HB2' ' A' ' 140' ' ' LYS . 16.0 tpp180 -83.71 -31.97 25.77 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.782 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 26.4 tp -66.53 -39.64 88.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 117.854 -1.538 . . . . 0.0 107.288 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.966 ' HE ' ' HG3' ' A' ' 19' ' ' GLU . 2.6 tmt_? -63.55 -32.79 74.36 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.302 169.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.072 ' HB2' ' HA ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -68.58 -45.16 72.75 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.567 ' HB3' HG21 ' A' ' 28' ' ' THR . . . -73.56 -28.75 62.02 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 110.141 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.719 HG11 HG22 ' A' ' 25' ' ' VAL . 25.5 m -86.73 -19.73 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 139' ' ' ARG . 19.6 mm-40 -143.7 -64.8 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.288 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.561 ' H ' ' HA ' ' A' ' 140' ' ' LYS . 71.5 tt0 43.88 -106.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.028 -165.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 22.0 tp 50.65 21.86 0.98 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -84.88 -62.2 1.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.845 -0.534 . . . . 0.0 110.02 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.54 120.7 24.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -121.12 -23.97 5.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 169.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' A' ' 150' ' ' HIS . 19.2 t-80 -66.37 129.79 41.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.658 172.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 10.8 t-80 75.54 -55.09 0.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.765 0.666 . . . . 0.0 111.111 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -160.59 148.45 16.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.8 p80 . . . . . 0 C--O 1.244 0.77 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.563 174.238 . . . . . . . . 0 0 . 1 stop_ save_